| S.no |
Heading Name |
Date |
Edit |
Delete |
| 1 |
10. Regulation of Translation by Amino Acid Deprivation and mTOR |
2024-07-05 |
|
|
| 2 |
9. Ribosome Biogenesis and Translation Regulation Mechanisms |
2024-07-05 |
|
|
| 3 |
8. Translation Regulation by mTOR through 4EBP and S6K1 |
2024-07-05 |
|
|
| 4 |
7. Developing Concepts in Translational Regulation |
2024-07-05 |
|
|
| 5 |
6. Translation Elongation Regulation and Signaling Pathways |
2024-07-05 |
|
|
| 6 |
5. Translational Regulation of Selective mRNAs during Stress |
2024-07-05 |
|
|
| 7 |
4. mRNA Translation Regulation by Chaperones |
2024-07-05 |
|
|
| 8 |
3. tRNAs Fine-Tune Translation Under Stress |
2024-07-05 |
|
|
| 9 |
2. Translational Reprogramming Under Stress |
2024-07-05 |
|
|
| 10 |
1. Overview of the Eukaryotic Translation Process |
2024-07-05 |
|
|
| 11 |
Data used and methodology |
2024-06-24 |
|
|
| 12 |
Quality Assessment |
2024-06-14 |
|
|
| 13 |
Data Extra-Action and Management |
2024-06-14 |
|
|
| 14 |
Search Methods for Identification Of Studies |
2024-06-14 |
|
|
| 15 |
Material Flow Resource Optimization |
2024-06-13 |
|
|
| 16 |
Optimization Approaches |
2024-06-13 |
|
|
| 17 |
Institutional Ethics Committee |
2024-05-29 |
|
|
| 18 |
A Curative Measure to Non-Adherence and Non-Compliance to PPE |
2024-05-27 |
|
|
| 19 |
Specific Types of PPE Used, Their Effectiveness, and any Challenges Associated with their Availability or Quality in Cameroon's Healthcare |
2024-05-27 |
|
|
| 20 |
Reasons for the Non-Adherence and Non-Compliance |
2024-05-27 |
|
|
| 21 |
Epidemiology of Diseases (Nosocomial Infections) |
2024-05-27 |
|
|
| 22 |
What is Occupational Safety and Health? |
2024-05-27 |
|
|
| 23 |
Occupational Safety and Health Administration |
2024-05-27 |
|
|
| 24 |
Techniques and Technologies |
2024-05-21 |
|
|
| 25 |
Impacts on Individuals and Society |
2024-05-21 |
|
|
| 26 |
Technological Innovations |
2024-05-21 |
|
|
| 27 |
key |
2024-05-17 |
|
|
| 28 |
Research Question and Hypothesis |
2024-04-18 |
|
|
| 29 |
Development Of Live Biotherapeutic Products (LBPS) |
2024-04-11 |
|
|
| 30 |
Microbiome-Based Treatments For CDI And rCDI |
2024-04-11 |
|
|
| 31 |
Dysbiosis And The Cycle Of Recurrent Clostridiodes Difficile |
2024-04-11 |
|
|
| 32 |
Dysbiosis And The Cycle Of Recurrent Clostridiodes Dificler |
2024-04-11 |
|
|
| 33 |
Data Access |
2024-04-10 |
|
|
| 34 |
Fellowship |
2024-04-02 |
|
|
| 35 |
Data Availability And Sharing |
2024-03-22 |
|
|
| 36 |
Authors' Details |
2024-03-18 |
|
|
| 37 |
Authorsâ?? Details |
2024-03-18 |
|
|
| 38 |
Disclosure of potential conflicts of interest |
2024-03-18 |
|
|
| 39 |
Stengths of The Study |
2024-03-12 |
|
|
| 40 |
Limitations Of The Systematic Review |
2024-03-12 |
|
|
| 41 |
Emerging Issues |
2024-03-12 |
|
|
| 42 |
Stricta Gaps |
2024-03-12 |
|
|
| 43 |
East X West/Tradition X Modernity |
2024-03-12 |
|
|
| 44 |
Competing Interests Disclosure |
2024-02-26 |
|
|
| 45 |
Publishing Policies |
2024-02-22 |
|
|
| 46 |
Acquisition of Authorization and Data Processing |
2024-02-22 |
|
|
| 47 |
IH Caused Downregulation of mir-181a1, Resulting in Increased Esm1 and Icam-1 in Vascular Endothelial Cells |
2024-02-21 |
|
|
| 48 |
Increased Esm1 Caused Icam-1 Increase |
2024-02-21 |
|
|
| 49 |
Increased Expression of Icam-1 and Esm1 by IH in Vascular Endothelial Cells |
2024-02-21 |
|
|
| 50 |
Intermittent Hypoxia in SAS |
2024-02-21 |
|
|
| 51 |
Political Discourse, Smart Generation, and Modeled Behavior |
2024-02-17 |
|
|
| 52 |
Identify Courses Where Career/Vocational Identity Happens |
2024-02-17 |
|
|
| 53 |
Improving Program Outcomes |
2024-02-17 |
|
|
| 54 |
Summary Of Author Contributions |
2024-02-13 |
|
|
| 55 |
Impact Statement |
2024-02-12 |
|
|
| 56 |
Question and Answer |
2024-02-12 |
|
|
| 57 |
Ethics And Declarations |
2024-01-31 |
|
|
| 58 |
Conclusión |
2024-01-22 |
|
|
| 59 |
Statement of Competing Interests |
2024-01-17 |
|
|
| 60 |
Ethical Approval and Informed Consent Statements |
2024-01-17 |
|
|
| 61 |
Ethical Approval and Informed Consent Statements |
2024-01-17 |
|
|
| 62 |
Funding Research Na |
2024-01-09 |
|
|
| 63 |
Introduction(HPV) |
2024-01-05 |
|
|
| 64 |
4555959659 |
2024-01-02 |
|
|
| 65 |
4565 |
2024-01-02 |
|
|
| 66 |
rgmwpegr |
2024-01-02 |
|
|
| 67 |
Declaration Of Generative AI In Scientific Writing |
2023-12-23 |
|
|
| 68 |
Innovative Membrane Materials and Designs |
2023-12-15 |
|
|
| 69 |
Membrane-Based Processes in Water Treatment |
2023-12-15 |
|
|
| 70 |
Understanding Political Economy across Nations |
2023-12-14 |
|
|
| 71 |
Economic System |
2023-12-14 |
|
|
| 72 |
Collectivism and Individualism |
2023-12-14 |
|
|
| 73 |
Political System |
2023-12-14 |
|
|
| 74 |
Treatment Approach |
2023-12-14 |
|
|
| 75 |
Diagnosis of AD |
2023-12-14 |
|
|
| 76 |
Institutional Review Statement |
2023-12-13 |
|
|
| 77 |
Financial Interests |
2023-12-13 |
|
|
| 78 |
Genetic variation and diversity are fundamental aspects of life on Earth. These concepts form the very essence of evolution, allowing species to adapt and thrive in a constantl |
2023-12-13 |
|
|
| 79 |
Funding Agency |
2023-12-05 |
|
|
| 80 |
Competing Financial Interests |
2023-12-01 |
|
|
| 81 |
Declaration of Financial/Other Relationships |
2023-11-23 |
|
|
| 82 |
Therapeutic Applications Of Herbal Medicines |
2023-11-20 |
|
|
| 83 |
Statement of Consent |
2023-11-14 |
|
|
| 84 |
Research Delimitations |
2023-11-02 |
|
|
| 85 |
The Concept of Evolutionary Mismatch |
2023-11-01 |
|
|
| 86 |
Evolution of Human Language and Obstetric Care |
2023-11-01 |
|
|
| 87 |
Labor across Humans and Non-Human Primates |
2023-11-01 |
|
|
| 88 |
Analysis of Clinical Studies considering the Evolutionary Framework |
2023-11-01 |
|
|
| 89 |
IRB Protocol Approval |
2023-10-28 |
|
|
| 90 |
Future Study and Limitations |
2023-10-28 |
|
|
| 91 |
Ethical and Administrative Considerations |
2023-10-26 |
|
|
| 92 |
Accession Code |
2023-10-23 |
|
|
| 93 |
Author Statement |
2023-10-20 |
|
|
| 94 |
Methods And Objectives |
2023-10-18 |
|
|
| 95 |
Research Recommendation |
2023-10-16 |
|
|
| 96 |
Financial Support/Funding |
2023-10-16 |
|
|
| 97 |
Questionnaires |
2023-10-16 |
|
|
| 98 |
Author Credit Statement |
2023-10-12 |
|
|
| 99 |
Author Credit Statetment |
2023-10-12 |
|
|
| 100 |
Running Head |
2023-10-12 |
|
|
| 101 |
What is the Central Finding |
2023-10-12 |
|
|
| 102 |
What is New Aspect of the Work |
2023-10-12 |
|
|
| 103 |
Strategies To Mitigate Risks And Challenges In The Medical Devices Supply Chain |
2023-10-12 |
|
|
| 104 |
Economic Implications Of Global Supply Chain On Medical Devices |
2023-10-12 |
|
|
| 105 |
Geographic Distribution Of The Medical Device Supply Chain |
2023-10-12 |
|
|
| 106 |
False Lumen Expansion (FLE): Residual Problem in Type A and Type B AADs |
2023-10-11 |
|
|
| 107 |
Significant change for the first time in 50 Years |
2023-10-11 |
|
|
| 108 |
Treatment of AAD in the 20th Century |
2023-10-11 |
|
|
| 109 |
Other Transporters: BSEP, OCT1, MRP2, and OATP2B1 |
2023-10-09 |
|
|
| 110 |
Endogenous Biomarkers for Transporter Function |
2023-10-09 |
|
|
| 111 |
Declaration of Interest Statement |
2023-10-07 |
|
|
| 112 |
Research Involving Human Participants |
2023-10-04 |
|
|
| 113 |
Funds |
2023-09-27 |
|
|
| 114 |
Conflict of Interest Disclosures and Other Ethics Statements |
2023-09-26 |
|
|
| 115 |
Acknowledgement and Funding |
2023-09-20 |
|
|
| 116 |
Author contribution statement |
2023-09-15 |
|
|
| 117 |
Availability and Data Materials |
2023-09-14 |
|
|
| 118 |
Areas for Further Research |
2023-09-13 |
|
|
| 119 |
Types of Knee Surgery |
2023-09-12 |
|
|
| 120 |
Key Benefits of Robotic Surgery |
2023-09-12 |
|
|
| 121 |
Challenges and Limitations |
2023-09-06 |
|
|
| 122 |
Therapeutic Vaccines |
2023-09-06 |
|
|
| 123 |
Prophylactic Vaccines |
2023-09-06 |
|
|
| 124 |
Summary of relevance |
2023-09-05 |
|
|
| 125 |
Limitations and Data Availability Statement |
2023-09-02 |
|
|
| 126 |
Ethic Statement |
2023-09-01 |
|
|
| 127 |
Appendices |
2023-09-01 |
|
|
| 128 |
Conclusón |
2023-08-25 |
|
|
| 129 |
Financiacion |
2023-08-24 |
|
|
| 130 |
Metodologa |
2023-08-24 |
|
|
| 131 |
Genetic Defects Can Lead to Positive Body Size Growth |
2023-08-22 |
|
|
| 132 |
A New Definition of Genetics |
2023-08-22 |
|
|
| 133 |
Mutual Equilibrium of the Actual Functional Requirements of Different Cell Types |
2023-08-22 |
|
|
| 134 |
Equilibrium between the Driving Force of Unstable State Cells and Senescence or Apoptosis |
2023-08-22 |
|
|
| 135 |
Contribution |
2023-08-16 |
|
|
| 136 |
Immobilization of Whole-Cell Biosensors |
2023-08-09 |
|
|
| 137 |
Construction of Biosensing Strains |
2023-08-09 |
|
|
| 138 |
Data Statement |
2023-08-07 |
|
|
| 139 |
New Evidence for Clinical Association Between Allergy and Pterygium |
2023-07-27 |
|
|
| 140 |
Pterygium and Allergy |
2023-07-27 |
|
|
| 141 |
Patient's Perspective |
2023-07-20 |
|
|
| 142 |
Patient’S Perspective |
2023-07-20 |
|
|
| 143 |
Consent Statement |
2023-07-14 |
|
|
| 144 |
Implicaions for Nursing Pracice |
2023-07-11 |
|
|
| 145 |
Off Label use Discussion |
2023-07-07 |
|
|
| 146 |
Future Materials and Technologies |
2023-07-07 |
|
|
| 147 |
1980S-2000S Materials and Technologies |
2023-07-07 |
|
|
| 148 |
1960S-1970S Materials and Technologies |
2023-07-07 |
|
|
| 149 |
Funding Statements |
2023-07-06 |
|
|
| 150 |
Abbreviation |
2023-07-03 |
|
|
| 151 |
Dentine Hypersensitivity |
2023-07-01 |
|
|
| 152 |
Mechanism of Action of Silver Diamine Fluoride |
2023-07-01 |
|
|
| 153 |
The State’s Obligations |
2023-07-01 |
|
|
| 154 |
The States Obligations |
2023-07-01 |
|
|
| 155 |
The Stateâ??s Obligations |
2023-07-01 |
|
|
| 156 |
Domestic Laws Related to Health and Environment in India |
2023-07-01 |
|
|
| 157 |
Effect of Unhealthy Environment on Health in India |
2023-07-01 |
|
|
| 158 |
Situation in India |
2023-07-01 |
|
|
| 159 |
The Status in India Concerning Health and Environment |
2023-07-01 |
|
|
| 160 |
The Right to Health and The Right to a Healthy Environment |
2023-07-01 |
|
|
| 161 |
Financial and Non-financial Interest |
2023-07-01 |
|
|
| 162 |
Further Scope |
2023-07-01 |
|
|
| 163 |
Acknowledgements and Declaration |
2023-06-28 |
|
|
| 164 |
Consent to Participate and/or Consent to Publish |
2023-06-28 |
|
|
| 165 |
Compliance with Ethical Standards and Ethical Approval |
2023-06-28 |
|
|
| 166 |
Sponsorship or Financial Support |
2023-06-22 |
|
|
| 167 |
Knowledge of Prekese Bread Preference |
2023-06-21 |
|
|
| 168 |
Sensory Evaluation and Acceptability of Prekese Flour Products |
2023-06-21 |
|
|
| 169 |
Analytical Measurements |
2023-06-21 |
|
|
| 170 |
Sensory Composition of Prekese Bread |
2023-06-21 |
|
|
| 171 |
ETHICS AND REGISTRATION |
2023-06-21 |
|
|
| 172 |
Un-Blinded Ethics Statement |
2023-06-19 |
|
|
| 173 |
Informed Consent Statements |
2023-06-16 |
|
|
| 174 |
Additional Information |
2023-06-13 |
|
|
| 175 |
Carbon stored in soils |
2023-06-08 |
|
|
| 176 |
Patient Permission/Consent Statement |
2023-06-08 |
|
|
| 177 |
Merits and Demerits of the NOC Method |
2023-06-05 |
|
|
| 178 |
Growth of Defect-Free Ingot by NOC Method |
2023-06-05 |
|
|
| 179 |
Growth of Defect-Free Ingot by CZ (CZOCHRALSKI) Method |
2023-06-05 |
|
|
| 180 |
CHARACTERISATION |
2023-06-03 |
|
|
| 181 |
Declaration of Interests Statement |
2023-06-01 |
|
|
| 182 |
Evaluation of ACRO hCG Pregnancy Rapid Test Dipstick (Urine) |
2023-06-01 |
|
|
| 183 |
Conflicts of Interest and Source of Funding Statement |
2023-06-01 |
|
|
| 184 |
MATERIALS |
2023-05-31 |
|
|
| 185 |
DISCUSSION |
2023-05-31 |
|
|
| 186 |
Ethical Compliance |
2023-05-29 |
|
|
| 187 |
Aims |
2023-05-25 |
|
|
| 188 |
Teaching and Learning Methods Of Professionalism |
2023-05-25 |
|
|
| 189 |
Nursing Professionalism |
2023-05-25 |
|
|
| 190 |
Docs Burn Out: Really? |
2023-05-25 |
|
|
| 191 |
Pharmaceutical Payments May Influence Clinical Decision Making? |
2023-05-25 |
|
|
| 192 |
Hyposkillia: Deficiency of Clinical Skill |
2023-05-25 |
|
|
| 193 |
Study Approval |
2023-05-23 |
|
|
| 194 |
Duality of Interest |
2023-05-23 |
|
|
| 195 |
Funding and/or Conflicts of Interests/Competing Interests |
2023-05-23 |
|
|
| 196 |
Competing Interests and Funding |
2023-05-18 |
|
|
| 197 |
Ethical Concerns |
2023-05-17 |
|
|
| 198 |
Data sources and methodology |
2023-05-12 |
|
|
| 199 |
Orcid Details |
2023-05-12 |
|
|
| 200 |
Challenges and Future Directions |
2023-05-09 |
|
|
| 201 |
Applications of Swarm Robotics |
2023-05-09 |
|
|
| 202 |
Disclosure and Conflict of Interest |
2023-05-04 |
|
|
| 203 |
Contribution of this Study |
2023-04-29 |
|
|
| 204 |
Role of Nurses |
2023-04-29 |
|
|
| 205 |
Mechanism of Spontaneous Cancers in the Daily Life |
2023-04-29 |
|
|
| 206 |
Mechanism of Solid Cancers Induced by Radiation |
2023-04-29 |
|
|
| 207 |
Recommendations Considering Immunization Agenda 2030 |
2023-04-28 |
|
|
| 208 |
Diagnosis of Chronic Gastritis |
2023-04-25 |
|
|
| 209 |
Symptoms of Pancreas Tissue |
2023-04-25 |
|
|
| 210 |
Onsent for Publication |
2023-04-24 |
|
|
| 211 |
Macrófago universal considera TNF |
2023-04-19 |
|
|
| 212 |
Las citoquinas proinflamatorias actúan para construir |
2023-04-19 |
|
|
| 213 |
HCC incorpora orientación masculina, antecedentes familiares |
2023-04-19 |
|
|
| 214 |
Los transportadores de HBV deben ser guiados |
2023-04-19 |
|
|
| 215 |
Anti-HBc podría ser un signo de enfermedad por VHB en curso |
2023-04-19 |
|
|
| 216 |
La galactosa puede tener un mayor impacto |
2023-04-19 |
|
|
| 217 |
La galactosa puede afectar la salud cognitiva |
2023-04-19 |
|
|
| 218 |
La galactosa es un azúcar simple que se encuentra naturalmente |
2023-04-19 |
|
|
| 219 |
Tratamiento de la disfagia orofaríngea |
2023-04-19 |
|
|
| 220 |
Síntomas de la disfagia orofaríngea |
2023-04-19 |
|
|
| 221 |
Trastorno de la deglución que afecta a los músculos |
2023-04-19 |
|
|
| 222 |
Proveedores de atención médica involucrados en riñón |
2023-04-19 |
|
|
| 223 |
Los proveedores de atención médica juegan un papel fundamental |
2023-04-19 |
|
|
| 224 |
El trasplante de riñón generalmente se considera un método seguro |
2023-04-19 |
|
|
| 225 |
La obesidad aumenta el riesgo |
2023-04-19 |
|
|
| 226 |
Actividad física regular |
2023-04-19 |
|
|
| 227 |
Formas más efectivas de reducir el riesgo |
2023-04-19 |
|
|
| 228 |
Case Studies |
2023-04-14 |
|
|
| 229 |
Ethics and Consent Statement |
2023-04-12 |
|
|
| 230 |
Availability of Data and Supporting Materials Section |
2023-04-12 |
|
|
| 231 |
How This Fits In With Quality In Primary Care |
2023-04-12 |
|
|
| 232 |
Limitations and Future Prospects |
2023-04-11 |
|
|
| 233 |
Code/Data Availability |
2023-04-07 |
|
|
| 234 |
Declarations and Ethics Statements |
2023-04-07 |
|
|
| 235 |
Fisiopatología de las diferentes vías |
2023-04-06 |
|
|
| 236 |
Instrumentos de la reacción invulnerable |
2023-04-06 |
|
|
| 237 |
Analizar el colapso cardiovascular |
2023-04-06 |
|
|
| 238 |
El colapso cardiovascular es heterogéneo |
2023-04-06 |
|
|
| 239 |
Esquema contemporáneo del estudio de la transmisión de enfermedades |
2023-04-06 |
|
|
| 240 |
Activa el paso de células necróticas |
2023-04-06 |
|
|
| 241 |
Llama la atención que, independientemente del efecto significativo |
2023-04-06 |
|
|
| 242 |
Fundamentalmente única en relación con la apoptosis |
2023-04-06 |
|
|
| 243 |
Gasto de atención incorporar gasto |
2023-04-06 |
|
|
| 244 |
La satisfacción está más debilitada en CHF |
2023-04-06 |
|
|
| 245 |
Transmisión de enfermedades de CHF |
2023-04-06 |
|
|
| 246 |
Treating Pancreas Gallstones |
2023-04-06 |
|
|
| 247 |
Differential Expression Analysis |
2023-04-05 |
|
|
| 248 |
Functional Classification by KEGG |
2023-04-05 |
|
|
| 249 |
Gene Ontology Classification |
2023-04-05 |
|
|
| 250 |
CDD and COG Classification |
2023-04-05 |
|
|
| 251 |
Functional Annotation of Assembled Unigenes |
2023-04-05 |
|
|
| 252 |
Sequencing and Sequence Analysis |
2023-04-05 |
|
|
| 253 |
Flagellar Regeneration |
2023-04-05 |
|
|
| 254 |
MATERIAL AND METHODS |
2023-04-05 |
|
|
| 255 |
Differential Gene Expression Analysis |
2023-04-05 |
|
|
| 256 |
De Novo and Annotation |
2023-04-05 |
|
|
| 257 |
Illumina Sequencing |
2023-04-05 |
|
|
| 258 |
Algal Strain, Culture Condition and Cells Treatment |
2023-04-05 |
|
|
| 259 |
Future Prospective |
2023-04-04 |
|
|
| 260 |
Vaccine Azee Discovered and Mechanisms of Action 1 of 2 |
2023-03-27 |
|
|
| 261 |
Zelalem Kiros Bitsue and his Immunologic Discoveries |
2023-03-27 |
|
|
| 262 |
Zelalem Kiros Bitsue and his Vaccine Discoveries |
2023-03-27 |
|
|
| 263 |
The Discovery Process: Innovation and Immunology |
2023-03-27 |
|
|
| 264 |
Immunologic Clearance and Immune Mechanisms |
2023-03-27 |
|
|
| 265 |
The Pandemics and Immune Cells |
2023-03-27 |
|
|
| 266 |
Chimera Virus (SARS-COV-2) |
2023-03-27 |
|
|
| 267 |
Implications for Health Promotion |
2023-03-27 |
|
|
| 268 |
Methods Basically Used |
2023-03-23 |
|
|
| 269 |
Operative Technique |
2023-03-23 |
|
|
| 270 |
Formulation And Methods |
2023-03-23 |
|
|
| 271 |
Study of Intervention |
2023-03-21 |
|
|
| 272 |
Observation and Modeling |
2023-03-21 |
|
|
| 273 |
Description |
2023-03-21 |
|
|
| 274 |
Discussion On Findings |
2023-03-20 |
|
|
| 275 |
Ethical Approval Statement |
2023-03-17 |
|
|
| 276 |
Waste Reduction and Disposal |
2023-03-15 |
|
|
| 277 |
Limitations and Conclusions |
2023-03-10 |
|
|
| 278 |
Postscript |
2023-03-10 |
|
|
| 279 |
Appendix |
2023-03-09 |
|
|
| 280 |
Declarations Competing Interests |
2023-03-06 |
|
|
| 281 |
Funding Received |
2023-03-06 |
|
|
| 282 |
Practical Implications and Conclusion |
2023-03-06 |
|
|
| 283 |
Methods and Measures |
2023-03-06 |
|
|
| 284 |
Limitation of the Investigation |
2023-03-03 |
|
|
| 285 |
Guidelines for a Nutritious Diet for Acute Pancreatitis |
2023-03-02 |
|
|
| 286 |
Guidelines fo a Nutritious Diet for Acute Pancreatitis |
2023-03-02 |
|
|
| 287 |
Benefits of a Nutritious Diet for Acute Pancreatitis |
2023-03-02 |
|
|
| 288 |
Genetics and Certain Medical Conditions |
2023-03-02 |
|
|
| 289 |
Sophisticated Models are Frequency |
2023-03-02 |
|
|
| 290 |
Survey Among Gastrointestinal Problem |
2023-03-02 |
|
|
| 291 |
Conclussion |
2023-02-28 |
|
|
| 292 |
Methodology and Experiments |
2023-02-27 |
|
|
| 293 |
Summary Statement |
2023-02-27 |
|
|
| 294 |
Potential Conflict of Interest |
2023-02-25 |
|
|
| 295 |
Conflict of the Interest |
2023-02-25 |
|
|
| 296 |
Analysis of Paralogs and Homologs of OCP and their Components |
2023-02-25 |
|
|
| 297 |
Echinenone Studies |
2023-02-25 |
|
|
| 298 |
Preface of the Book |
2023-02-25 |
|
|
| 299 |
The Formation Of Micro-Plastics In The Ocean |
2023-02-24 |
|
|
| 300 |
Categories of Mircro-Plastics |
2023-02-24 |
|
|
| 301 |
CTRI Registration |
2023-02-23 |
|
|
| 302 |
Estrategias Metodológicas |
2023-02-23 |
|
|
| 303 |
Resultados Y Discusión |
2023-02-23 |
|
|
| 304 |
Resultados Y Discusión |
2023-02-23 |
|
|
| 305 |
Basic Components |
2023-02-23 |
|
|
| 306 |
Types of Capsules |
2023-02-23 |
|
|
| 307 |
Function of Lipids |
2023-02-22 |
|
|
| 308 |
Compliance with ethical standards |
2023-02-21 |
|
|
| 309 |
Compliance with ethical standards |
2023-02-21 |
|
|
| 310 |
Funding and Disclosures |
2023-02-15 |
|
|
| 311 |
Risk Elements of Alzheime's Disease |
2023-02-15 |
|
|
| 312 |
Different Types of TMS |
2023-02-15 |
|
|
| 313 |
Ethics and Dissemination |
2023-02-13 |
|
|
| 314 |
Ethics Approval and Participant’s Consent |
2023-02-13 |
|
|
| 315 |
Supplementary Information |
2023-02-13 |
|
|
| 316 |
Reference |
2023-02-13 |
|
|
| 317 |
Summary Table |
2023-02-13 |
|
|
| 318 |
Ethics Approval and Participant’s Consent |
2023-02-09 |
|
|
| 319 |
Types of Thrombosis |
2023-02-07 |
|
|
| 320 |
Symptoms of Atherosclerosis |
2023-02-07 |
|
|
| 321 |
Complications of Atherosclerosis |
2023-02-07 |
|
|
| 322 |
Diversity Arrays Technology |
2023-02-06 |
|
|
| 323 |
Randomly Amplified Polymorphic DNA Markers |
2023-02-06 |
|
|
| 324 |
Inter Simple Sequence Repeats |
2023-02-06 |
|
|
| 325 |
Simple Sequence Repeats |
2023-02-06 |
|
|
| 326 |
Molecular Markers in Groundnut |
2023-02-06 |
|
|
| 327 |
Markers for Target Traits |
2023-02-06 |
|
|
| 328 |
Marker Assisted Selection |
2023-02-06 |
|
|
| 329 |
Genomic Resources |
2023-02-06 |
|
|
| 330 |
Status Production of Groundnut |
2023-02-06 |
|
|
| 331 |
Ethical Declaration |
2023-02-02 |
|
|
| 332 |
Role of Funding Sources |
2023-01-24 |
|
|
| 333 |
Natural management products for weed |
2023-01-23 |
|
|
| 334 |
Vaccination and Treatment |
2023-01-21 |
|
|
| 335 |
Differences Between Seizures and Convulsion |
2023-01-19 |
|
|
| 336 |
Evaluation of Ischemic Stroke |
2023-01-19 |
|
|
| 337 |
Causes of Ischemic Stroke |
2023-01-19 |
|
|
| 338 |
Common Causes of Intellectual Disabilities |
2023-01-19 |
|
|
| 339 |
Neurovascular Coupling Dysfunction |
2023-01-19 |
|
|
| 340 |
Viral Reasons |
2023-01-19 |
|
|
| 341 |
Early Signs |
2023-01-10 |
|
|
| 342 |
ECT Alone or Combination ECT and Drugs? |
2023-01-10 |
|
|
| 343 |
History of ECT |
2023-01-10 |
|
|
| 344 |
Role of the Funding Source |
2023-01-10 |
|
|
| 345 |
Acknowledgements and Any Additional Information’s Concerning Research Grants |
2023-01-09 |
|
|
| 346 |
Material Studied |
2023-01-09 |
|
|
| 347 |
Future Works |
2023-01-06 |
|
|
| 348 |
Gravitational field energy |
2023-01-03 |
|
|
| 349 |
Lagrangian Quantum Mechanics |
2023-01-03 |
|
|
| 350 |
Deviation from the Standard Model |
2023-01-03 |
|
|
| 351 |
The Fate of the Stars |
2023-01-03 |
|
|
| 352 |
Fat Necrosis |
2023-01-02 |
|
|
| 353 |
Conflict of Interest Form |
2022-12-30 |
|
|
| 354 |
Data Avaliability |
2022-12-29 |
|
|
| 355 |
Conclusion and Summary |
2022-12-29 |
|
|
| 356 |
Membrane Distillation Techniques |
2022-12-29 |
|
|
| 357 |
Principle of Membrane Distillation |
2022-12-29 |
|
|
| 358 |
Remedy |
2022-12-29 |
|
|
| 359 |
Usage of the plants |
2022-12-29 |
|
|
| 360 |
Established in Field and Consumed by Trained Creatures |
2022-12-29 |
|
|
| 361 |
Causes of Epilepsy in Children |
2022-12-28 |
|
|
| 362 |
Treatment of Hydrocephalus |
2022-12-28 |
|
|
| 363 |
Types of Bipolar Disorders |
2022-12-28 |
|
|
| 364 |
Declaration of consent |
2022-12-28 |
|
|
| 365 |
Types of Pain Management |
2022-12-27 |
|
|
| 366 |
Factors in Hair Follicle Harvesting Technique |
2022-12-27 |
|
|
| 367 |
Availability Statement Of Data And Material |
2022-12-26 |
|
|
| 368 |
Empirical Test And Result Analysis |
2022-12-26 |
|
|
| 369 |
Theoretical Basis |
2022-12-26 |
|
|
| 370 |
Declaration of Funding Sources |
2022-12-23 |
|
|
| 371 |
Selection for Host Resistance |
2022-12-22 |
|
|
| 372 |
Auto-Sterilization of Tsetse by Using Insect Growth Regulators (IGR) |
2022-12-22 |
|
|
| 373 |
The Use of Entomopathogenic Fungi (EPF) |
2022-12-22 |
|
|
| 374 |
The Use of Tsetse Fly Symbionts |
2022-12-22 |
|
|
| 375 |
The Use of Symbionts and Pathogen |
2022-12-22 |
|
|
| 376 |
Integrated Control of Tsetse Flies, with Emphasis on Biological Control |
2022-12-22 |
|
|
| 377 |
Description of the Vector (Glossina) and the Parasite (Trypanosoma Spp) |
2022-12-22 |
|
|
| 378 |
Significación clínica |
2022-12-21 |
|
|
| 379 |
Preocupaciones WES |
2022-12-21 |
|
|
| 380 |
WES es atractiva con su enfoque novedoso |
2022-12-21 |
|
|
| 381 |
Areas of the Tongue Observed in TCM |
2022-12-19 |
|
|
| 382 |
Colors of an Unhealthy Tongue |
2022-12-19 |
|
|
| 383 |
Microscopic Features |
2022-12-19 |
|
|
| 384 |
Life Cycle and Transmission |
2022-12-19 |
|
|
| 385 |
Acknowledgment and Declaration |
2022-12-19 |
|
|
| 386 |
External Beams |
2022-12-15 |
|
|
| 387 |
Laboratory Testing |
2022-12-15 |
|
|
| 388 |
How are Parasitic Illnesses Recognised and Treated? |
2022-12-15 |
|
|
| 389 |
Common Symptoms of Intestinal Worms |
2022-12-15 |
|
|
| 390 |
Leprosy is spread by Coming into Contact with an Infected Person |
2022-12-15 |
|
|
| 391 |
Diagnosis Tests |
2022-12-15 |
|
|
| 392 |
Resistance to Drugs |
2022-12-15 |
|
|
| 393 |
Control and Prevention |
2022-12-15 |
|
|
| 394 |
Transmission of E.Coli |
2022-12-15 |
|
|
| 395 |
Clinical-Medical Image |
2022-12-13 |
|
|
| 396 |
Data Access Statement |
2022-12-09 |
|
|
| 397 |
Genome Hypomethylation and Chronic Respiratory Diseases |
2022-12-09 |
|
|
| 398 |
Genome Hypomethylation and Cardiovascular Diseases |
2022-12-09 |
|
|
| 399 |
Genome Hypomethylation in Obesity and Diabetes |
2022-12-09 |
|
|
| 400 |
Genome Hypomethylation and Cancer |
2022-12-09 |
|
|
| 401 |
Genome Hypomethylation |
2022-12-09 |
|
|
| 402 |
Genome Methylation |
2022-12-09 |
|
|
| 403 |
Application of Single-Cell Multi-Omics to Cancer Persistent Cells |
2022-12-08 |
|
|
| 404 |
Mechanisms Revealed at Cell-Level |
2022-12-08 |
|
|
| 405 |
External Factors of Cancer Persistent Cells’ Emerging |
2022-12-08 |
|
|
| 406 |
Metabolism Pathway Change |
2022-12-08 |
|
|
| 407 |
Gene Expression and Transcriptional Factor Level |
2022-12-08 |
|
|
| 408 |
Multi-Omics of Cancer Persistent Cells |
2022-12-08 |
|
|
| 409 |
History Of Abdominoplasty |
2022-12-08 |
|
|
| 410 |
Pyrimidines As Human Urea Transport Protein (Ut-B) Inhibitors |
2022-12-07 |
|
|
| 411 |
Pyrimidines as Anti-Tubercular Agents |
2022-12-07 |
|
|
| 412 |
Pyrimidines as Anti-Thyroid Agents |
2022-12-07 |
|
|
| 413 |
Pyrimidines as Antiprotozoal Agent |
2022-12-07 |
|
|
| 414 |
Pyrimidines as Antiparkinsonian Agent |
2022-12-07 |
|
|
| 415 |
Pyrimidines as Anti-Oxidant Agents |
2022-12-07 |
|
|
| 416 |
Caso clínico |
2022-12-07 |
|
|
| 417 |
Mortality Rate |
2022-12-07 |
|
|
| 418 |
Causes of Gallstones |
2022-12-07 |
|
|
| 419 |
Liver Transplantation |
2022-12-07 |
|
|
| 420 |
Pancreas Transplantation |
2022-12-07 |
|
|
| 421 |
Human Subject Approval Statement |
2022-12-07 |
|
|
| 422 |
Biodiversity Resources |
2022-12-05 |
|
|
| 423 |
Declaration of Funding Resources |
2022-12-05 |
|
|
| 424 |
Data Availability Declaration |
2022-12-05 |
|
|
| 425 |
Author Contributions Statement |
2022-12-05 |
|
|
| 426 |
Types of Wastewater Treatment |
2022-12-03 |
|
|
| 427 |
Causes of Squamous Cell Carcinoma |
2022-12-03 |
|
|
| 428 |
Membrane Types and Structure |
2022-12-03 |
|
|
| 429 |
Examples of Semipermeable Membrane |
2022-12-03 |
|
|
| 430 |
Different Types of Therapy’s for Bipolar Disorders |
2022-12-03 |
|
|
| 431 |
Information Security Types |
2022-12-02 |
|
|
| 432 |
Fuentes de Financiación |
2022-11-30 |
|
|
| 433 |
Fuentes de Financiación |
2022-11-30 |
|
|
| 434 |
Material y Métodos |
2022-11-30 |
|
|
| 435 |
Limitation of The Study and Suggested Areas for Further Study |
2022-11-30 |
|
|
| 436 |
Experimental Design and Data Analysis |
2022-11-30 |
|
|
| 437 |
Funding and Acknowledgments |
2022-11-30 |
|
|
| 438 |
Regional Overview |
2022-11-30 |
|
|
| 439 |
Zipline Kits Market: Competitive Landscape |
2022-11-30 |
|
|
| 440 |
Zipline Kits Market: Segmentation |
2022-11-30 |
|
|
| 441 |
INTRODUCTION |
2022-11-29 |
|
|
| 442 |
Autthor’ Contribution |
2022-11-29 |
|
|
| 443 |
Competing Interests/Funding |
2022-11-29 |
|
|
| 444 |
Ethics Approval to Participate |
2022-11-29 |
|
|
| 445 |
Risk Need Responsivity Model of Criminal Behavior |
2022-11-29 |
|
|
| 446 |
Declaration Of Conflicting Interests |
2022-11-28 |
|
|
| 447 |
Integrating Theory Into Practice |
2022-11-28 |
|
|
| 448 |
Non-Criminogenic Treatment Needs |
2022-11-28 |
|
|
| 449 |
Pro-Criminal Attitudes |
2022-11-28 |
|
|
| 450 |
Education/Employment |
2022-11-28 |
|
|
| 451 |
Utilizing AAAS to Target Treatment Needs |
2022-11-28 |
|
|
| 452 |
Compliance with the Ethical Standards |
2022-11-28 |
|
|
| 453 |
Statistical tests and analysis |
2022-11-25 |
|
|
| 454 |
Marcadores invasivos de EHNA y Cirrosis |
2022-11-25 |
|
|
| 455 |
Diagnostico |
2022-11-25 |
|
|
| 456 |
Functions of Biological Membranes |
2022-11-25 |
|
|
| 457 |
Structure and Components of the Cell Membrane |
2022-11-25 |
|
|
| 458 |
Structure of Cell Membrane |
2022-11-25 |
|
|
| 459 |
Future Scope of Natural Dyes |
2022-11-24 |
|
|
| 460 |
Challenges for Natural Dyes |
2022-11-24 |
|
|
| 461 |
Advantages of Natural Dyes |
2022-11-24 |
|
|
| 462 |
Natural Dyes (A Sustainable Option) |
2022-11-24 |
|
|
| 463 |
Problems with Using Conventional Inks |
2022-11-24 |
|
|
| 464 |
Compositions of Printing Inks |
2022-11-24 |
|
|
| 465 |
Global Market (Natural Dyes) |
2022-11-24 |
|
|
| 466 |
Comparative Discussion on Patent |
2022-11-23 |
|
|
| 467 |
Contemporary Case on Patent Infringement |
2022-11-23 |
|
|
| 468 |
Conflicts of Interests |
2022-11-19 |
|
|
| 469 |
Acknowledgement |
2022-11-19 |
|
|
| 470 |
Prevention of Pulmonary Embolism |
2022-11-18 |
|
|
| 471 |
Symptoms of Pulmonary Embolism |
2022-11-18 |
|
|
| 472 |
Causes a Pulmonary Embolism |
2022-11-18 |
|
|
| 473 |
Symptoms of Venous Thromboembolism |
2022-11-18 |
|
|
| 474 |
Causes Venous Thromboembolism |
2022-11-18 |
|
|
| 475 |
Causes of Deep Vein Thrombosis |
2022-11-17 |
|
|
| 476 |
Symptoms of Deep Vein Thrombosis |
2022-11-17 |
|
|
| 477 |
Complications of Deep Vein Thrombosis |
2022-11-17 |
|
|
| 478 |
Types of Blood Clot |
2022-11-17 |
|
|
| 479 |
Treatments for Arterial Thrombosis |
2022-11-17 |
|
|
| 480 |
Treatments for arterial thrombosis |
2022-11-17 |
|
|
| 481 |
Causes of Arterial Thrombosis |
2022-11-17 |
|
|
| 482 |
Symptoms and Risks of Arterial Thrombosis |
2022-11-17 |
|
|
| 483 |
Electromagnetic Therapy of Glaucoma |
2022-11-16 |
|
|
| 484 |
Mortality/Morbidity |
2022-11-14 |
|
|
| 485 |
International |
2022-11-14 |
|
|
| 486 |
Mechanism of Oil Recovery |
2022-11-14 |
|
|
| 487 |
Traces of Oragnic Compounds |
2022-11-14 |
|
|
| 488 |
Five Orbiting Moons |
2022-11-14 |
|
|
| 489 |
Radiation Therapy |
2022-11-14 |
|
|
| 490 |
Altocumulus, Cirrocumulus and Lenticular Clouds |
2022-11-14 |
|
|
| 491 |
Lunar Tetrad |
2022-11-14 |
|
|
| 492 |
Control or Managements |
2022-11-14 |
|
|
| 493 |
Symptoms and History of Pathogen |
2022-11-14 |
|
|
| 494 |
Stem End Rot |
2022-11-14 |
|
|
| 495 |
Control or Management |
2022-11-14 |
|
|
| 496 |
Symptoms and History of Pathogen Colletotrichum Gloeosporioides |
2022-11-14 |
|
|
| 497 |
Symptoms and History of Pathogen Colletotrichum Gloeosporioides |
2022-11-14 |
|
|
| 498 |
Anthracnose |
2022-11-14 |
|
|
| 499 |
Post-Harvest Diseases |
2022-11-14 |
|
|
| 500 |
Diseases and Disorders |
2022-11-14 |
|
|
| 501 |
CONCLUSION |
2022-11-11 |
|
|
| 502 |
Materiales Y Metodos |
2022-11-11 |
|
|
| 503 |
Concusión |
2022-11-11 |
|
|
| 504 |
Hidratación en Adultos y Niños Mayores de 5 Años |
2022-11-11 |
|
|
| 505 |
Paraclinicos |
2022-11-11 |
|
|
| 506 |
Clínica |
2022-11-11 |
|
|
| 507 |
Clasificacion de la Diarrea |
2022-11-11 |
|
|
| 508 |
Definición |
2022-11-11 |
|
|
| 509 |
Classification of Regeneration Techniques |
2022-11-10 |
|
|
| 510 |
Types of Obesity |
2022-11-10 |
|
|
| 511 |
Some Typical Side Effects of Abusing Diet Pills |
2022-11-10 |
|
|
| 512 |
Social and Ethical Issues Regarding Abortion |
2022-11-10 |
|
|
| 513 |
Societal Ethics |
2022-11-10 |
|
|
| 514 |
Health Ethics Framework |
2022-11-10 |
|
|
| 515 |
Environmental Ethical Framework |
2022-11-10 |
|
|
| 516 |
Education Ethical Framework |
2022-11-10 |
|
|
| 517 |
Defence and Security Ethical Framework |
2022-11-10 |
|
|
| 518 |
Agricultural Ethical Framework |
2022-11-10 |
|
|
| 519 |
Key Highlights and Thematic Areas |
2022-11-10 |
|
|
| 520 |
Fund Project |
2022-11-10 |
|
|
| 521 |
Soft Computing Techniques |
2022-11-10 |
|
|
| 522 |
Fundamental Technologies |
2022-11-10 |
|
|
| 523 |
Goals |
2022-11-10 |
|
|
| 524 |
Machine Learning Process |
2022-11-10 |
|
|
| 525 |
Main Concepts and Methods |
2022-11-04 |
|
|
| 526 |
Individual Contributions |
2022-11-02 |
|
|
| 527 |
The Safety of Sacubitril/Valsartan in lowering Hypertension |
2022-11-01 |
|
|
| 528 |
The Efficacy of Sacubitril/Valsartan in lowering Hypertension |
2022-11-01 |
|
|
| 529 |
Article Summary |
2022-10-20 |
|
|
| 530 |
Expresiones de gratitud |
2022-10-20 |
|
|
| 531 |
Aprobación ética y consentimiento para participar |
2022-10-20 |
|
|
| 532 |
Consentimiento para publicación |
2022-10-20 |
|
|
| 533 |
Disponibilidad de datos |
2022-10-20 |
|
|
| 534 |
Revisión de literatura |
2022-10-20 |
|
|
| 535 |
1.Keywords |
2022-10-17 |
|
|
| 536 |
Symptoms and Transmission |
2022-10-17 |
|
|
| 537 |
Administration of Data Management in Clinical Research: Mini Review |
2022-10-13 |
|
|
| 538 |
Recent Advancement in Alkylative Cyclization Reactions |
2022-10-11 |
|
|
| 539 |
Antibody in Colorectal Neuroendocrine Carcinoma |
2022-10-07 |
|
|
| 540 |
Gep-Necs Treatment |
2022-10-07 |
|
|
| 541 |
Management of Hyperglycaemia |
2022-10-07 |
|
|
| 542 |
Laparoscopic Pancreatic Surgery |
2022-10-07 |
|
|
| 543 |
Survival After Surgery |
2022-10-07 |
|
|
| 544 |
Robotic-Assisted Pancreatic Surgery |
2022-10-07 |
|
|
| 545 |
Diabetes Insipidus Grade |
2022-10-07 |
|
|
| 546 |
Details |
2022-10-06 |
|
|
| 547 |
Types of Gallbladder Surgery |
2022-09-29 |
|
|
| 548 |
Protocol Registration |
2022-09-28 |
|
|
| 549 |
Declarations and Acknowledgements |
2022-09-28 |
|
|
| 550 |
Sterile Insect Technique (SIT) |
2022-09-28 |
|
|
| 551 |
Informed Consent and Patient Details |
2022-09-28 |
|
|
| 552 |
Clinical Presentation of Parkinson's Disease |
2022-09-28 |
|
|
| 553 |
Omega-3 Supplements |
2022-09-28 |
|
|
| 554 |
Deficiency |
2022-09-28 |
|
|
| 555 |
Source of Omega 3 |
2022-09-28 |
|
|
| 556 |
COVID-19 and Parkinson's Disease |
2022-09-27 |
|
|
| 557 |
Vitamin D and COVID-19 |
2022-09-27 |
|
|
| 558 |
Vitamin D and Parkinson's Disease |
2022-09-27 |
|
|
| 559 |
Early-Onset Alzheimer's Disease |
2022-09-27 |
|
|
| 560 |
Stages of Alzheimer's Disease |
2022-09-27 |
|
|
| 561 |
Mechanical Components |
2022-09-26 |
|
|
| 562 |
Avaialability of Data and Material |
2022-09-26 |
|
|
| 563 |
Written Consent for Publication |
2022-09-26 |
|
|
| 564 |
Applications of Virtual Manufacturing |
2022-09-26 |
|
|
| 565 |
Semicondutor Design Companies |
2022-09-26 |
|
|
| 566 |
Semiconductor and Display Fabs |
2022-09-26 |
|
|
| 567 |
India Semiconductor Mission |
2022-09-26 |
|
|
| 568 |
Pattern Recognition |
2022-09-24 |
|
|
| 569 |
Assessment of Pain |
2022-09-24 |
|
|
| 570 |
Treatment and Prevention |
2022-09-23 |
|
|
| 571 |
History of the Disease |
2022-09-23 |
|
|
| 572 |
Applications of Ultrafiltration (UF) Membrane |
2022-09-23 |
|
|
| 573 |
Applications of Nano Filtration (NF) Membrane |
2022-09-23 |
|
|
| 574 |
Cotes’s Spiral |
2022-09-22 |
|
|
| 575 |
Cotesâ??s Spiral |
2022-09-22 |
|
|
| 576 |
Analysis of Satellite Images, and Synoptic Charts |
2022-09-22 |
|
|
| 577 |
News |
2022-09-22 |
|
|
| 578 |
Hierarchical Preparation of Work Places |
2022-09-22 |
|
|
| 579 |
Advantages of Technology |
2022-09-22 |
|
|
| 580 |
Critical Analysis |
2022-09-22 |
|
|
| 581 |
Techniques for Cyber Attack |
2022-09-22 |
|
|
| 582 |
Reasons for Cyber Attacks |
2022-09-22 |
|
|
| 583 |
Surgery for Tinnitus |
2022-09-21 |
|
|
| 584 |
Tinnitus |
2022-09-21 |
|
|
| 585 |
Clinical Implementation of Metabolomics |
2022-09-20 |
|
|
| 586 |
Metabolic Effects of Cancer Therapy |
2022-09-20 |
|
|
| 587 |
Role of Angiogenesis in Cancer Growth |
2022-09-20 |
|
|
| 588 |
Role of Natural Compounds in Proper Regulation of Tight Junctions |
2022-09-20 |
|
|
| 589 |
Role of TJs in Pathophysiology of Various Malignancies |
2022-09-20 |
|
|
| 590 |
Disruption of Tight Junctions |
2022-09-20 |
|
|
| 591 |
Function of Tight Junctions |
2022-09-20 |
|
|
| 592 |
Structure of Tight Junctions |
2022-09-20 |
|
|
| 593 |
Industry Specific Factors |
2022-09-19 |
|
|
| 594 |
Empirical Studies on Determinant of No Performing Loans |
2022-09-19 |
|
|
| 595 |
Scope and Limitation of the Study |
2022-09-19 |
|
|
| 596 |
Statement of Problem |
2022-09-19 |
|
|
| 597 |
Author's Disclosure Statement |
2022-09-16 |
|
|
| 598 |
Authorâ??s Disclosure Statement |
2022-09-16 |
|
|
| 599 |
Authorâ??s Disclosure (Conflict of Interest) Statement |
2022-09-16 |
|
|
| 600 |
Authorâ??s Disclosure (Conflict of Interest) Statement |
2022-09-16 |
|
|
| 601 |
Authorship Confirmation/Contribution Statement |
2022-09-16 |
|
|
| 602 |
Authors Confliction |
2022-09-15 |
|
|
| 603 |
Competent Interest |
2022-09-07 |
|
|
| 604 |
Magnetic resonance imaging (MRI) |
2022-09-05 |
|
|
| 605 |
Masticatory Muscle Pain Attributed to Systemic/Central Pain Disorders |
2022-09-02 |
|
|
| 606 |
Movement Disorders |
2022-09-02 |
|
|
| 607 |
Neoplasms |
2022-09-02 |
|
|
| 608 |
Hypertrophy |
2022-09-02 |
|
|
| 609 |
Contractures |
2022-09-02 |
|
|
| 610 |
Muscle Pain |
2022-09-02 |
|
|
| 611 |
Myalgia |
2022-09-02 |
|
|
| 612 |
Classification of Masticatory Muscle Disorder |
2022-09-02 |
|
|
| 613 |
Masticatory Muscle Pain Model |
2022-09-02 |
|
|
| 614 |
Neurophysiology of Masticatory Muscle Pain |
2022-09-02 |
|
|
| 615 |
Competing in Interests |
2022-09-02 |
|
|
| 616 |
Purpose of study |
2022-08-30 |
|
|
| 617 |
Clinical Presentation and Symptomatology |
2022-08-30 |
|
|
| 618 |
Key learning points |
2022-08-27 |
|
|
| 619 |
Our Likely Inconceivability about Eti at A Different Stage of Evolution |
2022-08-26 |
|
|
| 620 |
Driving Search Strategies for Extraterrestrial Life |
2022-08-26 |
|
|
| 621 |
Hypertension and Healthcare |
2022-08-26 |
|
|
| 622 |
Authorship Confirmations |
2022-08-24 |
|
|
| 623 |
Multiple Asset Model |
2022-08-24 |
|
|
| 624 |
Single Asset Model and an Adaptive Theory of Speculation |
2022-08-24 |
|
|
| 625 |
Turbulence and Complexity in Financial Returns Dynamics |
2022-08-24 |
|
|
| 626 |
Types of Transportation |
2022-08-24 |
|
|
| 627 |
Structure of the Cell Membrane |
2022-08-23 |
|
|
| 628 |
Classification of Membrane Processes |
2022-08-23 |
|
|
| 629 |
Introduction |
2022-08-23 |
|
|
| 630 |
Authorship Confirmation/ Contribution Statement |
2022-08-22 |
|
|
| 631 |
Authors Disclosure |
2022-08-22 |
|
|
| 632 |
Author’s Disclosure |
2022-08-22 |
|
|
| 633 |
Background and purpose |
2022-08-22 |
|
|
| 634 |
PV in India |
2022-08-22 |
|
|
| 635 |
Scope and Barriers of Pharmacovigilance |
2022-08-22 |
|
|
| 636 |
Clinical Trial and its Limitation |
2022-08-22 |
|
|
| 637 |
Justification as a Health Care Professional |
2022-08-20 |
|
|
| 638 |
Controversy |
2022-08-20 |
|
|
| 639 |
Position of a Health Care Professional |
2022-08-20 |
|
|
| 640 |
Ethical Dilemma |
2022-08-20 |
|
|
| 641 |
¿Qué sabemos acerca de este problema y qué aporta este estudio? |
2022-08-19 |
|
|
| 642 |
Meta |
2022-08-19 |
|
|
| 643 |
Limitations in our Study |
2022-08-16 |
|
|
| 644 |
Pneumococcal Disease and Immunization: The Iraq Scenario |
2022-08-12 |
|
|
| 645 |
Global Impact of Pneumococcal Vaccines: Case Studies |
2022-08-12 |
|
|
| 646 |
Global Prevention Strategies |
2022-08-12 |
|
|
| 647 |
Global Burden of Pneumococcal Disease |
2022-08-12 |
|
|
| 648 |
Pneumococcal Infection Landscape: Epidemiology and Transmission |
2022-08-12 |
|
|
| 649 |
Effects of Personalized Medicine and Virus Mutations on the Severity of Disease |
2022-08-11 |
|
|
| 650 |
Different Approaches for Medical Treatment: Antiviral Drugs, Vaccines, and Stem Cell Therapies |
2022-08-11 |
|
|
| 651 |
Genomic Structure and Impact of Different Mutations on the Severity of Infection |
2022-08-11 |
|
|
| 652 |
Transmission and Risk Factors |
2022-08-11 |
|
|
| 653 |
Ethical Declarations |
2022-08-10 |
|
|
| 654 |
Factors that Promote Male Participation in Antenatal Care |
2022-08-10 |
|
|
| 655 |
Barriers to Male Participation during Antenatal Care |
2022-08-10 |
|
|
| 656 |
Other Information |
2022-08-10 |
|
|
| 657 |
Descriptive Data |
2022-08-10 |
|
|
| 658 |
Author Information |
2022-08-10 |
|
|
| 659 |
Informed Consent and IRB Approval |
2022-08-10 |
|
|
| 660 |
Social Construction of Divorce in Nigeria Customary and Religious Law |
2022-08-05 |
|
|
| 661 |
Social construction of marriage in religion |
2022-08-05 |
|
|
| 662 |
Gender Based Violence and Covid-19 Lockdown |
2022-08-05 |
|
|
| 663 |
Nigerian Law and The Marriage Culture |
2022-08-05 |
|
|
| 664 |
Methods of Fishery |
2022-08-04 |
|
|
| 665 |
Abbreviation/Acronym |
2022-08-03 |
|
|
| 666 |
Abbreviations/Acronym |
2022-08-02 |
|
|
| 667 |
Review of Sample and Social Construction of Illness |
2022-07-30 |
|
|
| 668 |
Directions for Future Research |
2022-07-28 |
|
|
| 669 |
Genetic Counselling |
2022-07-28 |
|
|
| 670 |
Genetic Attributes |
2022-07-28 |
|
|
| 671 |
Pathogenesis and Pathophysiology |
2022-07-28 |
|
|
| 672 |
Histological Attributes |
2022-07-28 |
|
|
| 673 |
Clinical Implications |
2022-07-28 |
|
|
| 674 |
Clinical Diagnosis |
2022-07-28 |
|
|
| 675 |
Prosthodontics and COVID-19 |
2022-07-26 |
|
|
| 676 |
COVID-19 in Istanbul |
2022-07-26 |
|
|
| 677 |
Physical Injuries of Oral Mucosa |
2022-07-26 |
|
|
| 678 |
Procedures in Cosmetic Dentistry |
2022-07-26 |
|
|
| 679 |
Classification of Mouthguards |
2022-07-26 |
|
|
| 680 |
Conclusiones |
2022-07-23 |
|
|
| 681 |
Finerenone |
2022-07-23 |
|
|
| 682 |
Bloqueo Del Sistema Renina Angiotensina Aldosterona |
2022-07-23 |
|
|
| 683 |
Hipertensión Arterial |
2022-07-23 |
|
|
| 684 |
Agonistas Del Receptor Del Péptido Similar Al Glucagón 1 |
2022-07-23 |
|
|
| 685 |
SGLT-2i |
2022-07-23 |
|
|
| 686 |
Metformina |
2022-07-23 |
|
|
| 687 |
Agentes Hipoglucemiantes |
2022-07-23 |
|
|
| 688 |
Hiperglicemia |
2022-07-23 |
|
|
| 689 |
Tratamiento |
2022-07-23 |
|
|
| 690 |
Genética Y Epigenética |
2022-07-23 |
|
|
| 691 |
Autofagia Desregulada |
2022-07-23 |
|
|
| 692 |
Sistema Renina Angiotensina Aldosterona |
2022-07-23 |
|
|
| 693 |
Factores Inflamatorios |
2022-07-23 |
|
|
| 694 |
Factores Metabólicos |
2022-07-23 |
|
|
| 695 |
Factores Hemodinámicos |
2022-07-23 |
|
|
| 696 |
Fisiopatología |
2022-07-23 |
|
|
| 697 |
Factores de Riesgo |
2022-07-23 |
|
|
| 698 |
Epidemiologia |
2022-07-23 |
|
|
| 699 |
Classification Based on Material Type of Inorganic Membrane |
2022-07-22 |
|
|
| 700 |
Conclusions and Future Investigation |
2022-07-19 |
|
|
| 701 |
Mythology |
2022-07-18 |
|
|
| 702 |
Challenges and extensions to Rl |
2022-07-18 |
|
|
| 703 |
Types of Reinforcement |
2022-07-18 |
|
|
| 704 |
Properties of a swarm Intelligence system |
2022-07-18 |
|
|
| 705 |
Applications of evolutionary Programming |
2022-07-18 |
|
|
| 706 |
Desirable properties of swarm Robotics systems |
2022-07-18 |
|
|
| 707 |
Potential applications of Swarm robotics |
2022-07-18 |
|
|
| 708 |
Rhabdomyolysis |
2022-07-16 |
|
|
| 709 |
Applications of centrifugal Pump |
2022-07-15 |
|
|
| 710 |
Operating principle of Centrifugal pump |
2022-07-15 |
|
|
| 711 |
Advantage of Pantograph |
2022-07-15 |
|
|
| 712 |
Emission Control Methods |
2022-07-15 |
|
|
| 713 |
Preventing Genital Skin Cancers |
2022-07-15 |
|
|
| 714 |
Advanced Treatment Methods |
2022-07-15 |
|
|
| 715 |
Tumor Testing for Biomarkers |
2022-07-15 |
|
|
| 716 |
Journal Information |
2022-07-15 |
|
|
| 717 |
Previous Presentations |
2022-07-15 |
|
|
| 718 |
Ethics and Permissions |
2022-07-15 |
|
|
| 719 |
Contributions from the Authors |
2022-07-15 |
|
|
| 720 |
Principles of ethics in medical Research |
2022-07-14 |
|
|
| 721 |
Treatment options for colon Cancer |
2022-07-14 |
|
|
| 722 |
Diagnosis of Colon Cancer |
2022-07-14 |
|
|
| 723 |
Treatment of esophageal Cancer |
2022-07-14 |
|
|
| 724 |
Clinical diagnosis of Esophageal cancer |
2022-07-14 |
|
|
| 725 |
Special considerations: what Should be done? |
2022-07-14 |
|
|
| 726 |
The Empirical Evidence |
2022-07-14 |
|
|
| 727 |
The Setting |
2022-07-14 |
|
|
| 728 |
Public Health Strategy |
2022-07-14 |
|
|
| 729 |
Autonomy In Africa |
2022-07-14 |
|
|
| 730 |
Universalist Ethical Stand |
2022-07-14 |
|
|
| 731 |
Women’s lack of reproductive Autonomy |
2022-07-14 |
|
|
| 732 |
The culture of gender Inequality |
2022-07-14 |
|
|
| 733 |
Pleiotropic Effects of Macrolide Antibiotics |
2022-07-08 |
|
|
| 734 |
Desciption |
2022-07-08 |
|
|
| 735 |
Study Flow |
2022-07-07 |
|
|
| 736 |
Management of Patients with AAS |
2022-07-07 |
|
|
| 737 |
Multidisciplinary Teams in The Management of AAS |
2022-07-07 |
|
|
| 738 |
Objective and Conclusion |
2022-07-07 |
|
|
| 739 |
Steps |
2022-07-07 |
|
|
| 740 |
Prevalence and Impact of Substance Abuse in Hospitalized Patients with CVD/CEVD |
2022-07-06 |
|
|
| 741 |
Highlights of 2019 |
2022-07-06 |
|
|
| 742 |
Anticuerpos contra la Covid - 19 y Lactantes |
2022-07-05 |
|
|
| 743 |
Anticuerpos Materno-Fetales |
2022-07-05 |
|
|
| 744 |
Guidelines On Severe Acute Pancreatitis |
2022-07-05 |
|
|
| 745 |
Trestment of Walled-Off Pancreatic Necrosis(Wopn) |
2022-07-05 |
|
|
| 746 |
Public Health and Its Current Challenges |
2022-07-05 |
|
|
| 747 |
Public Health |
2022-07-05 |
|
|
| 748 |
Automating room disinfection |
2022-07-05 |
|
|
| 749 |
In search of efficiency |
2022-07-05 |
|
|
| 750 |
Photo courtesy of ECOLAB |
2022-07-05 |
|
|
| 751 |
Sectors of Healthcare Industry |
2022-07-05 |
|
|
| 752 |
Published Articles 2020 |
2022-07-04 |
|
|
| 753 |
Importance of training and awareness in HWM |
2022-07-04 |
|
|
| 754 |
Suggestion for Further Research |
2022-07-04 |
|
|
| 755 |
Estado del Arte |
2022-07-04 |
|
|
| 756 |
Bibliography |
2022-07-04 |
|
|
| 757 |
Rapid pH change |
2022-07-01 |
|
|
| 758 |
Mountain Fisheries |
2022-07-01 |
|
|
| 759 |
Fish Biodiversity |
2022-07-01 |
|
|
| 760 |
Effect of COVID-19 in Rural Fisheries |
2022-07-01 |
|
|
| 761 |
Importance of Aquaculture |
2022-07-01 |
|
|
| 762 |
Advantages of Aquaculture |
2022-07-01 |
|
|
| 763 |
Ctenoid scales |
2022-07-01 |
|
|
| 764 |
Cycloid scales |
2022-07-01 |
|
|
| 765 |
Ganoid scales |
2022-07-01 |
|
|
| 766 |
Cosmoid scales |
2022-07-01 |
|
|
| 767 |
Placoid scales |
2022-07-01 |
|
|
| 768 |
Methods of Fish Farming |
2022-07-01 |
|
|
| 769 |
Pituitary Dysfunction Screening |
2022-07-01 |
|
|
| 770 |
TBI and Pituitary Dysfunction Research |
2022-07-01 |
|
|
| 771 |
Pituitary Dysfunction |
2022-07-01 |
|
|
| 772 |
Fabrication Approaches |
2022-06-30 |
|
|
| 773 |
Single Gene Inheritance Disorders |
2022-06-30 |
|
|
| 774 |
Uses of Genetic Tests |
2022-06-30 |
|
|
| 775 |
Market analysis reports |
2022-06-30 |
|
|
| 776 |
Important and scope: |
2022-06-30 |
|
|
| 777 |
Individual sports in elite athletes |
2022-06-30 |
|
|
| 778 |
Thyroid |
2022-06-29 |
|
|
| 779 |
Hormones, Energy Metabolism and The Ageing Process |
2022-06-29 |
|
|
| 780 |
Fratility and Hormones |
2022-06-29 |
|
|
| 781 |
Risks to consider |
2022-06-29 |
|
|
| 782 |
Pharmacology of steroids |
2022-06-29 |
|
|
| 783 |
Testosterone and Growth |
2022-06-29 |
|
|
| 784 |
Gender's Function |
2022-06-29 |
|
|
| 785 |
The Social Environment's Role |
2022-06-29 |
|
|
| 786 |
The Importance of Parental Testosterone Levels |
2022-06-29 |
|
|
| 787 |
Is the Hormone-Behavior Relationship Linear? |
2022-06-29 |
|
|
| 788 |
Is the Hormoneâ??Behavior Relationship Linear? |
2022-06-29 |
|
|
| 789 |
Testosterone and Adjustment |
2022-06-29 |
|
|
| 790 |
Consent and Ethical Approval |
2022-06-28 |
|
|
| 791 |
Social paradigms of medicine in Astrobiology |
2022-06-25 |
|
|
| 792 |
In-Hospital Space Analog |
2022-06-25 |
|
|
| 793 |
Classification of Overdentures |
2022-06-24 |
|
|
| 794 |
Benefits of Overdentures |
2022-06-24 |
|
|
| 795 |
Types of X-rays |
2022-06-24 |
|
|
| 796 |
The Novelty of the Study |
2022-06-24 |
|
|
| 797 |
Aim & Objectives |
2022-06-24 |
|
|
| 798 |
Methods for Improving Thermal Efficiency of Gas Turbine |
2022-06-21 |
|
|
| 799 |
Major Ethical Issues In Healthcare System |
2022-06-21 |
|
|
| 800 |
Reporte de un caso |
2022-06-21 |
|
|
| 801 |
Cutaneous Infections in The Context of AD |
2022-06-20 |
|
|
| 802 |
Other Diseases |
2022-06-20 |
|
|
| 803 |
Eosinophilic Dermatoses |
2022-06-20 |
|
|
| 804 |
Acantholytic Disorders |
2022-06-20 |
|
|
| 805 |
Genetic Diseases |
2022-06-20 |
|
|
| 806 |
Oligonucleotide Therapeutics for Allergy |
2022-06-20 |
|
|
| 807 |
Future Directions and Recommendations |
2022-06-20 |
|
|
| 808 |
Types of Autoencoders |
2022-06-20 |
|
|
| 809 |
Cumplimiento de normas éticas |
2022-06-15 |
|
|
| 810 |
Situs Inversus Totalis (SIT) |
2022-06-15 |
|
|
| 811 |
Diagnóstico |
2022-06-15 |
|
|
| 812 |
Manifestaciones clínicas |
2022-06-15 |
|
|
| 813 |
Epidemiología |
2022-06-15 |
|
|
| 814 |
Revisión de la literature |
2022-06-15 |
|
|
| 815 |
Presentación de caso |
2022-06-15 |
|
|
| 816 |
Applications of Electro Dialysis |
2022-06-15 |
|
|
| 817 |
Financiación |
2022-06-14 |
|
|
| 818 |
Reporte de Caso |
2022-06-14 |
|
|
| 819 |
Oxidative Stress and Metabolic Switch in Cardiac Diseases |
2022-06-14 |
|
|
| 820 |
Pathological Implications of Oxidative Stress in Cardiovascular Diseases |
2022-06-14 |
|
|
| 821 |
Cellular Metabolism and Redox Balance |
2022-06-14 |
|
|
| 822 |
Metabolomic Technologies |
2022-06-14 |
|
|
| 823 |
Statements and Declarations |
2022-06-14 |
|
|
| 824 |
Functions of The Liver |
2022-06-09 |
|
|
| 825 |
Anatomy of Liver |
2022-06-09 |
|
|
| 826 |
HIV Rapid Test Kit Materials and Method |
2022-06-08 |
|
|
| 827 |
HIV Prevention |
2022-06-08 |
|
|
| 828 |
Factors Responsible for Increased Patronage and Self-Medication With Herbal Medicine |
2022-06-08 |
|
|
| 829 |
Interviews |
2022-06-08 |
|
|
| 830 |
FUTURE CONCERNS |
2022-06-04 |
|
|
| 831 |
RADIATION POISONING PATHOMECHANISM |
2022-06-03 |
|
|
| 832 |
TOXICITY OF RADIATION |
2022-06-03 |
|
|
| 833 |
Disclosure of Funding |
2022-06-03 |
|
|
| 834 |
TACE |
2022-06-03 |
|
|
| 835 |
Funding and Sponsorship |
2022-06-02 |
|
|
| 836 |
Research Ethics |
2022-06-02 |
|
|
| 837 |
What are Schizoid Personality Disorder's Consequences? |
2022-06-02 |
|
|
| 838 |
What Causes Schizoid Personality Disorder? |
2022-06-02 |
|
|
| 839 |
What do you know about Schizoid Personality Disorder? |
2022-06-02 |
|
|
| 840 |
Related Disorders |
2022-06-02 |
|
|
| 841 |
When to See a Doctor? |
2022-06-02 |
|
|
| 842 |
Traumatic Brain Injury |
2022-05-31 |
|
|
| 843 |
Blunt Force Trauma |
2022-05-31 |
|
|
| 844 |
Steps Involved |
2022-05-31 |
|
|
| 845 |
Forensic Investigation |
2022-05-31 |
|
|
| 846 |
Letetr To Editor |
2022-05-31 |
|
|
| 847 |
Limitaciones del Estudio |
2022-05-30 |
|
|
| 848 |
Oral Changes at Menopause |
2022-05-28 |
|
|
| 849 |
Chemical Injuries of Oral Mucosa |
2022-05-28 |
|
|
| 850 |
Oral Mucosal Trauma and Injuries |
2022-05-28 |
|
|
| 851 |
HPV Vaccine |
2022-05-28 |
|
|
| 852 |
Anatomy of the Oral Cavity |
2022-05-28 |
|
|
| 853 |
Conflictos de interés |
2022-05-28 |
|
|
| 854 |
Agradecimientos Financiamiento |
2022-05-28 |
|
|
| 855 |
Invisalign Braces |
2022-05-28 |
|
|
| 856 |
Consentimiento informado |
2022-05-28 |
|
|
| 857 |
Declaración de conflicto de intereses |
2022-05-28 |
|
|
| 858 |
Casoclínico |
2022-05-28 |
|
|
| 859 |
Proteolysis of Pancreatic Zymogens |
2022-05-27 |
|
|
| 860 |
Signaling in Premature Protease Activation |
2022-05-27 |
|
|
| 861 |
Mechanisms of Pancreatitis |
2022-05-27 |
|
|
| 862 |
Detection and Management |
2022-05-27 |
|
|
| 863 |
Surgical Techniques |
2022-05-27 |
|
|
| 864 |
Etiologies of Exocrine Pancreatic Insufficiency |
2022-05-27 |
|
|
| 865 |
Treatment of Chronic Pancreatic Insufficiency |
2022-05-27 |
|
|
| 866 |
Role of Pancreatic Proteases |
2022-05-27 |
|
|
| 867 |
Mapping of GAD genes |
2022-05-27 |
|
|
| 868 |
Role of Glutamate Receptors |
2022-05-27 |
|
|
| 869 |
Enhanced Productivity of Gamma-Amino Butyric Acid |
2022-05-27 |
|
|
| 870 |
Conversion of Glutamic Acid into Gamma-Amino Butyric Acid |
2022-05-27 |
|
|
| 871 |
MONTE CARLO SIMULATION |
2022-05-26 |
|
|
| 872 |
Interactive Models |
2022-05-23 |
|
|
| 873 |
Prospective building blocks of Sios inspired by non-interactive Robotic devices |
2022-05-23 |
|
|
| 874 |
Complex Dynamics of A Quantum Recurrent Neural Network |
2022-05-23 |
|
|
| 875 |
Entropy |
2022-05-23 |
|
|
| 876 |
Quantum Neural Computing Field Theory |
2022-05-23 |
|
|
| 877 |
Computational Structure of Quantum Artificial Neural Networks and Quantum Neural Map |
2022-05-23 |
|
|
| 878 |
Risk Factors To Be Prevented To Control Peripheral Artery Disease |
2022-05-20 |
|
|
| 879 |
Management and Outcome |
2022-05-20 |
|
|
| 880 |
Clinical Presentation and Diagnosis |
2022-05-20 |
|
|
| 881 |
Etiology and Pathogenesis |
2022-05-20 |
|
|
| 882 |
CRAAP TEST |
2022-05-18 |
|
|
| 883 |
Contribution of Active and Break Spells to the All India Seasonal Summer Monsoon Rainfall in IMD and TRMM Data Sets |
2022-05-18 |
|
|
| 884 |
Results Discussion |
2022-05-17 |
|
|
| 885 |
Tool and Technique |
2022-05-17 |
|
|
| 886 |
Inter-Comparisons in Rainfall on Event (Daily) Time Scale between TRMM 3B42 V7 and IMD Gridded Data |
2022-05-17 |
|
|
| 887 |
Inter-comparisons in Monsoon variability between IMD and TRMM on Various Time and Spatial Scale |
2022-05-17 |
|
|
| 888 |
Monsoon Variability on Various Time and Spatial Scales based on IMD Gridded Data |
2022-05-17 |
|
|
| 889 |
Teaching Points |
2022-05-16 |
|
|
| 890 |
.. |
2022-05-11 |
|
|
| 891 |
Case descripción |
2022-05-10 |
|
|
| 892 |
Entidad a la que pertenece |
2022-05-10 |
|
|
| 893 |
Según Los Datos Recolectados |
2022-05-10 |
|
|
| 894 |
Major Achievements |
2022-05-07 |
|
|
| 895 |
Discription |
2022-05-06 |
|
|
| 896 |
Nomenclature |
2022-05-06 |
|
|
| 897 |
Ethical Compliance Statement |
2022-05-06 |
|
|
| 898 |
Author Roles |
2022-05-06 |
|
|
| 899 |
Diagnosis of Fascioliasis |
2022-05-06 |
|
|
| 900 |
Immunotherapy |
2022-05-06 |
|
|
| 901 |
Post-Traumatic Stress |
2022-05-06 |
|
|
| 902 |
Chemical Periodicity of Inner Transition Metals or F-Block Elements |
2022-05-05 |
|
|
| 903 |
Chemical Periodicity Down Groups and Across Periods in S, P, and D-Block |
2022-05-05 |
|
|
| 904 |
Ethics Declaration |
2022-05-04 |
|
|
| 905 |
Constraints of Vaccine Effectiveness |
2022-05-03 |
|
|
| 906 |
Evaluation of Vaccine Effectiveness |
2022-05-03 |
|
|
| 907 |
Epidemiology of Vaccine |
2022-05-03 |
|
|
| 908 |
Diagnose |
2022-05-03 |
|
|
| 909 |
Treatment of Pain Due to Epidural Fibrosis |
2022-05-03 |
|
|
| 910 |
Prevention of Lumbar Epidural Fibrosis |
2022-05-03 |
|
|
| 911 |
Role of Epidural Fibrosis in Pathophysiology of FBSS |
2022-05-03 |
|
|
| 912 |
Evaluation of Epidural Fibrosis |
2022-05-03 |
|
|
| 913 |
Pathophysiology of Epidural Fibrosis |
2022-05-03 |
|
|
| 914 |
Epidemiology and Etiology of FBSS |
2022-05-03 |
|
|
| 915 |
EALIM's Methods |
2022-05-03 |
|
|
| 916 |
EALIMâ??s Methods |
2022-05-03 |
|
|
| 917 |
EALIMâ??s Methods |
2022-05-03 |
|
|
| 918 |
EALIMâ??s Methods |
2022-05-03 |
|
|
| 919 |
Interpretation |
2022-05-02 |
|
|
| 920 |
Configurational Analysis of Stereoisomers in Chemical Methods |
2022-05-02 |
|
|
| 921 |
Diuretics |
2022-04-30 |
|
|
| 922 |
Problems |
2022-04-30 |
|
|
| 923 |
Chronic Kidney Disease (CKD) |
2022-04-30 |
|
|
| 924 |
Genomic Biomarkers |
2022-04-29 |
|
|
| 925 |
The relationship between testosterone dynamics and aggression in animals and animal models |
2022-04-29 |
|
|
| 926 |
Status based on the biosocial model |
2022-04-29 |
|
|
| 927 |
Challenge Hypothesis |
2022-04-29 |
|
|
| 928 |
Human Aggression and Testosterone Levels |
2022-04-29 |
|
|
| 929 |
Effects of Incretin |
2022-04-29 |
|
|
| 930 |
Extrapancreatic Glucagon |
2022-04-29 |
|
|
| 931 |
Role of Neuropeptide Gene Glucagon |
2022-04-29 |
|
|
| 932 |
Pseudo-Hyperglucagonemia in Pancreatectomized Patients |
2022-04-29 |
|
|
| 933 |
Signaling to Pancreatic Neuroendocrine Tumor Formation |
2022-04-29 |
|
|
| 934 |
Impact of Hepatic Glucagon Receptor (GCGR) Signaling |
2022-04-29 |
|
|
| 935 |
Working Principle |
2022-04-29 |
|
|
| 936 |
Working of anti-lock braking system (ABS) |
2022-04-29 |
|
|
| 937 |
Components of anti-lock braking system |
2022-04-29 |
|
|
| 938 |
Car Body Types and Usage of Ackerman |
2022-04-29 |
|
|
| 939 |
Working |
2022-04-29 |
|
|
| 940 |
Signaling to Alpha Cell Hyperproliferation |
2022-04-29 |
|
|
| 941 |
Hepatic Glucagon Receptor (GCGR) Signaling |
2022-04-29 |
|
|
| 942 |
Patient History |
2022-04-29 |
|
|
| 943 |
Ai could be a tremendous aid inVarious sectors |
2022-04-29 |
|
|
| 944 |
Ai could be a tremendous aid in Various sectors |
2022-04-29 |
|
|
| 945 |
Inference |
2022-04-28 |
|
|
| 946 |
Research |
2022-04-28 |
|
|
| 947 |
Etilogy and Pathogenesis |
2022-04-28 |
|
|
| 948 |
Amyotrophic Lateral |
2022-04-28 |
|
|
| 949 |
Bioreactor System Importance in 3D Tissue Engineering |
2022-04-27 |
|
|
| 950 |
Causes of Hyperdontia |
2022-04-27 |
|
|
| 951 |
Types of Hyperdontia |
2022-04-27 |
|
|
| 952 |
Causes and Risk Factors |
2022-04-27 |
|
|
| 953 |
Dental Significance of Taurodontism |
2022-04-27 |
|
|
| 954 |
Fast Teeth Straightening Options |
2022-04-27 |
|
|
| 955 |
Types of Teeth Misalignment |
2022-04-27 |
|
|
| 956 |
Clinical and Radiographic Features |
2022-04-27 |
|
|
| 957 |
Hypercementosis in Endodontics |
2022-04-27 |
|
|
| 958 |
Uses of Forensic Odontology |
2022-04-27 |
|
|
| 959 |
Data |
2022-04-27 |
|
|
| 960 |
Identification and Individualization of Firearm |
2022-04-27 |
|
|
| 961 |
Types of Existing Ballistics |
2022-04-27 |
|
|
| 962 |
Firearms and Ballistics |
2022-04-27 |
|
|
| 963 |
Types of Evidence |
2022-04-27 |
|
|
| 964 |
Environmental Risk Factors |
2022-04-27 |
|
|
| 965 |
Inherited Risk Factors |
2022-04-27 |
|
|
| 966 |
Dual N-Back Trainig |
2022-04-27 |
|
|
| 967 |
Ethics Approval and Consent to Participate |
2022-04-26 |
|
|
| 968 |
Statement |
2022-04-26 |
|
|
| 969 |
Beneficial Mutations |
2022-04-26 |
|
|
| 970 |
Disease Causation |
2022-04-26 |
|
|
| 971 |
Other Autoimmune Adverse Manifestations |
2022-04-26 |
|
|
| 972 |
Neurological Adverse Manifestations |
2022-04-26 |
|
|
| 973 |
Paradoxical Inflammation |
2022-04-26 |
|
|
| 974 |
Autoimmune Adverse Manifestations and Disease Development |
2022-04-26 |
|
|
| 975 |
Biological Agents Used to Treat Rheumatic Diseases |
2022-04-26 |
|
|
| 976 |
Memantine Use in Autism Spectrum Disorder |
2022-04-26 |
|
|
| 977 |
Memantine Use in Obsessive Compulsive Disorder (OCD) |
2022-04-26 |
|
|
| 978 |
Memantine Use in Attention Deficit Hyperactivity Disorder (ADHD) |
2022-04-26 |
|
|
| 979 |
Memantine Use in Major Depressive Disorder (MDD) |
2022-04-26 |
|
|
| 980 |
Memantine Use in Schizophrenia |
2022-04-26 |
|
|
| 981 |
Mementine Use in Bipolar Disorder |
2022-04-26 |
|
|
| 982 |
Procedure for Placing the Tubes |
2022-04-26 |
|
|
| 983 |
Conclusion and Practical Algorithm |
2022-04-25 |
|
|
| 984 |
Study Aim and Methodology |
2022-04-25 |
|
|
| 985 |
Pancreatic Machine Perfusion |
2022-04-23 |
|
|
| 986 |
Zebrafish Pancreas Development |
2022-04-23 |
|
|
| 987 |
Pancreas Organogenesis |
2022-04-23 |
|
|
| 988 |
Models of Pancreas Development |
2022-04-23 |
|
|
| 989 |
Guidelines on Severe Acute Pancreatitis |
2022-04-22 |
|
|
| 990 |
Acute Pancreatitis |
2022-04-22 |
|
|
| 991 |
Management of Pancreatic Trauma |
2022-04-22 |
|
|
| 992 |
Treatment of Walled-Off Pancreatic Necrosis (WOPN) |
2022-04-22 |
|
|
| 993 |
Palabras clave |
2022-04-22 |
|
|
| 994 |
Psychoses |
2022-04-22 |
|
|
| 995 |
Vernonia elaeagnifolia plant information |
2022-04-22 |
|
|
| 996 |
Common names |
2022-04-22 |
|
|
| 997 |
Taxonomic classification |
2022-04-22 |
|
|
| 998 |
Harvesting and Yield |
2022-04-22 |
|
|
| 999 |
Soil and Climate |
2022-04-22 |
|
|
| 1000 |
Origin and Distribution |
2022-04-22 |
|
|
| 1001 |
Physical Appearance |
2022-04-22 |
|
|
| 1002 |
Principales acciones Y mecanismo De la colchicine según la Evidencia clínica |
2022-04-21 |
|
|
| 1003 |
Conflicto De Interés |
2022-04-21 |
|
|
| 1004 |
Financiamiento |
2022-04-21 |
|
|
| 1005 |
Presentación Del Caso |
2022-04-21 |
|
|
| 1006 |
Presentación Del Caso |
2022-04-21 |
|
|
| 1007 |
Presentación Del Caso |
2022-04-21 |
|
|
| 1008 |
Topics of Pharmacokinetics |
2022-04-20 |
|
|
| 1009 |
Midstream: Kenya Petroleum Refineries LTD |
2022-04-20 |
|
|
| 1010 |
Laws and Regulations |
2022-04-20 |
|
|
| 1011 |
Oncology and Radiology |
2022-04-19 |
|
|
| 1012 |
Sessions and Tracks |
2022-04-19 |
|
|
| 1013 |
Features of Ethnographic Research |
2022-04-19 |
|
|
| 1014 |
Forms |
2022-04-19 |
|
|
| 1015 |
Compliance with Ethics Guidelines |
2022-04-18 |
|
|
| 1016 |
Instrumentation of HPLC |
2022-04-18 |
|
|
| 1017 |
Prospects of antiviral Agricultural antibiotics |
2022-04-18 |
|
|
| 1018 |
Mechanism of antibiotics to Control plant virus diseases |
2022-04-18 |
|
|
| 1019 |
Agricultural antiviral Antibiotics |
2022-04-18 |
|
|
| 1020 |
Research status of antiviral Antibiotics |
2022-04-18 |
|
|
| 1021 |
Extracts from Fungi |
2022-04-18 |
|
|
| 1022 |
Extracts from Bacteria |
2022-04-18 |
|
|
| 1023 |
Microbe Based Antiviral Agents |
2022-04-18 |
|
|
| 1024 |
Plant-Derived Compounds |
2022-04-18 |
|
|
| 1025 |
Substances Of Animal Origin |
2022-04-18 |
|
|
| 1026 |
Synthetic Chemical Substances |
2022-04-18 |
|
|
| 1027 |
How to Hire |
2022-04-18 |
|
|
| 1028 |
Future of school nurse in Pakistan |
2022-04-18 |
|
|
| 1029 |
Future 0f school nurse in Pakistan |
2022-04-18 |
|
|
| 1030 |
Role of School Nurse |
2022-04-18 |
|
|
| 1031 |
School Nurse |
2022-04-18 |
|
|
| 1032 |
Health challenges at school Level |
2022-04-18 |
|
|
| 1033 |
History of School Nurse |
2022-04-18 |
|
|
| 1034 |
Types of Tooth Restoration |
2022-04-18 |
|
|
| 1035 |
Advantages of Dental Implants |
2022-04-18 |
|
|
| 1036 |
Causes and Symptoms of Periodontitis |
2022-04-18 |
|
|
| 1037 |
Diagnosis and Treatment |
2022-04-18 |
|
|
| 1038 |
Pneumoconiosis Caused By Specific Exposures |
2022-04-18 |
|
|
| 1039 |
Dental Technicians’ Pneumoconiosis |
2022-04-18 |
|
|
| 1040 |
Caring for caregiver |
2022-04-18 |
|
|
| 1041 |
Challenges and difficulties |
2022-04-18 |
|
|
| 1042 |
Editorial notes |
2022-04-18 |
|
|
| 1043 |
Caregiving |
2022-04-16 |
|
|
| 1044 |
Limitations the Study |
2022-04-15 |
|
|
| 1045 |
Mood Disorder Symptoms |
2022-04-15 |
|
|
| 1046 |
The Future of Surgery |
2022-04-15 |
|
|
| 1047 |
Health Disorders in People |
2022-04-15 |
|
|
| 1048 |
Health Disorders in Mental Health |
2022-04-15 |
|
|
| 1049 |
Probability Theory of Machine Learning |
2022-04-15 |
|
|
| 1050 |
Machine Learning Methods |
2022-04-15 |
|
|
| 1051 |
Stress Management |
2022-04-15 |
|
|
| 1052 |
Fundamental principle of Applied mechanics |
2022-04-13 |
|
|
| 1053 |
Fidelidad |
2022-04-11 |
|
|
| 1054 |
Efectos de finerenone sobre el potasio |
2022-04-11 |
|
|
| 1055 |
Mecanismo De Acción |
2022-04-11 |
|
|
| 1056 |
Farmacologia Y Farmacodinamia De Finerenone |
2022-04-11 |
|
|
| 1057 |
Antagonista Mineralcorticoide Y Su Rol En Erd |
2022-04-11 |
|
|
| 1058 |
Chronic Kidney Disease Causes |
2022-04-11 |
|
|
| 1059 |
Estrategias terapéuticas en ERD |
2022-04-11 |
|
|
| 1060 |
Fisiopatología de ERD |
2022-04-11 |
|
|
| 1061 |
Enfermedad Renal Diabetica |
2022-04-11 |
|
|
| 1062 |
Introduccion |
2022-04-11 |
|
|
| 1063 |
Consideraciones Eticas |
2022-04-11 |
|
|
| 1064 |
Sickle Cell Anemia |
2022-04-11 |
|
|
| 1065 |
Caso Clinico |
2022-04-11 |
|
|
| 1066 |
Consideraciones Éticas |
2022-04-11 |
|
|
| 1067 |
Metodología |
2022-04-11 |
|
|
| 1068 |
Protein Biosynthesis during Translation |
2022-04-11 |
|
|
| 1069 |
Discusion |
2022-04-11 |
|
|
| 1070 |
Resultados |
2022-04-11 |
|
|
| 1071 |
Metodologia |
2022-04-11 |
|
|
| 1072 |
Stem Cell Division |
2022-04-11 |
|
|
| 1073 |
Cancer Theory |
2022-04-11 |
|
|
| 1074 |
Goal of Zollinger-Ellison Syndrome Therapy |
2022-04-08 |
|
|
| 1075 |
Kawasaki Disease Treatment |
2022-04-08 |
|
|
| 1076 |
Kawasaki Disease Diagnosis |
2022-04-08 |
|
|
| 1077 |
Brief Work Done by Different Workers |
2022-04-08 |
|
|
| 1078 |
Barley Diversity |
2022-04-08 |
|
|
| 1079 |
Barley Classification |
2022-04-08 |
|
|
| 1080 |
Benefits of Barley Consumption |
2022-04-08 |
|
|
| 1081 |
Availability of Data and Materials |
2022-04-08 |
|
|
| 1082 |
Ethics Approval and Consent Participate |
2022-04-08 |
|
|
| 1083 |
Atopic Dermatitis Diagnosis |
2022-04-08 |
|
|
| 1084 |
Role of CT CAG in Diagnosis |
2022-04-06 |
|
|
| 1085 |
Dual Lad Variants and Their Clinical Significance |
2022-04-06 |
|
|
| 1086 |
Dual Lad: Morphological Classification |
2022-04-06 |
|
|
| 1087 |
Dual Lad: Embryologic Basis |
2022-04-06 |
|
|
| 1088 |
Dual Lad: Anatomy and Definition |
2022-04-06 |
|
|
| 1089 |
Importance of Mistranslation |
2022-04-04 |
|
|
| 1090 |
Importance of Drug Analysis |
2022-04-04 |
|
|
| 1091 |
Contributorship Statement |
2022-03-30 |
|
|
| 1092 |
Conflict Disclosures |
2022-03-30 |
|
|
| 1093 |
About the Disease |
2022-03-30 |
|
|
| 1094 |
Some Heart Diseases Related to HIV |
2022-03-30 |
|
|
| 1095 |
Implication of Medicinal Cannabis in the Future |
2022-03-29 |
|
|
| 1096 |
Endocannabinoid System |
2022-03-29 |
|
|
| 1097 |
Cannabis in the 21th Century and Beyond |
2022-03-29 |
|
|
| 1098 |
Cannabis in the 20th Century |
2022-03-29 |
|
|
| 1099 |
Cannabis in the 19th Century |
2022-03-29 |
|
|
| 1100 |
Ancient History of Cannabis |
2022-03-29 |
|
|
| 1101 |
Facial Cleft Treatment in this New Era |
2022-03-29 |
|
|
| 1102 |
Stages of Oral Cancer |
2022-03-29 |
|
|
| 1103 |
Risk Factors for Oral Cancer |
2022-03-29 |
|
|
| 1104 |
Fondos |
2022-03-24 |
|
|
| 1105 |
Conflicto de Intereses |
2022-03-24 |
|
|
| 1106 |
Agradecimientos |
2022-03-24 |
|
|
| 1107 |
Materiales y Métodos |
2022-03-23 |
|
|
| 1108 |
Discusión |
2022-03-23 |
|
|
| 1109 |
Introducción |
2022-03-23 |
|
|
| 1110 |
Conclusion |
2022-03-23 |
|
|
| 1111 |
Métodos |
2022-03-23 |
|
|
| 1112 |
Métodos |
2022-03-23 |
|
|
| 1113 |
Métodos |
2022-03-23 |
|
|
| 1114 |
Referencias |
2022-03-23 |
|
|
| 1115 |
Multiple myeloma Complications |
2022-03-23 |
|
|
| 1116 |
Causes of Dvt |
2022-03-23 |
|
|
| 1117 |
Blood Vessels and Types |
2022-03-23 |
|
|
| 1118 |
Circulatory System Circuits |
2022-03-23 |
|
|
| 1119 |
Analytical Techniques Used the Diagnosis of Sars Cov-2 |
2022-03-22 |
|
|
| 1120 |
Biochemical Characterization of Sars-Cov-2 Virus |
2022-03-22 |
|
|
| 1121 |
Maxillary Sinus Aspergillosis in an Immunocompetent adult female |
2022-03-21 |
|
|
| 1122 |
Knowledge and Practice of Breast Self-Examination and associated Factors among women Students in west Arsi Zone, Southeast Ethiopia |
2022-03-21 |
|
|
| 1123 |
Limitation of our Study |
2022-03-17 |
|
|
| 1124 |
Hepatitis Vaccines |
2022-03-17 |
|
|
| 1125 |
Causes of Hepatitis |
2022-03-17 |
|
|
| 1126 |
Types of Hepatitis |
2022-03-17 |
|
|
| 1127 |
Antibiotics that Target Cell |
2022-03-17 |
|
|
| 1128 |
Psychopath Personality |
2022-03-17 |
|
|
| 1129 |
Psychotherapy |
2022-03-17 |
|
|
| 1130 |
Treatment/Counteraction |
2022-03-17 |
|
|
| 1131 |
Manifestations |
2022-03-17 |
|
|
| 1132 |
Common Triggers of Drug Allergies |
2022-03-17 |
|
|
| 1133 |
Types of Drug Allergies |
2022-03-17 |
|
|
| 1134 |
Symptoms of Drug Allergies |
2022-03-17 |
|
|
| 1135 |
Concepts of Pharmacodynamics |
2022-03-17 |
|
|
| 1136 |
Effects of pharmacodynamics On the body |
2022-03-17 |
|
|
| 1137 |
Importance of Pharmacodynamics |
2022-03-17 |
|
|
| 1138 |
Attention Deficit Hyperactivity Disease |
2022-03-16 |
|
|
| 1139 |
ATTENTION-DEFICIT/HYPERACTIVITY DISORDER |
2022-03-14 |
|
|
| 1140 |
CYBER PSYCHOLOGY |
2022-03-14 |
|
|
| 1141 |
PSYCHOLOGICAL STRESS LEVELS |
2022-03-14 |
|
|
| 1142 |
Treatments and Therapies |
2022-03-14 |
|
|
| 1143 |
Schizophrenia: Symptoms and Treatments |
2022-03-14 |
|
|
| 1144 |
OPPOSITIONAL DEFIANT DISORDER |
2022-03-14 |
|
|
| 1145 |
Prevention from corona virus |
2022-03-11 |
|
|
| 1146 |
Conflict of Authors |
2022-03-11 |
|
|
| 1147 |
Stroke Symptoms |
2022-03-10 |
|
|
| 1148 |
Symptoms and Signs |
2022-03-10 |
|
|
| 1149 |
History of Neuropharmacology |
2022-03-08 |
|
|
| 1150 |
Applications of Neuropharmacology |
2022-03-08 |
|
|
| 1151 |
Causes of Liver Disease |
2022-03-08 |
|
|
| 1152 |
Stages of Liver Disease |
2022-03-08 |
|
|
| 1153 |
Osteosarcoma |
2022-03-08 |
|
|
| 1154 |
Gallstone Disease |
2022-03-08 |
|
|
| 1155 |
Over Load of Iron Transplantation |
2022-03-08 |
|
|
| 1156 |
Hepatobiliary Manifestations of Sickle Cell Disease |
2022-03-08 |
|
|
| 1157 |
Available Therapies |
2022-03-08 |
|
|
| 1158 |
Causes Of Wilsonâ??s Disease |
2022-03-08 |
|
|
| 1159 |
Causes of Wilson’s Disease |
2022-03-08 |
|
|
| 1160 |
Detection Techniques |
2022-03-08 |
|
|
| 1161 |
Types of Industrial Fermenters |
2022-03-05 |
|
|
| 1162 |
Types of Small Fermenters |
2022-03-05 |
|
|
| 1163 |
Uses of Withania somnifera |
2022-03-05 |
|
|
| 1164 |
Chemical Constituents of Withania somnifera |
2022-03-04 |
|
|
| 1165 |
Characteristics of Withania Somnifera |
2022-03-04 |
|
|
| 1166 |
Roles of Amino Acids in Human Body |
2022-03-04 |
|
|
| 1167 |
Types of Carbohydrates |
2022-03-04 |
|
|
| 1168 |
Mutation Changes Within a Gene |
2022-03-04 |
|
|
| 1169 |
Post Traumatic Epilepsy |
2022-03-03 |
|
|
| 1170 |
Causes Of Atrial Fibrilliation |
2022-03-03 |
|
|
| 1171 |
Management and Leadership Skills |
2022-03-02 |
|
|
| 1172 |
Different Management Styles |
2022-03-02 |
|
|
| 1173 |
Need for Organization Management |
2022-03-02 |
|
|
| 1174 |
Analytical Strategy |
2022-03-02 |
|
|
| 1175 |
Rewarding Work |
2022-03-02 |
|
|
| 1176 |
Motivation for Public Services |
2022-03-02 |
|
|
| 1177 |
Injury Classification |
2022-03-02 |
|
|
| 1178 |
Future |
2022-03-02 |
|
|
| 1179 |
Tools and Techniques |
2022-03-02 |
|
|
| 1180 |
Mobile Forensic Research Process |
2022-03-02 |
|
|
| 1181 |
Steps to Process |
2022-03-02 |
|
|
| 1182 |
Detection |
2022-03-02 |
|
|
| 1183 |
Types of Discoloration |
2022-03-02 |
|
|
| 1184 |
Biochemical Studies of Anabolic Steroids |
2022-03-02 |
|
|
| 1185 |
Mandibular Incisor Extraction: Whether Or Not - A Couple of Case Reports |
2022-02-28 |
|
|
| 1186 |
Dental Hygiene for Children: Conducting a Scoping Review for Assessing the Prevalence of Dental Caries in Primary Schools |
2022-02-28 |
|
|
| 1187 |
Juvenile Ossifying Fibroma of the Maxilla: A Case Report of a 15 year Old Girl |
2022-02-28 |
|
|
| 1188 |
Mental Foramen Location among Iraqi Population: Cross Sectional Study |
2022-02-28 |
|
|
| 1189 |
Periodontal Status and its Impact on Oral Health Related Quality of Life (OHRQOL) |
2022-02-28 |
|
|
| 1190 |
Prevalence of Four Canals in Mandibular First Molars in Libyan Subpopulation: An InVivo Study |
2022-02-28 |
|
|
| 1191 |
|
2022-02-28 |
|
|
| 1192 |
The Impact of Mucosal Bio adhesive on Oral Aphthous Ulcer Pain and Duration |
2022-02-28 |
|
|
| 1193 |
Can Umblical Cord-Derived Mesenchymal Stem Cells be used in Retinal Diseases: A Case Presentation of Leber Congenital Amaurosis |
2022-02-26 |
|
|
| 1194 |
Resurgent Decompressive Cranial Surgery Following Severe Traumatic Brain Injury |
2022-02-26 |
|
|
| 1195 |
An Overview of the Biomedical Significance of Alpha1-Antitrypsin |
2022-02-26 |
|
|
| 1196 |
Treatment of Temporal Lobe Epilepsy with Stem Cells |
2022-02-26 |
|
|
| 1197 |
Literature Review and Theoretical Framework |
2022-02-24 |
|
|
| 1198 |
Literature Review and Hypothesis Development |
2022-02-24 |
|
|
| 1199 |
Variables in the Study |
2022-02-24 |
|
|
| 1200 |
Method of Data Analysis |
2022-02-24 |
|
|
| 1201 |
Research Gap |
2022-02-24 |
|
|
| 1202 |
Experiments with Intraduodenal Infusion |
2022-02-23 |
|
|
| 1203 |
Experiments With Pancreatic Juice Diversion |
2022-02-23 |
|
|
| 1204 |
Implications for Care |
2022-02-23 |
|
|
| 1205 |
Systematic Review |
2022-02-23 |
|
|
| 1206 |
Theoretical Foundation of the Model |
2022-02-23 |
|
|
| 1207 |
Helicopter Parenting |
2022-02-23 |
|
|
| 1208 |
Cystic Fibrosis |
2022-02-23 |
|
|
| 1209 |
Pathologic Features |
2022-02-23 |
|
|
| 1210 |
Complications for Appendicitis |
2022-02-23 |
|
|
| 1211 |
Details of Ethics Approval |
2022-02-23 |
|
|
| 1212 |
Contribution to Authorship |
2022-02-23 |
|
|
| 1213 |
Disclosure of Intersts |
2022-02-23 |
|
|
| 1214 |
Pre-Operative Cardiovascular Optimization before Renal Transplantation |
2022-02-23 |
|
|
| 1215 |
Characterized as the Time between Atazanavir Inception and the Beginning of Signs or Manifestations of Nephrolithiasis |
2022-02-23 |
|
|
| 1216 |
Geriatric Standards can Assist with Meeting this New Test |
2022-02-23 |
|
|
| 1217 |
Albeit A Metabolic Acidosis likewise Happens in those with Ongoing Kidney Sickness |
2022-02-23 |
|
|
| 1218 |
Landscape of Kidney Tissue in Human Nephrotic Syndrome |
2022-02-23 |
|
|
| 1219 |
Submicron-Sized Nb-Doped Lithium Garnet for High Ionic Conductivity Solid Electrolyte and Performance |
2022-02-23 |
|
|
| 1220 |
Hydraulic stimulation of geothermal reservoirs: fluid flow, electric potential and microseismicity |
2022-02-23 |
|
|
| 1221 |
Application of Analytical Chemistry and Bioanalytical Chemistry |
2022-02-23 |
|
|
| 1222 |
Electrochemical impedance spectroscopy & Solid oxide electrolysis |
2022-02-23 |
|
|
| 1223 |
Electrochemistry for Soft Nanoparticle Detection: Gradients Prepared Using Bipolar Electrodeposition |
2022-02-23 |
|
|
| 1224 |
Types of Progeria |
2022-02-22 |
|
|
| 1225 |
Goal of Nutrigenomics |
2022-02-22 |
|
|
| 1226 |
Advantages and Disadvantages |
2022-02-22 |
|
|
| 1227 |
How Will Diet Affect Our Gene Expression? |
2022-02-22 |
|
|
| 1228 |
Nutrigenetics |
2022-02-22 |
|
|
| 1229 |
Advantages of GMO |
2022-02-22 |
|
|
| 1230 |
Transgenic Plants |
2022-02-22 |
|
|
| 1231 |
Hereditary Qualities |
2022-02-22 |
|
|
| 1232 |
Chemotherapy |
2022-02-21 |
|
|
| 1233 |
Cancer Prevention |
2022-02-21 |
|
|
| 1234 |
The Classical Action of Steroid Hormones |
2022-02-21 |
|
|
| 1235 |
Risk-Prediction Model |
2022-02-19 |
|
|
| 1236 |
Screening for Pancreatic Cancer |
2022-02-19 |
|
|
| 1237 |
Potential of Smartphone Technology for Cancer Detection and Diagnosis |
2022-02-19 |
|
|
| 1238 |
Potential Benefits of this Application |
2022-02-19 |
|
|
| 1239 |
Biliscreen Functioning |
2022-02-19 |
|
|
| 1240 |
Financial Interest |
2022-02-19 |
|
|
| 1241 |
Epidemiology And Clinical Presentation |
2022-02-18 |
|
|
| 1242 |
Nanocrystal Starch of Purple Sweetpotato Production |
2022-02-18 |
|
|
| 1243 |
Causes of Coastal Pollution |
2022-02-18 |
|
|
| 1244 |
In Addition to this a New Life-Giving Formula to Save the Life of a Patient in a Dangerous or Fatal Condition |
2022-02-17 |
|
|
| 1245 |
Highly Effective Vaccine and Medicine! |
2022-02-17 |
|
|
| 1246 |
Results/Discussion |
2022-02-17 |
|
|
| 1247 |
Treatment Phases |
2022-02-17 |
|
|
| 1248 |
Dosage and Administration |
2022-02-16 |
|
|
| 1249 |
Operations |
2022-02-16 |
|
|
| 1250 |
Advantages of Data Mining |
2022-02-16 |
|
|
| 1251 |
Data Mining Uses |
2022-02-16 |
|
|
| 1252 |
Results and Obeservations |
2022-02-15 |
|
|
| 1253 |
The Source of any Support Recieved |
2022-02-15 |
|
|
| 1254 |
The Conflict of Interest |
2022-02-15 |
|
|
| 1255 |
Other Diagnostic Methods |
2022-02-15 |
|
|
| 1256 |
Causes of Marfans |
2022-02-14 |
|
|
| 1257 |
Effects of Poor Attitudes of Health Workers on Maternal Health |
2022-02-10 |
|
|
| 1258 |
Phase 0 Clinical Trials |
2022-02-09 |
|
|
| 1259 |
Competing of Interest |
2022-02-09 |
|
|
| 1260 |
Current Treatments |
2022-02-09 |
|
|
| 1261 |
Genetic Risk Factors |
2022-02-09 |
|
|
| 1262 |
Unequal Access to Educational Resources and Technology |
2022-02-09 |
|
|
| 1263 |
Online Learning |
2022-02-09 |
|
|
| 1264 |
Factors Affecting Microbial Bioremediation |
2022-02-08 |
|
|
| 1265 |
Bioremediation Principles |
2022-02-08 |
|
|
| 1266 |
Biological Activities of the EO of Olea erupaea |
2022-02-07 |
|
|
| 1267 |
Biological Activities of the EO of Olea erupaea |
2022-02-07 |
|
|
| 1268 |
Feed Nutritional Composition |
2022-02-07 |
|
|
| 1269 |
Key Diseases |
2022-02-04 |
|
|
| 1270 |
CAN THE FUEL DEBRIS BE SAFELY REMOVED? |
2022-02-03 |
|
|
| 1271 |
BANANA SPLIT FOR HYDROGEN PRODUCTION |
2022-02-03 |
|
|
| 1272 |
BIOMASS PYROLYSIS |
2022-02-03 |
|
|
| 1273 |
BIOMASS GASIFICATION |
2022-02-03 |
|
|
| 1274 |
Complications of Sickle Cell Anemia |
2022-02-01 |
|
|
| 1275 |
Symptoms and Diagnosis |
2022-02-01 |
|
|
| 1276 |
Atopic Dermatitis |
2022-01-31 |
|
|
| 1277 |
Skin Disorders |
2022-01-31 |
|
|
| 1278 |
Mechanisms |
2022-01-31 |
|
|
| 1279 |
Treatment and Prognosis |
2022-01-29 |
|
|
| 1280 |
Morphological, Biochemical and Growth Characteristics |
2022-01-13 |
|
|
| 1281 |
Tests Useful In Forensic Assessment and Evaluation |
2022-01-12 |
|
|
| 1282 |
Dental Conditions and Caries |
2022-01-12 |
|
|
| 1283 |
Squamous-Cell Carcinoma |
2022-01-05 |
|
|
| 1284 |
Polygenic Risk Score for NAFLD-Related HCC |
2022-01-05 |
|
|
| 1285 |
Hepatic Lipogenesis Carcinogenesis |
2022-01-05 |
|
|
| 1286 |
The Key Factors in NAFLD-Associated HCC |
2022-01-05 |
|
|
| 1287 |
Link between Hypertension and NAFLD along with Genetic Relation |
2022-01-05 |
|
|
| 1288 |
Risk Factors and Multifactorial Process in NAFLD-Associated HCC |
2022-01-05 |
|
|
| 1289 |
Non Invasive Elastography and Magnetic Resonance Imaging as Alternatives to Liver Biopsy |
2022-01-05 |
|
|
| 1290 |
Non-Invasive Elastography and Magnetic Resonance Imaging as Alternatives to Liver Biopsy |
2022-01-05 |
|
|
| 1291 |
Non-Invasive Elastography and Magnetic Resonance Imaging as Alternatives to Liver Biopsy |
2022-01-05 |
|
|
| 1292 |
Clinical Presentations in NAFLD/NASH-Related HCC |
2022-01-05 |
|
|
| 1293 |
Association between NAFLD/NASH and Atherosclerosis |
2022-01-05 |
|
|
| 1294 |
Histopathology and Diagnosis |
2022-01-05 |
|
|
| 1295 |
Isomerism |
2022-01-03 |
|
|
| 1296 |
Secondary Outcomes |
2021-12-31 |
|
|
| 1297 |
Study Results |
2021-12-31 |
|
|
| 1298 |
Quality Sleep |
2021-12-31 |
|
|
| 1299 |
Mindfulness |
2021-12-31 |
|
|
| 1300 |
Habit Formation |
2021-12-31 |
|
|
| 1301 |
Behavior Change |
2021-12-31 |
|
|
| 1302 |
Medication Iteration |
2021-12-31 |
|
|
| 1303 |
Blood Glucose Monitoring |
2021-12-31 |
|
|
| 1304 |
Beliefs |
2021-12-30 |
|
|
| 1305 |
Modern Herbal Medicine |
2021-12-30 |
|
|
| 1306 |
Types of Drug Interactions |
2021-12-30 |
|
|
| 1307 |
Types of Toxicology |
2021-12-30 |
|
|
| 1308 |
Dose Response Complexities |
2021-12-30 |
|
|
| 1309 |
Testing Methods |
2021-12-30 |
|
|
| 1310 |
Branches of Clinical Pharmacology |
2021-12-30 |
|
|
| 1311 |
A SEA OF QUESTIONS |
2021-12-28 |
|
|
| 1312 |
A NEW OPEN OCEAN |
2021-12-28 |
|
|
| 1313 |
Key Concepts |
2021-12-27 |
|
|
| 1314 |
2nd Position (As per Healthcare Provider Point of View) |
2021-12-24 |
|
|
| 1315 |
1st Position (From the Organizational Point of View) |
2021-12-24 |
|
|
| 1316 |
Composition of Artificial Blood |
2021-12-16 |
|
|
| 1317 |
Cryptococcosis Status In Ethiopia |
2021-12-16 |
|
|
| 1318 |
Role of International Organizations |
2021-12-16 |
|
|
| 1319 |
Clinical Signs |
2021-12-16 |
|
|
| 1320 |
History Of Cryptococcosis |
2021-12-16 |
|
|
| 1321 |
Soil Moisture |
2021-12-16 |
|
|
| 1322 |
Technologies |
2021-12-15 |
|
|
| 1323 |
Advantages of IoT |
2021-12-15 |
|
|
| 1324 |
Tourism Risk Perception of Local Communities |
2021-12-14 |
|
|
| 1325 |
Teorethical Background |
2021-12-14 |
|
|
| 1326 |
Overview of Knowledge and Palliative Care |
2021-12-14 |
|
|
| 1327 |
Pain and Palliative Care Education in Mozambique |
2021-12-14 |
|
|
| 1328 |
Importance of The Work |
2021-12-14 |
|
|
| 1329 |
The Value Of Monitoring By Combination Of Qb And Pa |
2021-12-14 |
|
|
| 1330 |
Limitations in Current Practise and Previous Research |
2021-12-14 |
|
|
| 1331 |
The Life of a Sea Horse |
2021-12-14 |
|
|
| 1332 |
Limitation of Flies Abundance |
2021-12-13 |
|
|
| 1333 |
Options Include |
2021-12-13 |
|
|
| 1334 |
Emotional Modifications May Also Include |
2021-12-13 |
|
|
| 1335 |
Cognitive Modifications May Also Include |
2021-12-13 |
|
|
| 1336 |
Physical Signs Include |
2021-12-13 |
|
|
| 1337 |
Limitations and Recommendations |
2021-12-13 |
|
|
| 1338 |
Research Includes |
2021-12-13 |
|
|
| 1339 |
Alzheimer's Disease and Down Syndrome Research |
2021-12-13 |
|
|
| 1340 |
Appreciation |
2021-12-13 |
|
|
| 1341 |
The Link Between Bone and Cardiac Inflammation |
2021-12-10 |
|
|
| 1342 |
Cardiovascular Involvement In Spondyloarthropathies |
2021-12-10 |
|
|
| 1343 |
Rsi |
2021-12-10 |
|
|
| 1344 |
Editorial on Acute Patient Care |
2021-12-10 |
|
|
| 1345 |
Modern Methods of Preservation and Conservation of Mutilated Health Records |
2021-12-10 |
|
|
| 1346 |
Diagnostic Approaches for Care of Severely Injured Patient |
2021-12-10 |
|
|
| 1347 |
Funding Conclusion |
2021-12-10 |
|
|
| 1348 |
Results and Dicsussion |
2021-12-08 |
|
|
| 1349 |
Early childhood to adult |
2021-12-08 |
|
|
| 1350 |
Infants |
2021-12-08 |
|
|
| 1351 |
Epigenetics and Development |
2021-12-08 |
|
|
| 1352 |
Non-coding RNA |
2021-12-08 |
|
|
| 1353 |
Histone-modified |
2021-12-08 |
|
|
| 1354 |
Histone-modifie |
2021-12-08 |
|
|
| 1355 |
Mitochondrial inheritance |
2021-12-08 |
|
|
| 1356 |
Stages |
2021-12-08 |
|
|
| 1357 |
Company Support |
2021-12-08 |
|
|
| 1358 |
Patient Conset |
2021-12-08 |
|
|
| 1359 |
Is Sleep Paralysis a Sign of Something More Serious? |
2021-12-07 |
|
|
| 1360 |
What is Chronotherapy and How Does it Work? Sleep Disorders and Depression: The Benefits of Chronotherapeutic Treatment |
2021-12-07 |
|
|
| 1361 |
Cataplexy how it is Diagnosed and Treated |
2021-12-07 |
|
|
| 1362 |
Editorâ??s Note on Different Types of Parasomnia |
2021-12-07 |
|
|
| 1363 |
Editorâ??s Note on Different Types of Parasomnia |
2021-12-07 |
|
|
| 1364 |
Editorâ??s Note on Different Types of Parasomnia |
2021-12-07 |
|
|
| 1365 |
Parasomnia; How it is Diagnosed and Treated |
2021-12-07 |
|
|
| 1366 |
Techniques by Chromatographic Bed Shape |
2021-12-07 |
|
|
| 1367 |
Literature Review and Hypothesis |
2021-12-06 |
|
|
| 1368 |
What is Drug Reactions and What its Side Effect |
2021-12-04 |
|
|
| 1369 |
What is Epigenetics and What its Type |
2021-12-04 |
|
|
| 1370 |
A Basic Overview of How Drugs Work |
2021-12-04 |
|
|
| 1371 |
Interactions Between Different Drugs |
2021-12-04 |
|
|
| 1372 |
An Overview of Pharmacology |
2021-12-04 |
|
|
| 1373 |
An Overview of Bypass Surgery |
2021-12-04 |
|
|
| 1374 |
A Briefly Introduction of Pulmonary Embolism. |
2021-12-04 |
|
|
| 1375 |
A Briefly Introduction of Pulmonary Embolism |
2021-12-04 |
|
|
| 1376 |
Symptoms and Causes of Carotid Artery Disease |
2021-12-04 |
|
|
| 1377 |
Introduction and Presentation of Vascular Disease |
2021-12-04 |
|
|
| 1378 |
An Overview and Symptoms of Aorta |
2021-12-04 |
|
|
| 1379 |
Availability of Data and Information |
2021-12-03 |
|
|
| 1380 |
Epidemiology of lymphobia disease |
2021-12-03 |
|
|
| 1381 |
Therapies in alzheimer's disease |
2021-12-03 |
|
|
| 1382 |
Management of amblyopia |
2021-12-03 |
|
|
| 1383 |
Energy Balance and Conceptual Process Costs |
2021-12-02 |
|
|
| 1384 |
Algae Feedstocks |
2021-12-02 |
|
|
| 1385 |
Liquefaction Process Results |
2021-12-02 |
|
|
| 1386 |
Wet Biomass Feedstocks-Properties and Preparation for Processing |
2021-12-02 |
|
|
| 1387 |
Introduction on Hydrothermal Liquefaction |
2021-12-02 |
|
|
| 1388 |
Evaluation Parameters |
2021-12-02 |
|
|
| 1389 |
Formulations |
2021-12-02 |
|
|
| 1390 |
Components of FFS |
2021-12-02 |
|
|
| 1391 |
Properties of Film |
2021-12-02 |
|
|
| 1392 |
Film Forming System |
2021-12-02 |
|
|
| 1393 |
Skin |
2021-12-02 |
|
|
| 1394 |
Drafting, Approval of the Submitted Manuscript |
2021-12-02 |
|
|
| 1395 |
Interpretation of the Data |
2021-12-02 |
|
|
| 1396 |
Conception and Design of Manuscript |
2021-12-02 |
|
|
| 1397 |
Ethics Committee Record |
2021-12-01 |
|
|
| 1398 |
Conflicts of Interest and Financial Support |
2021-12-01 |
|
|
| 1399 |
End and Significance |
2021-12-01 |
|
|
| 1400 |
Analysis of Images |
2021-12-01 |
|
|
| 1401 |
Brain Connections |
2021-11-30 |
|
|
| 1402 |
Review of Assessment of Msd |
2021-11-30 |
|
|
| 1403 |
Bibliometric Analysis |
2021-11-30 |
|
|
| 1404 |
Material |
2021-11-29 |
|
|
| 1405 |
Results, Discussion and Achievements |
2021-11-29 |
|
|
| 1406 |
Research Methodology and Materials |
2021-11-29 |
|
|
| 1407 |
Using Clay Mineral as a Possible Seasonal Indicator for the Sunda Shelf |
2021-11-27 |
|
|
| 1408 |
Composition of Clay Mineralogy |
2021-11-27 |
|
|
| 1409 |
A Fusion of Mscs And The Crispr-Cas9 Technology in Bone Regeneration Therapy |
2021-11-27 |
|
|
| 1410 |
Potential and Limitations of Mscs in Bone Regeneration Therapy |
2021-11-27 |
|
|
| 1411 |
Hazard Factors |
2021-11-27 |
|
|
| 1412 |
Conflicts of Interest and Source Funding |
2021-11-27 |
|
|
| 1413 |
Structure Of Corona Virus |
2021-11-26 |
|
|
| 1414 |
Black Fungus Infection (Mucormycosis) |
2021-11-26 |
|
|
| 1415 |
Drugs Interaction |
2021-11-26 |
|
|
| 1416 |
D-Dimer |
2021-11-26 |
|
|
| 1417 |
Compliance and Severity of COVID-19 Associated ARDS |
2021-11-26 |
|
|
| 1418 |
Research Funding |
2021-11-26 |
|
|
| 1419 |
About the Story |
2021-11-26 |
|
|
| 1420 |
Behaviour Changes |
2021-11-25 |
|
|
| 1421 |
Analysis of Issue |
2021-11-24 |
|
|
| 1422 |
Definition of Negligence |
2021-11-24 |
|
|
| 1423 |
Vaccination Challengers |
2021-11-23 |
|
|
| 1424 |
Discriminant Pcr Test |
2021-11-23 |
|
|
| 1425 |
Results of Evaluation |
2021-11-23 |
|
|
| 1426 |
Repurposing Accomplishments |
2021-11-23 |
|
|
| 1427 |
Computer-Aided Drug Design |
2021-11-23 |
|
|
| 1428 |
Rational Drug Discovery |
2021-11-23 |
|
|
| 1429 |
Drug Targets |
2021-11-23 |
|
|
| 1430 |
Pathophysiology of Fatigue in MS |
2021-11-22 |
|
|
| 1431 |
All These Measures Yielded Negligible Improvements |
2021-11-22 |
|
|
| 1432 |
Types of Thyroid Nodule |
2021-11-22 |
|
|
| 1433 |
Advances in Adaptation to Biotic and Abiotic Stress |
2021-11-22 |
|
|
| 1434 |
Tomato Production Output Index |
2021-11-22 |
|
|
| 1435 |
PSYCHOLOGICAL ASPECTS OF CANNABIS |
2021-11-22 |
|
|
| 1436 |
Covid-19 And Antimicrobial Resistance |
2021-11-22 |
|
|
| 1437 |
Why antibiotics are used in a viral pandemic? |
2021-11-22 |
|
|
| 1438 |
Use of Antibiotics During Covid-19 |
2021-11-22 |
|
|
| 1439 |
Conceptual |
2021-11-22 |
|
|
| 1440 |
Resilience-Building Management of The Gut Microbiota |
2021-11-20 |
|
|
| 1441 |
Conclusion and Significance |
2021-11-20 |
|
|
| 1442 |
Methodology and Theoretical Orientation |
2021-11-20 |
|
|
| 1443 |
Potential implications for future antimicrobial drug discovery to treat Burkholderia -related diseases |
2021-11-19 |
|
|
| 1444 |
Evaluation of Microspheres |
2021-11-19 |
|
|
| 1445 |
Bacopa monniera |
2021-11-19 |
|
|
| 1446 |
Ginko biloba |
2021-11-19 |
|
|
| 1447 |
Ginko biloba |
2021-11-19 |
|
|
| 1448 |
Need and Significance |
2021-11-19 |
|
|
| 1449 |
Source funding |
2021-11-18 |
|
|
| 1450 |
Ethical Analysis |
2021-11-17 |
|
|
| 1451 |
Arguments of proponents and Critics |
2021-11-17 |
|
|
| 1452 |
Advantages of TeleMedicine |
2021-11-17 |
|
|
| 1453 |
TeleMedicine Vs TeleHealth |
2021-11-17 |
|
|
| 1454 |
Addressing the Challenges |
2021-11-17 |
|
|
| 1455 |
Ethical Questions |
2021-11-17 |
|
|
| 1456 |
Challenges |
2021-11-17 |
|
|
| 1457 |
Review Status |
2021-11-17 |
|
|
| 1458 |
Dissemination |
2021-11-17 |
|
|
| 1459 |
Meta Analytic Approach |
2021-11-17 |
|
|
| 1460 |
Methods and Analysis |
2021-11-17 |
|
|
| 1461 |
Fish in Paduan Dietetics in Relation to Other Diseases |
2021-11-15 |
|
|
| 1462 |
Paduan Dietetics on Cancer and Fish |
2021-11-15 |
|
|
| 1463 |
Promotion and Application of the Model |
2021-11-15 |
|
|
| 1464 |
Model Evaluations |
2021-11-15 |
|
|
| 1465 |
Conclusion Review |
2021-11-15 |
|
|
| 1466 |
Treatment for Fibrosarcoma |
2021-11-12 |
|
|
| 1467 |
Cause and Risk Factors |
2021-11-12 |
|
|
| 1468 |
Symptons of Fibrosarcoma |
2021-11-12 |
|
|
| 1469 |
Complications Associated With Bone Marrow Transplant |
2021-11-12 |
|
|
| 1470 |
Different Types of Transplant |
2021-11-12 |
|
|
| 1471 |
Aim of the Research |
2021-11-12 |
|
|
| 1472 |
Establishment and Solution of The Model |
2021-11-12 |
|
|
| 1473 |
Index Selection |
2021-11-12 |
|
|
| 1474 |
Screening |
2021-11-11 |
|
|
| 1475 |
Tests |
2021-11-11 |
|
|
| 1476 |
Sperm Size |
2021-11-11 |
|
|
| 1477 |
Sperm Quality |
2021-11-11 |
|
|
| 1478 |
Signs and Symptoms of Sexually Transmitted Disease |
2021-11-11 |
|
|
| 1479 |
Policy Recommendations |
2021-11-11 |
|
|
| 1480 |
Therapeutic Modality |
2021-11-10 |
|
|
| 1481 |
Chloroquine and Hydroxychloroquine |
2021-11-10 |
|
|
| 1482 |
Natural Products |
2021-11-10 |
|
|
| 1483 |
Protease Inhibitors |
2021-11-10 |
|
|
| 1484 |
Interferons |
2021-11-10 |
|
|
| 1485 |
Acknowledge |
2021-11-09 |
|
|
| 1486 |
Severity of Symptomatic Infection |
2021-11-09 |
|
|
| 1487 |
Research Review |
2021-11-09 |
|
|
| 1488 |
Methodology and Results |
2021-11-08 |
|
|
| 1489 |
Appendix I |
2021-11-08 |
|
|
| 1490 |
Conclusion and Policy |
2021-11-08 |
|
|
| 1491 |
Disclosure of Funding Support |
2021-11-05 |
|
|
| 1492 |
Functions of Mitochondria |
2021-11-03 |
|
|
| 1493 |
Functions of Mitochondria |
2021-11-03 |
|
|
| 1494 |
Functions of Mitochondria |
2021-11-03 |
|
|
| 1495 |
Functions of Mitochondria |
2021-11-03 |
|
|
| 1496 |
Functions of Mitochondria |
2021-11-03 |
|
|
| 1497 |
Structure of Mitochondria |
2021-11-03 |
|
|
| 1498 |
Intoxication |
2021-11-03 |
|
|
| 1499 |
Pharmacodynamics of Zopiclone |
2021-11-03 |
|
|
| 1500 |
Zopiclone |
2021-11-03 |
|
|
| 1501 |
Management and Insomnia |
2021-11-03 |
|
|
| 1502 |
Historical Resources |
2021-11-03 |
|
|
| 1503 |
Ecotourism Resources of The Area |
2021-11-03 |
|
|
| 1504 |
Strengths of India Mice Brand |
2021-11-03 |
|
|
| 1505 |
Acknowledgements and Funding |
2021-11-03 |
|
|
| 1506 |
Safety Culture |
2021-11-03 |
|
|
| 1507 |
Availability of Safety Data |
2021-11-03 |
|
|
| 1508 |
Interoperability |
2021-11-03 |
|
|
| 1509 |
Applying Human Factors Practices in Aviation to Healthcare |
2021-11-03 |
|
|
| 1510 |
Medical and aviation error in the u.s. |
2021-11-03 |
|
|
| 1511 |
Proceedings |
2021-11-03 |
|
|
| 1512 |
Computer Software |
2021-11-02 |
|
|
| 1513 |
Computer Hardware |
2021-11-02 |
|
|
| 1514 |
Patients with an "impaired immune system" may nevertheless be able to benefit |
2021-11-02 |
|
|
| 1515 |
Treatments with Monoclonal Antibodies |
2021-11-02 |
|
|
| 1516 |
Antibodies are no longer useful |
2021-11-02 |
|
|
| 1517 |
Serology |
2021-11-02 |
|
|
| 1518 |
Virulence, Pathogenesis, and Clinical Presentation |
2021-11-02 |
|
|
| 1519 |
Arthropod Vectors and Identification |
2021-11-02 |
|
|
| 1520 |
Epidemiology and Transmission |
2021-11-02 |
|
|
| 1521 |
Sneezing |
2021-11-02 |
|
|
| 1522 |
Purification of Eosinophil MBP and CLC Proteins |
2021-11-02 |
|
|
| 1523 |
Purification of Eosinophil Granules |
2021-11-02 |
|
|
| 1524 |
Enterococcus |
2021-11-02 |
|
|
| 1525 |
Escherichia coli |
2021-11-02 |
|
|
| 1526 |
Staphylococcus Aureus |
2021-11-02 |
|
|
| 1527 |
Campylobacter and Salmonella |
2021-11-02 |
|
|
| 1528 |
Therapy in Children |
2021-11-02 |
|
|
| 1529 |
Cost Effectiveness and Other Practical Aspects |
2021-11-02 |
|
|
| 1530 |
Drug Interactions and Comorbidities |
2021-11-02 |
|
|
| 1531 |
Titration |
2021-11-02 |
|
|
| 1532 |
Dosage and Titration |
2021-11-02 |
|
|
| 1533 |
Combination Therapy or Monotherapy |
2021-11-02 |
|
|
| 1534 |
Initiation of Therapy |
2021-11-02 |
|
|
| 1535 |
Mechanism of Action and Relevant Pharmacokinetics |
2021-11-02 |
|
|
| 1536 |
Non-Obstructive Coronary Artery Disease Myocardial Infarction |
2021-11-02 |
|
|
| 1537 |
Tissue Engineering Vascular Graft |
2021-11-01 |
|
|
| 1538 |
Key Messages |
2021-11-01 |
|
|
| 1539 |
Limitations for Further Studies |
2021-11-01 |
|
|
| 1540 |
Invention |
2021-11-01 |
|
|
| 1541 |
Recent Advances |
2021-11-01 |
|
|
| 1542 |
Funding Declaration |
2021-11-01 |
|
|
| 1543 |
Immunosuperssion |
2021-11-01 |
|
|
| 1544 |
Antioxidation |
2021-11-01 |
|
|
| 1545 |
Toxicokinetics |
2021-11-01 |
|
|
| 1546 |
Mechanism of Toxicity |
2021-11-01 |
|
|
| 1547 |
How did Life Begin? A Review of the Environmental and Biomolecular Hypotheses Surrounding Abiogenesis |
2021-11-01 |
|
|
| 1548 |
Assessment of Cross-Reactivity (CR) |
2021-11-01 |
|
|
| 1549 |
Diagnostic Approaches |
2021-11-01 |
|
|
| 1550 |
Monitoring the Acute Response |
2021-11-01 |
|
|
| 1551 |
Drug-Recognition and Immune Response |
2021-11-01 |
|
|
| 1552 |
Other Drugs |
2021-11-01 |
|
|
| 1553 |
Macrolids |
2021-11-01 |
|
|
| 1554 |
Sulfonamides |
2021-11-01 |
|
|
| 1555 |
Quinolones, Particularly Fluorquinolones (FQ) |
2021-11-01 |
|
|
| 1556 |
Non-Steroidal Anti-Inflammatory Drugs |
2021-11-01 |
|
|
| 1557 |
Betalactams |
2021-11-01 |
|
|
| 1558 |
Iodinated Contrast Media |
2021-11-01 |
|
|
| 1559 |
Anticonvulsants |
2021-11-01 |
|
|
| 1560 |
Drugs Involved |
2021-11-01 |
|
|
| 1561 |
Classification of T-Cell Drug Reactions |
2021-11-01 |
|
|
| 1562 |
Conflicting Interest |
2021-11-01 |
|
|
| 1563 |
What Are The Different Types of Sleep Disorders? |
2021-10-30 |
|
|
| 1564 |
Sleeping Pills Its Usage And Their Side Effects |
2021-10-30 |
|
|
| 1565 |
An Overview of Attention-deficit/Hyperactivity Disorder (ADHD) |
2021-10-30 |
|
|
| 1566 |
Depression and its Side Effects |
2021-10-30 |
|
|
| 1567 |
Alzheimer's Diseases: Symptoms and Signs |
2021-10-30 |
|
|
| 1568 |
Treatment of Congenital Heart Disease |
2021-10-30 |
|
|
| 1569 |
Pregnancy Considerations |
2021-10-30 |
|
|
| 1570 |
Key Points in the Treatment of Gdm |
2021-10-30 |
|
|
| 1571 |
Author’s Contributions |
2021-10-30 |
|
|
| 1572 |
Selected Heavy Metal Removals from Pharmaceutical Effluent |
2021-10-30 |
|
|
| 1573 |
Methods of Treatments of Pharmaceutical Effluent |
2021-10-30 |
|
|
| 1574 |
Pharmaceutical Effluent Impact |
2021-10-30 |
|
|
| 1575 |
Concepts of Phytoremediation’s |
2021-10-30 |
|
|
| 1576 |
Funding and Disclosure |
2021-10-29 |
|
|
| 1577 |
Spread of Diseases |
2021-10-29 |
|
|
| 1578 |
Different types of Microbes |
2021-10-29 |
|
|
| 1579 |
Disclosure of Interests |
2021-10-29 |
|
|
| 1580 |
Molecular Pathogenesis |
2021-10-28 |
|
|
| 1581 |
Appendix a. Supplementary data |
2021-10-28 |
|
|
| 1582 |
Various Measures For Analysis |
2021-10-28 |
|
|
| 1583 |
Cell Passage |
2021-10-28 |
|
|
| 1584 |
Extraction of Oleoropine |
2021-10-28 |
|
|
| 1585 |
CONCLUSIONS AND IMPLICATIONS |
2021-10-28 |
|
|
| 1586 |
Discussions of Findings |
2021-10-28 |
|
|
| 1587 |
Disclosure of Conflicts of Interest |
2021-10-27 |
|
|
| 1588 |
Authorship Contribution |
2021-10-27 |
|
|
| 1589 |
Rapid Communication |
2021-10-27 |
|
|
| 1590 |
Depression |
2021-10-27 |
|
|
| 1591 |
Eating Disorders |
2021-10-27 |
|
|
| 1592 |
Insomnia |
2021-10-27 |
|
|
| 1593 |
Economic Analysis |
2021-10-27 |
|
|
| 1594 |
Tau Hypothesis and AD |
2021-10-27 |
|
|
| 1595 |
Tau Pathology |
2021-10-27 |
|
|
| 1596 |
Amyloids and Alzheimer’s |
2021-10-27 |
|
|
| 1597 |
Cost |
2021-10-27 |
|
|
| 1598 |
What is Alzheimer ’s Disease? |
2021-10-27 |
|
|
| 1599 |
Quality-of-Life |
2021-10-27 |
|
|
| 1600 |
Induction of Platinum Resistance |
2021-10-27 |
|
|
| 1601 |
Risk of Recurrence in Ovarian Cancer |
2021-10-27 |
|
|
| 1602 |
The Data |
2021-10-27 |
|
|
| 1603 |
Consent of Publication |
2021-10-27 |
|
|
| 1604 |
Consent of Participate |
2021-10-27 |
|
|
| 1605 |
Caprine Arthritis Encephalitis |
2021-10-27 |
|
|
| 1606 |
Equine Infectious Anemia (Swamp Fever) |
2021-10-27 |
|
|
| 1607 |
Animal Retrovirus Diseases |
2021-10-27 |
|
|
| 1608 |
The HIV-1 |
2021-10-27 |
|
|
| 1609 |
Human Immunodeficiency Viruses (HIV-1 and HIV-2) |
2021-10-27 |
|
|
| 1610 |
Computer Code Availability |
2021-10-27 |
|
|
| 1611 |
The Role of Terpene for Human |
2021-10-27 |
|
|
| 1612 |
The Role of Terpene in Plants |
2021-10-27 |
|
|
| 1613 |
Major Types of Terpene |
2021-10-27 |
|
|
| 1614 |
Terpenoids Biosynthetic Pathways |
2021-10-27 |
|
|
| 1615 |
Luminiferous Ether |
2021-10-27 |
|
|
| 1616 |
Primary features of the IBM Module |
2021-10-26 |
|
|
| 1617 |
Intelligence based Diabetes Management System(IBDM) |
2021-10-26 |
|
|
| 1618 |
Liposuction Types |
2021-10-26 |
|
|
| 1619 |
Functional Parameters |
2021-10-26 |
|
|
| 1620 |
Drink |
2021-10-26 |
|
|
| 1621 |
Eggs |
2021-10-26 |
|
|
| 1622 |
Cheese |
2021-10-26 |
|
|
| 1623 |
Vegetables |
2021-10-26 |
|
|
| 1624 |
Birds |
2021-10-26 |
|
|
| 1625 |
Goat, Hare, Deer, Venison |
2021-10-26 |
|
|
| 1626 |
Beef, Pork, Lamb |
2021-10-26 |
|
|
| 1627 |
Paduan Diets |
2021-10-26 |
|
|
| 1628 |
Clinical Studies in Gynaecology |
2021-10-26 |
|
|
| 1629 |
Clinical Studies in Obstetrics |
2021-10-26 |
|
|
| 1630 |
Equipment Development |
2021-10-26 |
|
|
| 1631 |
Qualities That Distinguish Fetal, Maternal, and Middle Sections of the Placenta |
2021-10-25 |
|
|
| 1632 |
Quality Expression in Different Parts of Placenta |
2021-10-25 |
|
|
| 1633 |
Gene Expression in Villus Parenchyma of Placenta Relative to Other Normal Human Tissues |
2021-10-25 |
|
|
| 1634 |
Impacts |
2021-10-25 |
|
|
| 1635 |
Hormonal Defects |
2021-10-25 |
|
|
| 1636 |
Hereditary Factors |
2021-10-25 |
|
|
| 1637 |
Climate and Lifestyle |
2021-10-25 |
|
|
| 1638 |
Male Reproductive Organ |
2021-10-25 |
|
|
| 1639 |
Takayasu's Arteritis and Kidney Association |
2021-10-25 |
|
|
| 1640 |
Classification of 190 Countries |
2021-10-25 |
|
|
| 1641 |
Infection Statuses of 190 Countries |
2021-10-25 |
|
|
| 1642 |
Procedure for Fitting the Infection Curve |
2021-10-25 |
|
|
| 1643 |
BARRIER-FREE' ENVIRONMENT AND INTERNAL CONTRASTS |
2021-10-25 |
|
|
| 1644 |
HYPNOTIZED BY THE PAST |
2021-10-25 |
|
|
| 1645 |
MORTALITY HOT SPOTS AND GLIMMERS OF HOPE |
2021-10-25 |
|
|
| 1646 |
TRAGIC PRACTICES |
2021-10-25 |
|
|
| 1647 |
Introduction and Etiology |
2021-10-25 |
|
|
| 1648 |
Importance of Antibiotics on Human Health |
2021-10-25 |
|
|
| 1649 |
Importanceâ??s of Antibiotics on Human Health |
2021-10-25 |
|
|
| 1650 |
Importanceâ??s of Antibiotics on Human Health |
2021-10-25 |
|
|
| 1651 |
Role of ketamine in emergency department |
2021-10-25 |
|
|
| 1652 |
Challenges in trauma care |
2021-10-25 |
|
|
| 1653 |
Overview of brain hematoma |
2021-10-25 |
|
|
| 1654 |
Sepsis management in adults |
2021-10-25 |
|
|
| 1655 |
A Report on various levels at trauma care |
2021-10-25 |
|
|
| 1656 |
Biomarkers of Sickness Movement |
2021-10-23 |
|
|
| 1657 |
Importance of B and T cells in the pathogenesis |
2021-10-23 |
|
|
| 1658 |
ANCA and other antibodies |
2021-10-23 |
|
|
| 1659 |
Terminology of vasculitides, AAV can be sorted into the accompanying kinds |
2021-10-23 |
|
|
| 1660 |
Human immunodeficiency virus |
2021-10-23 |
|
|
| 1661 |
Principle of Terahertz Sensing |
2021-10-23 |
|
|
| 1662 |
Announcement: Call for Paper |
2021-10-22 |
|
|
| 1663 |
For what reason do I need a prosthetic Ankle? |
2021-10-22 |
|
|
| 1664 |
Ankle Replacement |
2021-10-22 |
|
|
| 1665 |
Therapeutic Strategy for COVID-19 |
2021-10-21 |
|
|
| 1666 |
Endothelial Biomarkers and Function Studies in COVID-19 |
2021-10-21 |
|
|
| 1667 |
Clinical Manifestation of Endotheliitis in COVID-19 |
2021-10-21 |
|
|
| 1668 |
Endothelial Damage and Immune Dysregulation in COVID-19 |
2021-10-21 |
|
|
| 1669 |
Association between Endothelial Damage and Hypercoagulability in COVID-19 |
2021-10-21 |
|
|
| 1670 |
Endothelial Dysfunction and Damage in COVID-19 |
2021-10-21 |
|
|
| 1671 |
Characterization of Exosomes |
2021-10-21 |
|
|
| 1672 |
Formation of Exosomes |
2021-10-21 |
|
|
| 1673 |
Biogenesis of Exosomes |
2021-10-21 |
|
|
| 1674 |
Life Cycle |
2021-10-21 |
|
|
| 1675 |
Experimental Methods and Characterization |
2021-10-21 |
|
|
| 1676 |
PER |
2021-10-20 |
|
|
| 1677 |
Post-operative management and Assessment |
2021-10-20 |
|
|
| 1678 |
Concluding Remark |
2021-10-20 |
|
|
| 1679 |
Challenges in applications of intelligent Packaging systems |
2021-10-20 |
|
|
| 1680 |
Sensors |
2021-10-20 |
|
|
| 1681 |
Indicators |
2021-10-20 |
|
|
| 1682 |
Stretching and Warming Up |
2021-10-20 |
|
|
| 1683 |
Evidence against Pre-Workout Warmup |
2021-10-20 |
|
|
| 1684 |
Warm-Up Evidence |
2021-10-20 |
|
|
| 1685 |
Bone Adaptation to Exercise |
2021-10-20 |
|
|
| 1686 |
Aging and Bone Loss |
2021-10-20 |
|
|
| 1687 |
Home Remedies to Cure Knee Pain |
2021-10-20 |
|
|
| 1688 |
Childhood Lupus |
2021-10-20 |
|
|
| 1689 |
Drug-Induced Lupus Erythematosus |
2021-10-20 |
|
|
| 1690 |
The effect of ALG on established immunity |
2021-10-19 |
|
|
| 1691 |
Macrophage agglulinating activity of ALG |
2021-10-19 |
|
|
| 1692 |
Equipment for Photocatalytic Air Treatment |
2021-10-19 |
|
|
| 1693 |
Translation of DNA |
2021-10-19 |
|
|
| 1694 |
Transcription of DNA |
2021-10-19 |
|
|
| 1695 |
Replications of DNA |
2021-10-19 |
|
|
| 1696 |
When does the â??Central Dogma' come into play? |
2021-10-19 |
|
|
| 1697 |
When does the â??Central Dogma' come into play? |
2021-10-19 |
|
|
| 1698 |
Importanceâ??s of Antibiotics on Human Health |
2021-10-19 |
|
|
| 1699 |
Importanceâ??s of Antibiotics on Human Health |
2021-10-19 |
|
|
| 1700 |
Importanceâ??s of Antibiotics on Human Health |
2021-10-19 |
|
|
| 1701 |
High-performance liquid chromatography |
2021-10-19 |
|
|
| 1702 |
Ultracentrifugation |
2021-10-19 |
|
|
| 1703 |
Differential solubilisation and precipitation |
2021-10-19 |
|
|
| 1704 |
Functions of Medication Errors |
2021-10-19 |
|
|
| 1705 |
Antagonistic drug event |
2021-10-19 |
|
|
| 1706 |
Medication Error |
2021-10-19 |
|
|
| 1707 |
Materials required |
2021-10-19 |
|
|
| 1708 |
How to use Phenol/Chloroform for DNA purification |
2021-10-19 |
|
|
| 1709 |
Lab and Molecular Diagnosis |
2021-10-19 |
|
|
| 1710 |
Clinical Manifestations |
2021-10-19 |
|
|
| 1711 |
Liability Factors |
2021-10-19 |
|
|
| 1712 |
Mucormycosis |
2021-10-19 |
|
|
| 1713 |
Atherogenic Dyslipidemia in Diabetes (ADD) |
2021-10-19 |
|
|
| 1714 |
Data Avaiability |
2021-10-19 |
|
|
| 1715 |
Pediatrics |
2021-10-19 |
|
|
| 1716 |
Pregnancy |
2021-10-19 |
|
|
| 1717 |
Special Populations |
2021-10-19 |
|
|
| 1718 |
Approach to treatment |
2021-10-19 |
|
|
| 1719 |
General measures |
2021-10-19 |
|
|
| 1720 |
Treatment of Supraventricular Tachycardia (SVT) |
2021-10-19 |
|
|
| 1721 |
Temperature and time |
2021-10-19 |
|
|
| 1722 |
Survey of clinical practice |
2021-10-19 |
|
|
| 1723 |
Clinical uses of the PT/INR |
2021-10-19 |
|
|
| 1724 |
Clinical uses of the Activated Partial Thromboplastin Time (APTT) |
2021-10-19 |
|
|
| 1725 |
Laser photocoagulation |
2021-10-19 |
|
|
| 1726 |
Symptoms and clinical signs |
2021-10-19 |
|
|
| 1727 |
Hematological disorders |
2021-10-19 |
|
|
| 1728 |
Degenerative changes of vessel wall |
2021-10-19 |
|
|
| 1729 |
Systemic risk factors |
2021-10-19 |
|
|
| 1730 |
Authors Contributions Statement |
2021-10-18 |
|
|
| 1731 |
Retinal Vein Occlusion |
2021-10-18 |
|
|
| 1732 |
Editorial Note on Photosynthetic Organisms in the Ocean |
2021-10-18 |
|
|
| 1733 |
LHRH Agonist and Antagonist |
2021-10-18 |
|
|
| 1734 |
Preparation |
2021-10-18 |
|
|
| 1735 |
Harmone Medical Care may be Used |
2021-10-18 |
|
|
| 1736 |
Why It's Done? |
2021-10-18 |
|
|
| 1737 |
Narcolepsy and Cataplexy |
2021-10-18 |
|
|
| 1738 |
Muscle disorders |
2021-10-18 |
|
|
| 1739 |
Statistical Analyses |
2021-10-18 |
|
|
| 1740 |
Information Collected on Physician Respondents |
2021-10-18 |
|
|
| 1741 |
Phenotypic expression and 22q11.2DS |
2021-10-18 |
|
|
| 1742 |
Survey Design and Measures |
2021-10-18 |
|
|
| 1743 |
Genes on 22q11.2 that causes congenital disorders |
2021-10-18 |
|
|
| 1744 |
Mechanism |
2021-10-18 |
|
|
| 1745 |
Surgical treatment |
2021-10-18 |
|
|
| 1746 |
Research Needs and Perspectives |
2021-10-18 |
|
|
| 1747 |
Result and Interpretations |
2021-10-18 |
|
|
| 1748 |
Management and Treatment |
2021-10-18 |
|
|
| 1749 |
Strength and Limitations |
2021-10-18 |
|
|
| 1750 |
Plan for Data Analysis |
2021-10-18 |
|
|
| 1751 |
Covid-19 Epigenetics Market |
2021-10-18 |
|
|
| 1752 |
Advantages of Participating at Webinar |
2021-10-18 |
|
|
| 1753 |
Why to attend? |
2021-10-18 |
|
|
| 1754 |
Glance at Global Genomics Market |
2021-10-18 |
|
|
| 1755 |
Conference Highlights: |
2021-10-18 |
|
|
| 1756 |
Market Analysis |
2021-10-18 |
|
|
| 1757 |
Guest Editor Benefits |
2021-10-18 |
|
|
| 1758 |
Roles and Responsibility |
2021-10-18 |
|
|
| 1759 |
Announcement to Authors and Editors |
2021-10-18 |
|
|
| 1760 |
Responsible Factors For Sperm DNA Fragmentation |
2021-10-16 |
|
|
| 1761 |
Quantitative Statistical Methods to Understand AIDS Epidemic |
2021-10-16 |
|
|
| 1762 |
Cardiac Risk Assessment among Patients with HIV Disease |
2021-10-16 |
|
|
| 1763 |
Congenital Human Immunodeficiency Virus Risk during Pregnancy |
2021-10-16 |
|
|
| 1764 |
HIV-Associated Dementia: A Neurocognitive Disorder |
2021-10-16 |
|
|
| 1765 |
Molecular Diagnosis of HIV Wasting Syndrome |
2021-10-16 |
|
|
| 1766 |
Study Limitation |
2021-10-14 |
|
|
| 1767 |
Rare/Severe Side-Effects |
2021-10-14 |
|
|
| 1768 |
COVID-19 Vaccine and Immunogenicity |
2021-10-14 |
|
|
| 1769 |
Potential Link Between Symptoms of Covid-19 and Harmful Effects of Formaldehyde and Aniline |
2021-10-14 |
|
|
| 1770 |
Fluorocarbons |
2021-10-14 |
|
|
| 1771 |
Harmful Effects and Symptoms of Aniline |
2021-10-14 |
|
|
| 1772 |
Aniline |
2021-10-14 |
|
|
| 1773 |
Harmful Effects and Symptoms of Formaldehyde |
2021-10-14 |
|
|
| 1774 |
Formaldehyde |
2021-10-14 |
|
|
| 1775 |
Funding None |
2021-10-14 |
|
|
| 1776 |
Contributon of Author |
2021-10-14 |
|
|
| 1777 |
DNA Methylation and Mutation |
2021-10-14 |
|
|
| 1778 |
Methylation and Carginogenesis |
2021-10-14 |
|
|
| 1779 |
Unifying Themes in Carcinogenesis |
2021-10-14 |
|
|
| 1780 |
Environmental Causes |
2021-10-14 |
|
|
| 1781 |
Ethical review |
2021-10-14 |
|
|
| 1782 |
DESIGN AND ANALYSIS |
2021-10-14 |
|
|
| 1783 |
Leprosy Treatment |
2021-10-13 |
|
|
| 1784 |
Key Facts |
2021-10-13 |
|
|
| 1785 |
Applications of Alkanes |
2021-10-13 |
|
|
| 1786 |
Structure and Bonding |
2021-10-13 |
|
|
| 1787 |
Perspectives Towards Prevention and Control of Sth Infection In Bali |
2021-10-13 |
|
|
| 1788 |
Hygiene and Sanitation and other Factors Associated with Sth Infection |
2021-10-13 |
|
|
| 1789 |
Reinfection of Sth Infection Among Elementary School children |
2021-10-13 |
|
|
| 1790 |
Anthelmintic Treatment Trial |
2021-10-13 |
|
|
| 1791 |
Intensity of Infection |
2021-10-13 |
|
|
| 1792 |
Single Species Infection vs Multiple Species Infection |
2021-10-13 |
|
|
| 1793 |
Prevalence of Sth Infection among Elementary School children |
2021-10-13 |
|
|
| 1794 |
Prevalence of Sth Infection in Different Groups of Population in Bali |
2021-10-13 |
|
|
| 1795 |
Acknowledgements and Discloure of Funding |
2021-10-13 |
|
|
| 1796 |
Drugs used for Treatment of Ischemic Heart Disease |
2021-10-13 |
|
|
| 1797 |
Percutaneous Trans Luminal Coronary Angioplasty |
2021-10-13 |
|
|
| 1798 |
Brief Note |
2021-10-13 |
|
|
| 1799 |
Limitations and Challenges of Stem Cell Researc |
2021-10-13 |
|
|
| 1800 |
Limitations and Challenges of Stem Cell Research |
2021-10-13 |
|
|
| 1801 |
Application and Uses of Stem Cell Research |
2021-10-13 |
|
|
| 1802 |
Properties of Stem Cells |
2021-10-13 |
|
|
| 1803 |
Pulse Variability, Health and Well-Being |
2021-10-13 |
|
|
| 1804 |
Hatchery Technology |
2021-10-13 |
|
|
| 1805 |
Echinoculture |
2021-10-13 |
|
|
| 1806 |
Nursing Care in Cancer Therapy |
2021-10-13 |
|
|
| 1807 |
Editorial on Patient Safety |
2021-10-13 |
|
|
| 1808 |
Long Term Care |
2021-10-13 |
|
|
| 1809 |
Dissemination of Mangroves in Goa |
2021-10-13 |
|
|
| 1810 |
The Board of Mangroves in India |
2021-10-13 |
|
|
| 1811 |
Miscellaneous Uses |
2021-10-13 |
|
|
| 1812 |
Significant Uses of Mangroves |
2021-10-13 |
|
|
| 1813 |
Significance of Mangroves |
2021-10-13 |
|
|
| 1814 |
Drug Resistances |
2021-10-13 |
|
|
| 1815 |
Headache disorders |
2021-10-13 |
|
|
| 1816 |
Dementia |
2021-10-13 |
|
|
| 1817 |
Epilepsy |
2021-10-13 |
|
|
| 1818 |
Editorial Note on Sources and Side Effects of Dioxins |
2021-10-13 |
|
|
| 1819 |
Results the Future of Car T-Cell Therapy |
2021-10-13 |
|
|
| 1820 |
BRIEF NOTE |
2021-10-13 |
|
|
| 1821 |
Health Economics |
2021-10-12 |
|
|
| 1822 |
Population Health |
2021-10-12 |
|
|
| 1823 |
Diagnostic Evaluation |
2021-10-12 |
|
|
| 1824 |
Types of Lung Cancer |
2021-10-12 |
|
|
| 1825 |
Observation in Practice |
2021-10-12 |
|
|
| 1826 |
Narcolepsy and Cataplexy |
2021-10-11 |
|
|
| 1827 |
A Report on Ultra-Efficient 3D Printed Catalysts |
2021-10-11 |
|
|
| 1828 |
Editorial Note on Introduction and Types of Proteomics |
2021-10-11 |
|
|
| 1829 |
Introduction and Sources of Epigallocatechin-3-Gallate (EGCG) |
2021-10-11 |
|
|
| 1830 |
Creation of Hydrogen Gas |
2021-10-11 |
|
|
| 1831 |
Characteristics of Breast Cancer |
2021-10-11 |
|
|
| 1832 |
Significance of COVID Vaccine |
2021-10-11 |
|
|
| 1833 |
Risk Factors and Management Strategies |
2021-10-11 |
|
|
| 1834 |
Presence of association |
2021-10-11 |
|
|
| 1835 |
Letter from Editor |
2021-10-09 |
|
|
| 1836 |
Basic Reproduction Number |
2021-10-08 |
|
|
| 1837 |
Sidarthe Model Formulation |
2021-10-08 |
|
|
| 1838 |
Pneumatic Systems for Aircraft |
2021-10-08 |
|
|
| 1839 |
Computational Analysis and Study of Atmospheric Ice Accretion on Different NACA Profile Series |
2021-10-08 |
|
|
| 1840 |
Review and Update |
2021-10-08 |
|
|
| 1841 |
Pathophysiology of Hypertension in pregnancy |
2021-10-07 |
|
|
| 1842 |
Complications of hypertensive Disorders of pregnancy |
2021-10-07 |
|
|
| 1843 |
Risk Factors For Hypertension In Pregnancy |
2021-10-07 |
|
|
| 1844 |
Diagnosis and Classification of Blood Pressure |
2021-10-07 |
|
|
| 1845 |
Preventing Dengue Fever |
2021-10-07 |
|
|
| 1846 |
Treatment for Dengue Fever |
2021-10-07 |
|
|
| 1847 |
Diagnosing Dengue Fever |
2021-10-07 |
|
|
| 1848 |
Warning Signs of Severe Dengue Fever |
2021-10-07 |
|
|
| 1849 |
Warning Sings of Severe Dengue Fever |
2021-10-07 |
|
|
| 1850 |
Symptoms of Dengue Fever |
2021-10-07 |
|
|
| 1851 |
Types of Hypertension |
2021-10-07 |
|
|
| 1852 |
Types of Congestive Heart Failure (CHF) |
2021-10-07 |
|
|
| 1853 |
An Overview on Myocarditis |
2021-10-07 |
|
|
| 1854 |
Models and Variables |
2021-10-07 |
|
|
| 1855 |
Analytical Framework |
2021-10-07 |
|
|
| 1856 |
Morphology |
2021-10-06 |
|
|
| 1857 |
Causes and Prevention |
2021-10-06 |
|
|
| 1858 |
Methods of Research |
2021-10-06 |
|
|
| 1859 |
Supplementary Files |
2021-10-05 |
|
|
| 1860 |
Availability of Data and Materials |
2021-10-05 |
|
|
| 1861 |
Editorial-Announcement: |
2021-10-05 |
|
|
| 1862 |
Plant growth promoting ability of halophilic Bacillus marisflavi K7SpZMAO002 isolated from coastal sand dune of Goa-India |
2021-10-05 |
|
|
| 1863 |
Phenotypic and Genotypic Antibiotic Resistance Features of S. aureus isolated from Milk and Cheese |
2021-10-05 |
|
|
| 1864 |
Potential application of selected phosphate solubilizing bacteria isolated from Chenopodium quinoa Willd rhizosphere in early plant growth promotion |
2021-10-05 |
|
|
| 1865 |
Evaluation Of Antimicrobial Activity Of N-Hexane Extract Of Different Parts Of Pumpkin (Seed, Leaves And Pulp) |
2021-10-05 |
|
|
| 1866 |
Pesticide residue Analysis in pea samples available in Hilly areas of Himachal Pradesh (Solan, India) (Conventionally and organically raised) by coupling QuEChERS technique with GC |
2021-10-05 |
|
|
| 1867 |
Blood Test |
2021-10-05 |
|
|
| 1868 |
Factors that Contribute to Colorectal Cancer |
2021-10-05 |
|
|
| 1869 |
Risk of Colorectal Cancer |
2021-10-05 |
|
|
| 1870 |
Darwin Process |
2021-10-05 |
|
|
| 1871 |
Importance of Ethics |
2021-10-05 |
|
|
| 1872 |
Ginseng |
2021-10-05 |
|
|
| 1873 |
Ginkgo Biloba |
2021-10-05 |
|
|
| 1874 |
Bacopa Monniera |
2021-10-05 |
|
|
| 1875 |
Guarana |
2021-10-05 |
|
|
| 1876 |
Yohimbine |
2021-10-05 |
|
|
| 1877 |
Betel Nut |
2021-10-05 |
|
|
| 1878 |
Herbal Cognitive Enhancers |
2021-10-05 |
|
|
| 1879 |
CDP-Choline |
2021-10-05 |
|
|
| 1880 |
Piracetam and Phenylpiracetam |
2021-10-05 |
|
|
| 1881 |
Synthetic Cannabinoids |
2021-10-05 |
|
|
| 1882 |
Flakka |
2021-10-05 |
|
|
| 1883 |
Synthetic Cathinones |
2021-10-05 |
|
|
| 1884 |
Designer Drugs |
2021-10-05 |
|
|
| 1885 |
Marjuiana, Cannabis |
2021-10-05 |
|
|
| 1886 |
Khat, Cathinone |
2021-10-05 |
|
|
| 1887 |
Amphetamine |
2021-10-05 |
|
|
| 1888 |
Nicotine |
2021-10-05 |
|
|
| 1889 |
Caffeine |
2021-10-05 |
|
|
| 1890 |
Further Use of Soda Ash and Lime Solutions from Caustic Plant |
2021-10-04 |
|
|
| 1891 |
Bio-Fuels Production Versus Valorization of Biomass for Value added Product Manufacture |
2021-10-04 |
|
|
| 1892 |
Possibility Envelope Mapping of Post Kraft Process Applications Progressive Sampling of Alternatives and Value-Added Derivatives |
2021-10-04 |
|
|
| 1893 |
Life Cycle Stages of Microstructural Products and Processes |
2021-10-04 |
|
|
| 1894 |
Utilization of Clozapine |
2021-10-04 |
|
|
| 1895 |
High Energy Demand and Emissions and Waste Profile of Wood and Pulp Industries |
2021-10-04 |
|
|
| 1896 |
Lists of Abbreviations |
2021-10-04 |
|
|
| 1897 |
Open-Source Development & Distribution |
2021-10-04 |
|
|
| 1898 |
Enzyme-Linked Immunosorbent Assay (ELISA) |
2021-10-01 |
|
|
| 1899 |
Polymerase Chain Reaction (PCR) |
2021-10-01 |
|
|
| 1900 |
Neural Engineering |
2021-10-01 |
|
|
| 1901 |
Neuroscience |
2021-10-01 |
|
|
| 1902 |
Dental Pulp Regeneration |
2021-10-01 |
|
|
| 1903 |
Periodontal Regeneration |
2021-10-01 |
|
|
| 1904 |
Clinical Trials Protocol Registration |
2021-10-01 |
|
|
| 1905 |
Other Registrations |
2021-10-01 |
|
|
| 1906 |
Key Activities |
2021-10-01 |
|
|
| 1907 |
Conclusions and Perspectives |
2021-09-30 |
|
|
| 1908 |
Results of Statistical Analysis |
2021-09-30 |
|
|
| 1909 |
Microorganisms and Antimicrobial Textiles |
2021-09-30 |
|
|
| 1910 |
Various Factors Affecting UV Protection on Textile Materials |
2021-09-30 |
|
|
| 1911 |
UV Protective Textiles |
2021-09-30 |
|
|
| 1912 |
Causes and Transmission Cycles |
2021-09-30 |
|
|
| 1913 |
MALDI-TOF-MS |
2021-09-30 |
|
|
| 1914 |
Forces of Nature |
2021-09-30 |
|
|
| 1915 |
Types of Optical Fiber |
2021-09-30 |
|
|
| 1916 |
Standard of Optical Fiber |
2021-09-30 |
|
|
| 1917 |
Correspondence |
2021-09-30 |
|
|
| 1918 |
Modern Nanotechnology |
2021-09-30 |
|
|
| 1919 |
Refraction |
2021-09-30 |
|
|
| 1920 |
ORCID ID |
2021-09-30 |
|
|
| 1921 |
Consent for Publications |
2021-09-29 |
|
|
| 1922 |
Hypoxia |
2021-09-29 |
|
|
| 1923 |
Mortality and Its Risk Factors |
2021-09-29 |
|
|
| 1924 |
Pathology |
2021-09-29 |
|
|
| 1925 |
Pathogenesis and Clinical Features |
2021-09-29 |
|
|
| 1926 |
Message for the General Community And Especially for People Who Have Comorbidity of Covid-19 |
2021-09-29 |
|
|
| 1927 |
Consequences on Pregnant Mothers Who Have Comorbidity of Covid-19 |
2021-09-29 |
|
|
| 1928 |
Comorbidity of Covid-19 on Pregnant Mothers |
2021-09-29 |
|
|
| 1929 |
Latest Developments of Covid-19 Outbreak |
2021-09-29 |
|
|
| 1930 |
Literature of Review |
2021-09-29 |
|
|
| 1931 |
Overview of Endovascular Techniques for Foreign Body Removal |
2021-09-29 |
|
|
| 1932 |
Venous Foreign Bodies |
2021-09-29 |
|
|
| 1933 |
Plants as a Source of Antioxidants |
2021-09-29 |
|
|
| 1934 |
Purification of the Bioactive Molecule |
2021-09-29 |
|
|
| 1935 |
Ultrasonic-Assisted Extraction (UAE) |
2021-09-29 |
|
|
| 1936 |
Microwave-Assisted Extraction (MAE) |
2021-09-29 |
|
|
| 1937 |
Methods to Extract Bioactive Compounds from Plants |
2021-09-29 |
|
|
| 1938 |
Disclosure Statements |
2021-09-29 |
|
|
| 1939 |
Points to Remember |
2021-09-29 |
|
|
| 1940 |
Patients, Materials and Methods |
2021-09-29 |
|
|
| 1941 |
Conflicting Interests |
2021-09-29 |
|
|
| 1942 |
Limitations Future Research |
2021-09-29 |
|
|
| 1943 |
Cerebral Vessels in Aging Humans |
2021-09-29 |
|
|
| 1944 |
Impact of Tattoos on the Disease Activity |
2021-09-28 |
|
|
| 1945 |
Complications Related to Tattoos in SLE |
2021-09-28 |
|
|
| 1946 |
Prevalance and Charateristics of Tattoos in SLE Patients |
2021-09-28 |
|
|
| 1947 |
Motivations |
2021-09-28 |
|
|
| 1948 |
Author's Information |
2021-09-28 |
|
|
| 1949 |
Availability of Data and Material (Data Transparency) |
2021-09-28 |
|
|
| 1950 |
Creatinine kinase-cardiac Muscle biomarker (CK-MB) |
2021-09-28 |
|
|
| 1951 |
Contribution Details |
2021-09-27 |
|
|
| 1952 |
Personal Data |
2021-09-27 |
|
|
| 1953 |
Cancer |
2021-09-27 |
|
|
| 1954 |
Industrial Multi Objective Optimization |
2021-09-27 |
|
|
| 1955 |
Technical Report |
2021-09-25 |
|
|
| 1956 |
Airships in the Arctic |
2021-09-25 |
|
|
| 1957 |
Airships and Ecotourism |
2021-09-25 |
|
|
| 1958 |
Challenges to Ecotourism in Canada |
2021-09-25 |
|
|
| 1959 |
Vegan Consumption |
2021-09-25 |
|
|
| 1960 |
Veganism |
2021-09-25 |
|
|
| 1961 |
Discussion and Prospects |
2021-09-25 |
|
|
| 1962 |
Analytical Discussion |
2021-09-25 |
|
|
| 1963 |
Route of Transmission |
2021-09-25 |
|
|
| 1964 |
Validation |
2021-09-24 |
|
|
| 1965 |
Introduction to Chromatography |
2021-09-24 |
|
|
| 1966 |
Introduction to Spectroscopy |
2021-09-24 |
|
|
| 1967 |
Analytical Method |
2021-09-24 |
|
|
| 1968 |
Transdermal Permeation: Factors Affecting It the Infiltrate Molecules' Physicochemical Properties |
2021-09-24 |
|
|
| 1969 |
Essential Oils as Penetration Enhancers |
2021-09-24 |
|
|
| 1970 |
Penetration-Enhancing Mechanism |
2021-09-24 |
|
|
| 1971 |
Essential Oils and Their Compounds Can Penetrate the Skin |
2021-09-24 |
|
|
| 1972 |
The Protein Transformation |
2021-09-24 |
|
|
| 1973 |
Bacterial Culture |
2021-09-24 |
|
|
| 1974 |
Analysis of the Study |
2021-09-23 |
|
|
| 1975 |
Declaration of Competing Interest |
2021-09-23 |
|
|
| 1976 |
Ethics Approval/Consent to Participate/Consent for Publication |
2021-09-23 |
|
|
| 1977 |
Natural Rights |
2021-09-23 |
|
|
| 1978 |
Factors of Consideration |
2021-09-23 |
|
|
| 1979 |
Declaration for Conflict of Interests |
2021-09-23 |
|
|
| 1980 |
Brief Conceptualization of Cognitive Behavioral Therapy about Two Models |
2021-09-22 |
|
|
| 1981 |
Rehm's Self-Control Theory |
2021-09-22 |
|
|
| 1982 |
Lewinsohn's Behavioral Theory of Depression |
2021-09-22 |
|
|
| 1983 |
Theory of Helplessness Learned from Seligman |
2021-09-22 |
|
|
| 1984 |
Beck's Cognitive Model |
2021-09-22 |
|
|
| 1985 |
Depression in DSM-IV; DSM-5 and ICD-10 |
2021-09-22 |
|
|
| 1986 |
Depression in Statistics |
2021-09-22 |
|
|
| 1987 |
Recommendations for Further Research |
2021-09-22 |
|
|
| 1988 |
Stages in Diabetic Nephropathy |
2021-09-22 |
|
|
| 1989 |
Suggestions and Restrictions |
2021-09-22 |
|
|
| 1990 |
Antioxidant Study |
2021-09-22 |
|
|
| 1991 |
Compound 2',4'-Dihydroxy-3',5'-Dimethyl-6'-Methoxychalcone |
2021-09-22 |
|
|
| 1992 |
Bioassay Guided Fractionation & Isolation of the Constituent from Ethyl Acetate Extracts of the Leaves of Syzygium Balsame |
2021-09-22 |
|
|
| 1993 |
Extraction of the Plant Material |
2021-09-22 |
|
|
| 1994 |
How can we Maintain Environmental Sustainability? |
2021-09-21 |
|
|
| 1995 |
Negative Natural Impacts of COVID-19 |
2021-09-21 |
|
|
| 1996 |
Positive Natural Impacts of COVID-19 |
2021-09-21 |
|
|
| 1997 |
Legacy of the Paralympic Games |
2021-09-21 |
|
|
| 1998 |
Successful Treatment of Chronic Pain and Depression Likely Includes a Combination of Pharmacotherapy and Psychotherapy |
2021-09-21 |
|
|
| 1999 |
Pain Patients Should be Assessed for Depression, and Depressed Patients Should be Assessed for Pain |
2021-09-21 |
|
|
| 2000 |
There is a Vicious Cycle where Pain Begets Depression and Vice Versa |
2021-09-21 |
|
|
| 2001 |
Molecular Patterns of Recognition |
2021-09-21 |
|
|
| 2002 |
Immaturity of Dendritic Cells |
2021-09-21 |
|
|
| 2003 |
Dimensionality |
2021-09-21 |
|
|
| 2004 |
Confined Attribute Dysfunction |
2021-09-21 |
|
|
| 2005 |
Distributional Biology |
2021-09-21 |
|
|
| 2006 |
Funding Acknowledgements |
2021-09-20 |
|
|
| 2007 |
Funding for the Study |
2021-09-18 |
|
|
| 2008 |
Preoperative Assessment |
2021-09-18 |
|
|
| 2009 |
Limitations of CBCT |
2021-09-17 |
|
|
| 2010 |
Postoperative Assessment |
2021-09-17 |
|
|
| 2011 |
Further recommendation |
2021-09-17 |
|
|
| 2012 |
Funding Acknowledgement |
2021-09-16 |
|
|
| 2013 |
Reproduction |
2021-09-15 |
|
|
| 2014 |
Plant Production Platforms |
2021-09-14 |
|
|
| 2015 |
Techniques Used for Measurements |
2021-09-14 |
|
|
| 2016 |
Radon and Lung Cancer |
2021-09-14 |
|
|
| 2017 |
Different Sources of Radon |
2021-09-14 |
|
|
| 2018 |
Physical and Chemical Properties of Radon |
2021-09-14 |
|
|
| 2019 |
Radon Decay |
2021-09-14 |
|
|
| 2020 |
Bioethics Concerns |
2021-09-14 |
|
|
| 2021 |
Review of Relevant Literature |
2021-09-14 |
|
|
| 2022 |
TTP In Skin Diseases |
2021-09-14 |
|
|
| 2023 |
Random Forest (RF) |
2021-09-14 |
|
|
| 2024 |
Bootstrap Method |
2021-09-14 |
|
|
| 2025 |
Stationary Wavelet Transforms |
2021-09-14 |
|
|
| 2026 |
Adaptive Local Power-Law Transform (ALPLT) |
2021-09-14 |
|
|
| 2027 |
Intelligent Feature Plaque Detection Model |
2021-09-14 |
|
|
| 2028 |
Results of the Delphi Study |
2021-09-14 |
|
|
| 2029 |
History of Centralized Sewage Treatment System |
2021-09-13 |
|
|
| 2030 |
Design of Centralized Sewage Treatment System |
2021-09-13 |
|
|
| 2031 |
Sewage Treatment Scenario in India |
2021-09-13 |
|
|
| 2032 |
End-Matter |
2021-09-13 |
|
|
| 2033 |
Aspects of Safety |
2021-09-13 |
|
|
| 2034 |
Probiotics Commercially Available for Urogenital Tract |
2021-09-13 |
|
|
| 2035 |
Relation between Probiotics and Fertility |
2021-09-13 |
|
|
| 2036 |
Administration Vehicles |
2021-09-13 |
|
|
| 2037 |
Drug Interactions |
2021-09-13 |
|
|
| 2038 |
Exhaustively, the method of this strategy is partitioned into three stages: |
2021-09-13 |
|
|
| 2039 |
Atom chromatography |
2021-09-13 |
|
|
| 2040 |
Particle chromatograph |
2021-09-13 |
|
|
| 2041 |
Paper chromatography |
2021-09-13 |
|
|
| 2042 |
Elite fluid chromatography (HPLC) |
2021-09-13 |
|
|
| 2043 |
Flimsy layer chromatography (TLC) |
2021-09-13 |
|
|
| 2044 |
ELISA displays the accompanying benefits: |
2021-09-13 |
|
|
| 2045 |
Naturally Fortified Fruits Salad |
2021-09-13 |
|
|
| 2046 |
Remedial Egg Mix-Tip to Manage the Problem of Insomia |
2021-09-13 |
|
|
| 2047 |
Standard |
2021-09-13 |
|
|
| 2048 |
Tip to Enhance the Mouth Feel and to Beat the Hunger |
2021-09-13 |
|
|
| 2049 |
Natural Cantaloupe, Honey Dew Melon, Musk Melon/Melon Juice |
2021-09-13 |
|
|
| 2050 |
Natural Water Melon Fruity Juice |
2021-09-13 |
|
|
| 2051 |
Naturally Fortified Grewia Fruity Juice |
2021-09-13 |
|
|
| 2052 |
Naturally Fortified Mango Fruity Juice |
2021-09-13 |
|
|
| 2053 |
Presentation |
2021-09-13 |
|
|
| 2054 |
Opinion on Radioimmunoassay and its Important |
2021-09-13 |
|
|
| 2055 |
Urbanism |
2021-09-09 |
|
|
| 2056 |
Health |
2021-09-09 |
|
|
| 2057 |
Economies |
2021-09-09 |
|
|
| 2058 |
Cultural |
2021-09-09 |
|
|
| 2059 |
FIELDS |
2021-09-09 |
|
|
| 2060 |
INTERNATIONAL PERSPECTIVES |
2021-09-09 |
|
|
| 2061 |
GENETIC REVOLUTION |
2021-09-09 |
|
|
| 2062 |
HISTORICAL BACKGROUND |
2021-09-09 |
|
|
| 2063 |
Neuroethnography |
2021-09-09 |
|
|
| 2064 |
Neuroanthropology: A Humanistic Science |
2021-09-09 |
|
|
| 2065 |
An Anthropological Definition of Culture |
2021-09-09 |
|
|
| 2066 |
Result and Observation |
2021-09-08 |
|
|
| 2067 |
Working Mechanism |
2021-09-08 |
|
|
| 2068 |
Microfluid Crispr Chip Parts |
2021-09-08 |
|
|
| 2069 |
Types of Wireless Sensor Networks |
2021-09-08 |
|
|
| 2070 |
The Case |
2021-09-07 |
|
|
| 2071 |
Diagnosis of Pre-Maglignant Lesions and Penile Cancer |
2021-09-07 |
|
|
| 2072 |
Author's Contribution Statement |
2021-09-07 |
|
|
| 2073 |
Mechanism of action of Cellulase |
2021-09-07 |
|
|
| 2074 |
Improving Care |
2021-09-06 |
|
|
| 2075 |
Cultural Responsivity |
2021-09-06 |
|
|
| 2076 |
Key Highlights |
2021-09-06 |
|
|
| 2077 |
Diet |
2021-09-04 |
|
|
| 2078 |
A Typical Femur Fractures (AFF) |
2021-09-04 |
|
|
| 2079 |
Strains |
2021-09-04 |
|
|
| 2080 |
Neurologic Injury |
2021-09-04 |
|
|
| 2081 |
Limit of Detection |
2021-09-04 |
|
|
| 2082 |
Authors’ Contributions |
2021-09-04 |
|
|
| 2083 |
Breif Report |
2021-09-04 |
|
|
| 2084 |
Diet for a Healthy Heart |
2021-09-03 |
|
|
| 2085 |
Abnormal Heart Rhythm Diseaseâ??Arrhythmia |
2021-09-03 |
|
|
| 2086 |
Computer Tomography (CT) Coronary Angiogram |
2021-09-03 |
|
|
| 2087 |
Heart Murmurs and its Causes |
2021-09-03 |
|
|
| 2088 |
Mitral Valve Stenosis |
2021-09-03 |
|
|
| 2089 |
Ceramic and Polymer Nanocomposites for Aerospace |
2021-09-02 |
|
|
| 2090 |
Report of The Case |
2021-09-02 |
|
|
| 2091 |
Paternal Testing |
2021-09-01 |
|
|
| 2092 |
Monitoring Clinically Significant Antibodies |
2021-09-01 |
|
|
| 2093 |
Science is Focused on Liver-Coordinated Quality Treatment for Cell Work |
2021-09-01 |
|
|
| 2094 |
Genetic and Molecular Biological Approaches for Molecular Science |
2021-09-01 |
|
|
| 2095 |
Ponderal Index of Real Body Mass Index and Basal Metabolic Rate |
2021-09-01 |
|
|
| 2096 |
Tracing Physical Behavior in Virtual Reality in Social Psychology |
2021-09-01 |
|
|
| 2097 |
Exploring the Brain and the Mind at the Edinburgh Functional Magnetic Resonance Imaging |
2021-09-01 |
|
|
| 2098 |
Funding Acknowledgments |
2021-09-01 |
|
|
| 2099 |
Tissue-Specific Transcriptome Sequencing Analysis Expands the Non-Human Primate Reference |
2021-09-01 |
|
|
| 2100 |
Shotgun Sequencing in Human Genetics |
2021-09-01 |
|
|
| 2101 |
Metagenomics can provide valuable insights into the functional |
2021-09-01 |
|
|
| 2102 |
DNA Groupings of Numerous Creatures of Bacteriophage |
2021-09-01 |
|
|
| 2103 |
DNA Sequencing Which is based on Nucleobase-Specific Partial Chemical Modification |
2021-09-01 |
|
|
| 2104 |
Artificial Gene Synthesis Recombination Innovation in Engineered |
2021-09-01 |
|
|
| 2105 |
Immune Properties of Stem Cells and Interactions with the Immune System |
2021-09-01 |
|
|
| 2106 |
Resembling Embryonic Stem Cells are Immature Microorganisms |
2021-09-01 |
|
|
| 2107 |
Monitoring of Diseases in Bio-Therapeutics |
2021-09-01 |
|
|
| 2108 |
DNA is Isolated and Partially Digested with Restriction Enzymes |
2021-09-01 |
|
|
| 2109 |
Hair Regeneration-Mesenchymal Stem Cell |
2021-09-01 |
|
|
| 2110 |
Genome wide Association Study Medication and P4 Medication |
2021-09-01 |
|
|
| 2111 |
Functional on Genomics, Proteomics, Metabolomics - Stem Cell |
2021-09-01 |
|
|
| 2112 |
Chemical Synthesis of Proteins is a Valuable Tool in Chemical Biology |
2021-09-01 |
|
|
| 2113 |
Can Stem Cells Beat COVID-19? |
2021-09-01 |
|
|
| 2114 |
Diagnosis of Cracked Tooth Syndrome |
2021-09-01 |
|
|
| 2115 |
How 5g Networks and Artificial Intelligence Can Help? |
2021-08-31 |
|
|
| 2116 |
Combining 5g and Ai |
2021-08-31 |
|
|
| 2117 |
Material and Research Methods |
2021-08-31 |
|
|
| 2118 |
Healthcare |
2021-08-31 |
|
|
| 2119 |
Key Parts of a Blockchain |
2021-08-31 |
|
|
| 2120 |
Analyzing the Evolution of Aerospace Ecosystem Development |
2021-08-31 |
|
|
| 2121 |
Designing a Low-Cost Space Simulator |
2021-08-31 |
|
|
| 2122 |
Severity of allergic contact Dermatitis |
2021-08-31 |
|
|
| 2123 |
Significance of allergic Contact dermatitis |
2021-08-31 |
|
|
| 2124 |
ORCID |
2021-08-31 |
|
|
| 2125 |
Skin Layers and NO Effects |
2021-08-31 |
|
|
| 2126 |
Source of NO in the Skin |
2021-08-31 |
|
|
| 2127 |
Soucre of NO in the Skin |
2021-08-31 |
|
|
| 2128 |
Diabetes Insipidus |
2021-08-31 |
|
|
| 2129 |
Hypophysitis |
2021-08-31 |
|
|
| 2130 |
Thyroid Dysfunction |
2021-08-31 |
|
|
| 2131 |
Extraction Procedures of Asiaticoside from Centella Asiatica |
2021-08-31 |
|
|
| 2132 |
Neuroinfection & neuroimmunology |
2021-08-31 |
|
|
| 2133 |
Executive function deficits in neurodevelopmental disorders |
2021-08-31 |
|
|
| 2134 |
Enhancing The Process of Bone Augmentations in Craniofacial Region |
2021-08-31 |
|
|
| 2135 |
Is peritoneal lavage with water the optimal washout as a preventative method for peritoneal disease following colorectal cancer resection? A systematic review |
2021-08-31 |
|
|
| 2136 |
Retrosepective Study of Sagittal Split Ramus Osteotomy with Intraoral Vertical Ramus Osteotomy on Mandibular Prognathism Accompanied with Facial Asymmetry Patients |
2021-08-31 |
|
|
| 2137 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2138 |
Body dysmorphic disorders enhanced by social media. What is our role as surgeons? |
2021-08-31 |
|
|
| 2139 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2140 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2141 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2142 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2143 |
Socio-demographic characteristics, clinical profile and prevalence of existing mental illness among suicide attempters attending emergency services at two hospitals in Hawassa city |
2021-08-31 |
|
|
| 2144 |
Designing a coordinate skin mapping system for skin cancer surgeries on the head for preventing wrong-site surgeries |
2021-08-31 |
|
|
| 2145 |
Physical illness complicating the presentation of bipolar disorder in an elderly patient |
2021-08-31 |
|
|
| 2146 |
Stem Cells (SC) therapy as an emerging therapy in neurology |
2021-08-31 |
|
|
| 2147 |
What are the Early Indications of Type 2 Diabetes? |
2021-08-30 |
|
|
| 2148 |
What are the Ideal Glucose Levels? |
2021-08-30 |
|
|
| 2149 |
What occurs after you quit smoking? |
2021-08-30 |
|
|
| 2150 |
Dental Fluorosis and its Diagnosis in Humans |
2021-08-30 |
|
|
| 2151 |
What is Dyspnea? |
2021-08-30 |
|
|
| 2152 |
Tooth Brightening for Delicate Teeth |
2021-08-30 |
|
|
| 2153 |
Tooth Disintegration by Taking Acidic Food Varieties |
2021-08-30 |
|
|
| 2154 |
Human Necessities Shortages Dental Cleanliness |
2021-08-30 |
|
|
| 2155 |
Scientific Hypertension and High Blood Pressure |
2021-08-30 |
|
|
| 2156 |
Microbial Biogeochemistry and Extreme Environments |
2021-08-30 |
|
|
| 2157 |
Forensic Medication Uncovered Techniques |
2021-08-30 |
|
|
| 2158 |
Epidemiological Research of Epilepsy |
2021-08-30 |
|
|
| 2159 |
Applications of Extremophiles in Astrobiology |
2021-08-30 |
|
|
| 2160 |
The Colon and Rectum Make up the Internal Organ |
2021-08-30 |
|
|
| 2161 |
Cardiac Electrophysiology and Heart Rhythm in Human Body |
2021-08-30 |
|
|
| 2162 |
Role of Allergy and Clinical Immunology in Medical Sciences |
2021-08-30 |
|
|
| 2163 |
Diabetic Ketoacidosis: Evaluation and Treatment |
2021-08-30 |
|
|
| 2164 |
Acetone Breathing Measurement for Diagnosis of Diabetic Ketoacidosis |
2021-08-30 |
|
|
| 2165 |
Dissection of Human Body for Suicide Reason Identification |
2021-08-30 |
|
|
| 2166 |
A Brief on Disorders which Leads to Death |
2021-08-30 |
|
|
| 2167 |
Funding Acknowledgment |
2021-08-30 |
|
|
| 2168 |
Radioactive Elements May Be Crucial To The Habitability of Rocky Planets |
2021-08-30 |
|
|
| 2169 |
Applied Chemistry on Forensic Pathology Science |
2021-08-30 |
|
|
| 2170 |
Nutritional Bioenergetics in Fish Relationship between Abstinence Metabolism |
2021-08-30 |
|
|
| 2171 |
Endoscopic Ultrasound Utilizes Sound Waves |
2021-08-30 |
|
|
| 2172 |
Choice Examination Utilizes an Assortment Of Instruments |
2021-08-30 |
|
|
| 2173 |
Research Article |
2021-08-30 |
|
|
| 2174 |
Interdisciplinary Consortium for Astrobiology Research |
2021-08-30 |
|
|
| 2175 |
Mitochondrial Pathology of Genetics Mitochondrial Disease |
2021-08-30 |
|
|
| 2176 |
Banquet Operations |
2021-08-30 |
|
|
| 2177 |
Statistical Surveying and Market Research |
2021-08-30 |
|
|
| 2178 |
To Get Familiar with Malignancy and How it Starts and Spreads |
2021-08-30 |
|
|
| 2179 |
Disruptive Innovation in Dentistry |
2021-08-30 |
|
|
| 2180 |
Mitochondrial Difficult Deficiency of Nuclear DNA in Chromosomes |
2021-08-30 |
|
|
| 2181 |
Radioactive Elements May Make Planets Suitable or Hostile to Life |
2021-08-30 |
|
|
| 2182 |
A Brief on Innovation towards Forensic Science |
2021-08-30 |
|
|
| 2183 |
Leadership Management and Its Fundamentals |
2021-08-30 |
|
|
| 2184 |
The Prostate Organ Begin to Outgrow Control |
2021-08-30 |
|
|
| 2185 |
Cancer Cells And Oncogenes Driven Organic Chemistry |
2021-08-30 |
|
|
| 2186 |
Clients' Assessment and Sentiments |
2021-08-30 |
|
|
| 2187 |
A Mental or Behavioural Post Traumatic Disorder |
2021-08-30 |
|
|
| 2188 |
Editorial Announcement |
2021-08-30 |
|
|
| 2189 |
Acknowlegement |
2021-08-30 |
|
|
| 2190 |
Types of Cell |
2021-08-30 |
|
|
| 2191 |
Resistance |
2021-08-30 |
|
|
| 2192 |
Mode of Action of Remdesivir |
2021-08-30 |
|
|
| 2193 |
Remdesivir’s availability in India |
2021-08-30 |
|
|
| 2194 |
Remdesivir Clinical Trials |
2021-08-30 |
|
|
| 2195 |
Editorial Note on Magneto-plasma Dynamic Thruster |
2021-08-30 |
|
|
| 2196 |
Potential Flow through a Cascade of Aerofoils |
2021-08-30 |
|
|
| 2197 |
The Innovation of Laser Polishing |
2021-08-28 |
|
|
| 2198 |
Regulation of Genetic Engineering Concerns Approaches Taken By Governments Assess |
2021-08-28 |
|
|
| 2199 |
Professional Aspects of Engineering |
2021-08-28 |
|
|
| 2200 |
Polymeric Nanoparticles: Production, Characterization |
2021-08-28 |
|
|
| 2201 |
Biological Process of TCA Cycle in Synthesis Of DNA |
2021-08-28 |
|
|
| 2202 |
The Stroma Contains Nonmalignant |
2021-08-28 |
|
|
| 2203 |
Super Superior Fluid Chromatography |
2021-08-28 |
|
|
| 2204 |
Ms Ionization Sources |
2021-08-28 |
|
|
| 2205 |
Potential for novel treatment Approaches |
2021-08-28 |
|
|
| 2206 |
A Mouse Model To Study Chronic Wound Development And Progression |
2021-08-28 |
|
|
| 2207 |
New Regulatory Challenges for AI in the Healthcare System |
2021-08-28 |
|
|
| 2208 |
Altai Gaps and Strengths |
2021-08-28 |
|
|
| 2209 |
Building Up a Trustworthy AI-Based Tool for P5 Medicine |
2021-08-28 |
|
|
| 2210 |
Preliminary Activities to Perform a Responsible Altai |
2021-08-28 |
|
|
| 2211 |
Hegelian Applications |
2021-08-28 |
|
|
| 2212 |
Kantian Implication for Children with ADHD |
2021-08-28 |
|
|
| 2213 |
Immanuel Kant and the Paradoxes of Respecting (Moral) Rules |
2021-08-28 |
|
|
| 2214 |
Sigmund Freud and the Psychoanalytic Tradition |
2021-08-28 |
|
|
| 2215 |
In Search of Constructive Ideas |
2021-08-28 |
|
|
| 2216 |
Review of Works |
2021-08-27 |
|
|
| 2217 |
Molecular Mechanism Involved In Rhabdomyolysis |
2021-08-27 |
|
|
| 2218 |
Study Selection |
2021-08-27 |
|
|
| 2219 |
Source |
2021-08-27 |
|
|
| 2220 |
Outcome |
2021-08-27 |
|
|
| 2221 |
Conservative and Endodontic Therapy |
2021-08-27 |
|
|
| 2222 |
Comparison |
2021-08-27 |
|
|
| 2223 |
Intervention/Exposure |
2021-08-27 |
|
|
| 2224 |
Population |
2021-08-27 |
|
|
| 2225 |
Focused Question |
2021-08-27 |
|
|
| 2226 |
Systematic Search Strategy |
2021-08-27 |
|
|
| 2227 |
About to Study |
2021-08-27 |
|
|
| 2228 |
Histone Code |
2021-08-27 |
|
|
| 2229 |
Prognostic Diagnostic |
2021-08-27 |
|
|
| 2230 |
Epigenetic Diagnostic |
2021-08-27 |
|
|
| 2231 |
DNA Hypomethylation |
2021-08-27 |
|
|
| 2232 |
Genome |
2021-08-27 |
|
|
| 2233 |
Interventions |
2021-08-27 |
|
|
| 2234 |
Recommendations for Screening and Assessment |
2021-08-27 |
|
|
| 2235 |
How to Recognise Depression in Pregnancy? |
2021-08-27 |
|
|
| 2236 |
Depression During Pregnancy |
2021-08-27 |
|
|
| 2237 |
Stress During Pregnancy |
2021-08-27 |
|
|
| 2238 |
Mental Health During Pregnancy |
2021-08-27 |
|
|
| 2239 |
Effect of Vaccination |
2021-08-27 |
|
|
| 2240 |
Confict of Interest |
2021-08-27 |
|
|
| 2241 |
Future Trends |
2021-08-26 |
|
|
| 2242 |
Various Agents Used As Local Drug Delivery |
2021-08-26 |
|
|
| 2243 |
Devices used as Local Drug Delivery |
2021-08-26 |
|
|
| 2244 |
Principle |
2021-08-26 |
|
|
| 2245 |
Factors for the Emergence of Infectious Diseases |
2021-08-26 |
|
|
| 2246 |
Emerging Zoonoses Burden in Ethiopia |
2021-08-26 |
|
|
| 2247 |
Emerging Zoonoses Burden Globally |
2021-08-26 |
|
|
| 2248 |
Funding and Conflict of Interest |
2021-08-26 |
|
|
| 2249 |
Data Sharing |
2021-08-26 |
|
|
| 2250 |
Why in UK and Europe |
2021-08-25 |
|
|
| 2251 |
Breast Cancer Biology in USA and Canada |
2021-08-25 |
|
|
| 2252 |
Breast Cancer in Middle East |
2021-08-25 |
|
|
| 2253 |
Perioperative Phases |
2021-08-25 |
|
|
| 2254 |
Multimodal Approach to Pain Management |
2021-08-25 |
|
|
| 2255 |
Assessment of Opioid Risk |
2021-08-25 |
|
|
| 2256 |
Opioid Prescription |
2021-08-25 |
|
|
| 2257 |
Arthritic Knee and Hip Pain |
2021-08-25 |
|
|
| 2258 |
Total Joint Arthroplasty and the Perioperative Pain Response |
2021-08-25 |
|
|
| 2259 |
Refutation |
2021-08-25 |
|
|
| 2260 |
Counterargument |
2021-08-25 |
|
|
| 2261 |
Evidence |
2021-08-25 |
|
|
| 2262 |
Argument |
2021-08-25 |
|
|
| 2263 |
An Aid To Thought, Not a Substitute For It? |
2021-08-24 |
|
|
| 2264 |
Beyond the Basics? |
2021-08-24 |
|
|
| 2265 |
Only Efficiency? |
2021-08-24 |
|
|
| 2266 |
What Does ‘Working Better’ Mean? |
2021-08-24 |
|
|
| 2267 |
What Is ‘It’? |
2021-08-24 |
|
|
| 2268 |
Prevention and Treatment |
2021-08-24 |
|
|
| 2269 |
Chemistry and Treatment |
2021-08-24 |
|
|
| 2270 |
Biology and Distribution |
2021-08-23 |
|
|
| 2271 |
Data Analysis and Discussion |
2021-08-23 |
|
|
| 2272 |
Conclusion and Policy Recommendations |
2021-08-21 |
|
|
| 2273 |
Presentation and Discussion of Empirical Results |
2021-08-21 |
|
|
| 2274 |
Description of the Study |
2021-08-21 |
|
|
| 2275 |
Extraction |
2021-08-21 |
|
|
| 2276 |
Review of Previous Studies |
2021-08-21 |
|
|
| 2277 |
Plant Bio-Reactors |
2021-08-21 |
|
|
| 2278 |
Plastids |
2021-08-21 |
|
|
| 2279 |
Production in Transgenic Green Tissues |
2021-08-21 |
|
|
| 2280 |
Seed Based Systems |
2021-08-21 |
|
|
| 2281 |
Non-Surfactant Stabilizers |
2021-08-21 |
|
|
| 2282 |
Surfactants |
2021-08-21 |
|
|
| 2283 |
Initiators |
2021-08-21 |
|
|
| 2284 |
Components |
2021-08-21 |
|
|
| 2285 |
Free Radical Polymerization |
2021-08-21 |
|
|
| 2286 |
Conclusions and Limitations |
2021-08-21 |
|
|
| 2287 |
Cancelation |
2021-08-21 |
|
|
| 2288 |
Results |
2021-08-21 |
|
|
| 2289 |
Cumulative Asymmetric Adjustments |
2021-08-21 |
|
|
| 2290 |
Results of NARDL |
2021-08-21 |
|
|
| 2291 |
Empirical Results and Discussion |
2021-08-21 |
|
|
| 2292 |
Data, Model and Methods |
2021-08-21 |
|
|
| 2293 |
Code Available |
2021-08-20 |
|
|
| 2294 |
The Study Design |
2021-08-20 |
|
|
| 2295 |
Type of Packing |
2021-08-20 |
|
|
| 2296 |
Nano Materials |
2021-08-20 |
|
|
| 2297 |
Role of Nanotechnology In Food Packaging |
2021-08-20 |
|
|
| 2298 |
Test Procedure and Evaluation |
2021-08-20 |
|
|
| 2299 |
Cause for Type 2 Diabetes |
2021-08-19 |
|
|
| 2300 |
Cause for Type 1 Diabetes |
2021-08-19 |
|
|
| 2301 |
Cause for Type 1 Diabetes |
2021-08-19 |
|
|
| 2302 |
Types of Diabetes |
2021-08-19 |
|
|
| 2303 |
Clinical Effects of Vitamin D |
2021-08-19 |
|
|
| 2304 |
Vitamin D Deficiency |
2021-08-19 |
|
|
| 2305 |
Recent Advancements in TUDSS |
2021-08-19 |
|
|
| 2306 |
Physiology of Human Nail |
2021-08-19 |
|
|
| 2307 |
Managing Research on Argotechnology |
2021-08-19 |
|
|
| 2308 |
Transferring Agricultural Technology |
2021-08-19 |
|
|
| 2309 |
Management of Pre-diabetes |
2021-08-19 |
|
|
| 2310 |
Declaration of Conflict of Interests |
2021-08-19 |
|
|
| 2311 |
Case Description and Method |
2021-08-19 |
|
|
| 2312 |
Symptoms and Sign |
2021-08-18 |
|
|
| 2313 |
Different kinds of Inserts |
2021-08-18 |
|
|
| 2314 |
Working of Cochlear Insert |
2021-08-18 |
|
|
| 2315 |
Success of Cochlear Inserts |
2021-08-18 |
|
|
| 2316 |
Models of Political-Bureaucratic Relations |
2021-08-18 |
|
|
| 2317 |
Conceptualisation of Successions Politics and Administration |
2021-08-18 |
|
|
| 2318 |
Context and Historical Dimension of Succession Politics |
2021-08-18 |
|
|
| 2319 |
Pharmacognostic Studies |
2021-08-18 |
|
|
| 2320 |
Methodologys |
2021-08-18 |
|
|
| 2321 |
Internal Iliac Artery Stenosis: Diagnosis and How To Manage It |
2021-08-18 |
|
|
| 2322 |
Coronary Angioplasty and Stents Placement Surgery |
2021-08-18 |
|
|
| 2323 |
Carotid Endarterectomy Surgery Recovery |
2021-08-18 |
|
|
| 2324 |
An overview of Deep Vein Thrombosis |
2021-08-18 |
|
|
| 2325 |
An Outlook: Carotid Artery Disease (CAD) |
2021-08-18 |
|
|
| 2326 |
Review Analysis |
2021-08-17 |
|
|
| 2327 |
Applications and Discussion |
2021-08-17 |
|
|
| 2328 |
Methodology Adopted |
2021-08-17 |
|
|
| 2329 |
Funding Support |
2021-08-17 |
|
|
| 2330 |
Sources of Heavy Metals |
2021-08-17 |
|
|
| 2331 |
The Bio-Materials Tests |
2021-08-17 |
|
|
| 2332 |
Conclusions and Technologies |
2021-08-17 |
|
|
| 2333 |
Need for New Initiative on Foliar |
2021-08-17 |
|
|
| 2334 |
Structure-Based Drug Design |
2021-08-16 |
|
|
| 2335 |
opinnion |
2021-08-16 |
|
|
| 2336 |
Author's Funding |
2021-08-16 |
|
|
| 2337 |
Management of the Safety Database |
2021-08-16 |
|
|
| 2338 |
Contrast Between Us, Eu And Indian Pv |
2021-08-16 |
|
|
| 2339 |
Pharmacovigilance System Workflow as per Indian Scenario |
2021-08-16 |
|
|
| 2340 |
Legislation In India Pharmacovigilance |
2021-08-16 |
|
|
| 2341 |
History of Pharmacovigilance in India |
2021-08-16 |
|
|
| 2342 |
Particle Shape and Surface Area |
2021-08-16 |
|
|
| 2343 |
Particle Size and Particle Size Distribution |
2021-08-16 |
|
|
| 2344 |
Fabrication Protection and Cost Reduction |
2021-08-16 |
|
|
| 2345 |
Application Areas and Limitations |
2021-08-16 |
|
|
| 2346 |
Mutant Strains |
2021-08-13 |
|
|
| 2347 |
Cross-Immunity |
2021-08-13 |
|
|
| 2348 |
Age Variation |
2021-08-13 |
|
|
| 2349 |
A Systematic Note of the Effects of WBV on Balance, Mobility, and Strength in Aging Adults |
2021-08-13 |
|
|
| 2350 |
Antibacterial Properties of Rhazya stricta and Methicillin-Resistant Staphylococcus aureus |
2021-08-13 |
|
|
| 2351 |
During Infection, S. scitamineum and U. esculenta have Confined Enzyme Activity at the Smut Gall |
2021-08-13 |
|
|
| 2352 |
The Effect of Essential Oil from Guava (Psidium guajava) Leaves on Male Guinea Pig Reproductive Parameters (Cavia porcellus) |
2021-08-13 |
|
|
| 2353 |
Curcumin Therapy's Efficacy in the Treatment of Inflammation and Cancer. |
2021-08-13 |
|
|
| 2354 |
Roles and Responsibilities |
2021-08-13 |
|
|
| 2355 |
New Member Added to the Editorial Board |
2021-08-13 |
|
|
| 2356 |
Diagnosis and Management of Pneumonia |
2021-08-12 |
|
|
| 2357 |
Treatment of Chronic Obstructive Pulmonary Ailment |
2021-08-12 |
|
|
| 2358 |
Causes and Treatment |
2021-08-12 |
|
|
| 2359 |
Sessions |
2021-08-12 |
|
|
| 2360 |
Welcome Message |
2021-08-12 |
|
|
| 2361 |
Mass Medication |
2021-08-12 |
|
|
| 2362 |
Trail Registration |
2021-08-12 |
|
|
| 2363 |
Proprietoship |
2021-08-12 |
|
|
| 2364 |
Veins |
2021-08-12 |
|
|
| 2365 |
Contribution of the Authors |
2021-08-11 |
|
|
| 2366 |
Past Conference |
2021-08-11 |
|
|
| 2367 |
Conflict Of Interest |
2021-08-11 |
|
|
| 2368 |
Conflict of Interest |
2021-08-11 |
|
|
| 2369 |
Conflict of Interest |
2021-08-11 |
|
|
| 2370 |
Roles and Responsibilites |
2021-08-11 |
|
|
| 2371 |
Editorial Invitation |
2021-08-11 |
|
|
| 2372 |
Areas for Further Study |
2021-08-10 |
|
|
| 2373 |
Justice |
2021-08-10 |
|
|
| 2374 |
Beneficence and Non-Maleficence |
2021-08-10 |
|
|
| 2375 |
Respect for Autonomy |
2021-08-10 |
|
|
| 2376 |
Medical Ethical Considerations |
2021-08-10 |
|
|
| 2377 |
Children and COVID-19-Following the Science |
2021-08-10 |
|
|
| 2378 |
Participants and Methods |
2021-08-10 |
|
|
| 2379 |
Electrical Arrangement of the Heart |
2021-08-10 |
|
|
| 2380 |
Normal Heartbeat |
2021-08-10 |
|
|
| 2381 |
Treatment for Cardiovascular Disease |
2021-08-10 |
|
|
| 2382 |
Prevention for Cardiovascular Disease |
2021-08-10 |
|
|
| 2383 |
Symptoms of Cardiovascular Disease |
2021-08-10 |
|
|
| 2384 |
Ageing and Covid-19 |
2021-08-10 |
|
|
| 2385 |
Gratefulness |
2021-08-10 |
|
|
| 2386 |
Research findings in Psychology which are quite surprising |
2021-08-09 |
|
|
| 2387 |
Specializing |
2021-08-09 |
|
|
| 2388 |
Scope of Practice |
2021-08-09 |
|
|
| 2389 |
Educational Requirements for Counseling Psychologists |
2021-08-09 |
|
|
| 2390 |
Educational Requirements for Counselors |
2021-08-09 |
|
|
| 2391 |
Participants and Methodology |
2021-08-09 |
|
|
| 2392 |
Decelerations |
2021-08-09 |
|
|
| 2393 |
Drug Delivery System |
2021-08-09 |
|
|
| 2394 |
Aspects of Development |
2021-08-09 |
|
|
| 2395 |
Plain English Summary |
2021-08-09 |
|
|
| 2396 |
Compliance with Ethical Requirement |
2021-08-09 |
|
|
| 2397 |
Seminal Technical Approach CFDNAS from the Animal Model to Humans |
2021-08-09 |
|
|
| 2398 |
Idiopathic Infertility and Other Functional Sperm Defects (DNA Fragmentation, ROS, Methylation, Proteomics, MI-RNA) |
2021-08-09 |
|
|
| 2399 |
Circulating Nucleic Acids and Male Infertility |
2021-08-09 |
|
|
| 2400 |
Circulating Nucleic Acids and Female Infertility |
2021-08-09 |
|
|
| 2401 |
Free Nucleic Acids |
2021-08-09 |
|
|
| 2402 |
Incidence and Frequency of Feeding Related Errors |
2021-08-07 |
|
|
| 2403 |
Laboratory Tests |
2021-08-06 |
|
|
| 2404 |
Conflict |
2021-08-06 |
|
|
| 2405 |
About the Conference |
2021-08-06 |
|
|
| 2406 |
Vulnerable |
2021-08-06 |
|
|
| 2407 |
Providing Consultations |
2021-08-06 |
|
|
| 2408 |
Discussion and Results |
2021-08-05 |
|
|
| 2409 |
Types of Operations |
2021-08-05 |
|
|
| 2410 |
Qualities of Good Litter Material |
2021-08-05 |
|
|
| 2411 |
Recycling of Nutrients in Deep Litter System |
2021-08-05 |
|
|
| 2412 |
Litter Management |
2021-08-05 |
|
|
| 2413 |
Factors Effecting |
2021-08-05 |
|
|
| 2414 |
Symptoms of A Brain Tumor |
2021-08-05 |
|
|
| 2415 |
Types of Brain Tumors |
2021-08-05 |
|
|
| 2416 |
Brain Tumor |
2021-08-05 |
|
|
| 2417 |
Viewpoint |
2021-08-05 |
|
|
| 2418 |
Types of Coma |
2021-08-05 |
|
|
| 2419 |
Discussion and Recommendations |
2021-08-04 |
|
|
| 2420 |
Finding and Discussion |
2021-08-04 |
|
|
| 2421 |
Remarks |
2021-08-04 |
|
|
| 2422 |
What I Saw in this Field? |
2021-08-04 |
|
|
| 2423 |
Recommendation and Future Research |
2021-08-04 |
|
|
| 2424 |
Discussion and Findings |
2021-08-04 |
|
|
| 2425 |
Limitations of the Review |
2021-08-04 |
|
|
| 2426 |
Strengths of the Review |
2021-08-04 |
|
|
| 2427 |
Learning Objectives |
2021-08-04 |
|
|
| 2428 |
Data Availability Statement |
2021-08-03 |
|
|
| 2429 |
Informed Consent Statement |
2021-08-03 |
|
|
| 2430 |
Institutional Review Board Statement |
2021-08-03 |
|
|
| 2431 |
Image Article |
2021-08-02 |
|
|
| 2432 |
Micronutrient Deficiency in Athletes and Inefficiency of Supplementation |
2021-08-02 |
|
|
| 2433 |
Flexibility to Survive: the Potential Approaches for Disruption Management of the Food Truck Sector |
2021-08-02 |
|
|
| 2434 |
The Covid-19 Disruption on the Food Truck Sector |
2021-08-02 |
|
|
| 2435 |
Food Away from Home and Food Trucks |
2021-08-02 |
|
|
| 2436 |
Mitochondrial Donation |
2021-08-02 |
|
|
| 2437 |
Male Inheritance |
2021-08-02 |
|
|
| 2438 |
Mitochondrial Bottleneck |
2021-08-02 |
|
|
| 2439 |
Female Inheritance |
2021-08-02 |
|
|
| 2440 |
Denaturation of Air |
2021-08-02 |
|
|
| 2441 |
Synthetic Denaturation as another Option |
2021-08-02 |
|
|
| 2442 |
Denaturation Because of Compound Specialists |
2021-08-02 |
|
|
| 2443 |
Naturally Instigated Denaturation |
2021-08-02 |
|
|
| 2444 |
Limitations and Suggestions for Further Research |
2021-08-02 |
|
|
| 2445 |
Hormonal Deviations |
2021-08-02 |
|
|
| 2446 |
An Epidemic Aspect |
2021-08-02 |
|
|
| 2447 |
Clinical Investigations |
2021-08-02 |
|
|
| 2448 |
Conclusion and Future Work |
2021-08-02 |
|
|
| 2449 |
Integrative Approaches to Treating Chronic Pain: A Whole-Person Approach to Managing Symptoms |
2021-08-02 |
|
|
| 2450 |
Integrative Approaches to Treating Chronic Pain: A Whole-Person Approach to Managing Symptoms |
2021-08-02 |
|
|
| 2451 |
The Use and Efficacy of Invasive Procedures for Chronic Pain Conditions |
2021-08-02 |
|
|
| 2452 |
Use of Glasses |
2021-08-02 |
|
|
| 2453 |
Complexities from Eye Stress |
2021-08-02 |
|
|
| 2454 |
Basic Reasons for Eye Strain |
2021-08-02 |
|
|
| 2455 |
Additional Information and Declarations |
2021-08-02 |
|
|
| 2456 |
Conclusion and The Way Forward |
2021-07-30 |
|
|
| 2457 |
Overview of Minning Invetment in Ethiopia |
2021-07-30 |
|
|
| 2458 |
Overview of Minning Investment in Ethiopia |
2021-07-30 |
|
|
| 2459 |
Definitions of Research Variables |
2021-07-30 |
|
|
| 2460 |
Urological Complications |
2021-07-30 |
|
|
| 2461 |
Scope for Further Research |
2021-07-30 |
|
|
| 2462 |
A New Device |
2021-07-29 |
|
|
| 2463 |
Counter Measures |
2021-07-29 |
|
|
| 2464 |
The “Baby Heart Syndrome” (BHS) Theory |
2021-07-29 |
|
|
| 2465 |
Management of Potato Late Blight |
2021-07-29 |
|
|
| 2466 |
Disease Cycle and Epidemiology |
2021-07-29 |
|
|
| 2467 |
Institutional Review Board Statement |
2021-07-28 |
|
|
| 2468 |
Treatment of Neurodegeneration |
2021-07-28 |
|
|
| 2469 |
Neurodegeneration |
2021-07-28 |
|
|
| 2470 |
Ailments |
2021-07-28 |
|
|
| 2471 |
Medications |
2021-07-28 |
|
|
| 2472 |
Causes of Psychosis |
2021-07-28 |
|
|
| 2473 |
Sorts of Stroke |
2021-07-28 |
|
|
| 2474 |
Stroke Manifestations |
2021-07-28 |
|
|
| 2475 |
Factors Brain Tumor |
2021-07-28 |
|
|
| 2476 |
Formulating an Institution-Specific Pathway |
2021-07-28 |
|
|
| 2477 |
Testing for COVID Before Surgery |
2021-07-28 |
|
|
| 2478 |
Method of Analysing Physicochemical Parameters |
2021-07-27 |
|
|
| 2479 |
Determining the Depth of Deep Geological Repository |
2021-07-27 |
|
|
| 2480 |
Setup of Deep Geological Repository |
2021-07-27 |
|
|
| 2481 |
Developing Countries Affected By E Waste |
2021-07-27 |
|
|
| 2482 |
Renal Artery |
2021-07-27 |
|
|
| 2483 |
ANALYTICAL RELATIONS |
2021-07-27 |
|
|
| 2484 |
Enabling People Proactively to Battle against COVID-19 |
2021-07-27 |
|
|
| 2485 |
Mental Results of Pandemic in Different Nations |
2021-07-27 |
|
|
| 2486 |
Government Responses to COVID-19 |
2021-07-27 |
|
|
| 2487 |
COVID Aid, Relief and Economic Security Act, Department of Education |
2021-07-27 |
|
|
| 2488 |
Conflict of Interest Self-Report |
2021-07-27 |
|
|
| 2489 |
Threats and Decline |
2021-07-27 |
|
|
| 2490 |
Reproduction of this Species |
2021-07-27 |
|
|
| 2491 |
Habitat |
2021-07-27 |
|
|
| 2492 |
Conservation |
2021-07-27 |
|
|
| 2493 |
Habitat and Distribution |
2021-07-27 |
|
|
| 2494 |
IMPORTANCE OF LANGUAGE EDUCATION |
2021-07-27 |
|
|
| 2495 |
Diseases of Sponges |
2021-07-27 |
|
|
| 2496 |
Evolution |
2021-07-27 |
|
|
| 2497 |
Macrophage Therapy |
2021-07-26 |
|
|
| 2498 |
DC Therapy |
2021-07-26 |
|
|
| 2499 |
Stem Cell Therapy |
2021-07-26 |
|
|
| 2500 |
Cytokine-Based Immunotherapy |
2021-07-26 |
|
|
| 2501 |
Plasma Therapy |
2021-07-26 |
|
|
| 2502 |
Ruxolitinib |
2021-07-26 |
|
|
| 2503 |
Abidol-Umifenovir |
2021-07-26 |
|
|
| 2504 |
Baricitinib |
2021-07-26 |
|
|
| 2505 |
Tocilizumab |
2021-07-26 |
|
|
| 2506 |
Vaccine Development Approach |
2021-07-26 |
|
|
| 2507 |
Relationship to other Biological Sciences |
2021-07-26 |
|
|
| 2508 |
Allele-Specific Oligonucleotide |
2021-07-26 |
|
|
| 2509 |
Microarrays |
2021-07-26 |
|
|
| 2510 |
Macromolecule Blotting and Probing |
2021-07-26 |
|
|
| 2511 |
Polymerase Chain Reaction |
2021-07-26 |
|
|
| 2512 |
Molecular Cloning |
2021-07-26 |
|
|
| 2513 |
Oxysterols to the Rescue |
2021-07-26 |
|
|
| 2514 |
Analytical Methods |
2021-07-24 |
|
|
| 2515 |
Editor |
2021-07-24 |
|
|
| 2516 |
Patient’s Consent |
2021-07-24 |
|
|
| 2517 |
Methodos |
2021-07-23 |
|
|
| 2518 |
Long-Term Effects on the Lungs |
2021-07-23 |
|
|
| 2519 |
Branches of Aerodynamics |
2021-07-23 |
|
|
| 2520 |
Aerodynamics |
2021-07-23 |
|
|
| 2521 |
From the Lens of the Family |
2021-07-23 |
|
|
| 2522 |
From the Lens of the Patient |
2021-07-23 |
|
|
| 2523 |
From the Lens of Health Care Organization |
2021-07-23 |
|
|
| 2524 |
Uses |
2021-07-23 |
|
|
| 2525 |
Theories |
2021-07-23 |
|
|
| 2526 |
Deep Learning Methods |
2021-07-23 |
|
|
| 2527 |
About the Hepatitis B Virus |
2021-07-23 |
|
|
| 2528 |
Artificial Intelligence-Brain Heuristic Comparison |
2021-07-23 |
|
|
| 2529 |
Brain Disease and Mirror Neurons |
2021-07-23 |
|
|
| 2530 |
Causes of Health Issues During Covid-19 |
2021-07-23 |
|
|
| 2531 |
Medication |
2021-07-23 |
|
|
| 2532 |
A Note on Angiography |
2021-07-22 |
|
|
| 2533 |
In vivo Angiogenesis: Therapeutic potential and challenges |
2021-07-22 |
|
|
| 2534 |
Techniques used to Diagnose Cardiovascular Diseases |
2021-07-22 |
|
|
| 2535 |
Drugs to Treat Cardiovascular Diseases |
2021-07-22 |
|
|
| 2536 |
Immunotheraphy |
2021-07-21 |
|
|
| 2537 |
Ethical Standards Statement |
2021-07-21 |
|
|
| 2538 |
Declaration Of Conflicting Interests |
2021-07-21 |
|
|
| 2539 |
Brief Report |
2021-07-21 |
|
|
| 2540 |
Sequence Optimization and Oligo Design |
2021-07-20 |
|
|
| 2541 |
Its Side Effects |
2021-07-20 |
|
|
| 2542 |
Diet to be Taken |
2021-07-20 |
|
|
| 2543 |
The four components of this model are: |
2021-07-20 |
|
|
| 2544 |
Components of the Primary Respiratory Mechanism (PRM) |
2021-07-20 |
|
|
| 2545 |
Current Concerns in Delaying the Second Jabs |
2021-07-19 |
|
|
| 2546 |
Conceptual Acceptance of Single Jab Strategy |
2021-07-19 |
|
|
| 2547 |
The Current Position of Vaccines Deployment in the UK |
2021-07-19 |
|
|
| 2548 |
Study Section |
2021-07-19 |
|
|
| 2549 |
Epidemology of Myopia |
2021-07-19 |
|
|
| 2550 |
Essential Structure of Cell Membranes |
2021-07-17 |
|
|
| 2551 |
Asymmetric Structure of the Membrane |
2021-07-17 |
|
|
| 2552 |
Flavonoid Phloretin: Dermatological Applications |
2021-07-17 |
|
|
| 2553 |
A New Target for Chemotherapy: The Footprint of Kynurenine Pathway in Every Cancer |
2021-07-17 |
|
|
| 2554 |
Impact of Covid-19 |
2021-07-16 |
|
|
| 2555 |
Reflection |
2021-07-16 |
|
|
| 2556 |
The Study Output |
2021-07-16 |
|
|
| 2557 |
Analysis and Findings |
2021-07-16 |
|
|
| 2558 |
Situation Analysis |
2021-07-16 |
|
|
| 2559 |
Fundamental Lupus versus LN |
2021-07-16 |
|
|
| 2560 |
Limitation and Suggestions for Future Research |
2021-07-16 |
|
|
| 2561 |
Alexithymia |
2021-07-16 |
|
|
| 2562 |
The Concept of Disease as a Social Institution |
2021-07-16 |
|
|
| 2563 |
Ideas and Beliefs of a Discourse |
2021-07-16 |
|
|
| 2564 |
Definition and Types of Discourse |
2021-07-16 |
|
|
| 2565 |
Review and Literature |
2021-07-15 |
|
|
| 2566 |
Short Notes on Elimination Reactions |
2021-07-15 |
|
|
| 2567 |
Editorial on Alkanes and Nomenclature |
2021-07-15 |
|
|
| 2568 |
A Short Notes on Functional Groups |
2021-07-15 |
|
|
| 2569 |
When Open Heart Surgery Needed? |
2021-07-15 |
|
|
| 2570 |
How Does the New CoronaVirus Stoke Cardiac Damage? |
2021-07-15 |
|
|
| 2571 |
Preliminaries of NN |
2021-07-15 |
|
|
| 2572 |
Methodolgy |
2021-07-15 |
|
|
| 2573 |
Editorial on Rearrangement Reactions |
2021-07-15 |
|
|
| 2574 |
A Brief Note on Organometallics |
2021-07-15 |
|
|
| 2575 |
Optimum Secure IOT Model |
2021-07-15 |
|
|
| 2576 |
Credential Security |
2021-07-15 |
|
|
| 2577 |
IOT and Block Chain: Security and Challenges |
2021-07-15 |
|
|
| 2578 |
Simple Tips for Early Prevention of Pcos |
2021-07-15 |
|
|
| 2579 |
Enantiomers: An Overview |
2021-07-15 |
|
|
| 2580 |
Editorial on Carboxylic Acids and Derivatives |
2021-07-15 |
|
|
| 2581 |
Editorial on Ring-Opening Reactions of Epoxides |
2021-07-15 |
|
|
| 2582 |
Associated Maternal Risk Factors for Low Birth Weight Neonates |
2021-07-15 |
|
|
| 2583 |
Treatment of Type B Aortic Dissection with TEVAR |
2021-07-15 |
|
|
| 2584 |
Coronavirus, Influenza and COVID-19 Resisting |
2021-07-14 |
|
|
| 2585 |
Immunity and Equilibrium Between Human and Microorganisms |
2021-07-14 |
|
|
| 2586 |
SARS-COV-2 or COVID-19 |
2021-07-14 |
|
|
| 2587 |
Chinese Medication |
2021-07-14 |
|
|
| 2588 |
Breast Cancer |
2021-07-14 |
|
|
| 2589 |
Illustration |
2021-07-14 |
|
|
| 2590 |
Clinical Problem |
2021-07-14 |
|
|
| 2591 |
Functions of Phytoconstituents in the Role of Wound Healing |
2021-07-14 |
|
|
| 2592 |
Biology And Behaviour |
2021-07-14 |
|
|
| 2593 |
Traditional Treatment of Wounds Improves with Medical Plants |
2021-07-14 |
|
|
| 2594 |
Pest Control |
2021-07-14 |
|
|
| 2595 |
Characteristics of a Good Herbal or Natural Agents in Wound Healing |
2021-07-14 |
|
|
| 2596 |
Traditional Healthcare Practices using Herbal Medicines |
2021-07-14 |
|
|
| 2597 |
Recent Advances in Agritourism |
2021-07-14 |
|
|
| 2598 |
Recent Approaches in Sustainable Agriculture |
2021-07-14 |
|
|
| 2599 |
Why We Should Ban All Toxic Agricultural Practices of Using NPK Fertilizers? |
2021-07-14 |
|
|
| 2600 |
Models |
2021-07-14 |
|
|
| 2601 |
Significance of Soil Fertility to Improve Crop Yield |
2021-07-14 |
|
|
| 2602 |
Importance of Agrobiodiversity |
2021-07-14 |
|
|
| 2603 |
Uses of Pesticides in Agriculture |
2021-07-14 |
|
|
| 2604 |
Recent Systematic Study Outcomes in Agrotechnology |
2021-07-14 |
|
|
| 2605 |
Importance and Advancement in Agriculture Technology |
2021-07-14 |
|
|
| 2606 |
Importance of Crop Protection Management |
2021-07-14 |
|
|
| 2607 |
Genetically Engineered Crops (Bacillus Thuringiensis Crops) |
2021-07-14 |
|
|
| 2608 |
Upcoming Issue: Nutritional Status |
2021-07-14 |
|
|
| 2609 |
About Conference |
2021-07-13 |
|
|
| 2610 |
Gene Polymorphisms in Eating Disorders |
2021-07-13 |
|
|
| 2611 |
The Development of a Survey Tool to Measuring Vaccine Hesitancy |
2021-07-13 |
|
|
| 2612 |
Scientific Lessons to be shared for Public Health Actions |
2021-07-13 |
|
|
| 2613 |
Epidemiology of the Infection |
2021-07-13 |
|
|
| 2614 |
Search Method |
2021-07-13 |
|
|
| 2615 |
Therapeutic Strategies |
2021-07-13 |
|
|
| 2616 |
Clinical Lessons |
2021-07-13 |
|
|
| 2617 |
Biologic Insights |
2021-07-13 |
|
|
| 2618 |
Cell Therapy Strategies |
2021-07-13 |
|
|
| 2619 |
Note |
2021-07-13 |
|
|
| 2620 |
Conflicts of Interest and Acknowledgements |
2021-07-09 |
|
|
| 2621 |
Distribution and Species Variation |
2021-07-09 |
|
|
| 2622 |
Distribution and Species Variation< |
2021-07-09 |
|
|
| 2623 |
Cold-Blooded Animals |
2021-07-09 |
|
|
| 2624 |
Ionized Drugs |
2021-07-09 |
|
|
| 2625 |
Ethics |
2021-07-08 |
|
|
| 2626 |
Composition Of Green Tea |
2021-07-08 |
|
|
| 2627 |
The Adverse Effect Of Green Tea Consumption |
2021-07-08 |
|
|
| 2628 |
Health Benefits Of Consuming Green Tea |
2021-07-08 |
|
|
| 2629 |
Molecular Mechanism of Posttranscriptional HIV Latency |
2021-07-08 |
|
|
| 2630 |
HIV Latency |
2021-07-08 |
|
|
| 2631 |
Maintaining Chlorophyll Content Predicts Drought Tolerance |
2021-07-08 |
|
|
| 2632 |
Breeding For Drought Tolerance By Monitoring Chlorophyll Content |
2021-07-08 |
|
|
| 2633 |
Methods to Quantify Chlorophylls |
2021-07-08 |
|
|
| 2634 |
Chemical and Physical Properties of the Chlorophylls |
2021-07-08 |
|
|
| 2635 |
Data and Materials |
2021-07-08 |
|
|
| 2636 |
Purpose of the Work |
2021-07-08 |
|
|
| 2637 |
Specific Sports Overview of the Problem |
2021-07-08 |
|
|
| 2638 |
Development of Shear Wave Elastography |
2021-07-07 |
|
|
| 2639 |
Editotrial Note |
2021-07-07 |
|
|
| 2640 |
Perspectives |
2021-07-07 |
|
|
| 2641 |
DC-OCs as Potent Players in the Context of Breast Tumor Bone Metastasis |
2021-07-07 |
|
|
| 2642 |
Dendritic Cells Development into Osteoclasts Type Cells (DC-OCs) |
2021-07-07 |
|
|
| 2643 |
T Cell-Dependent Formation of Breast Tumor Pre-Metastatic Bone Niche |
2021-07-07 |
|
|
| 2644 |
A Propos a Man with Spectacles |
2021-07-07 |
|
|
| 2645 |
Titanium in Spectacle Frames |
2021-07-07 |
|
|
| 2646 |
Titanium and Autoimmune Reactions |
2021-07-07 |
|
|
| 2647 |
Further Adverse Effects |
2021-07-07 |
|
|
| 2648 |
The Yellow Nail Syndrome |
2021-07-07 |
|
|
| 2649 |
Toxic and Allergic Consequences |
2021-07-07 |
|
|
| 2650 |
Statements |
2021-07-07 |
|
|
| 2651 |
Eventual Fate of Microbiology |
2021-07-07 |
|
|
| 2652 |
Utilizations of Microbiology |
2021-07-07 |
|
|
| 2653 |
Creation of Microbial Food Societies |
2021-07-07 |
|
|
| 2654 |
Capacity of Microbial Food Societies in Food |
2021-07-07 |
|
|
| 2655 |
Author Contributuion |
2021-07-07 |
|
|
| 2656 |
Discussion and Recommendation |
2021-07-06 |
|
|
| 2657 |
Comparison of Health Care System |
2021-07-06 |
|
|
| 2658 |
Monitoring Framework WHO Six Building Blocks |
2021-07-06 |
|
|
| 2659 |
Background and Demographic Profile of Iran and Nigeria |
2021-07-06 |
|
|
| 2660 |
Restriction of Fundamental Human Rights during Times of National Emergency |
2021-07-06 |
|
|
| 2661 |
Assessing the Bioethical Norms and International Human Rights Standards |
2021-07-06 |
|
|
| 2662 |
Arguments for and Against COVID-19 Vaccination for School Children |
2021-07-06 |
|
|
| 2663 |
Declaration of Conflict of Interest |
2021-07-06 |
|
|
| 2664 |
Itinerary structure and port Organization |
2021-07-06 |
|
|
| 2665 |
World Cruises |
2021-07-06 |
|
|
| 2666 |
Questions to Further Research |
2021-07-06 |
|
|
| 2667 |
Compare and Contrast Themes and Gaps in Literature |
2021-07-06 |
|
|
| 2668 |
Psychosocial Support |
2021-07-06 |
|
|
| 2669 |
Patient Education |
2021-07-06 |
|
|
| 2670 |
Evidence-Based Prevention Methods for Phenylketonuria |
2021-07-06 |
|
|
| 2671 |
Maintenance Therapy |
2021-07-05 |
|
|
| 2672 |
Sequencing Therapy |
2021-07-05 |
|
|
| 2673 |
Combination Therapy |
2021-07-05 |
|
|
| 2674 |
Bimodal Effect of Vitamin A and Biphasic Immune Pathogenesis in COVID-19 |
2021-07-05 |
|
|
| 2675 |
Pathogenesis of COVID-19, Viral Tropism and Retinoid Signaling Disorder |
2021-07-05 |
|
|
| 2676 |
Retinol Depletion and Retinoid Signaling Mechanism in COVID-19 |
2021-07-05 |
|
|
| 2677 |
PERMANENT BIRTH CONTROL METHODS |
2021-07-05 |
|
|
| 2678 |
HORMONAL METHODS OF BIRTH CONTROL |
2021-07-05 |
|
|
| 2679 |
BARRIER METHODS FOR BIRTH CONTROL |
2021-07-05 |
|
|
| 2680 |
Researches about The Efficacy of Miswak |
2021-07-05 |
|
|
| 2681 |
Chemical Constituents |
2021-07-05 |
|
|
| 2682 |
Reasons behind Studying this Field |
2021-07-03 |
|
|
| 2683 |
Work Environment |
2021-07-03 |
|
|
| 2684 |
Specializations |
2021-07-03 |
|
|
| 2685 |
What is Human Factors Psychology? |
2021-07-03 |
|
|
| 2686 |
Perspectives on Educational Psychology from a Various Aspects |
2021-07-03 |
|
|
| 2687 |
Diagnosis of Developmental Psychology |
2021-07-03 |
|
|
| 2688 |
When to Consult a Developmental Psychologist? |
2021-07-03 |
|
|
| 2689 |
Theories of Developmental Psychology |
2021-07-03 |
|
|
| 2690 |
Questions About developmental Psychology |
2021-07-03 |
|
|
| 2691 |
COQ10 AND HMG-COA Reductases |
2021-07-03 |
|
|
| 2692 |
Cardiac Surgery |
2021-07-03 |
|
|
| 2693 |
Arrhythmias |
2021-07-03 |
|
|
| 2694 |
Cardiomyopathy |
2021-07-03 |
|
|
| 2695 |
Congestive Heart Failure |
2021-07-03 |
|
|
| 2696 |
Myocardial Infarction |
2021-07-03 |
|
|
| 2697 |
Coronary Artery Disease |
2021-07-03 |
|
|
| 2698 |
Hypertension |
2021-07-03 |
|
|
| 2699 |
Atherosclerosis |
2021-07-03 |
|
|
| 2700 |
Integrated Self-Driving Travel Scheme Planning |
2021-07-03 |
|
|
| 2701 |
Dynamic Programming and Clustering-Based Heuristic Algorithm |
2021-07-03 |
|
|
| 2702 |
Solution Methods |
2021-07-03 |
|
|
| 2703 |
Hotel Selection in Travel Planning |
2021-07-03 |
|
|
| 2704 |
Travel Routing Optimization |
2021-07-03 |
|
|
| 2705 |
Orienteering Problem with Hotel Selection |
2021-07-03 |
|
|
| 2706 |
Travel Salesman Problem with Hotel Selection |
2021-07-03 |
|
|
| 2707 |
Opinion Note on Cystic Fibrosis |
2021-07-02 |
|
|
| 2708 |
Opinion Note on Cystic Fibrosis |
2021-07-02 |
|
|
| 2709 |
Opinion Note on Cystic Fibrosis |
2021-07-02 |
|
|
| 2710 |
Opinion Note on Cystic Fibrosis |
2021-07-02 |
|
|
| 2711 |
Review Article on Polymerase Response |
2021-07-02 |
|
|
| 2712 |
Notes on Therapeutic Science |
2021-07-02 |
|
|
| 2713 |
Notes on Genetically Modify Crops |
2021-07-02 |
|
|
| 2714 |
Publications |
2021-07-02 |
|
|
| 2715 |
Publication |
2021-07-02 |
|
|
| 2716 |
Limitations and Future Research |
2021-07-02 |
|
|
| 2717 |
UNESCO |
2021-07-02 |
|
|
| 2718 |
Yoga Theraphy, Chronic low back pain (CLBP) |
2021-07-02 |
|
|
| 2719 |
Environmental Health and Biodiversity |
2021-07-02 |
|
|
| 2720 |
Environmental Health Perspectives |
2021-07-02 |
|
|
| 2721 |
IMPACT |
2021-07-02 |
|
|
| 2722 |
CAUSES OF IRRATIONAL PRESCRIBING OF DRUGS |
2021-07-02 |
|
|
| 2723 |
MSC-Based Therapy |
2021-07-02 |
|
|
| 2724 |
The Immunomodulatory Role of MSCS |
2021-07-02 |
|
|
| 2725 |
Therapeutic Applications of MSC |
2021-07-02 |
|
|
| 2726 |
Importance of Mesenchymal Stem Cell |
2021-07-02 |
|
|
| 2727 |
Previous Publication |
2021-07-01 |
|
|
| 2728 |
Future Of Social Media Research |
2021-06-28 |
|
|
| 2729 |
Healthcare Providers On Social Media |
2021-06-28 |
|
|
| 2730 |
Social Media Platforms Overtime |
2021-06-28 |
|
|
| 2731 |
Chronic Conditions On Social Media |
2021-06-28 |
|
|
| 2732 |
Case Discussion |
2021-06-25 |
|
|
| 2733 |
Presentation of Case |
2021-06-25 |
|
|
| 2734 |
Compliance with ethical statements |
2021-06-25 |
|
|
| 2735 |
Simulated Clinical User Study Validation |
2021-06-24 |
|
|
| 2736 |
Safety Pen Needle Description |
2021-06-24 |
|
|
| 2737 |
When to Approach Doctors |
2021-06-24 |
|
|
| 2738 |
List of Rare Skin Diseases |
2021-06-24 |
|
|
| 2739 |
Statement of Authorship |
2021-06-23 |
|
|
| 2740 |
Extreme Hyperglycemia in COVID-19 |
2021-06-18 |
|
|
| 2741 |
Effect of Outpatient Glycemic Control on Severity of COVID-19 |
2021-06-18 |
|
|
| 2742 |
Interrelationships Between Diabetes, Hyperglycemia and Severity of COVID-19 |
2021-06-18 |
|
|
| 2743 |
Mortality |
2021-06-18 |
|
|
| 2744 |
Incidence of Different Aetiology |
2021-06-18 |
|
|
| 2745 |
Recent advance in direct ethanol fuel cell for sustainable energy produc- tion |
2021-06-18 |
|
|
| 2746 |
Metal-organic framework membranes for CO2 capture, biofuel purifica- tion and water desalination: A computational perspective |
2021-06-18 |
|
|
| 2747 |
Uses of Antipsychotic Drugs in the Treatment of Schizophrenia |
2021-06-18 |
|
|
| 2748 |
Schizophrenia |
2021-06-18 |
|
|
| 2749 |
Clinical Employments |
2021-06-18 |
|
|
| 2750 |
Tumor in the Cerebellum |
2021-06-18 |
|
|
| 2751 |
Division |
2021-06-18 |
|
|
| 2752 |
Structure |
2021-06-18 |
|
|
| 2753 |
Edotrial Note On Cerebellum |
2021-06-18 |
|
|
| 2754 |
Employments |
2021-06-18 |
|
|
| 2755 |
Metencephalon |
2021-06-18 |
|
|
| 2756 |
Edotrial Note On Brain Stem |
2021-06-18 |
|
|
| 2757 |
Relative Bioavailability and Bioequivalence |
2021-06-18 |
|
|
| 2758 |
Outright Bioavailability |
2021-06-18 |
|
|
| 2759 |
Bioavailability |
2021-06-18 |
|
|
| 2760 |
Editorial Note on Anxiety Disorders |
2021-06-18 |
|
|
| 2761 |
Obesrvations and Results |
2021-06-17 |
|
|
| 2762 |
Contribution Author |
2021-06-16 |
|
|
| 2763 |
Different Impact of Actin Isoforms on the Process of Cell Division |
2021-06-15 |
|
|
| 2764 |
Cytoplasmic Actin Isoforms: Structures and Functions in the Interphase Non- Muscle Cells |
2021-06-15 |
|
|
| 2765 |
Mechanism of Action of NCS 613 in Lupus Nephritis |
2021-06-15 |
|
|
| 2766 |
PDE4 Inhibitors are Attracting Drugs for Chronic Inflammatory Diseases |
2021-06-15 |
|
|
| 2767 |
Regulation of cAMP Signaling by PDE4 Isozymes in Immune Cells |
2021-06-15 |
|
|
| 2768 |
Regulation of cAMP Signaling By PDE4 during Inflammation |
2021-06-15 |
|
|
| 2769 |
Models of Health and Medicalization |
2021-06-14 |
|
|
| 2770 |
Detection of Metals |
2021-06-14 |
|
|
| 2771 |
Liquid Chromatography-Mass Spectrometry |
2021-06-14 |
|
|
| 2772 |
Gas Chromatography-Mass Spectrometry |
2021-06-14 |
|
|
| 2773 |
Detection and Classification |
2021-06-14 |
|
|
| 2774 |
Reasons for sinus |
2021-06-14 |
|
|
| 2775 |
Investigating |
2021-06-14 |
|
|
| 2776 |
Radiological Analysis |
2021-06-14 |
|
|
| 2777 |
Animals |
2021-06-14 |
|
|
| 2778 |
Practical Application |
2021-06-14 |
|
|
| 2779 |
Behaviour |
2021-06-14 |
|
|
| 2780 |
Distribution And Habitat |
2021-06-14 |
|
|
| 2781 |
Life Cycle |
2021-06-14 |
|
|
| 2782 |
Trends Changing Cyber Security |
2021-06-11 |
|
|
| 2783 |
Cyber Security |
2021-06-11 |
|
|
| 2784 |
Cyber Crime |
2021-06-11 |
|
|
| 2785 |
Conflict of Interest and Competing Interests |
2021-06-10 |
|
|
| 2786 |
Data Sharing Statement |
2021-06-10 |
|
|
| 2787 |
Methodologies of Sad |
2021-06-09 |
|
|
| 2788 |
Software Systems |
2021-06-09 |
|
|
| 2789 |
Challenges and Way Forward |
2021-06-09 |
|
|
| 2790 |
Use Cases |
2021-06-09 |
|
|
| 2791 |
Benefits of Blockchain Based Supply Chain Applications |
2021-06-09 |
|
|
| 2792 |
Traditional Versus Blockchain Applications |
2021-06-09 |
|
|
| 2793 |
Value of Blockchain in Supply Chain |
2021-06-09 |
|
|
| 2794 |
Will Auto ml Replace Data Scientists? |
2021-06-09 |
|
|
| 2795 |
Resources available for learning Data Science |
2021-06-09 |
|
|
| 2796 |
High Demand for Data Scientists |
2021-06-09 |
|
|
| 2797 |
Auto ML |
2021-06-09 |
|
|
| 2798 |
Role of Machine Learning in Data Science |
2021-06-09 |
|
|
| 2799 |
Artificial Intelligence |
2021-06-09 |
|
|
| 2800 |
Machine Learning |
2021-06-09 |
|
|
| 2801 |
Data science vs. Auto ML |
2021-06-09 |
|
|
| 2802 |
Patient |
2021-06-09 |
|
|
| 2803 |
Significance Statement |
2021-06-08 |
|
|
| 2804 |
Wheezing - Asthma Relationship |
2021-06-07 |
|
|
| 2805 |
Wheezing Phenotypes in Children |
2021-06-07 |
|
|
| 2806 |
Diagnosis Approach |
2021-06-07 |
|
|
| 2807 |
Common and Manufactured Polymer Nanoparticles |
2021-06-07 |
|
|
| 2808 |
Nanotechnology and Nanoparticles |
2021-06-07 |
|
|
| 2809 |
The Development Factor/RTK Hub in Metazoans Is the Foundation of Organic entity Uprightness |
2021-06-07 |
|
|
| 2810 |
Sonic Hedgehog Pathway and Ameloblastoma |
2021-06-07 |
|
|
| 2811 |
Sonic Hedgehog Flagging Pathway |
2021-06-07 |
|
|
| 2812 |
Advancement |
2021-06-07 |
|
|
| 2813 |
Sorts of Transplantation |
2021-06-07 |
|
|
| 2814 |
What is End-stage Renal Illness |
2021-06-07 |
|
|
| 2815 |
Competing Interest Statement |
2021-06-05 |
|
|
| 2816 |
Laboratory Findings and Diagnostics |
2021-06-04 |
|
|
| 2817 |
Improving Healthcare Team Outcomes |
2021-06-04 |
|
|
| 2818 |
Monitoring |
2021-06-04 |
|
|
| 2819 |
Antagonistic Effects |
2021-06-04 |
|
|
| 2820 |
Organization |
2021-06-04 |
|
|
| 2821 |
Destinations and Signs |
2021-06-04 |
|
|
| 2822 |
Conclusions and Future Direction |
2021-06-03 |
|
|
| 2823 |
Noteworthy Points When Establishing the IONM Protocol |
2021-06-03 |
|
|
| 2824 |
Ethics and Legal Obligations |
2021-06-03 |
|
|
| 2825 |
Advantages and Disadvantages of Telephone Consultation |
2021-06-03 |
|
|
| 2826 |
Evidence Base for Telephone Consultation |
2021-06-03 |
|
|
| 2827 |
Occupational Health Controls |
2021-06-03 |
|
|
| 2828 |
Telemedicine and SARS COV 2 |
2021-06-03 |
|
|
| 2829 |
Conclusion on ‘He Way From Here’ |
2021-06-03 |
|
|
| 2830 |
Working-or not-in a Pandemic |
2021-06-03 |
|
|
| 2831 |
Brexit and the Mental Health of the Uk |
2021-06-03 |
|
|
| 2832 |
Promoting Mental Health at Work in the Uk |
2021-06-03 |
|
|
| 2833 |
Crossover study |
2021-06-01 |
|
|
| 2834 |
Self-controlled study |
2021-06-01 |
|
|
| 2835 |
Randomised controlled trial (RCT) |
2021-06-01 |
|
|
| 2836 |
Experimental (Interventional) Studies |
2021-06-01 |
|
|
| 2837 |
Analytical (inferential) studies |
2021-06-01 |
|
|
| 2838 |
Descriptive Studies |
2021-06-01 |
|
|
| 2839 |
Cohort Study |
2021-06-01 |
|
|
| 2840 |
Materials Used |
2021-06-01 |
|
|
| 2841 |
Exercises Protocol |
2021-06-01 |
|
|
| 2842 |
How to get help for addiction? |
2021-06-01 |
|
|
| 2843 |
Pharmacological Treatment |
2021-06-01 |
|
|
| 2844 |
Classification of Osteoporosis |
2021-06-01 |
|
|
| 2845 |
Types of Osteoporosis |
2021-06-01 |
|
|
| 2846 |
Composition of Bone |
2021-06-01 |
|
|
| 2847 |
How should you talk to someone with anxiety? |
2021-05-31 |
|
|
| 2848 |
Essential Influences |
2021-05-31 |
|
|
| 2849 |
Major Contexts in Child Psychology |
2021-05-31 |
|
|
| 2850 |
History and Development |
2021-05-31 |
|
|
| 2851 |
Types of Fractures |
2021-05-31 |
|
|
| 2852 |
Signs and Indications of A Fracture |
2021-05-31 |
|
|
| 2853 |
Treatment of Osteoporosis |
2021-05-31 |
|
|
| 2854 |
Diagnosis of Osteoporosis |
2021-05-31 |
|
|
| 2855 |
Dietary Factors |
2021-05-31 |
|
|
| 2856 |
Main Risk Factors |
2021-05-31 |
|
|
| 2857 |
The Stages of Osteoporosis |
2021-05-31 |
|
|
| 2858 |
Announcement: Call For Paper (Gynecology And Obstetrics) |
2021-05-31 |
|
|
| 2859 |
Webinar on Gynecology and Womens Health |
2021-05-31 |
|
|
| 2860 |
Clinical Symptoms and Prognosis |
2021-05-31 |
|
|
| 2861 |
Ultrasound Characteristics |
2021-05-31 |
|
|
| 2862 |
Histopsthology |
2021-05-31 |
|
|
| 2863 |
Macroscopy |
2021-05-31 |
|
|
| 2864 |
Epidimiology |
2021-05-31 |
|
|
| 2865 |
Message from Editorial Office |
2021-05-31 |
|
|
| 2866 |
Steps To Be Followed In Respiration Exercise |
2021-05-31 |
|
|
| 2867 |
Meditation and Emotional Well-Being |
2021-05-31 |
|
|
| 2868 |
Clinical Significance of UTIS |
2021-05-30 |
|
|
| 2869 |
Chemokines |
2021-05-28 |
|
|
| 2870 |
Patterns of Tissue Pathology |
2021-05-28 |
|
|
| 2871 |
The Electrochemical Portrayal of Old Coins |
2021-05-28 |
|
|
| 2872 |
Graphical Abstract |
2021-05-28 |
|
|
| 2873 |
Occupational Infection And Occupational Injury |
2021-05-27 |
|
|
| 2874 |
Outline Portraying Ankylosing Spondylitis |
2021-05-27 |
|
|
| 2875 |
Signs And Indications |
2021-05-27 |
|
|
| 2876 |
Public Administration |
2021-05-27 |
|
|
| 2877 |
Sexual Offenders |
2021-05-27 |
|
|
| 2878 |
Clinical Forensic Psychology |
2021-05-27 |
|
|
| 2879 |
Difference between Psychitary and Neurology |
2021-05-27 |
|
|
| 2880 |
Professional Path |
2021-05-27 |
|
|
| 2881 |
Job Purpose |
2021-05-27 |
|
|
| 2882 |
Similarities between Forensic Psychology and Psychotherapy |
2021-05-27 |
|
|
| 2883 |
Forensic Clinical Psychology |
2021-05-27 |
|
|
| 2884 |
Sensational Aspects of Forensic Psychology |
2021-05-27 |
|
|
| 2885 |
Saprogenesis and Pathogenesis |
2021-05-26 |
|
|
| 2886 |
Evolution Health Care |
2021-05-25 |
|
|
| 2887 |
Types Of Cross Infection |
2021-05-25 |
|
|
| 2888 |
How Do These Communicable Disesase Spread |
2021-05-25 |
|
|
| 2889 |
What Is An Communicable Disease |
2021-05-25 |
|
|
| 2890 |
Health Care Associated Infections |
2021-05-25 |
|
|
| 2891 |
How to Deal with Covid-19-Related Iprs |
2021-05-25 |
|
|
| 2892 |
The Covid-19 Infection |
2021-05-25 |
|
|
| 2893 |
Conference Details |
2021-05-25 |
|
|
| 2894 |
Case Illustrations |
2021-05-25 |
|
|
| 2895 |
Methods and Collection of Data |
2021-05-25 |
|
|
| 2896 |
Mental Disorder |
2021-05-24 |
|
|
| 2897 |
Aim and Objectives |
2021-05-24 |
|
|
| 2898 |
Limitations and Strengths |
2021-05-24 |
|
|
| 2899 |
Significance of Risk Factors |
2021-05-24 |
|
|
| 2900 |
Issues and Way Forward |
2021-05-24 |
|
|
| 2901 |
Search Strategy |
2021-05-24 |
|
|
| 2902 |
Study Design and Methods |
2021-05-24 |
|
|
| 2903 |
Diagnosis for Brain Cancer |
2021-05-24 |
|
|
| 2904 |
Side Effects of Brain Cancer |
2021-05-24 |
|
|
| 2905 |
General Side Effects |
2021-05-24 |
|
|
| 2906 |
Symptoms of Brain Cancer |
2021-05-24 |
|
|
| 2907 |
But did we Really got Things Right |
2021-05-24 |
|
|
| 2908 |
What we Learned from the First Wave and what we got Right |
2021-05-24 |
|
|
| 2909 |
Autonomy and the Principle of Autonomy |
2021-05-24 |
|
|
| 2910 |
Paternalism and Respect for People |
2021-05-24 |
|
|
| 2911 |
Hotel Management |
2021-05-22 |
|
|
| 2912 |
Administration of Justice |
2021-05-22 |
|
|
| 2913 |
Accounting-Innovations |
2021-05-22 |
|
|
| 2914 |
Climate Change Issues and Way Forward |
2021-05-21 |
|
|
| 2915 |
Impact of Climate Change in Nepal |
2021-05-21 |
|
|
| 2916 |
Survey and Feedback |
2021-05-21 |
|
|
| 2917 |
Memberships and Reprints |
2021-05-21 |
|
|
| 2918 |
Advertisement Platfrom |
2021-05-21 |
|
|
| 2919 |
Submission Process |
2021-05-21 |
|
|
| 2920 |
Article Types |
2021-05-21 |
|
|
| 2921 |
History And Biology |
2021-05-21 |
|
|
| 2922 |
Behavior |
2021-05-21 |
|
|
| 2923 |
Data Collection and Analysis |
2021-05-20 |
|
|
| 2924 |
Danaparoid And Sulodexide |
2021-05-20 |
|
|
| 2925 |
Gags As Potential Treatment |
2021-05-20 |
|
|
| 2926 |
Editors Words |
2021-05-20 |
|
|
| 2927 |
Study Observations |
2021-05-20 |
|
|
| 2928 |
Conflicts Of Interest |
2021-05-19 |
|
|
| 2929 |
Physiological and Psychological Response of Comfort during the Exposure to an Environmental Stressor |
2021-05-19 |
|
|
| 2930 |
Authorsâ?? Information |
2021-05-18 |
|
|
| 2931 |
Authorsâ?? Information |
2021-05-18 |
|
|
| 2932 |
Authorsâ?? Information |
2021-05-18 |
|
|
| 2933 |
Authorsâ?? Information |
2021-05-18 |
|
|
| 2934 |
Methodology and Patients |
2021-05-17 |
|
|
| 2935 |
Methodology and Study Area |
2021-05-17 |
|
|
| 2936 |
Proximal Origin of the Novel Coronavirus |
2021-05-17 |
|
|
| 2937 |
SARS-COV-2: Structural Features and Notable Attributes in the Genome |
2021-05-17 |
|
|
| 2938 |
What is Coronavirus? |
2021-05-17 |
|
|
| 2939 |
USTH Administrative Policy Assessment on Hemophilia |
2021-05-17 |
|
|
| 2940 |
Aknowledgement |
2021-05-17 |
|
|
| 2941 |
Institutional Structures Have Become Weaker In Sustaining Peace In Communities |
2021-05-17 |
|
|
| 2942 |
THe Decline In Social and Public Services Will Become Prolonged Issues of The After Pandemic Era |
2021-05-17 |
|
|
| 2943 |
He Decline In Social and Public Services Will Become Prolonged Issues of The After Pandemic Era |
2021-05-17 |
|
|
| 2944 |
Ethnic Inequalities are Hidden but are No Myth |
2021-05-17 |
|
|
| 2945 |
Health Inequalities are Widespread Around The World |
2021-05-17 |
|
|
| 2946 |
Author Declaration |
2021-05-17 |
|
|
| 2947 |
Future Requirements |
2021-05-17 |
|
|
| 2948 |
Disease Puzzle Studies |
2021-05-17 |
|
|
| 2949 |
The New Concepts |
2021-05-17 |
|
|
| 2950 |
Visual Analogue Scale |
2021-05-17 |
|
|
| 2951 |
Instruments |
2021-05-17 |
|
|
| 2952 |
Study Strength |
2021-05-16 |
|
|
| 2953 |
Factors Associated With Contraceptive Uptake |
2021-05-16 |
|
|
| 2954 |
Prior Presentation |
2021-05-15 |
|
|
| 2955 |
Revelance of the Study |
2021-05-15 |
|
|
| 2956 |
Limitation on the Study |
2021-05-15 |
|
|
| 2957 |
Neuromuscular Adaptations |
2021-05-14 |
|
|
| 2958 |
Behavioural Adaptations |
2021-05-14 |
|
|
| 2959 |
Psychological Adaptations |
2021-05-14 |
|
|
| 2960 |
Disclousers |
2021-05-14 |
|
|
| 2961 |
Diagnostic Criteria for Frailty |
2021-05-14 |
|
|
| 2962 |
Various concepts advocated as related to “frailty” |
2021-05-14 |
|
|
| 2963 |
Cryopreservation and Liquid Nitrogen |
2021-05-14 |
|
|
| 2964 |
Tearcare System: An Innovation for the Treatment of MGD and DED |
2021-05-14 |
|
|
| 2965 |
Methods of Data Analysis |
2021-05-14 |
|
|
| 2966 |
Data Processing and Analyses |
2021-05-14 |
|
|
| 2967 |
Data Collection Technique and Quality Control |
2021-05-14 |
|
|
| 2968 |
What this Paper Adds |
2021-05-14 |
|
|
| 2969 |
What was Known |
2021-05-14 |
|
|
| 2970 |
Usability Testing |
2021-05-14 |
|
|
| 2971 |
Transformation Issues |
2021-05-14 |
|
|
| 2972 |
Alternatives to Open Dumping |
2021-05-13 |
|
|
| 2973 |
Waste Disposal in Jorhat |
2021-05-13 |
|
|
| 2974 |
The Future of Data Mining |
2021-05-13 |
|
|
| 2975 |
How Data Mining Works |
2021-05-13 |
|
|
| 2976 |
What is Data Mining? |
2021-05-13 |
|
|
| 2977 |
Ectosomes |
2021-05-13 |
|
|
| 2978 |
Exosomes |
2021-05-13 |
|
|
| 2979 |
Extracellular Vesicles |
2021-05-13 |
|
|
| 2980 |
Integration of Other Technologies |
2021-05-13 |
|
|
| 2981 |
What is blockchain? |
2021-05-13 |
|
|
| 2982 |
Disadvantage of Mobile Computing |
2021-05-13 |
|
|
| 2983 |
Advantage of Mobile Computing |
2021-05-13 |
|
|
| 2984 |
Features of Mobile Computing |
2021-05-13 |
|
|
| 2985 |
Future of Mobile Computing |
2021-05-13 |
|
|
| 2986 |
Fundametals of Data Mining |
2021-05-13 |
|
|
| 2987 |
Uses of DNA Sequencing |
2021-05-13 |
|
|
| 2988 |
Understanding the Accumulation of Old and Insoluble Proteins with Age |
2021-05-12 |
|
|
| 2989 |
A Better Strategy for Proteome Maintenance |
2021-05-12 |
|
|
| 2990 |
Longevity is Correlated with Longer Protein Half-Lives in Mammals |
2021-05-12 |
|
|
| 2991 |
Rights and Permissions |
2021-05-12 |
|
|
| 2992 |
Will the Emerging Variants Create a Vaccine Problem? |
2021-05-12 |
|
|
| 2993 |
Nucleic Acid (DNA and RNA) Based Vaccine |
2021-05-12 |
|
|
| 2994 |
Replication Incompetent and Replication Competent Vector Vaccine |
2021-05-12 |
|
|
| 2995 |
Subunit Vaccine (Recombinant Protein Vaccines) |
2021-05-12 |
|
|
| 2996 |
Whole Virus Vaccine (Inactivated and Live-Attenuated Vaccine) |
2021-05-12 |
|
|
| 2997 |
Vaccine Strategies |
2021-05-12 |
|
|
| 2998 |
Detection Methods other than RT-PCR |
2021-05-12 |
|
|
| 2999 |
Transmissibility of these New Variants |
2021-05-12 |
|
|
| 3000 |
The Emerging New Variants of SARS-COV-2 |
2021-05-12 |
|
|
| 3001 |
Different Clades of SARS-COV-2 |
2021-05-12 |
|
|
| 3002 |
Method of Collection of Data |
2021-05-12 |
|
|
| 3003 |
Future Considerations |
2021-05-11 |
|
|
| 3004 |
Protocols for Inspection and Detection |
2021-05-11 |
|
|
| 3005 |
Grant Information |
2021-05-11 |
|
|
| 3006 |
Human Rights |
2021-05-11 |
|
|
| 3007 |
Source(s) of Support Finance |
2021-05-11 |
|
|
| 3008 |
Anaphase |
2021-05-11 |
|
|
| 3009 |
Prophase |
2021-05-11 |
|
|
| 3010 |
Methods and Results |
2021-05-11 |
|
|
| 3011 |
History of Animal Genetic Resources |
2021-05-11 |
|
|
| 3012 |
Animal Genetic Resources |
2021-05-11 |
|
|
| 3013 |
Depiction |
2021-05-11 |
|
|
| 3014 |
Birthplaces |
2021-05-11 |
|
|
| 3015 |
Illustrative Cases |
2021-05-11 |
|
|
| 3016 |
Test-Retest Reliability |
2021-05-11 |
|
|
| 3017 |
Item Analysis |
2021-05-11 |
|
|
| 3018 |
Confirmatory Factor Analysis |
2021-05-11 |
|
|
| 3019 |
Translation Process |
2021-05-11 |
|
|
| 3020 |
Data Collecting Tools |
2021-05-11 |
|
|
| 3021 |
Common Risk Factors for Periodontal Disease and Covid-19 |
2021-05-11 |
|
|
| 3022 |
Oncological Outcomes in MIDP |
2021-05-11 |
|
|
| 3023 |
Left-to-Right and Right-to-Left Dissection Procedures in DP for the Management of Cancer of the Body or Tail of the Pancreas |
2021-05-11 |
|
|
| 3024 |
Financial Interest Statement |
2021-05-11 |
|
|
| 3025 |
SUSD2 is a Double Agent |
2021-05-11 |
|
|
| 3026 |
Therapeutic Strategy for NAFLD/NASH-Related HCC |
2021-05-11 |
|
|
| 3027 |
Risk Stratification in NAFLD/NASH-Related HCC |
2021-05-11 |
|
|
| 3028 |
Combined Effect of Variants |
2021-05-11 |
|
|
| 3029 |
Current Genetic Advances in NAFLD/NASH-Related HCC |
2021-05-11 |
|
|
| 3030 |
Characteristic Clinical Manifestations in NAFLD/NASH-Related HCC |
2021-05-11 |
|
|
| 3031 |
Link Between NAFLD/NASH and Atherosclerosis |
2021-05-11 |
|
|
| 3032 |
Discussion and Limitations |
2021-05-11 |
|
|
| 3033 |
The Data which were Collected |
2021-05-10 |
|
|
| 3034 |
Partial Budget Analysis |
2021-05-10 |
|
|
| 3035 |
Functional Networks |
2021-05-10 |
|
|
| 3036 |
Target Formation Mapping with Seismoelectric Data |
2021-05-10 |
|
|
| 3037 |
Seismoelectric Survey Principle and Method |
2021-05-10 |
|
|
| 3038 |
Data Acquisition and Display |
2021-05-10 |
|
|
| 3039 |
Disadvantages of Gene Therapy |
2021-05-10 |
|
|
| 3040 |
Advantages of Gene Therapy |
2021-05-10 |
|
|
| 3041 |
Types of Gene Therapy |
2021-05-10 |
|
|
| 3042 |
Gene Therapy and its Importance |
2021-05-10 |
|
|
| 3043 |
Role of MBL2 Gene In Malaria |
2021-05-10 |
|
|
| 3044 |
Genetics and BWF |
2021-05-10 |
|
|
| 3045 |
Action of Quinine On Red Blood Cells (Rbc) |
2021-05-10 |
|
|
| 3046 |
Action of P. Falciparum On Red Blood Cells (Rbc) |
2021-05-10 |
|
|
| 3047 |
Immunology Pathogenesis Of Bwf |
2021-05-10 |
|
|
| 3048 |
Indications |
2021-05-10 |
|
|
| 3049 |
Obscure |
2021-05-10 |
|
|
| 3050 |
Post-Testicular |
2021-05-10 |
|
|
| 3051 |
Pretesticular |
2021-05-10 |
|
|
| 3052 |
Plasmid DNA |
2021-05-07 |
|
|
| 3053 |
Vaccine Development |
2021-05-07 |
|
|
| 3054 |
Vitamins Prophylactic Therapy |
2021-05-07 |
|
|
| 3055 |
Staph Infections |
2021-05-07 |
|
|
| 3056 |
Voluntary Administration |
2021-05-06 |
|
|
| 3057 |
Social Security Funds |
2021-05-06 |
|
|
| 3058 |
Scientific Managements |
2021-05-06 |
|
|
| 3059 |
Public Financial Management |
2021-05-06 |
|
|
| 3060 |
Explanation |
2021-05-03 |
|
|
| 3061 |
Donating Peripheral Blood Stem Cells |
2021-05-03 |
|
|
| 3062 |
Reasons for a PBSCT |
2021-05-03 |
|
|
| 3063 |
Purpose of Stem Cell Transplants |
2021-05-03 |
|
|
| 3064 |
Format of Problem-Solving Therapy |
2021-05-01 |
|
|
| 3065 |
Types of Problems Treated |
2021-05-01 |
|
|
| 3066 |
Psychological Disorder Prevalence |
2021-05-01 |
|
|
| 3067 |
Purpose of Getting a Diagnosis |
2021-05-01 |
|
|
| 3068 |
How are Psychological Disorders Diagnosed? |
2021-05-01 |
|
|
| 3069 |
What is a Psychological Disorder? |
2021-05-01 |
|
|
| 3070 |
What to Expect? |
2021-05-01 |
|
|
| 3071 |
How It Helps? |
2021-05-01 |
|
|
| 3072 |
What It Involves? |
2021-05-01 |
|
|
| 3073 |
Benefits |
2021-05-01 |
|
|
| 3074 |
Benefits of Psychoanalytic Therapy |
2021-05-01 |
|
|
| 3075 |
Dealing with Unconscious Forces |
2021-05-01 |
|
|
| 3076 |
Intensive Treatment |
2021-05-01 |
|
|
| 3077 |
How it Works? |
2021-05-01 |
|
|
| 3078 |
Summary and Hypothesis |
2021-05-01 |
|
|
| 3079 |
Confounded UTIs |
2021-05-01 |
|
|
| 3080 |
The Board |
2021-05-01 |
|
|
| 3081 |
Asymptomatic bacteriuria |
2021-05-01 |
|
|
| 3082 |
Intermittent UTI |
2021-05-01 |
|
|
| 3083 |
Simple versus convoluted UTI |
2021-05-01 |
|
|
| 3084 |
What is Urinary lot contaminations |
2021-05-01 |
|
|
| 3085 |
Updating Healthcare Team Outcomes |
2021-05-01 |
|
|
| 3086 |
Staging |
2021-05-01 |
|
|
| 3087 |
History and Physical |
2021-05-01 |
|
|
| 3088 |
Difficulties |
2021-05-01 |
|
|
| 3089 |
Ends |
2021-04-30 |
|
|
| 3090 |
Non Infectious Complications |
2021-04-30 |
|
|
| 3091 |
Infectious Complications |
2021-04-30 |
|
|
| 3092 |
MR Peritoneography |
2021-04-30 |
|
|
| 3093 |
CT Peritoneography |
2021-04-30 |
|
|
| 3094 |
CT Peritoneography |
2021-04-30 |
|
|
| 3095 |
Vaginismus |
2021-04-30 |
|
|
| 3096 |
Dyspareunia and Vulvodynia |
2021-04-30 |
|
|
| 3097 |
HPV Causes |
2021-04-30 |
|
|
| 3098 |
Distribution |
2021-04-30 |
|
|
| 3099 |
Diagnosis and Tests |
2021-04-30 |
|
|
| 3100 |
Aims and scope |
2021-04-30 |
|
|
| 3101 |
Integrating the Online Mental Services in Health Services in the DRC: Developing a New Model |
2021-04-29 |
|
|
| 3102 |
Opportunities to Improve the Mental Health during the COVID-19 Pandemic and the Related Lock-Down Measures in the DRC |
2021-04-29 |
|
|
| 3103 |
Mental Health Challenges and Perspectives Associated with the COVID-19 and Related Lock-Down |
2021-04-29 |
|
|
| 3104 |
Neuralink Brain Computer Interfaces |
2021-04-29 |
|
|
| 3105 |
Big Data with AI in Fighting Covid-19 |
2021-04-29 |
|
|
| 3106 |
Artificial Intelligence in Combating Covid-19 |
2021-04-29 |
|
|
| 3107 |
Conflict of Interest Disclosure |
2021-04-29 |
|
|
| 3108 |
Funding Disclosure |
2021-04-29 |
|
|
| 3109 |
Indian Scenario |
2021-04-28 |
|
|
| 3110 |
|
2021-04-28 |
|
|
| 3111 |
Treatment Strategies |
2021-04-27 |
|
|
| 3112 |
Feeding Automation |
2021-04-26 |
|
|
| 3113 |
Milking Automation |
2021-04-26 |
|
|
| 3114 |
Artificial Breeding Process |
2021-04-26 |
|
|
| 3115 |
Computer and Internet Usage |
2021-04-26 |
|
|
| 3116 |
Coral Bleaching |
2021-04-26 |
|
|
| 3117 |
White Band Disease |
2021-04-26 |
|
|
| 3118 |
Black Band Disease |
2021-04-26 |
|
|
| 3119 |
About the Study |
2021-04-26 |
|
|
| 3120 |
Disadvantages and Limitations |
2021-04-26 |
|
|
| 3121 |
Ethnoveterinary Practice in India |
2021-04-26 |
|
|
| 3122 |
Results of Descriptive Analysis |
2021-04-26 |
|
|
| 3123 |
Scientific Responsibility Statement |
2021-04-26 |
|
|
| 3124 |
Abbreviation/Acronyms |
2021-04-23 |
|
|
| 3125 |
Barukenedamu |
2021-04-22 |
|
|
| 3126 |
Steps and Procedures Used in Feragezgn Customary Conflict Resolution Mechanisms |
2021-04-22 |
|
|
| 3127 |
Feragezagn Institution: The Customary Conflict Resolution Mechanism in Meskan Society |
2021-04-22 |
|
|
| 3128 |
Neighbour Conflict |
2021-04-22 |
|
|
| 3129 |
Alcoholism |
2021-04-22 |
|
|
| 3130 |
Family Related Conflicts |
2021-04-22 |
|
|
| 3131 |
Methods Data Analysis |
2021-04-22 |
|
|
| 3132 |
Scope of the Study |
2021-04-22 |
|
|
| 3133 |
Proposed System |
2021-04-21 |
|
|
| 3134 |
Related Works |
2021-04-21 |
|
|
| 3135 |
Supplementary Material |
2021-04-21 |
|
|
| 3136 |
Study Funding |
2021-04-20 |
|
|
| 3137 |
Traditional and Medicinal Uses |
2021-04-20 |
|
|
| 3138 |
Phytochemistry |
2021-04-20 |
|
|
| 3139 |
Botanical Description |
2021-04-20 |
|
|
| 3140 |
Jel Classification |
2021-04-19 |
|
|
| 3141 |
Cloud Implementation |
2021-04-19 |
|
|
| 3142 |
Highlighting |
2021-04-19 |
|
|
| 3143 |
Critical Path View |
2021-04-19 |
|
|
| 3144 |
Bill-Of-Materials Plus Operations View |
2021-04-19 |
|
|
| 3145 |
The CMSD Data Model |
2021-04-19 |
|
|
| 3146 |
Data Collection Results |
2021-04-19 |
|
|
| 3147 |
Scope and Objective |
2021-04-19 |
|
|
| 3148 |
ECG Intervals |
2021-04-19 |
|
|
| 3149 |
Electrocardiogram |
2021-04-19 |
|
|
| 3150 |
Information on Financing |
2021-04-19 |
|
|
| 3151 |
Opposition Opportunity |
2021-04-19 |
|
|
| 3152 |
Body Counts |
2021-04-19 |
|
|
| 3153 |
Hunger Pangs |
2021-04-19 |
|
|
| 3154 |
Vladimir Putin is in Deep Trouble |
2021-04-19 |
|
|
| 3155 |
Review As Soon As Possible |
2021-04-19 |
|
|
| 3156 |
Peptic Ulcer Treatment |
2021-04-17 |
|
|
| 3157 |
Management Strategies |
2021-04-17 |
|
|
| 3158 |
Challenges to Fish Production |
2021-04-17 |
|
|
| 3159 |
Fishery Potentials in Ethiopian Water Bodies |
2021-04-17 |
|
|
| 3160 |
Fish Diversity in Ethiopia |
2021-04-17 |
|
|
| 3161 |
Analysis of the Results |
2021-04-16 |
|
|
| 3162 |
Fourth Year |
2021-04-16 |
|
|
| 3163 |
Third Year |
2021-04-16 |
|
|
| 3164 |
Second Year |
2021-04-16 |
|
|
| 3165 |
Introducing Nirs into the Iomt System for the Health Promotion of the Elderly |
2021-04-16 |
|
|
| 3166 |
Evaluation of Very Early Mobilization by Nirs for Patients with Hyperacute Subarachnoid Hemorrhage |
2021-04-16 |
|
|
| 3167 |
Evaluation of Very Early Mobilization by Nirs for Patients with Hyperacute Subarachnoid Hemorrhage |
2021-04-16 |
|
|
| 3168 |
Effect of Aerobic Exercise on Cognitive Function in Post-Chronic Stroke Patients |
2021-04-16 |
|
|
| 3169 |
Herd Size |
2021-04-16 |
|
|
| 3170 |
Availability of Supporting Data |
2021-04-16 |
|
|
| 3171 |
Ethics Approval and Consent to Participate |
2021-04-16 |
|
|
| 3172 |
Medications developed from natural products |
2021-04-14 |
|
|
| 3173 |
Medications developed from traditional medicines that follow the traditional uses |
2021-04-14 |
|
|
| 3174 |
Customary Medicines |
2021-04-14 |
|
|
| 3175 |
Regular Products |
2021-04-14 |
|
|
| 3176 |
Quality norms and legitimate prerequisites in Germany: |
2021-04-14 |
|
|
| 3177 |
Investigation Populace |
2021-04-14 |
|
|
| 3178 |
Blinding |
2021-04-14 |
|
|
| 3179 |
Randomization |
2021-04-14 |
|
|
| 3180 |
Brazil (LATAM) |
2021-04-14 |
|
|
| 3181 |
European Union |
2021-04-14 |
|
|
| 3182 |
Unites States of America |
2021-04-14 |
|
|
| 3183 |
Documenting a Generic Drug Application |
2021-04-14 |
|
|
| 3184 |
Nonexclusive Drug Development |
2021-04-14 |
|
|
| 3185 |
Essential Pathways to Medical Device Approval |
2021-04-14 |
|
|
| 3186 |
Prerequisites for Clinical Trials |
2021-04-14 |
|
|
| 3187 |
The Pre-Clinical Stages: Prototype Development and Testing |
2021-04-14 |
|
|
| 3188 |
Testing the Hypothesis |
2021-04-14 |
|
|
| 3189 |
Other Clues |
2021-04-14 |
|
|
| 3190 |
TH17, THE LINK BETWEEN COVID-19 AND H4R |
2021-04-14 |
|
|
| 3191 |
H4R AND LUNG FIBROSIS |
2021-04-14 |
|
|
| 3192 |
HISTAMINE |
2021-04-14 |
|
|
| 3193 |
CYTOKINE STORM AND IMMUNE DYSREGULATION |
2021-04-14 |
|
|
| 3194 |
COVID-19 AND LUNG FIBROSIS |
2021-04-14 |
|
|
| 3195 |
Clinical Presentation |
2021-04-14 |
|
|
| 3196 |
Environmental Impacts of Plastics |
2021-04-13 |
|
|
| 3197 |
Short Review |
2021-04-08 |
|
|
| 3198 |
Treatments and Results |
2021-04-08 |
|
|
| 3199 |
Quality Assessment of the Included Studies |
2021-04-08 |
|
|
| 3200 |
Study |
2021-04-08 |
|
|
| 3201 |
Cytoskeleton |
2021-04-08 |
|
|
| 3202 |
A Prokaryotic Cell has Three Distinct Parts |
2021-04-08 |
|
|
| 3203 |
Development of An Ordinary Prokaryotic Cell |
2021-04-08 |
|
|
| 3204 |
Function |
2021-04-07 |
|
|
| 3205 |
Neurotransmission |
2021-04-07 |
|
|
| 3206 |
Myelin sheath creation |
2021-04-07 |
|
|
| 3207 |
Neuron Repair and Development |
2021-04-07 |
|
|
| 3208 |
Advances since 2015 |
2021-04-07 |
|
|
| 3209 |
Advanves since 2015 |
2021-04-07 |
|
|
| 3210 |
Viewpoint Before 2015 |
2021-04-07 |
|
|
| 3211 |
Limitations and Challenges |
2021-04-07 |
|
|
| 3212 |
EXPLOSIVE STRENGTH |
2021-04-07 |
|
|
| 3213 |
Obstructive Uropathy |
2021-04-07 |
|
|
| 3214 |
Diabetic Kidney Illness |
2021-04-07 |
|
|
| 3215 |
Clinical Manifestation |
2021-04-07 |
|
|
| 3216 |
BENEFITS OF YOGA IN A PANDEMIC |
2021-04-07 |
|
|
| 3217 |
YOGA ON ONLINE PLATFORMS |
2021-04-07 |
|
|
| 3218 |
Depression and Anxiety Disorders: Not the Same |
2021-04-07 |
|
|
| 3219 |
Renal Failure |
2021-04-07 |
|
|
| 3220 |
HYDROGEN CAN BE PRODUCED BY FOLLOWING METHODS |
2021-04-07 |
|
|
| 3221 |
THE METHOD OF PRODUCTION ALGAE FROM POND CAN BE DONE BE BY 3 METHODS |
2021-04-07 |
|
|
| 3222 |
The Dopamine-Depletion Hypothesis of Drug Addiction |
2021-04-07 |
|
|
| 3223 |
Attachment and the Establishment of Unique Modes of Communication between Parents and Children |
2021-04-07 |
|
|
| 3224 |
Testing |
2021-04-07 |
|
|
| 3225 |
Risks |
2021-04-07 |
|
|
| 3226 |
The Healthcare System in B & H |
2021-04-06 |
|
|
| 3227 |
Conditions Associated with a Hyperfibrinolytic State |
2021-04-06 |
|
|
| 3228 |
Challenges in Developing a Successful T Cell Based Therapeuti |
2021-04-06 |
|
|
| 3229 |
CHALLENGES IN DEVELOPING A SUCCESSFUL T CELL BASED THERAPEUTIC HIV VACCINE |
2021-04-06 |
|
|
| 3230 |
SPERMATOGENESIS |
2021-04-06 |
|
|
| 3231 |
MALE'S REPRODUCTIVE ORGAN |
2021-04-06 |
|
|
| 3232 |
Announcement |
2021-04-06 |
|
|
| 3233 |
Prevention |
2021-04-06 |
|
|
| 3234 |
Goals in Submitting for Publication |
2021-04-06 |
|
|
| 3235 |
MICROARRAY INVESTIGATION |
2021-04-06 |
|
|
| 3236 |
Healthy Food for Pregnant Woman |
2021-04-06 |
|
|
| 3237 |
Things Happening in Pregnancy |
2021-04-06 |
|
|
| 3238 |
Healthy Food Toward Healthy Diet |
2021-04-06 |
|
|
| 3239 |
The Sperm Dark Matter |
2021-04-06 |
|
|
| 3240 |
The Female Burden |
2021-04-06 |
|
|
| 3241 |
"Cotes' Spiral" and Results |
2021-04-05 |
|
|
| 3242 |
Date of Synoptic Charts of CB and Satellite Images |
2021-04-05 |
|
|
| 3243 |
The Anatomy of a Cyclone |
2021-04-05 |
|
|
| 3244 |
Policy and Government |
2021-04-05 |
|
|
| 3245 |
Constraints for Tropical Agroforestry System |
2021-04-05 |
|
|
| 3246 |
Agroforestry for Climate Change Mitigation |
2021-04-05 |
|
|
| 3247 |
Agroforestry for Food and Income Security |
2021-04-05 |
|
|
| 3248 |
Agroforestry for Soil Improvement |
2021-04-05 |
|
|
| 3249 |
Classification of Agroforestry System |
2021-04-05 |
|
|
| 3250 |
Agroforestry: A Global Overview |
2021-04-05 |
|
|
| 3251 |
Trauma detection |
2021-04-02 |
|
|
| 3252 |
The structures |
2021-04-02 |
|
|
| 3253 |
Why adolescents utilize web-based media |
2021-04-02 |
|
|
| 3254 |
Portable game addiction and depression |
2021-04-02 |
|
|
| 3255 |
Evaluation of psychiatric disorders in adolescents |
2021-04-02 |
|
|
| 3256 |
Pediatric Urology |
2021-04-02 |
|
|
| 3257 |
Challenging stigma related to mental disease |
2021-04-02 |
|
|
| 3258 |
Steps to address stigma |
2021-04-02 |
|
|
| 3259 |
Risk factors of depression and suicide |
2021-04-02 |
|
|
| 3260 |
To assess delirium, NICE (2010a) suggests numerous tools, together with the: |
2021-04-02 |
|
|
| 3261 |
Assessment tools |
2021-04-02 |
|
|
| 3262 |
Dementia and depression among older folks as public health problems |
2021-04-02 |
|
|
| 3263 |
To the Editors of the Clinics in Mother and Child Health |
2021-04-02 |
|
|
| 3264 |
Pharmacological Inhibition of PARP |
2021-04-02 |
|
|
| 3265 |
Involvement of PARP in Various Pathological Conditions |
2021-04-02 |
|
|
| 3266 |
Different Types of PARP |
2021-04-02 |
|
|
| 3267 |
PARP Structure |
2021-04-02 |
|
|
| 3268 |
Salinity Stress |
2021-04-02 |
|
|
| 3269 |
Combined Temperature and Drought Stress |
2021-04-02 |
|
|
| 3270 |
Temperature Stress |
2021-04-02 |
|
|
| 3271 |
Drought Stress |
2021-04-02 |
|
|
| 3272 |
An Approach to Monitor the Pathophysiological Status of Hdp, An Intractable Disease of Unknown Etiology, Using Peptidomics |
2021-04-02 |
|
|
| 3273 |
Transplantation and Lineage Tracing to Study Clonal Dynamics |
2021-04-02 |
|
|
| 3274 |
Transplantation of Transgenic or Pulse-Labeled Pgcs in Male and Female Gonads |
2021-04-02 |
|
|
| 3275 |
Clonal Tracking of Transplanted Transgenic Pluripotent Stem Cells in Non-Human Primate Models |
2021-04-02 |
|
|
| 3276 |
Multi-lineage Tracing |
2021-04-02 |
|
|
| 3277 |
Ssc Culture Approaches |
2021-04-02 |
|
|
| 3278 |
Genome-Editing Tools |
2021-04-02 |
|
|
| 3279 |
An Approach to Monitor the Pathophysiological Status of Hdp, An Intractable Disease of Unknown Etiology, Using Peptidomics |
2021-04-02 |
|
|
| 3280 |
Implementation and Impact |
2021-04-01 |
|
|
| 3281 |
Clinimetric Properties of the Himat |
2021-04-01 |
|
|
| 3282 |
The High-Level Mobility Assessment Tool (Himat) |
2021-04-01 |
|
|
| 3283 |
High-Level Mobility |
2021-04-01 |
|
|
| 3284 |
Bile Acids and Gut Microbiota |
2021-04-01 |
|
|
| 3285 |
Interaction Between Cdca and Intestinal Mucosa |
2021-04-01 |
|
|
| 3286 |
Interaction Between Lca and Intestinal Mucosa |
2021-04-01 |
|
|
| 3287 |
Interaction Between Dca and Intestinal Mucosa |
2021-04-01 |
|
|
| 3288 |
Interaction Between Udca and Intestinal Mucosa |
2021-04-01 |
|
|
| 3289 |
Introduction of Bile Acids |
2021-04-01 |
|
|
| 3290 |
Insulin |
2021-04-01 |
|
|
| 3291 |
Objectives and Methods |
2021-04-01 |
|
|
| 3292 |
Empirical Studies on Customary Dispute Settlement in Africa and Ethiopia |
2021-04-01 |
|
|
| 3293 |
ELDERSâ?? COUNCIL |
2021-04-01 |
|
|
| 3294 |
ELDERSâ?? COUNCIL |
2021-04-01 |
|
|
| 3295 |
ELDERSâ?? COUNCIL |
2021-04-01 |
|
|
| 3296 |
ELDERSâ?? COUNCIL |
2021-04-01 |
|
|
| 3297 |
Dispute Settlement Institutions and their Different Mechanisms |
2021-04-01 |
|
|
| 3298 |
Conceptualizing Dispute Settlement |
2021-04-01 |
|
|
| 3299 |
Definition of key Terms and Concepts |
2021-04-01 |
|
|
| 3300 |
Asherman Syndrome |
2021-04-01 |
|
|
| 3301 |
Pcos |
2021-04-01 |
|
|
| 3302 |
Reproductive System Disorders |
2021-04-01 |
|
|
| 3303 |
Editorial Note on Biology and Medicine Journal |
2021-04-01 |
|
|
| 3304 |
CRISPR and Genetic Engineering |
2021-04-01 |
|
|
| 3305 |
Cancer Biology in Biology and Medicine |
2021-04-01 |
|
|
| 3306 |
Data Analysis and Description |
2021-04-01 |
|
|
| 3307 |
Pharmacological Approaches |
2021-04-01 |
|
|
| 3308 |
Advanced Techniques in Biology & Medicine |
2021-04-01 |
|
|
| 3309 |
Biology and Medicine: A Multidisciplinary Approach for Promoting Healthy Life |
2021-04-01 |
|
|
| 3310 |
Covid-19 and Pregnancy |
2021-04-01 |
|
|
| 3311 |
Low Back Pain: Its Mechanisms, Symptoms and Diagnosis |
2021-04-01 |
|
|
| 3312 |
Market Review and Growth Analysis on Generic Medicine |
2021-04-01 |
|
|
| 3313 |
Conclusion and Future Prespective |
2021-03-31 |
|
|
| 3314 |
Classification of Biosensors |
2021-03-31 |
|
|
| 3315 |
Biosensors in Pathogens Detection |
2021-03-31 |
|
|
| 3316 |
Main Area Requiring Pathogen Detection |
2021-03-31 |
|
|
| 3317 |
Molecule Channels Underlying the Cardiac Action Potential |
2021-03-31 |
|
|
| 3318 |
The Relationship Between the Cardiac Action Potential and the Electrocardiogram |
2021-03-31 |
|
|
| 3319 |
The Ventricular Cardiac Action Potential |
2021-03-31 |
|
|
| 3320 |
The Initiation of the Heart Beat |
2021-03-31 |
|
|
| 3321 |
Etiology and Pathogenesis of Syncope |
2021-03-31 |
|
|
| 3322 |
Diagnostic Approach to Cardiogenic Syncope |
2021-03-31 |
|
|
| 3323 |
References |
2021-03-31 |
|
|
| 3324 |
Discussions in our Research Team |
2021-03-31 |
|
|
| 3325 |
Discussions at Three Academic Conferences |
2021-03-31 |
|
|
| 3326 |
Mechanisms Employed in the Potential Antiviral Activity of MB against SARS-CoV-2 |
2021-03-31 |
|
|
| 3327 |
Results and Data Analysis |
2021-03-31 |
|
|
| 3328 |
Potential Therapeutic Implications |
2021-03-31 |
|
|
| 3329 |
Macrophages, Hypoxia, and Infectious Diseases |
2021-03-31 |
|
|
| 3330 |
Macrophages, Hypoxia, and Inflammatory Diseases |
2021-03-31 |
|
|
| 3331 |
Macrophages |
2021-03-31 |
|
|
| 3332 |
Neutrophils, Hypoxia, and Infectious Diseases |
2021-03-31 |
|
|
| 3333 |
Neutrophils, Hypoxia, and Inflammatory Diseases |
2021-03-31 |
|
|
| 3334 |
Neutrophils |
2021-03-31 |
|
|
| 3335 |
Infection and Hypoxia |
2021-03-31 |
|
|
| 3336 |
Inflammation and Hypoxia |
2021-03-31 |
|
|
| 3337 |
Clinical Trials Prs |
2021-03-30 |
|
|
| 3338 |
Surgical Videoscope |
2021-03-30 |
|
|
| 3339 |
Tools for Visualization |
2021-03-30 |
|
|
| 3340 |
Treatment Result |
2021-03-30 |
|
|
| 3341 |
Gel Electrophoresis |
2021-03-30 |
|
|
| 3342 |
Techniques for Extraction & Storage of Biomolecules |
2021-03-30 |
|
|
| 3343 |
Blotting Techniques |
2021-03-30 |
|
|
| 3344 |
Clinical Features and Diagnosis |
2021-03-30 |
|
|
| 3345 |
The Experience |
2021-03-30 |
|
|
| 3346 |
Cognitive Performance as a Function of Job Match Logic Aptitude Test |
2021-03-30 |
|
|
| 3347 |
Diabetes in Kids |
2021-03-30 |
|
|
| 3348 |
Diagnosis and Diet Control |
2021-03-30 |
|
|
| 3349 |
Types of Diabetes Mellitus |
2021-03-30 |
|
|
| 3350 |
Conclusions and Suggestions |
2021-03-30 |
|
|
| 3351 |
Blood Types and Systemic Diseases |
2021-03-30 |
|
|
| 3352 |
Structured Question |
2021-03-30 |
|
|
| 3353 |
Cutaneous Polyarteritis Nodosa |
2021-03-30 |
|
|
| 3354 |
Cell Culture Method |
2021-03-30 |
|
|
| 3355 |
Serological Method |
2021-03-30 |
|
|
| 3356 |
Molecular Method |
2021-03-30 |
|
|
| 3357 |
Laboratory Testing Methods |
2021-03-30 |
|
|
| 3358 |
Biosafety Measures |
2021-03-30 |
|
|
| 3359 |
The Detection Rate of SARS-COV-2 from Various Specimens |
2021-03-30 |
|
|
| 3360 |
Factors Influencing Diagnostic Accuracy |
2021-03-30 |
|
|
| 3361 |
Serum |
2021-03-30 |
|
|
| 3362 |
Lower Respiratory Tracts Specimens |
2021-03-30 |
|
|
| 3363 |
Upper Respiratory Tract Specimens |
2021-03-30 |
|
|
| 3364 |
Specimen Types |
2021-03-30 |
|
|
| 3365 |
Specimen Collection: General Considerations |
2021-03-30 |
|
|
| 3366 |
Etiologic Agent |
2021-03-30 |
|
|
| 3367 |
Competing Interests Statement |
2021-03-29 |
|
|
| 3368 |
Narcissistic Personality Disorder |
2021-03-29 |
|
|
| 3369 |
Editorial Note for Journal of Alcoholism and Drug Dependence |
2021-03-29 |
|
|
| 3370 |
Short Note on Dark Side of Addiction |
2021-03-29 |
|
|
| 3371 |
A Note on Drug Addiction |
2021-03-29 |
|
|
| 3372 |
Short note on Hangover and its Effects |
2021-03-29 |
|
|
| 3373 |
Current Challenges Impairing Health Care Facilities Due to the Impact of SARS-CoV2 |
2021-03-29 |
|
|
| 3374 |
Materials and Experimental |
2021-03-29 |
|
|
| 3375 |
Selection of Sampling Sites |
2021-03-29 |
|
|
| 3376 |
Macronutrients and Trace Elements |
2021-03-29 |
|
|
| 3377 |
Nutrient Balance |
2021-03-29 |
|
|
| 3378 |
Conflicts of Interest |
2021-03-27 |
|
|
| 3379 |
Military Doctrine |
2021-03-26 |
|
|
| 3380 |
Visualization |
2021-03-26 |
|
|
| 3381 |
Maritime Security and Operations |
2021-03-26 |
|
|
| 3382 |
Management Information Systems |
2021-03-26 |
|
|
| 3383 |
Management Accounting |
2021-03-26 |
|
|
| 3384 |
Finance Ethics |
2021-03-26 |
|
|
| 3385 |
Clinical History |
2021-03-26 |
|
|
| 3386 |
Mental Imbalance |
2021-03-26 |
|
|
| 3387 |
Elements of Management |
2021-03-26 |
|
|
| 3388 |
Side Effects |
2021-03-26 |
|
|
| 3389 |
Effects of Obstructive Sleep Apnea by Amedeoxu |
2021-03-26 |
|
|
| 3390 |
Generator Set |
2021-03-25 |
|
|
| 3391 |
Algorithm of Imitation |
2021-03-25 |
|
|
| 3392 |
Algorithm of Generating of Free Energy |
2021-03-25 |
|
|
| 3393 |
Performance |
2021-03-25 |
|
|
| 3394 |
Biographical Notes |
2021-03-25 |
|
|
| 3395 |
Ethical Approvals |
2021-03-25 |
|
|
| 3396 |
Funding Information |
2021-03-25 |
|
|
| 3397 |
Therapeutic Options for Cle |
2021-03-24 |
|
|
| 3398 |
Immune Factors |
2021-03-24 |
|
|
| 3399 |
Genetics |
2021-03-24 |
|
|
| 3400 |
Management of Pregnant Women |
2021-03-24 |
|
|
| 3401 |
Treatment of Pregnant Women with Corona Virus |
2021-03-24 |
|
|
| 3402 |
Precautions to be Taken by Pregnant Women |
2021-03-24 |
|
|
| 3403 |
Susceptibility of Pregnant Women |
2021-03-24 |
|
|
| 3404 |
Futher Directions and Perspectives |
2021-03-24 |
|
|
| 3405 |
Fecal Microbiotia Transplantation |
2021-03-24 |
|
|
| 3406 |
Prebiotics |
2021-03-24 |
|
|
| 3407 |
Probiotics |
2021-03-24 |
|
|
| 3408 |
Therapeutics in Microbiota-ble Acid Pathway |
2021-03-24 |
|
|
| 3409 |
Mechanisms Underlying the Gut Microbiota-Bile Acid Pathway and Cvds |
2021-03-24 |
|
|
| 3410 |
Impact of Gut Microbiota on Bile Acid Metabolism |
2021-03-24 |
|
|
| 3411 |
Conclusion and Suggestions |
2021-03-24 |
|
|
| 3412 |
Prognosis |
2021-03-24 |
|
|
| 3413 |
Clinical Picture |
2021-03-24 |
|
|
| 3414 |
Etiology and Cause |
2021-03-24 |
|
|
| 3415 |
Dairy Industry: The quality, food safety, and regulatory affairs of food manufacturing, FSMA, and food industries challenges and taking initiatives for preventative control. |
2021-03-23 |
|
|
| 3416 |
Dairy Industry: Soil management and soil health |
2021-03-23 |
|
|
| 3417 |
Community Health Components |
2021-03-23 |
|
|
| 3418 |
What do we know and what should we explore? |
2021-03-22 |
|
|
| 3419 |
Does COVID-19 Alter or Complicate Aesthetic Outcomes? |
2021-03-22 |
|
|
| 3420 |
Methods and Methodology |
2021-03-19 |
|
|
| 3421 |
Pediatric Multiple Sclerosis |
2021-03-17 |
|
|
| 3422 |
Mechanism of Action |
2021-03-17 |
|
|
| 3423 |
Iron Mineral Formation |
2021-03-17 |
|
|
| 3424 |
Ultrastructure of Biofilm |
2021-03-17 |
|
|
| 3425 |
Biofilm Formation |
2021-03-17 |
|
|
| 3426 |
MRI in Paediatric Multiple Sclerosis |
2021-03-17 |
|
|
| 3427 |
Multiple Sclerosis in Children |
2021-03-17 |
|
|
| 3428 |
Calcium Channel Blockers |
2021-03-17 |
|
|
| 3429 |
2d-LC Solutions for Organic Compound Applications |
2021-03-17 |
|
|
| 3430 |
Treating |
2021-03-17 |
|
|
| 3431 |
Saperation |
2021-03-17 |
|
|
| 3432 |
Peritoneal dialysis |
2021-03-17 |
|
|
| 3433 |
Medication Interactions |
2021-03-17 |
|
|
| 3434 |
Antagonistic Reactions |
2021-03-17 |
|
|
| 3435 |
Pharmacology |
2021-03-17 |
|
|
| 3436 |
Angiotensin II Receptor Blockers |
2021-03-17 |
|
|
| 3437 |
Laser stylostixis for stroke and neurorehabilitation |
2021-03-17 |
|
|
| 3438 |
Albumin Ratio |
2021-03-17 |
|
|
| 3439 |
Signs and Symptoms of Neuroimmunological Disorders |
2021-03-17 |
|
|
| 3440 |
Bilateral Nephrectomy |
2021-03-17 |
|
|
| 3441 |
Neuroimmune disorders area unit characterised by inflammatory deregulating among the system. this issue can harvest developing analysis during this field. |
2021-03-17 |
|
|
| 3442 |
Autoimmune medical specialty Disorders |
2021-03-17 |
|
|
| 3443 |
Pathophysiology of MS |
2021-03-17 |
|
|
| 3444 |
Membranous Nephropathy |
2021-03-17 |
|
|
| 3445 |
Risk factors of Alcohol Neuropathy |
2021-03-17 |
|
|
| 3446 |
Evaluation & Tests |
2021-03-17 |
|
|
| 3447 |
Angiotensinogen |
2021-03-17 |
|
|
| 3448 |
Renin Angiotensin |
2021-03-17 |
|
|
| 3449 |
Treatment Alternatives |
2021-03-17 |
|
|
| 3450 |
Sign and Symptoms |
2021-03-17 |
|
|
| 3451 |
Symptomatology |
2021-03-17 |
|
|
| 3452 |
Nephroptosis |
2021-03-17 |
|
|
| 3453 |
Types of Submissions |
2021-03-17 |
|
|
| 3454 |
Pee sodium focus |
2021-03-17 |
|
|
| 3455 |
Fragmentary discharge of sodium |
2021-03-17 |
|
|
| 3456 |
Scope Of PV |
2021-03-17 |
|
|
| 3457 |
Urinalysis |
2021-03-17 |
|
|
| 3458 |
Sepsis-Induced Acute Tubular Necrosis |
2021-03-17 |
|
|
| 3459 |
Nephrotoxic-Induced Acute Tubular Necrosis |
2021-03-17 |
|
|
| 3460 |
Dear Readers, |
2021-03-17 |
|
|
| 3461 |
Tubular Necrosis |
2021-03-17 |
|
|
| 3462 |
Proteinuria |
2021-03-17 |
|
|
| 3463 |
Filtration and reabsorption of plasma proteins |
2021-03-17 |
|
|
| 3464 |
Sampling Procedure |
2021-03-16 |
|
|
| 3465 |
Empirical Framework |
2021-03-16 |
|
|
| 3466 |
Competing of interests |
2021-03-16 |
|
|
| 3467 |
Taxonomy and Biology of Penicillium Pinophilum (Talaromyces Pinophilus) |
2021-03-16 |
|
|
| 3468 |
Diversity in Ecosystem and Potential Role of Biological Agents |
2021-03-16 |
|
|
| 3469 |
Disease Management of Rhizoctonia Solani |
2021-03-16 |
|
|
| 3470 |
Infection Process and Symptoms |
2021-03-16 |
|
|
| 3471 |
Currently Available Diagnostic Tools For Congenital Cmv In Newborns In Africa |
2021-03-15 |
|
|
| 3472 |
Neonatal Prevalence Of Congential Cmv In Africa |
2021-03-15 |
|
|
| 3473 |
Approach |
2021-03-15 |
|
|
| 3474 |
Distribution and Host Range |
2021-03-15 |
|
|
| 3475 |
Taxonomy and Biology of Rhizoctonia Solani |
2021-03-15 |
|
|
| 3476 |
Sugar Beet Domestication and US Commercialization |
2021-03-15 |
|
|
| 3477 |
Graves' Disease |
2021-03-15 |
|
|
| 3478 |
Multiple Sclerosis |
2021-03-15 |
|
|
| 3479 |
Oral Health Conditions |
2021-03-15 |
|
|
| 3480 |
Award for Human Genome 2020 |
2021-03-14 |
|
|
| 3481 |
2019 Highlights of JPHC |
2021-03-12 |
|
|
| 3482 |
Authors Information |
2021-03-12 |
|
|
| 3483 |
Important Milestones in Climate Control |
2021-03-12 |
|
|
| 3484 |
Impact of Climate Change on Small Islands |
2021-03-12 |
|
|
| 3485 |
Consequences of Climate Changes |
2021-03-12 |
|
|
| 3486 |
Targeting the Needs of the Vulnerable |
2021-03-12 |
|
|
| 3487 |
HIV Self-Testing |
2021-03-12 |
|
|
| 3488 |
Social Perspective |
2021-03-12 |
|
|
| 3489 |
Ground Reality |
2021-03-12 |
|
|
| 3490 |
New Developments |
2021-03-12 |
|
|
| 3491 |
O2, Ar, and N2 Generation Industries |
2021-03-12 |
|
|
| 3492 |
CO and CO2 Generation, Capture Operation and their Conversion in Industrial Scale |
2021-03-12 |
|
|
| 3493 |
Results and Observation |
2021-03-11 |
|
|
| 3494 |
Immunosuppressive Agents |
2021-03-11 |
|
|
| 3495 |
Systemic Steroids |
2021-03-11 |
|
|
| 3496 |
Intravitreal Steroids |
2021-03-11 |
|
|
| 3497 |
Periocular Steroids |
2021-03-11 |
|
|
| 3498 |
Iontophoresis |
2021-03-11 |
|
|
| 3499 |
Topical Corticosteroids |
2021-03-11 |
|
|
| 3500 |
Local Delivery of Corticosteroids |
2021-03-11 |
|
|
| 3501 |
Determining Relevant References of Published Reviews |
2021-03-11 |
|
|
| 3502 |
Development of Search Strategies |
2021-03-11 |
|
|
| 3503 |
Prescription Monitoring |
2021-03-11 |
|
|
| 3504 |
Principles of Causality Assessment |
2021-03-11 |
|
|
| 3505 |
About Vigimed |
2021-03-11 |
|
|
| 3506 |
Treatments |
2021-03-11 |
|
|
| 3507 |
Ethics Approval and Constant to Participate |
2021-03-08 |
|
|
| 3508 |
Methods and Participants |
2021-03-08 |
|
|
| 3509 |
Epidemiology and Coronavirus |
2021-03-06 |
|
|
| 3510 |
Perspectives and Future Developments |
2021-03-06 |
|
|
| 3511 |
Antimicrobial Photodynamic Therapy for Prevention of Hospital Pneumonia |
2021-03-06 |
|
|
| 3512 |
Functionalization of Medical Devices with Photosensitizers |
2021-03-06 |
|
|
| 3513 |
Antimicrobial Photodynamic Therapy and its Mechanism |
2021-03-06 |
|
|
| 3514 |
Endotracheal Tube and its Complications and Risks |
2021-03-06 |
|
|
| 3515 |
Respiratory Tract Infections |
2021-03-06 |
|
|
| 3516 |
Strategies in Combating Covid-19 |
2021-03-05 |
|
|
| 3517 |
Candidate Vaccines Trial for Sars-Cov-2 Infection |
2021-03-05 |
|
|
| 3518 |
Laboratory Diagnosis for Covid-19 |
2021-03-05 |
|
|
| 3519 |
Host Immune Response to Sars-Cov-2 Infection |
2021-03-05 |
|
|
| 3520 |
Pathogenesis and Disease Characterization |
2021-03-05 |
|
|
| 3521 |
Sars-cov-2 viral attachment and Penetration mechanisms |
2021-03-05 |
|
|
| 3522 |
Transmission Route of Sar-Cov-2 Infection |
2021-03-05 |
|
|
| 3523 |
Molecular Characterization and Genetic Makeup of Sars-Cov-2 |
2021-03-05 |
|
|
| 3524 |
Epidemiology of Sars-Cov-2 |
2021-03-05 |
|
|
| 3525 |
Availability of Data Material |
2021-03-05 |
|
|
| 3526 |
Time Needed For A Newly Arisen Mutant To Increase Its Frequency To Become Dominant In The Sars-Cov-2 Population Depending On Its Selective Advantage Or Disadvantage |
2021-03-05 |
|
|
| 3527 |
Fixation Likelihood Of A Newly Arisen Mutant, Within The Sars-Cov-2 Population, Depending On Its Selective Advantage Or Disadvantage |
2021-03-05 |
|
|
| 3528 |
Probability That a New Sars-Cov-2 Mutant Newly Arisen In the Sars-Cov-2 Population Survives Through Time Depending On Its Selective Advantage Or Disadvantage |
2021-03-05 |
|
|
| 3529 |
Fixation and Extinction Dynamics Of New Mutants In The Sars-Cov-2 Meta-Population |
2021-03-05 |
|
|
| 3530 |
Dear Readers |
2021-03-05 |
|
|
| 3531 |
Chemical Warfare |
2021-03-05 |
|
|
| 3532 |
Effects of Nuclear Explosions |
2021-03-05 |
|
|
| 3533 |
Finance and Marketing |
2021-03-05 |
|
|
| 3534 |
Improvements in Defense Clinical Facilities |
2021-03-05 |
|
|
| 3535 |
Military Science |
2021-03-05 |
|
|
| 3536 |
Risk Mitigation |
2021-03-05 |
|
|
| 3537 |
Experimental Study |
2021-03-05 |
|
|
| 3538 |
Crisis management |
2021-03-05 |
|
|
| 3539 |
Mark to Market |
2021-03-05 |
|
|
| 3540 |
Defense Management |
2021-03-05 |
|
|
| 3541 |
Biological and Clinical Features |
2021-03-05 |
|
|
| 3542 |
Risk Assessment and Management |
2021-03-05 |
|
|
| 3543 |
Public Organization |
2021-03-04 |
|
|
| 3544 |
Democratic |
2021-03-04 |
|
|
| 3545 |
Human Resource Management |
2021-03-04 |
|
|
| 3546 |
Entrepreneurship |
2021-03-04 |
|
|
| 3547 |
Editorial Note of Review of Public Administration and Management |
2021-03-04 |
|
|
| 3548 |
Methodology and Procedures |
2021-03-04 |
|
|
| 3549 |
Special Topics |
2021-03-04 |
|
|
| 3550 |
Induction, Maintenance, and Taper |
2021-03-04 |
|
|
| 3551 |
Buprenorphine |
2021-03-04 |
|
|
| 3552 |
Data Collection Questionnaires |
2021-03-04 |
|
|
| 3553 |
Regulation Management |
2021-03-04 |
|
|
| 3554 |
Operations management |
2021-03-04 |
|
|
| 3555 |
Strategic Management |
2021-03-04 |
|
|
| 3556 |
Impact of Leadership and Learning Culture on Knowledge Management in Public Organizations |
2021-03-04 |
|
|
| 3557 |
Public Civil Services |
2021-03-04 |
|
|
| 3558 |
Pasteurization |
2021-03-04 |
|
|
| 3559 |
Dairy Technology |
2021-03-04 |
|
|
| 3560 |
Advances in Dairy Research |
2021-03-04 |
|
|
| 3561 |
Milk Proteomics |
2021-03-04 |
|
|
| 3562 |
Range of Diseases Affecting Dairy Cows |
2021-03-04 |
|
|
| 3563 |
Materials and Chemicals |
2021-03-03 |
|
|
| 3564 |
Editorial Note for Advances in Dairy Research |
2021-03-03 |
|
|
| 3565 |
Limitations and Implications |
2021-03-03 |
|
|
| 3566 |
Similar Trends |
2021-03-03 |
|
|
| 3567 |
Present Study and Hypotheses |
2021-03-03 |
|
|
| 3568 |
Social Consequences and Changes After Quarantine |
2021-03-03 |
|
|
| 3569 |
Emotion Dynamics During Covid-19 Pandemic |
2021-03-03 |
|
|
| 3570 |
Stressors During and After Quarantine |
2021-03-03 |
|
|
| 3571 |
Impact of Quarantine and Pandemics on Mental Health and Prevalent Emotions |
2021-03-03 |
|
|
| 3572 |
The Economic Loss of Dairy Cattle Poor Reproductive Performance in Central Highlands of Ethiopia |
2021-03-03 |
|
|
| 3573 |
Appraisal and Evaluation |
2021-03-03 |
|
|
| 3574 |
Limitations and Future Scope |
2021-03-03 |
|
|
| 3575 |
Notes on the Contributors |
2021-03-03 |
|
|
| 3576 |
Challenges Faced in Nanodentistry |
2021-03-02 |
|
|
| 3577 |
Nanotechnology in Periodontics |
2021-03-02 |
|
|
| 3578 |
Nanotechnology in Dentistry |
2021-03-02 |
|
|
| 3579 |
Implications of Nanotechnology |
2021-03-02 |
|
|
| 3580 |
Nanomedicine |
2021-03-02 |
|
|
| 3581 |
Nanomaterials |
2021-03-02 |
|
|
| 3582 |
Efficacy on Tocotrienols in the Treatment of non-alcoholic Steatohepatitis: A 10 year Systematic Review |
2021-03-02 |
|
|
| 3583 |
Retrospective audit in use of hypertonic saline with the management of acute symptomatic hyponatraemia with hospitalized patients |
2021-03-02 |
|
|
| 3584 |
Probiotics influence central nervous system |
2021-03-02 |
|
|
| 3585 |
Editorial Highlights for International Journal of Waste Resources |
2021-03-02 |
|
|
| 3586 |
Clinical Significance |
2021-03-02 |
|
|
| 3587 |
Statement of Human and Animal Rights |
2021-03-02 |
|
|
| 3588 |
Statement of Informed Consent |
2021-03-02 |
|
|
| 3589 |
Awards Content for Euro Renewable Energy 2021 |
2021-03-02 |
|
|
| 3590 |
Conference Announcement: 2nd International Conference on Current Trends in Recycling and E-Waste Management |
2021-03-02 |
|
|
| 3591 |
Editorial-Journal of Diabetes and Metabolism -2021 |
2021-03-02 |
|
|
| 3592 |
A Review on Role of Plant(s) Extracts and its Phytochemicals for the Management of Diabetes |
2021-03-02 |
|
|
| 3593 |
Prevalence and correlates of herbal medicine use among type 2 diabetic patients in Teaching Hospital in Ethiopia: a cross sectional study |
2021-03-02 |
|
|
| 3594 |
The Non Mineral Axis Klotho-Vitamin D in Diabetic Nephropathy: Review |
2021-03-02 |
|
|
| 3595 |
Anti-diabetic, Haematinic and Anti-cholesterolmic Effects of Wheat (Triticum aestivum Linn.) Grass Juice Metabolites to Cure Alloxan Monohydrate induced type-1 Diabetes in Albino R |
2021-03-02 |
|
|
| 3596 |
Awards 2021 |
2021-03-02 |
|
|
| 3597 |
Technological improvement and biomedical application-oriented research |
2021-03-02 |
|
|
| 3598 |
Ethical Considerations and Cosent |
2021-03-01 |
|
|
| 3599 |
Dairy Industry: Innovative sensor system and evaluation procedure for monitoring of food processing |
2021-03-01 |
|
|
| 3600 |
Dairy Industry: Food quality and health |
2021-03-01 |
|
|
| 3601 |
Dairy Industry: Food and Beverages are the major industries for the improvement of health, daily use of life, reduction in financial crises, poverty and hunger in the world |
2021-03-01 |
|
|
| 3602 |
Dairy Industry: Controlling Listeria monocytogenes & Salmonella in Food Processing using Phage technology |
2021-03-01 |
|
|
| 3603 |
Dairy Industry: Processing and preserving strategies on antioxidant food tablets and supplements |
2021-03-01 |
|
|
| 3604 |
Ethical Clearence |
2021-02-27 |
|
|
| 3605 |
Place of Study |
2021-02-27 |
|
|
| 3606 |
The Status of Infectious Bursal Diseases in Ethiopia |
2021-02-27 |
|
|
| 3607 |
General Accounts of Infectious Bursal Disease |
2021-02-27 |
|
|
| 3608 |
Measurement Procedures |
2021-02-27 |
|
|
| 3609 |
Diagnosis and Staging |
2021-02-27 |
|
|
| 3610 |
Method of Wood Property Analysis for Fuel Wood |
2021-02-26 |
|
|
| 3611 |
Adherence to National and International Regulations |
2021-02-26 |
|
|
| 3612 |
Declaration of Funding |
2021-02-26 |
|
|
| 3613 |
Facts |
2021-02-26 |
|
|
| 3614 |
Congnitive Psychology |
2021-02-26 |
|
|
| 3615 |
Biopsychology |
2021-02-26 |
|
|
| 3616 |
Developmental Psychology |
2021-02-26 |
|
|
| 3617 |
Abnormal Psychology |
2021-02-26 |
|
|
| 3618 |
Contraindications |
2021-02-26 |
|
|
| 3619 |
Life Systems and Physiology |
2021-02-26 |
|
|
| 3620 |
Cystourethroscopy |
2021-02-26 |
|
|
| 3621 |
Factors Leading to Increased Detection of Thyroid Cancer |
2021-02-26 |
|
|
| 3622 |
Treatment/Management |
2021-02-26 |
|
|
| 3623 |
Histopathology |
2021-02-26 |
|
|
| 3624 |
The Study of Disease Transmission |
2021-02-26 |
|
|
| 3625 |
Kidney Biopsy |
2021-02-26 |
|
|
| 3626 |
Causes of Systemic Mastocytosis |
2021-02-26 |
|
|
| 3627 |
Types of Systemic Mastocytosis |
2021-02-26 |
|
|
| 3628 |
Proposed Methodology |
2021-02-26 |
|
|
| 3629 |
The Historical Development of Pharmacoepidemiology |
2021-02-25 |
|
|
| 3630 |
Electronic Supplementary Material |
2021-02-25 |
|
|
| 3631 |
Data Collection and Tool |
2021-02-25 |
|
|
| 3632 |
Results and Discussion |
2021-02-24 |
|
|
| 3633 |
Scope and Implications |
2021-02-24 |
|
|
| 3634 |
Coping |
2021-02-24 |
|
|
| 3635 |
But which Compounds have this Property? |
2021-02-24 |
|
|
| 3636 |
Where is the Trps Located? |
2021-02-24 |
|
|
| 3637 |
But what are the Physiopathological Mechanisms Underlying these Changes? |
2021-02-24 |
|
|
| 3638 |
Types Of Local Anaesthetics In Oral And Maxillofacial Surgery |
2021-02-24 |
|
|
| 3639 |
Recuperation Patterns Of Motor Impairment |
2021-02-23 |
|
|
| 3640 |
Conversation |
2021-02-23 |
|
|
| 3641 |
Convesation |
2021-02-23 |
|
|
| 3642 |
Strategies |
2021-02-23 |
|
|
| 3643 |
Re-Evaluation |
2021-02-23 |
|
|
| 3644 |
Appraisal |
2021-02-23 |
|
|
| 3645 |
Clinical Highlights |
2021-02-23 |
|
|
| 3646 |
Cliniacal Highlights |
2021-02-23 |
|
|
| 3647 |
Blastocyst Stage Cryopreservation |
2021-02-23 |
|
|
| 3648 |
Oocyte Cryopreservation |
2021-02-23 |
|
|
| 3649 |
Vitrification |
2021-02-23 |
|
|
| 3650 |
Indications For Ovarian Tissue Cryopreservation (OTC) |
2021-02-23 |
|
|
| 3651 |
Cryopreservation Of Ovarian Tissues And Embryos |
2021-02-23 |
|
|
| 3652 |
Morphology of Apoptosis |
2021-02-20 |
|
|
| 3653 |
Future of Nano Medicine and Drug Delivery System |
2021-02-20 |
|
|
| 3654 |
Fundamentals of Nanotechnology Based Techniques in Designing of Drug |
2021-02-20 |
|
|
| 3655 |
Nano Based Drug Delivery Systems |
2021-02-20 |
|
|
| 3656 |
Therapeutic Potential of Adult Stem Cells |
2021-02-20 |
|
|
| 3657 |
Maintenance of Adult Stem Cells in the Organism |
2021-02-20 |
|
|
| 3658 |
Adult stem cells |
2021-02-20 |
|
|
| 3659 |
Mode of Action |
2021-02-20 |
|
|
| 3660 |
Coronavirus Classification |
2021-02-20 |
|
|
| 3661 |
Protiens as Drug Targets |
2021-02-19 |
|
|
| 3662 |
Membranes as Drug Targets |
2021-02-19 |
|
|
| 3663 |
RNA As Drug Target |
2021-02-19 |
|
|
| 3664 |
Nucleic Acids As Drug Targets |
2021-02-19 |
|
|
| 3665 |
Genes As Drug Targets |
2021-02-19 |
|
|
| 3666 |
Free Robux |
2021-02-18 |
|
|
| 3667 |
The Result of Interaction |
2021-02-18 |
|
|
| 3668 |
Ferrous Ion Oxidizers in the Marine Environment |
2021-02-18 |
|
|
| 3669 |
Characteristics of Utilization of different Types of Exogenous Carbon Sources |
2021-02-18 |
|
|
| 3670 |
Sole Carbon Source Tests |
2021-02-18 |
|
|
| 3671 |
Water Quality Improvement of Black-Odor River |
2021-02-18 |
|
|
| 3672 |
Avoidance |
2021-02-18 |
|
|
| 3673 |
Tapeworm |
2021-02-18 |
|
|
| 3674 |
Chagas Infection |
2021-02-18 |
|
|
| 3675 |
Side Effects of Parasitic Contaminations |
2021-02-18 |
|
|
| 3676 |
Instances of Parasitic Diseases |
2021-02-18 |
|
|
| 3677 |
Effect of Changing Spectrum of Infectious Diseases on Lexicon |
2021-02-18 |
|
|
| 3678 |
Applications Of Nanotechnology |
2021-02-18 |
|
|
| 3679 |
Charateristics Of Nanoparticles |
2021-02-18 |
|
|
| 3680 |
Anticipation |
2021-02-18 |
|
|
| 3681 |
Possible Complications |
2021-02-18 |
|
|
| 3682 |
Extent Of The Issue |
2021-02-18 |
|
|
| 3683 |
White Blood Cell Receptor Coordinated Antibodies |
2021-02-18 |
|
|
| 3684 |
Monoclonal Antibodies |
2021-02-18 |
|
|
| 3685 |
Confirmed Coronavirus Cases and Deaths By Country and Territory Or Conveyance |
2021-02-18 |
|
|
| 3686 |
Confirmed Coronavirus Cases and Deaths By Coutry and Territory Or Conveyance |
2021-02-18 |
|
|
| 3687 |
Existing Situation |
2021-02-18 |
|
|
| 3688 |
Spreads Of Coronavirus and Prevention |
2021-02-18 |
|
|
| 3689 |
Covid -19 Symptoms |
2021-02-18 |
|
|
| 3690 |
Morphology and Genome Sequence Of Coronavirus |
2021-02-18 |
|
|
| 3691 |
Future Recommendations |
2021-02-17 |
|
|
| 3692 |
Collaboration Of Veterinations and Medicos For Pandemic Preparedness |
2021-02-17 |
|
|
| 3693 |
Importance Of Verterinary Medicine For Vaccine Development |
2021-02-17 |
|
|
| 3694 |
Support Of Veterinary Laboratory |
2021-02-17 |
|
|
| 3695 |
Host Range |
2021-02-17 |
|
|
| 3696 |
Frameshift In Corona Virus |
2021-02-17 |
|
|
| 3697 |
Introduction and Problem |
2021-02-17 |
|
|
| 3698 |
Take Home Message |
2021-02-17 |
|
|
| 3699 |
Past Conference Editorial of Dermatology Medicine 2020 |
2021-02-16 |
|
|
| 3700 |
Speaker Publications |
2021-02-16 |
|
|
| 3701 |
Oservation |
2021-02-16 |
|
|
| 3702 |
Investigation Method |
2021-02-16 |
|
|
| 3703 |
Therapeutic Strategy For Chronic Liver Disease |
2021-02-16 |
|
|
| 3704 |
Liver Fibrosis In General Population |
2021-02-16 |
|
|
| 3705 |
Non-Cld-Related Atherosclerosis |
2021-02-16 |
|
|
| 3706 |
Cld-Related Atherosclerosis |
2021-02-16 |
|
|
| 3707 |
Liver Fibrosis |
2021-02-16 |
|
|
| 3708 |
Abstract Citation |
2021-02-16 |
|
|
| 3709 |
Journal of Dermatology Case Reports |
2021-02-16 |
|
|
| 3710 |
Treatment Methods |
2021-02-16 |
|
|
| 3711 |
Prevention Techniques |
2021-02-16 |
|
|
| 3712 |
Causes of Melanoma |
2021-02-16 |
|
|
| 3713 |
Melanoma |
2021-02-16 |
|
|
| 3714 |
Prevention and Management |
2021-02-15 |
|
|
| 3715 |
Life Cycle of Sarcoptes scabiei |
2021-02-15 |
|
|
| 3716 |
Treatment Methodology |
2021-02-15 |
|
|
| 3717 |
Types of Acne |
2021-02-15 |
|
|
| 3718 |
Phisiopathology of Acne |
2021-02-15 |
|
|
| 3719 |
Factors Responsible for the Physiopathology of Acne |
2021-02-15 |
|
|
| 3720 |
Decleration of Conflict of Interest |
2021-02-15 |
|
|
| 3721 |
Life-Years Saved from Covid-19 versus Life-Years Lost from Cancer |
2021-02-15 |
|
|
| 3722 |
Lives versus Life-Years |
2021-02-15 |
|
|
| 3723 |
The Covid-19 Trade off |
2021-02-15 |
|
|
| 3724 |
Therapeutic Routes of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3725 |
Diagnosis of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3726 |
Frequency of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3727 |
Etiology of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3728 |
Clinical Signs and Symptoms of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3729 |
Generalities of Androgenetic Alopecia Syndrome |
2021-02-12 |
|
|
| 3730 |
Withdrawals |
2021-02-12 |
|
|
| 3731 |
Declaration Statements |
2021-02-12 |
|
|
| 3732 |
Future Applications |
2021-02-12 |
|
|
| 3733 |
Crispr–Cas Concerns That Need To Be Addressed |
2021-02-12 |
|
|
| 3734 |
Addressing New Gene Editing Challenges In Clonal Hematopoiesis Research |
2021-02-12 |
|
|
| 3735 |
Crispr–Cas Genome Editing To Study Clonal Hematopoiesis |
2021-02-12 |
|
|
| 3736 |
Crispr-Cas Genome Editing To Study Clonal Hematopoiesis |
2021-02-12 |
|
|
| 3737 |
Grants or Other Financial Supports |
2021-02-12 |
|
|
| 3738 |
Authors's Contributions |
2021-02-11 |
|
|
| 3739 |
Probable Suggested Solutions for Solid Waste Management in the IHR |
2021-02-10 |
|
|
| 3740 |
Case Study: Alappuzha (Kerala) and Aima Panchayat (Himachal Pradesh) |
2021-02-10 |
|
|
| 3741 |
Current Policy and Management Practices |
2021-02-10 |
|
|
| 3742 |
Challenges and Issues of Solid Waste Management in the IHR |
2021-02-10 |
|
|
| 3743 |
Status of Municipal Solid Waste in the Indian Himalayan Region (IHR) |
2021-02-10 |
|
|
| 3744 |
Status of Municipal Solid Waste in India |
2021-02-10 |
|
|
| 3745 |
Applying the Proposed Method on the Benchmark: Increasing the Exposure and Vulnerability of a Small Residential Community in the North of Tehran for Industrial Waste |
2021-02-10 |
|
|
| 3746 |
Adaptive Decision Management System and Updating Game Theory for a Sequential Decision Scenario |
2021-02-10 |
|
|
| 3747 |
Examining the Evolving Conditions and Their Impact on the Performance of Industrial Infrastructure Projects and Communities |
2021-02-10 |
|
|
| 3748 |
Author Contributions and Acknowledgements |
2021-02-10 |
|
|
| 3749 |
Association between CPAP Compliance and Outcomes |
2021-02-10 |
|
|
| 3750 |
Sample Characteristics |
2021-02-10 |
|
|
| 3751 |
Strategies To Resolve Problems |
2021-02-10 |
|
|
| 3752 |
Model Of Nurse/Patient Empower |
2021-02-10 |
|
|
| 3753 |
Sources Of Power |
2021-02-10 |
|
|
| 3754 |
Component Of Kanter's Theory |
2021-02-10 |
|
|
| 3755 |
Kanter's Theory Of Empowerment |
2021-02-10 |
|
|
| 3756 |
Plan |
2021-02-09 |
|
|
| 3757 |
Diagnostic Formulation |
2021-02-09 |
|
|
| 3758 |
Laparoscopy |
2021-02-09 |
|
|
| 3759 |
Swot Analysis Of Current Program Approach |
2021-02-04 |
|
|
| 3760 |
Associated Factors in Malaria Transmission and Problem Exaggeration for Public Health in Baran |
2021-02-04 |
|
|
| 3761 |
Magnitude of Problem |
2021-02-04 |
|
|
| 3762 |
Program Approachs |
2021-02-04 |
|
|
| 3763 |
Clinical Trials Standard Approaches |
2021-02-04 |
|
|
| 3764 |
Key Concepts of Clinical Trails Design |
2021-02-04 |
|
|
| 3765 |
Embryonic Stem Cells Factors and Cancer |
2021-02-02 |
|
|
| 3766 |
Umbilical Cord Stem Cell Derived Exosomes and Cancer |
2021-02-02 |
|
|
| 3767 |
Exosomes in Cancer Therapy: Multiple Roles |
2021-02-02 |
|
|
| 3768 |
Exosomes and Cancer Diagnosis |
2021-02-02 |
|
|
| 3769 |
Exosomes Formation and Structure |
2021-02-02 |
|
|
| 3770 |
Declaration on Conflicts of Interests |
2021-02-02 |
|
|
| 3771 |
Next Steps-Recommendations |
2021-02-02 |
|
|
| 3772 |
Conclusion with Respect to Covid-19-Treatment |
2021-02-02 |
|
|
| 3773 |
Complex Onion Chemistry |
2021-02-02 |
|
|
| 3774 |
Practical Implications of the Study |
2021-02-02 |
|
|
| 3775 |
Theoretical Review |
2021-02-02 |
|
|
| 3776 |
Software and Computational Methods |
2021-02-01 |
|
|
| 3777 |
Importance of Vaccine |
2021-02-01 |
|
|
| 3778 |
Mechanism of HIV Drug Resistance |
2021-02-01 |
|
|
| 3779 |
Immunological Aspects of HIV |
2021-02-01 |
|
|
| 3780 |
Vaccine Prospect |
2021-02-01 |
|
|
| 3781 |
Other Potential Therapies |
2021-02-01 |
|
|
| 3782 |
Therapeutics |
2021-02-01 |
|
|
| 3783 |
Co-Morbidities of COVID 19 |
2021-02-01 |
|
|
| 3784 |
Pathogenesis and Clinical Manifestations |
2021-02-01 |
|
|
| 3785 |
Virus Genome Structure |
2021-02-01 |
|
|
| 3786 |
Descripition |
2021-01-30 |
|
|
| 3787 |
Study Area and Data Set |
2021-01-29 |
|
|
| 3788 |
Sourcing of Funding |
2021-01-29 |
|
|
| 3789 |
Guidelines for Pain Prevention Exercises in Elderly Individuals |
2021-01-29 |
|
|
| 3790 |
Vicious Cycle of Pain and Frailty |
2021-01-29 |
|
|
| 3791 |
Relationship between Oral Frailty and Meal Satisfaction |
2021-01-29 |
|
|
| 3792 |
Oral Frailty |
2021-01-29 |
|
|
| 3793 |
Research in Context |
2021-01-28 |
|
|
| 3794 |
Formation and Function of C@DNA as a Supra Molecular Catalyst |
2021-01-28 |
|
|
| 3795 |
Morphological Changes in a Single GV Observed by High-Speed Confocal Microscopy |
2021-01-28 |
|
|
| 3796 |
The increase in GVs (S) was 85% at 30 min after V* addition |
2021-01-28 |
|
|
| 3797 |
Increase Ratios of GVs By Wide-View/ High-Precision Confocal Microscopy |
2021-01-28 |
|
|
| 3798 |
Population Analysis of Selfreproducing GVs By Flow Cytometry |
2021-01-28 |
|
|
| 3799 |
Population Analysis of Selfreproducing GVs By Flow Cytometry |
2021-01-28 |
|
|
| 3800 |
Self-Reproducing GVs Containing DNAs of Different Lengths |
2021-01-28 |
|
|
| 3801 |
Final Considerations |
2021-01-27 |
|
|
| 3802 |
Development |
2021-01-27 |
|
|
| 3803 |
Conflicts of Financial Interest |
2021-01-27 |
|
|
| 3804 |
ACE2 Receptor and Vitamin D |
2021-01-23 |
|
|
| 3805 |
ACE2 Receptor and Host–Virus Interaction |
2021-01-23 |
|
|
| 3806 |
Immunopathology of SARS-CoV-2 |
2021-01-23 |
|
|
| 3807 |
Vitamin D3 |
2021-01-23 |
|
|
| 3808 |
Immunomodulatory Nanomedicine |
2021-01-23 |
|
|
| 3809 |
Message for the Elderly With Hypertension and Diabetes Mellitus |
2021-01-23 |
|
|
| 3810 |
The Latest Developments in the Covid-19 Outbreak in Indonesia |
2021-01-23 |
|
|
| 3811 |
Parents as Models |
2021-01-23 |
|
|
| 3812 |
Conception of a Child |
2021-01-23 |
|
|
| 3813 |
Associated Risk Factors |
2021-01-23 |
|
|
| 3814 |
Observations |
2021-01-22 |
|
|
| 3815 |
Alternatives to Introducing Medicine Into a Child’s System |
2021-01-22 |
|
|
| 3816 |
Consequences If Eb Problems are Left Untreated |
2021-01-22 |
|
|
| 3817 |
The Factors That Can Cause Eb Problems |
2021-01-22 |
|
|
| 3818 |
Specific Objectives |
2021-01-22 |
|
|
| 3819 |
Types of Prostate Cancer |
2021-01-22 |
|
|
| 3820 |
Other syndromes |
2021-01-22 |
|
|
| 3821 |
Hamartoma PTEN Syndrome |
2021-01-22 |
|
|
| 3822 |
Conflict of Interest and Source of Funding Statement |
2021-01-22 |
|
|
| 3823 |
Information about the Authors |
2021-01-22 |
|
|
| 3824 |
Contribution of author |
2021-01-22 |
|
|
| 3825 |
Expert Opinion |
2021-01-22 |
|
|
| 3826 |
Upcoming Conferences |
2021-01-22 |
|
|
| 3827 |
Types of Research Work |
2021-01-22 |
|
|
| 3828 |
Study Limitation and Future Scope |
2021-01-21 |
|
|
| 3829 |
Topics and Practices |
2021-01-21 |
|
|
| 3830 |
Overall Consensus |
2021-01-21 |
|
|
| 3831 |
Decleration of Patient Consent |
2021-01-21 |
|
|
| 3832 |
Study Outcome |
2021-01-21 |
|
|
| 3833 |
Clinical Protocol |
2021-01-21 |
|
|
| 3834 |
Clinical Outcome |
2021-01-21 |
|
|
| 3835 |
Groups |
2021-01-21 |
|
|
| 3836 |
Eligibility Criteria |
2021-01-21 |
|
|
| 3837 |
Operation Procedure |
2021-01-20 |
|
|
| 3838 |
Conclusion and Further Development |
2021-01-20 |
|
|
| 3839 |
Convolutional Neural Network(CNN) |
2021-01-20 |
|
|
| 3840 |
Process Description |
2021-01-20 |
|
|
| 3841 |
System Architecture |
2021-01-20 |
|
|
| 3842 |
Future Scope |
2021-01-20 |
|
|
| 3843 |
Adverse Effects |
2021-01-20 |
|
|
| 3844 |
Effects on Pediatric Patients |
2021-01-20 |
|
|
| 3845 |
Methods of Administration |
2021-01-20 |
|
|
| 3846 |
Drug Design |
2021-01-20 |
|
|
| 3847 |
Drug Development |
2021-01-20 |
|
|
| 3848 |
Data Mining |
2021-01-20 |
|
|
| 3849 |
Therapeutic Applications |
2021-01-20 |
|
|
| 3850 |
IBD or IBS |
2021-01-20 |
|
|
| 3851 |
Conclusion and Discussions |
2021-01-20 |
|
|
| 3852 |
ORCID IDs |
2021-01-20 |
|
|
| 3853 |
Combinations of HPV Vaccines with Other Therapies |
2021-01-20 |
|
|
| 3854 |
Combinations of Vaccine with Standard-of-Care Therapeutics |
2021-01-20 |
|
|
| 3855 |
Combinations of Multiple Therapeutic Modalities |
2021-01-20 |
|
|
| 3856 |
Preclinical Studies |
2021-01-20 |
|
|
| 3857 |
Rationale for Combination Treatments with Vaccines and Other Modalities |
2021-01-20 |
|
|
| 3858 |
Clinical Considerations and Conclusion |
2021-01-19 |
|
|
| 3859 |
Samples and Methods |
2021-01-19 |
|
|
| 3860 |
Epigenetic Genetic Modifications of Thymus Cancer |
2021-01-19 |
|
|
| 3861 |
Epigenetic Genetic Modifications of Lung Cancer |
2021-01-19 |
|
|
| 3862 |
Epigenetic Genetic Modifications of Pancreatic Cancer |
2021-01-19 |
|
|
| 3863 |
Epigenetic Genetic Modifications of Pituitary Cancer |
2021-01-19 |
|
|
| 3864 |
Epigenetic Genetic Modifications of Adrenocortical Cancer |
2021-01-19 |
|
|
| 3865 |
Epigenetic Genetic Modifications of Thyroid Cancer |
2021-01-19 |
|
|
| 3866 |
Epigenetic Targets for Treatment of Thyroid Cancer |
2021-01-19 |
|
|
| 3867 |
The Role of Micrornas in Thyroid Cancer |
2021-01-19 |
|
|
| 3868 |
Histone Modification in Thyroid Cancer |
2021-01-19 |
|
|
| 3869 |
Aberrant Gene Methylation in Thyroid Cancer |
2021-01-19 |
|
|
| 3870 |
Epigenetic Modifications in Thyroid Cancer |
2021-01-19 |
|
|
| 3871 |
Micrornas and Ovarian Cancer |
2021-01-19 |
|
|
| 3872 |
Histone Modification |
2021-01-19 |
|
|
| 3873 |
Methylation of Imprinted Genes in Ovarian Cancer |
2021-01-19 |
|
|
| 3874 |
CPG Island Methylator Phenotype Criteria (CIMP) |
2021-01-19 |
|
|
| 3875 |
Ovarian Cancer |
2021-01-19 |
|
|
| 3876 |
The Role of Micrornas in Prostate Cancer |
2021-01-19 |
|
|
| 3877 |
The Role of Histone Modification in Prostate Cancer |
2021-01-19 |
|
|
| 3878 |
The Role of Hypermethylation in Prostate Cancer |
2021-01-19 |
|
|
| 3879 |
The Role of Hypomethylation in Prostate Cancer |
2021-01-19 |
|
|
| 3880 |
Epigenetics Modifications in Prostate Cancer |
2021-01-19 |
|
|
| 3881 |
Prostate Cancer |
2021-01-19 |
|
|
| 3882 |
Imprinting Genes in Testicular Cancer |
2021-01-19 |
|
|
| 3883 |
Histone Modifications |
2021-01-19 |
|
|
| 3884 |
DNA Methylation |
2021-01-19 |
|
|
| 3885 |
Epigenetic Modification in Testicular Cancer |
2021-01-19 |
|
|
| 3886 |
Testicular Cancer |
2021-01-19 |
|
|
| 3887 |
Epigenetic Alterations in Tumors of the Endocrine System |
2021-01-19 |
|
|
| 3888 |
Histone Modifications and Carcinogenesis |
2021-01-19 |
|
|
| 3889 |
Carcinogenesis and DNA Methylation |
2021-01-19 |
|
|
| 3890 |
Liver Transplantation Types |
2021-01-19 |
|
|
| 3891 |
Study Purpose |
2021-01-19 |
|
|
| 3892 |
Exclusion Criteria |
2021-01-18 |
|
|
| 3893 |
Inclusion Criteria |
2021-01-18 |
|
|
| 3894 |
Contributions/Authorship |
2021-01-18 |
|
|
| 3895 |
Members |
2021-01-18 |
|
|
| 3896 |
Importance |
2021-01-18 |
|
|
| 3897 |
Realization 0f the Systematic Cadastre |
2021-01-12 |
|
|
| 3898 |
The Current Situation |
2021-01-12 |
|
|
| 3899 |
Significance of the Work |
2021-01-12 |
|
|
| 3900 |
Funds Received |
2021-01-11 |
|
|
| 3901 |
Contact |
2021-01-11 |
|
|
| 3902 |
Outstanding Masters/ Ph.D./ Post Doctorate thesis work Presentation in Mass Spectrometry Conference 2020 |
2021-01-11 |
|
|
| 3903 |
Best Poster Presentation in Mass Spectrometry Conference 2020 |
2021-01-11 |
|
|
| 3904 |
Best Keynote Speaker in Mass Spectrometry Conference 2020 |
2021-01-11 |
|
|
| 3905 |
Outstanding Speaker in Mass Spectrometry Conference 2020 |
2021-01-11 |
|
|
| 3906 |
List of Abbreviation/ Nomenclature |
2021-01-11 |
|
|
| 3907 |
Major Adverse Events that Could be Anticipated from a Sub-optimal Vaccine |
2021-01-11 |
|
|
| 3908 |
Criteria for a Successful Vaccine |
2021-01-11 |
|
|
| 3909 |
Vaccines |
2021-01-11 |
|
|
| 3910 |
Study Strengths and Limitations |
2021-01-09 |
|
|
| 3911 |
HIV Medication |
2021-01-09 |
|
|
| 3912 |
Methods and Findings |
2021-01-09 |
|
|
| 3913 |
Discussions and Conclusion |
2021-01-08 |
|
|
| 3914 |
Outcomes of Endotherapy: Unsettled Issues |
2021-01-08 |
|
|
| 3915 |
Potential Predictors of Successful Endotherapy |
2021-01-08 |
|
|
| 3916 |
Outcomes of Endotherapy: Facts |
2021-01-08 |
|
|
| 3917 |
Endoscopic Therapy in PD |
2021-01-08 |
|
|
| 3918 |
Which PD Patients Could Benefit from Endoscopic Therapy? |
2021-01-08 |
|
|
| 3919 |
Which Criteria Should We Use When Deciding Surgical Procedure? |
2021-01-08 |
|
|
| 3920 |
Surgical Options |
2021-01-08 |
|
|
| 3921 |
What is the Effet of Surgery on Quality of Life? |
2021-01-08 |
|
|
| 3922 |
What is Morbidity and Mortality? |
2021-01-08 |
|
|
| 3923 |
Should Endoscopic or Surgical Treatmen be Preferred? |
2021-01-08 |
|
|
| 3924 |
When To Consider Surgery? |
2021-01-08 |
|
|
| 3925 |
Intent To Treat |
2021-01-08 |
|
|
| 3926 |
Outcomes |
2021-01-08 |
|
|
| 3927 |
Inclusion and Exclusion Criteria |
2021-01-08 |
|
|
| 3928 |
Current Clinical Evidence |
2021-01-04 |
|
|
| 3929 |
Brain Bioavailability and Biodistribution After Nose-To Brain Delivery |
2021-01-04 |
|
|
| 3930 |
Novel Devices Not Yet Used in Clinical Trials |
2021-01-04 |
|
|
| 3931 |
Devices for Nose-To-Brain Delivery |
2021-01-04 |
|
|
| 3932 |
Overcoming Absorption Barriers |
2021-01-04 |
|
|
| 3933 |
Pathways for Nose-to-Brain Drug Delivery |
2021-01-04 |
|
|
| 3934 |
Arabic Medications in AA |
2021-01-04 |
|
|
| 3935 |
Topical Therapy |
2021-01-04 |
|
|
| 3936 |
Treatment of AA |
2021-01-04 |
|
|
| 3937 |
Bad Prognostic Findings in AA |
2021-01-04 |
|
|
| 3938 |
Progonstic Factors in AA Patients |
2021-01-04 |
|
|
| 3939 |
Psychosocial Impact of Alopecia Areata |
2021-01-04 |
|
|
| 3940 |
Famalial Incidene of Alopecia Areata |
2021-01-04 |
|
|
| 3941 |
Linear Alopcia Areata |
2021-01-04 |
|
|
| 3942 |
Theories Implicated in AA Phathogenisis |
2021-01-04 |
|
|
| 3943 |
Financial Support & Sponsorship |
2021-01-01 |
|
|
| 3944 |
Methodology and Findings |
2021-01-01 |
|
|
| 3945 |
Background and Justification |
2021-01-01 |
|
|
| 3946 |
Viral DM |
2021-01-01 |
|
|
| 3947 |
DM |
2021-01-01 |
|
|
| 3948 |
Satisfaction |
2021-01-01 |
|
|
| 3949 |
Two Types of Elements |
2021-01-01 |
|
|
| 3950 |
Effective Way to Stop or Kill Virus |
2021-01-01 |
|
|
| 3951 |
According to Virologist |
2021-01-01 |
|
|
| 3952 |
Aim of Research Work Plan |
2020-12-30 |
|
|
| 3953 |
Characteristics of Thermosetting Polymer |
2020-12-30 |
|
|
| 3954 |
Declaration of Interests |
2020-12-30 |
|
|
| 3955 |
Ethics Declarations |
2020-12-30 |
|
|
| 3956 |
Ways of Understanding Memory |
2020-12-30 |
|
|
| 3957 |
Long-term Memory |
2020-12-30 |
|
|
| 3958 |
Working Memory |
2020-12-30 |
|
|
| 3959 |
Short-term Memory |
2020-12-30 |
|
|
| 3960 |
Optimizing Energy Model |
2020-12-30 |
|
|
| 3961 |
Self-Optimization Model |
2020-12-30 |
|
|
| 3962 |
The Social Elements |
2020-12-30 |
|
|
| 3963 |
The Mental or Psychological Elements |
2020-12-30 |
|
|
| 3964 |
The Physical Elements |
2020-12-30 |
|
|
| 3965 |
Elements of Emotional Resilience |
2020-12-30 |
|
|
| 3966 |
How to Forestall Eye Infections |
2020-12-30 |
|
|
| 3967 |
Eye Infection Treatments |
2020-12-30 |
|
|
| 3968 |
Eye Infection Complications |
2020-12-30 |
|
|
| 3969 |
Causes and Kinds of Eye Infections |
2020-12-30 |
|
|
| 3970 |
Bronchitis Hindrance |
2020-12-30 |
|
|
| 3971 |
Diagnosing |
2020-12-30 |
|
|
| 3972 |
Types of Carcinoma |
2020-12-30 |
|
|
| 3973 |
Causes of Airway Obstruction |
2020-12-30 |
|
|
| 3974 |
Triggers |
2020-12-30 |
|
|
| 3975 |
Classifications |
2020-12-30 |
|
|
| 3976 |
Types |
2020-12-30 |
|
|
| 3977 |
Access to Safe Abortion Protects Women’s and Girls’ Health and Human Rights |
2020-12-30 |
|
|
| 3978 |
Justification and Consequences of My Position |
2020-12-30 |
|
|
| 3979 |
Doing Bo Harm,Promoting Patient Safety |
2020-12-30 |
|
|
| 3980 |
Virtual Ethics |
2020-12-30 |
|
|
| 3981 |
Kantian Deontology |
2020-12-30 |
|
|
| 3982 |
Professional Negligence |
2020-12-30 |
|
|
| 3983 |
2nd Position (From the Lens of Health Care Provider) |
2020-12-30 |
|
|
| 3984 |
1st Position (From the Lens of Family) |
2020-12-30 |
|
|
| 3985 |
Analysis of the Scenario |
2020-12-30 |
|
|
| 3986 |
Lego Medical Care Resources |
2020-12-30 |
|
|
| 3987 |
What if my Kid does not like Legos? |
2020-12-30 |
|
|
| 3988 |
Is Toy Medical Care Effective? |
2020-12-30 |
|
|
| 3989 |
How Toy Medical Care Works |
2020-12-30 |
|
|
| 3990 |
Why Toy Medical Care was Created |
2020-12-30 |
|
|
| 3991 |
How to find a Behavioral Therapist |
2020-12-30 |
|
|
| 3992 |
Types of Behavioral Therapy |
2020-12-30 |
|
|
| 3993 |
Pharmacological Interventions |
2020-12-30 |
|
|
| 3994 |
Non-Pharmacological Interventions |
2020-12-30 |
|
|
| 3995 |
PDD and PDD-NOS |
2020-12-30 |
|
|
| 3996 |
Epidemic of Weight Gain During Covid 19 Lockdowns |
2020-12-30 |
|
|
| 3997 |
One Case History of A Post Covid Syndrome |
2020-12-30 |
|
|
| 3998 |
The Genesis of Post-Covid Syndrome |
2020-12-30 |
|
|
| 3999 |
Side Effects of Lupus Nephritis |
2020-12-30 |
|
|
| 4000 |
Preventive Measures |
2020-12-30 |
|
|
| 4001 |
Market Report |
2020-12-30 |
|
|
| 4002 |
Why attend? |
2020-12-30 |
|
|
| 4003 |
Best Poster Presentation in Plant Biology 2020 |
2020-12-30 |
|
|
| 4004 |
Women Scientist (The Women of Science Award) |
2020-12-30 |
|
|
| 4005 |
Professional Level (The Research Contribution Award) |
2020-12-30 |
|
|
| 4006 |
Research on HIV |
2020-12-30 |
|
|
| 4007 |
HIV Genome Replication |
2020-12-30 |
|
|
| 4008 |
Novel Approach |
2020-12-30 |
|
|
| 4009 |
The Ethical Complexity of Rcts in Pregnancy |
2020-12-29 |
|
|
| 4010 |
Person's Challenge Trial |
2020-12-29 |
|
|
| 4011 |
Human Challenge Trial |
2020-12-29 |
|
|
| 4012 |
Availability of Data |
2020-12-29 |
|
|
| 4013 |
Strength of Study |
2020-12-29 |
|
|
| 4014 |
Data Quality Control |
2020-12-29 |
|
|
| 4015 |
Sampling technique |
2020-12-29 |
|
|
| 4016 |
Sample Size Determination |
2020-12-29 |
|
|
| 4017 |
Highlights of the Conference |
2020-12-29 |
|
|
| 4018 |
Nonclinical Considerations |
2020-12-29 |
|
|
| 4019 |
Quality/Cmc Considerations |
2020-12-29 |
|
|
| 4020 |
Humoral and Cellular Immunity |
2020-12-29 |
|
|
| 4021 |
Antigen Presentation |
2020-12-29 |
|
|
| 4022 |
Authors Statement of Consent |
2020-12-29 |
|
|
| 4023 |
Social Connections |
2020-12-29 |
|
|
| 4024 |
Journal Topics |
2020-12-29 |
|
|
| 4025 |
About the Journal |
2020-12-29 |
|
|
| 4026 |
Renal Stones |
2020-12-28 |
|
|
| 4027 |
Danger Factors |
2020-12-28 |
|
|
| 4028 |
Haematuria |
2020-12-28 |
|
|
| 4029 |
Nephron Composition |
2020-12-28 |
|
|
| 4030 |
Characterizations |
2020-12-26 |
|
|
| 4031 |
Major Challenges and Future Prospects |
2020-12-26 |
|
|
| 4032 |
Biodegradation as a Panacea to Pome Pollution |
2020-12-26 |
|
|
| 4033 |
Environmental Potentials of Pome Pollution |
2020-12-26 |
|
|
| 4034 |
Various Means of Remediating Pome |
2020-12-26 |
|
|
| 4035 |
Prevalence of Pome |
2020-12-26 |
|
|
| 4036 |
Results and Disussion |
2020-12-26 |
|
|
| 4037 |
Supplement |
2020-12-24 |
|
|
| 4038 |
Signs |
2020-12-24 |
|
|
| 4039 |
Cause |
2020-12-24 |
|
|
| 4040 |
Medical Uses |
2020-12-24 |
|
|
| 4041 |
Exposure Variables |
2020-12-24 |
|
|
| 4042 |
Clinical Background |
2020-12-24 |
|
|
| 4043 |
Preventing HIV |
2020-12-23 |
|
|
| 4044 |
Treatments and Follow-Up |
2020-12-22 |
|
|
| 4045 |
Clinical Presentations of Late-Onset Complications Related to Local Silicone Injections |
2020-12-22 |
|
|
| 4046 |
Autoimmune/Inflammatory Syndrome Induced by Adjuvants Related to Local Silicone Injections |
2020-12-22 |
|
|
| 4047 |
Microscopic Analyses |
2020-12-22 |
|
|
| 4048 |
Dermal Fillers and the Role of Silicone as an Adjuvant |
2020-12-22 |
|
|
| 4049 |
Abbreviations List |
2020-12-22 |
|
|
| 4050 |
Toxicity |
2020-12-22 |
|
|
| 4051 |
Methods and Patients |
2020-12-18 |
|
|
| 4052 |
Outcomes Measures |
2020-12-18 |
|
|
| 4053 |
Background and Need of the Study |
2020-12-18 |
|
|
| 4054 |
Long-Term Results |
2020-12-17 |
|
|
| 4055 |
Advances in Technique |
2020-12-17 |
|
|
| 4056 |
Aids |
2020-12-16 |
|
|
| 4057 |
Therapy for Hiv Prevention in Animal Models |
2020-12-16 |
|
|
| 4058 |
Hiv-1 Infection of Nonhuman Primates or Humanized Mice |
2020-12-16 |
|
|
| 4059 |
Animal Models for Sars-Cov-2 Research |
2020-12-16 |
|
|
| 4060 |
Cell Lines and Organoids for Sars-Cov-2 Research |
2020-12-16 |
|
|
| 4061 |
3rd World Congress on Antiviral Drug Discovery and Development Awards |
2020-12-16 |
|
|
| 4062 |
10th World Congress on Antiviral Drug Development |
2020-12-16 |
|
|
| 4063 |
New Strategies In The Treatment Of Arthritis |
2020-12-16 |
|
|
| 4064 |
Spondyloarthropathies (Spa) |
2020-12-16 |
|
|
| 4065 |
Rheumatoid Arthritis (Ra) |
2020-12-16 |
|
|
| 4066 |
Arthritis |
2020-12-16 |
|
|
| 4067 |
Complications of Systemic Diseases |
2020-12-16 |
|
|
| 4068 |
Associated Medicines |
2020-12-16 |
|
|
| 4069 |
Distribution and Articular Size |
2020-12-16 |
|
|
| 4070 |
Duration |
2020-12-16 |
|
|
| 4071 |
Business Awards |
2020-12-16 |
|
|
| 4072 |
General Objectives |
2020-12-15 |
|
|
| 4073 |
Gains and Obstacles |
2020-12-15 |
|
|
| 4074 |
Field of Action-Health |
2020-12-15 |
|
|
| 4075 |
How Might Our Research 'Add Value' To the Subject ? |
2020-12-15 |
|
|
| 4076 |
Concept |
2020-12-15 |
|
|
| 4077 |
Completing Interests |
2020-12-15 |
|
|
| 4078 |
Availiability of Data and Material |
2020-12-15 |
|
|
| 4079 |
Clinical Trials of Radiotherapy for COVID-19 Pneumonia |
2020-12-15 |
|
|
| 4080 |
Rational and Justification for the Use of Low-Dose Radiotherapy for COVID-19 Pneumonia |
2020-12-15 |
|
|
| 4081 |
Cardio-HART™ (a.k.a. “CHART”) is Cardiac-Telemedicine™ |
2020-12-14 |
|
|
| 4082 |
Post-Pandemic Cardiac-Telemedicine™ |
2020-12-14 |
|
|
| 4083 |
Post-Pandemic Cardiac-Telemedicineâ?¢ |
2020-12-14 |
|
|
| 4084 |
Post-Pandemic Cardiac-Telemedicineâ?¢ |
2020-12-14 |
|
|
| 4085 |
Post-Pandemic Cardiac-Telemedicineâ?¢ |
2020-12-14 |
|
|
| 4086 |
Post-Pandemic Cardiac-Telemedicineâ?¢ |
2020-12-14 |
|
|
| 4087 |
CE-Mark approved, just in time for the 2nd wave |
2020-12-14 |
|
|
| 4088 |
CE-Mark approved, just in time for the 2nd wave |
2020-12-14 |
|
|
| 4089 |
Sequencing Analysis |
2020-12-14 |
|
|
| 4090 |
Causes and Symptoms |
2020-12-14 |
|
|
| 4091 |
Causes of Transmission |
2020-12-14 |
|
|
| 4092 |
Worldwide Analysis |
2020-12-14 |
|
|
| 4093 |
Naturopathic Medicine |
2020-12-14 |
|
|
| 4094 |
Discussion on Pre intervention assessment findings |
2020-12-13 |
|
|
| 4095 |
A Community Based Cross-Methods and Materials |
2020-12-12 |
|
|
| 4096 |
Case 3 |
2020-12-11 |
|
|
| 4097 |
Histopathology of Dress Syndrome |
2020-12-11 |
|
|
| 4098 |
Viral Reactivation |
2020-12-11 |
|
|
| 4099 |
Genetic Factors |
2020-12-11 |
|
|
| 4100 |
Culprit Drugs |
2020-12-11 |
|
|
| 4101 |
Dress Syndrome Pathogenesis |
2020-12-11 |
|
|
| 4102 |
Skin Involvement in Dress Syndrome |
2020-12-11 |
|
|
| 4103 |
Diagnostic Criteria |
2020-12-11 |
|
|
| 4104 |
Data Avaliability Statement |
2020-12-10 |
|
|
| 4105 |
Conferences Highlights |
2020-12-10 |
|
|
| 4106 |
Socio-Economic Impacts of Hydatidosis/Cystic Echinococcosis |
2020-12-09 |
|
|
| 4107 |
Prevalence of Hydatidosis/Cystic Echinococcosis in Ethiopia |
2020-12-09 |
|
|
| 4108 |
Herd Immunity |
2020-12-09 |
|
|
| 4109 |
Diagnostic Techniques |
2020-12-09 |
|
|
| 4110 |
Clinical Symptoms |
2020-12-09 |
|
|
| 4111 |
Viral Structure and it's Bindings |
2020-12-09 |
|
|
| 4112 |
Epidemology |
2020-12-09 |
|
|
| 4113 |
Data Extraction |
2020-12-09 |
|
|
| 4114 |
Antibodies |
2020-12-09 |
|
|
| 4115 |
Prevention and Control of the Disease |
2020-12-09 |
|
|
| 4116 |
Risk Factors for the Occurrence and Spread of Middle East Respiratory Syndrome-Coronavirus |
2020-12-09 |
|
|
| 4117 |
Spatio Temporal Distributions and Spread of the Diseases |
2020-12-09 |
|
|
| 4118 |
Occurences of Middle East Respiratory Syndrome–Coronaviruses in Camel |
2020-12-09 |
|
|
| 4119 |
Etiology of Middle East Respiratory Syndrome Corona Virus |
2020-12-09 |
|
|
| 4120 |
Disadvantages |
2020-12-09 |
|
|
| 4121 |
Radio Protective Effects |
2020-12-08 |
|
|
| 4122 |
Bronchodilator Activity |
2020-12-08 |
|
|
| 4123 |
Immunomodulatory Activity |
2020-12-08 |
|
|
| 4124 |
Anti-Inflammatory Activity |
2020-12-08 |
|
|
| 4125 |
Anti-Oxidant and Radio-Protective Activity |
2020-12-08 |
|
|
| 4126 |
Anti-Helmintic Activity |
2020-12-08 |
|
|
| 4127 |
Anti-Virals |
2020-12-08 |
|
|
| 4128 |
Anti-Ulcer Activity |
2020-12-08 |
|
|
| 4129 |
Anti-Cancer Effect |
2020-12-08 |
|
|
| 4130 |
Anti-Microbials |
2020-12-08 |
|
|
| 4131 |
Anti-Oxidants |
2020-12-08 |
|
|
| 4132 |
Code Availability |
2020-12-08 |
|
|
| 4133 |
Conclusions and Future Work |
2020-12-08 |
|
|
| 4134 |
Conflict Of Interests |
2020-12-08 |
|
|
| 4135 |
Prevention/Protection |
2020-12-08 |
|
|
| 4136 |
Diagnosis of COVID-19 |
2020-12-08 |
|
|
| 4137 |
Statical Analysis |
2020-12-02 |
|
|
| 4138 |
Patients and Methods of Study |
2020-12-02 |
|
|
| 4139 |
Blood Bank with Apheresis and CBSU facility |
2020-12-01 |
|
|
| 4140 |
Author's Prespective |
2020-12-01 |
|
|
| 4141 |
Public and Private Blood Bank |
2020-12-01 |
|
|
| 4142 |
Blood Storage Units Facility |
2020-12-01 |
|
|
| 4143 |
Anaesthesia Congress scheduled on April 13-14, 2020 at London, UK |
2020-12-01 |
|
|
| 4144 |
Blood Bank with Population Study |
2020-12-01 |
|
|
| 4145 |
Blood Bank Distribution |
2020-12-01 |
|
|
| 4146 |
Working Definition |
2020-11-30 |
|
|
| 4147 |
Responsibilities |
2020-11-30 |
|
|
| 4148 |
Veterinary Pharmacovigilance |
2020-11-30 |
|
|
| 4149 |
Adverse Drug Reactions |
2020-11-30 |
|
|
| 4150 |
Over View |
2020-11-30 |
|
|
| 4151 |
Study Type and Objectives |
2020-11-30 |
|
|
| 4152 |
Ethics Review |
2020-11-30 |
|
|
| 4153 |
Trial Status |
2020-11-28 |
|
|
| 4154 |
Methods/Design |
2020-11-28 |
|
|
| 4155 |
Assessing Progress, Measuring Improvement and Determining Benefit |
2020-11-28 |
|
|
| 4156 |
Developing and Deploying an Effective CAGT Curriculum |
2020-11-28 |
|
|
| 4157 |
Key CAGT Training Concepts That Address Organizational Needs |
2020-11-28 |
|
|
| 4158 |
Educational Empowerment: Operational Delivery Teams, Sponsors and Sites |
2020-11-28 |
|
|
| 4159 |
Sources |
2020-11-28 |
|
|
| 4160 |
Personalized Medicine and Response to Novel Infectious Agents, Including COVID-19 |
2020-11-28 |
|
|
| 4161 |
Concerns about an Individual Approach to Vaccination |
2020-11-28 |
|
|
| 4162 |
Influenza as a Model for Population Based Infectious Disease Control |
2020-11-28 |
|
|
| 4163 |
Understanding the Variables Contributing to Altered Vaccination in Infectious Disease |
2020-11-28 |
|
|
| 4164 |
Major Types of Adjuvants |
2020-11-28 |
|
|
| 4165 |
Why GBS Vaccine in Urgently Needed |
2020-11-28 |
|
|
| 4166 |
Dangers of IAP |
2020-11-28 |
|
|
| 4167 |
Factors Associated With GBS Colonization during Pregnancy |
2020-11-28 |
|
|
| 4168 |
Global Prevalence of GBS Colonization among Pregnant Women |
2020-11-28 |
|
|
| 4169 |
Support |
2020-11-28 |
|
|
| 4170 |
Definition of Terms |
2020-11-27 |
|
|
| 4171 |
Prevention at Individual Level |
2020-11-27 |
|
|
| 4172 |
Advice for the Public |
2020-11-27 |
|
|
| 4173 |
Preventive, Public Health Measures and Control |
2020-11-27 |
|
|
| 4174 |
Factors Responsible for the Wide Spread of nCoV-19 |
2020-11-27 |
|
|
| 4175 |
WWF - Pakistan Launches Project to tackle Plastic Pollution |
2020-11-27 |
|
|
| 4176 |
Problems of Plastic Pollution |
2020-11-27 |
|
|
| 4177 |
Problems and Causes of Plastic Pollution |
2020-11-27 |
|
|
| 4178 |
My Position and Its Justification |
2020-11-26 |
|
|
| 4179 |
Islamic Perspective |
2020-11-26 |
|
|
| 4180 |
Global Perspective |
2020-11-26 |
|
|
| 4181 |
Right Based and Duty Based Ethics versus Paternalism |
2020-11-26 |
|
|
| 4182 |
Non-Maleficence versus Consequentialism |
2020-11-26 |
|
|
| 4183 |
Case Analysis |
2020-11-26 |
|
|
| 4184 |
Possible Reasons for Decision |
2020-11-26 |
|
|
| 4185 |
Regional Anesthesia |
2020-11-26 |
|
|
| 4186 |
Gabapentinoids |
2020-11-26 |
|
|
| 4187 |
Opioids |
2020-11-26 |
|
|
| 4188 |
Non-Steroidal Anti-Inflammatory Drugs (Nsaids) |
2020-11-26 |
|
|
| 4189 |
Acetaminophen |
2020-11-26 |
|
|
| 4190 |
Management During Pregnancy |
2020-11-26 |
|
|
| 4191 |
Consequences of Pain During Pregnancy |
2020-11-26 |
|
|
| 4192 |
Neuropathic Pain |
2020-11-26 |
|
|
| 4193 |
Pregnancy-Related Causes |
2020-11-26 |
|
|
| 4194 |
Guidelines for Young Researchers Forum |
2020-11-26 |
|
|
| 4195 |
Importance and Scope |
2020-11-26 |
|
|
| 4196 |
Learning Points |
2020-11-25 |
|
|
| 4197 |
Author's Contribution |
2020-11-25 |
|
|
| 4198 |
Authors Contribution Vailability Of Data And Materials |
2020-11-24 |
|
|
| 4199 |
Authorâ??s Contribution Vailability Of Data And Materials |
2020-11-24 |
|
|
| 4200 |
Image |
2020-11-24 |
|
|
| 4201 |
Conclusion and Future Directions |
2020-11-24 |
|
|
| 4202 |
Global Stability |
2020-11-24 |
|
|
| 4203 |
Financial Support and Sponsorship |
2020-11-24 |
|
|
| 4204 |
Frequency Distribution of Comorbidities in Studied Patients |
2020-11-24 |
|
|
| 4205 |
Material and Method |
2020-11-24 |
|
|
| 4206 |
Contributor Statement |
2020-11-23 |
|
|
| 4207 |
Innate Immune Enhancement with HSNIG |
2020-11-23 |
|
|
| 4208 |
Statement of Human Rights |
2020-11-23 |
|
|
| 4209 |
As A Critical View On The Trans Generational Inheritance Model In Humans Through Epigenetic Changes In Gametes |
2020-11-23 |
|
|
| 4210 |
As An Adult Disease Onset Model |
2020-11-23 |
|
|
| 4211 |
Expansion Of The Insulin Scenario For Learning And Memory To Other Animals |
2020-11-23 |
|
|
| 4212 |
MIPs For Memory Recall In Snail |
2020-11-23 |
|
|
| 4213 |
Insulin Resistance In Pancreatic A-Cells |
2020-11-23 |
|
|
| 4214 |
Insulin Resistance In Pancreatic Α-Cells |
2020-11-23 |
|
|
| 4215 |
Regulation Of Glucagon Secretion By Islet Hormones |
2020-11-23 |
|
|
| 4216 |
Introductionto C8H11NO2 |
2020-11-21 |
|
|
| 4217 |
Osteoporosis |
2020-11-21 |
|
|
| 4218 |
Footnotes |
2020-11-21 |
|
|
| 4219 |
Trail Redistration |
2020-11-21 |
|
|
| 4220 |
Hashimoto's Thyroiditis Disease |
2020-11-21 |
|
|
| 4221 |
Hashimoto’s Thyroiditis Disease |
2020-11-21 |
|
|
| 4222 |
Case History and Detail |
2020-11-20 |
|
|
| 4223 |
Abbreviation List |
2020-11-20 |
|
|
| 4224 |
Bullet Point Highlights |
2020-11-20 |
|
|
| 4225 |
Data and Materials Availability |
2020-11-20 |
|
|
| 4226 |
Ethical Approval for Human |
2020-11-20 |
|
|
| 4227 |
Limitation and Future Direction |
2020-11-19 |
|
|
| 4228 |
Clinical Report |
2020-11-19 |
|
|
| 4229 |
Acknowledgments and Disclosure Statements |
2020-11-19 |
|
|
| 4230 |
Treatment and Management |
2020-11-19 |
|
|
| 4231 |
Pathophisiology |
2020-11-19 |
|
|
| 4232 |
Occurance and Epidemiology |
2020-11-19 |
|
|
| 4233 |
Subjects, Materials and Methods |
2020-11-19 |
|
|
| 4234 |
Method of Registration |
2020-11-19 |
|
|
| 4235 |
Non-Pharmacological Theraphy |
2020-11-19 |
|
|
| 4236 |
Aim/Objectives |
2020-11-19 |
|
|
| 4237 |
Brief Introduction to the Konso |
2020-11-19 |
|
|
| 4238 |
Sarhul Ritual Subsumed |
2020-11-19 |
|
|
| 4239 |
The Ritual Space - sarna sthals (The Sacred Groves): An Enactment Of Symbolic Capital |
2020-11-19 |
|
|
| 4240 |
Sarhul Ritual as Memory and Belonging |
2020-11-19 |
|
|
| 4241 |
Sarhul Festival |
2020-11-19 |
|
|
| 4242 |
Traditional Leaders’ Interface with Municipal Councilors in Zimbabwe |
2020-11-19 |
|
|
| 4243 |
Governance and Institution of Traditional Leadership in Uganda |
2020-11-19 |
|
|
| 4244 |
Governance and Institution of Traditional Leadership in Namibia |
2020-11-19 |
|
|
| 4245 |
Governance and Institution of Traditional Leadership in Kenya |
2020-11-19 |
|
|
| 4246 |
Governance and Institution of Traditional Leadership in Ghana |
2020-11-19 |
|
|
| 4247 |
Traditional Leaders and Municipal Council in the Case Of Botswana |
2020-11-19 |
|
|
| 4248 |
Roles of Traditional Leaders in the New the New Democracy |
2020-11-19 |
|
|
| 4249 |
Legislation Governing Traditional Leaders in South Africa |
2020-11-19 |
|
|
| 4250 |
Background and History of Traditional Leaders During Colonization and Apartheid in South Africa |
2020-11-19 |
|
|
| 4251 |
Human Role |
2020-11-18 |
|
|
| 4252 |
Restricted Autonomy |
2020-11-18 |
|
|
| 4253 |
Responsibility |
2020-11-18 |
|
|
| 4254 |
Explain Ability |
2020-11-18 |
|
|
| 4255 |
Reliability |
2020-11-18 |
|
|
| 4256 |
Prudence |
2020-11-18 |
|
|
| 4257 |
Deep Artificial Intelligence (IAp) Codes and Algorithms for Automatic Programming of your Own Program |
2020-11-18 |
|
|
| 4258 |
Endocrine Oncology |
2020-11-18 |
|
|
| 4259 |
About Special Issue |
2020-11-18 |
|
|
| 4260 |
Cushing's Disease |
2020-11-18 |
|
|
| 4261 |
Remdesivir |
2020-11-18 |
|
|
| 4262 |
Other Adjunct Therapies |
2020-11-17 |
|
|
| 4263 |
Varenicline |
2020-11-17 |
|
|
| 4264 |
Counseling and Nicotine Replacement Therapy |
2020-11-17 |
|
|
| 4265 |
Antimalarial Drugs |
2020-11-16 |
|
|
| 4266 |
Lopinavir/Ritonavir |
2020-11-16 |
|
|
| 4267 |
Antiviral Drugs |
2020-11-16 |
|
|
| 4268 |
Properties of Edible Oil |
2020-11-13 |
|
|
| 4269 |
Material Needed |
2020-11-13 |
|
|
| 4270 |
Cooling Effectivity Assessment |
2020-11-13 |
|
|
| 4271 |
Innovative Sen Methods |
2020-11-13 |
|
|
| 4272 |
Artificial Neural Networks |
2020-11-13 |
|
|
| 4273 |
The Role of Biotechnology |
2020-11-13 |
|
|
| 4274 |
Targets for Biomass Manipulation |
2020-11-13 |
|
|
| 4275 |
Conclusions and Outlook |
2020-11-13 |
|
|
| 4276 |
Towards A National Bioeconomy Strategy |
2020-11-13 |
|
|
| 4277 |
Bioinitiatives in Colombia |
2020-11-13 |
|
|
| 4278 |
Transition towards Bioeconomy |
2020-11-13 |
|
|
| 4279 |
New Bio-Based Strategies, Increased Sustainability |
2020-11-13 |
|
|
| 4280 |
Accelerated Aging Tests |
2020-11-13 |
|
|
| 4281 |
Aging Characterization |
2020-11-13 |
|
|
| 4282 |
Materials Tested and Corresponding CSP Plants |
2020-11-13 |
|
|
| 4283 |
Approaches and Methodology |
2020-11-13 |
|
|
| 4284 |
Theory |
2020-11-13 |
|
|
| 4285 |
Cooperation between GCC Countries and Europe |
2020-11-13 |
|
|
| 4286 |
Renewable Energy Developments in Europe |
2020-11-13 |
|
|
| 4287 |
Challenges to Renewable Energy Community in GCC Countries |
2020-11-13 |
|
|
| 4288 |
Legal Structures for Energy Communities in GCC Countries and Iran |
2020-11-13 |
|
|
| 4289 |
Usage Scenario in Other Major German Cities |
2020-11-13 |
|
|
| 4290 |
Further Improvements |
2020-11-13 |
|
|
| 4291 |
Impact in Berlin |
2020-11-13 |
|
|
| 4292 |
Calculations for Energy Generation |
2020-11-13 |
|
|
| 4293 |
Infrastructure - Concept and Design |
2020-11-13 |
|
|
| 4294 |
Pointingonthetechnicalopportunities of Solar Energy Generation |
2020-11-13 |
|
|
| 4295 |
Emphasising the Implementation of Renewable Resourses Primarily With Solar Energy Application |
2020-11-13 |
|
|
| 4296 |
Considering the Transition between Centralized and Decentralised Energy Generations |
2020-11-13 |
|
|
| 4297 |
Comprising the Political Theories on the Nexus between Market and Energy Affairs |
2020-11-13 |
|
|
| 4298 |
Antitumor Function Of NK Cells |
2020-11-13 |
|
|
| 4299 |
Ccl2-Ccr2 Axis Inhibition For Treatment Of Cancer |
2020-11-13 |
|
|
| 4300 |
Anticancer Therapy By Propagermanium |
2020-11-13 |
|
|
| 4301 |
Propagermanium-Induced Nk Cell Activation |
2020-11-13 |
|
|
| 4302 |
Chemical And Pharmacological Properties Of Propagermanium |
2020-11-13 |
|
|
| 4303 |
Nickel And The Brain |
2020-11-13 |
|
|
| 4304 |
Arsenic And The Brain |
2020-11-13 |
|
|
| 4305 |
Cadmium And The Brain |
2020-11-13 |
|
|
| 4306 |
Chromium Toxicity To The Brain |
2020-11-13 |
|
|
| 4307 |
Gene Polymorphisms And DNA Methylation In Gastric Cancer |
2020-11-13 |
|
|
| 4308 |
DNA Methylation as a Biomarker In Gastric Cancer Predication And Disease Progression |
2020-11-13 |
|
|
| 4309 |
H. Pylori- Induced DNA Methylation in Gastric Cancer |
2020-11-13 |
|
|
| 4310 |
H. pylori Virulent Factors And Gastric Cancer |
2020-11-13 |
|
|
| 4311 |
In Vivo Studies Of Salivary Gland Regeneration |
2020-11-11 |
|
|
| 4312 |
KAMPO Treatment For Xerostomia |
2020-11-11 |
|
|
| 4313 |
Xerostomia Leads To Candidiasis |
2020-11-11 |
|
|
| 4314 |
Salivary Glands In Humans |
2020-11-11 |
|
|
| 4315 |
From Prevention To Treatment |
2020-11-11 |
|
|
| 4316 |
Therapeutic Mechanisms Of CBSCs |
2020-11-11 |
|
|
| 4317 |
Treatment Of Hie With Autologous CBSCS |
2020-11-11 |
|
|
| 4318 |
Risks and Complications |
2020-11-10 |
|
|
| 4319 |
Useful Preventive Herbal Medicines |
2020-11-10 |
|
|
| 4320 |
Ayurvedic Treatment |
2020-11-10 |
|
|
| 4321 |
Pandemic Diseases in Ayurveda |
2020-11-10 |
|
|
| 4322 |
COVID-19 Era and Challenges in Uro-Oncology |
2020-11-10 |
|
|
| 4323 |
Tackling the Risk of Patients Contracting COVID-19 during Hospital Stay |
2020-11-10 |
|
|
| 4324 |
Major Agricultural Industries in Worldwide |
2020-11-09 |
|
|
| 4325 |
Editoral |
2020-11-09 |
|
|
| 4326 |
Energy Transfer from Phycobiliproteins to Ps Ii In Cryptophytes Algae |
2020-11-09 |
|
|
| 4327 |
Energy Transfer from Pbs To Ps I |
2020-11-09 |
|
|
| 4328 |
Energy Transfer from Pbs To Ps Ii |
2020-11-09 |
|
|
| 4329 |
Can Good Nutrition Enhance Immunity? |
2020-11-09 |
|
|
| 4330 |
Other Factors That May Affect Nutrition |
2020-11-09 |
|
|
| 4331 |
Likely Interventions Required |
2020-11-09 |
|
|
| 4332 |
Occurrence of Malnutrition |
2020-11-09 |
|
|
| 4333 |
Association of Income Loss and Food Intake |
2020-11-09 |
|
|
| 4334 |
Relationship between Income and Food Intake |
2020-11-09 |
|
|
| 4335 |
Symptoms and Complications |
2020-11-06 |
|
|
| 4336 |
Treatment of Emotional Aspects |
2020-11-06 |
|
|
| 4337 |
Natural Remedies |
2020-11-06 |
|
|
| 4338 |
Menopause and Effects |
2020-11-06 |
|
|
| 4339 |
Ethical Standards |
2020-11-05 |
|
|
| 4340 |
Physical Examination |
2020-11-04 |
|
|
| 4341 |
Methodology and Methods |
2020-11-04 |
|
|
| 4342 |
Conservative Mangement |
2020-11-03 |
|
|
| 4343 |
Impacts of Oophorectomy |
2020-11-03 |
|
|
| 4344 |
Current Management |
2020-11-03 |
|
|
| 4345 |
Investigations and Imaging |
2020-11-03 |
|
|
| 4346 |
Clinical Representation |
2020-11-03 |
|
|
| 4347 |
Epidemiology and Risk Factors |
2020-11-03 |
|
|
| 4348 |
Biography |
2020-11-03 |
|
|
| 4349 |
Past Conference Report Petro Chemistry 2020 |
2020-11-03 |
|
|
| 4350 |
A Glimpse at Nicotinamide Riboside (NR) |
2020-11-03 |
|
|
| 4351 |
Nicotinamide Mononucleotide or Nicotinamide Riboside: Which One is Better? |
2020-11-03 |
|
|
| 4352 |
Natural Prevention of Glaucoma |
2020-10-31 |
|
|
| 4353 |
Natural Remedies for Glaucoma |
2020-10-31 |
|
|
| 4354 |
Diagnosis and Treatment |
2020-10-31 |
|
|
| 4355 |
Wet vs. Dry Macular Degeneration |
2020-10-31 |
|
|
| 4356 |
Penetrating Eye Injury |
2020-10-31 |
|
|
| 4357 |
Hyphaema |
2020-10-31 |
|
|
| 4358 |
Blunt Trauma |
2020-10-31 |
|
|
| 4359 |
Glaucoma Diagnosis |
2020-10-31 |
|
|
| 4360 |
Proposed Framework |
2020-10-31 |
|
|
| 4361 |
Nanotechnology in Medical Imaging |
2020-10-31 |
|
|
| 4362 |
Financial/Grant Support |
2020-10-30 |
|
|
| 4363 |
Proprietorship |
2020-10-30 |
|
|
| 4364 |
Global Burden of infectious Diseases |
2020-10-30 |
|
|
| 4365 |
Thromboembolism |
2020-10-29 |
|
|
| 4366 |
Conclusion: The Benefit of Carrageenans |
2020-10-29 |
|
|
| 4367 |
How to Use Carrageenan in Spray |
2020-10-29 |
|
|
| 4368 |
Therapeutic Proposal for the Child Population, In Order to Cut the Chain of Contagion |
2020-10-29 |
|
|
| 4369 |
Forms of Contagion |
2020-10-29 |
|
|
| 4370 |
COVID-19 and Saliva |
2020-10-29 |
|
|
| 4371 |
Patient Update |
2020-10-29 |
|
|
| 4372 |
Lymphoma |
2020-10-29 |
|
|
| 4373 |
Erythrocytosis |
2020-10-29 |
|
|
| 4374 |
Adenocarcinoma |
2020-10-29 |
|
|
| 4375 |
Hemostasis and Coagulation |
2020-10-29 |
|
|
| 4376 |
Bone Mineral Density Test |
2020-10-28 |
|
|
| 4377 |
Bardiet-Biedl Syndrome |
2020-10-28 |
|
|
| 4378 |
Syndromic Retinis Pigmentosa |
2020-10-28 |
|
|
| 4379 |
Factors Affecting the Retinitis Pigmentosa |
2020-10-28 |
|
|
| 4380 |
Causes of RP |
2020-10-28 |
|
|
| 4381 |
Prevalence |
2020-10-28 |
|
|
| 4382 |
Reserach Methodology |
2020-10-27 |
|
|
| 4383 |
Conflicts |
2020-10-27 |
|
|
| 4384 |
Prespective |
2020-10-27 |
|
|
| 4385 |
Drug-Drug Interactions |
2020-10-26 |
|
|
| 4386 |
Medication Evaluated in Clinical Trials |
2020-10-26 |
|
|
| 4387 |
Observations and Results |
2020-10-26 |
|
|
| 4388 |
Community Participation Framework Ledder |
2020-10-22 |
|
|
| 4389 |
Community Participation Framework as a Tool to Explain Stigma in Nursing |
2020-10-22 |
|
|
| 4390 |
The Antecedent of Nursing Image |
2020-10-22 |
|
|
| 4391 |
Rogers Used a Model to Understand Public Perception |
2020-10-22 |
|
|
| 4392 |
Historical Perspective |
2020-10-22 |
|
|
| 4393 |
Risk Fact |
2020-10-22 |
|
|
| 4394 |
Medical Treatment |
2020-10-22 |
|
|
| 4395 |
From the Lens of Family |
2020-10-22 |
|
|
| 4396 |
From the Lens of Patient |
2020-10-22 |
|
|
| 4397 |
From the Lens of Health Care Provider |
2020-10-22 |
|
|
| 4398 |
Assumptions of Ethical Dilemma |
2020-10-22 |
|
|
| 4399 |
Bioethical Implications |
2020-10-22 |
|
|
| 4400 |
Spanish Flu and Covid-19: Historical Considerations |
2020-10-22 |
|
|
| 4401 |
From the Lens of a Healthcare Provider |
2020-10-22 |
|
|
| 4402 |
From the Lens of the Organization |
2020-10-22 |
|
|
| 4403 |
Analysis of Ethical Dilemma |
2020-10-22 |
|
|
| 4404 |
Reflection on Contemporary Issues of Developing Countries |
2020-10-22 |
|
|
| 4405 |
Introduction and Background |
2020-10-22 |
|
|
| 4406 |
Aims and Methods |
2020-10-22 |
|
|
| 4407 |
Conclusion and Future Prospects |
2020-10-22 |
|
|
| 4408 |
COVID Era and Challenges in Uro-Oncology |
2020-10-21 |
|
|
| 4409 |
Risk Stratification |
2020-10-21 |
|
|
| 4410 |
Tackling Risk of Patient Contracting COVID in Hospital Stay |
2020-10-21 |
|
|
| 4411 |
Patient Isolation |
2020-10-21 |
|
|
| 4412 |
Different Classifications Used for Severity and Nature of Ureterocele |
2020-10-21 |
|
|
| 4413 |
Discussions and Literature Review |
2020-10-21 |
|
|
| 4414 |
Important Points to Follow in Indian Scenario to Prevent COVID-19 Infection |
2020-10-21 |
|
|
| 4415 |
Possible Therapeutic Targets |
2020-10-21 |
|
|
| 4416 |
Clinical Management |
2020-10-21 |
|
|
| 4417 |
Virology |
2020-10-21 |
|
|
| 4418 |
Origin of Covid-19 |
2020-10-21 |
|
|
| 4419 |
Therapeutic Role of Phytochemicals |
2020-10-21 |
|
|
| 4420 |
Lineage Relationship Between Ly6cHi Classical Monocytes And Ly6cLo Non-Classical Monocytes |
2020-10-20 |
|
|
| 4421 |
Immune System Mitigation Of Perinatal Liver Inflammation |
2020-10-20 |
|
|
| 4422 |
Case Summary |
2020-10-20 |
|
|
| 4423 |
Bioassays |
2020-10-20 |
|
|
| 4424 |
Results of Findings |
2020-10-20 |
|
|
| 4425 |
Soft Computing (Sc) |
2020-10-20 |
|
|
| 4426 |
Conflicts of Interest Disclosure |
2020-10-20 |
|
|
| 4427 |
Statistical Methods |
2020-10-19 |
|
|
| 4428 |
Conclusion, Current Challanges and Future Prespective |
2020-10-19 |
|
|
| 4429 |
Structuring an Article |
2020-10-19 |
|
|
| 4430 |
The Manuscript |
2020-10-19 |
|
|
| 4431 |
Submission Procedure |
2020-10-19 |
|
|
| 4432 |
Introduction to Authors |
2020-10-19 |
|
|
| 4433 |
Editorial Article |
2020-10-19 |
|
|
| 4434 |
Human Factors and Ergonomics in Healthcare |
2020-10-19 |
|
|
| 4435 |
Human Growth and Posture |
2020-10-19 |
|
|
| 4436 |
Scope of Ergonomics |
2020-10-19 |
|
|
| 4437 |
Editorial Commentary |
2020-10-16 |
|
|
| 4438 |
Test |
2020-10-16 |
|
|
| 4439 |
Detailed Description |
2020-10-16 |
|
|
| 4440 |
Conclusion and Limitations of The Research |
2020-10-16 |
|
|
| 4441 |
Background Information |
2020-10-16 |
|
|
| 4442 |
Countermeasures for Future Hospitality and Tourism Industry |
2020-10-16 |
|
|
| 4443 |
Impact of Covid-19 on Tourism Industry |
2020-10-16 |
|
|
| 4444 |
Impact of Covid-19 on Hospitality Industry |
2020-10-16 |
|
|
| 4445 |
Comparison of SARS and Covid-19 |
2020-10-16 |
|
|
| 4446 |
Impact of SARS happened in 2002 |
2020-10-16 |
|
|
| 4447 |
Accomplishments and Future Research |
2020-10-16 |
|
|
| 4448 |
Cultural Tourism Attractions of Dorzé Village |
2020-10-16 |
|
|
| 4449 |
Cultural Tourism Attractions of Dorzé Village |
2020-10-16 |
|
|
| 4450 |
Credit Authorship Contribution Statement |
2020-10-15 |
|
|
| 4451 |
Entomotoxicology |
2020-10-14 |
|
|
| 4452 |
DNA Analysis For Identification Of Different Species |
2020-10-14 |
|
|
| 4453 |
To Determine Elapsed Time Since Death |
2020-10-14 |
|
|
| 4454 |
Post-Mortem Changes And Entomological Association |
2020-10-14 |
|
|
| 4455 |
Solid Waste Problem In India |
2020-10-10 |
|
|
| 4456 |
Limitations of Clinical Trials |
2020-10-10 |
|
|
| 4457 |
Pharmacovigilace in Clinical Trails |
2020-10-10 |
|
|
| 4458 |
Goals of Pharmacovigilance |
2020-10-10 |
|
|
| 4459 |
Review Literature |
2020-10-10 |
|
|
| 4460 |
Other Adjuvants |
2020-10-10 |
|
|
| 4461 |
CpG ODN |
2020-10-10 |
|
|
| 4462 |
Montanide ISA51 |
2020-10-10 |
|
|
| 4463 |
Virsomes |
2020-10-10 |
|
|
| 4464 |
As Adjuvants |
2020-10-10 |
|
|
| 4465 |
MF59 |
2020-10-10 |
|
|
| 4466 |
Aluminum-Containing Adjuvants |
2020-10-10 |
|
|
| 4467 |
Necrosis |
2020-10-08 |
|
|
| 4468 |
Molecular Diagnostics |
2020-10-08 |
|
|
| 4469 |
Conclusion/Chorology of the Species and Origin of the Turkish Population |
2020-10-08 |
|
|
| 4470 |
Contribution of our Study to Science |
2020-10-07 |
|
|
| 4471 |
Limits of our Study |
2020-10-07 |
|
|
| 4472 |
Data Collected |
2020-10-07 |
|
|
| 4473 |
Data Collecte |
2020-10-07 |
|
|
| 4474 |
Study Population |
2020-10-07 |
|
|
| 4475 |
Authors Role |
2020-10-07 |
|
|
| 4476 |
Intervention |
2020-10-07 |
|
|
| 4477 |
Supplementary Data |
2020-10-07 |
|
|
| 4478 |
Availability of The Data And Materials |
2020-10-07 |
|
|
| 4479 |
Relevance To Clinical Practice |
2020-10-07 |
|
|
| 4480 |
Appendix: Proofs of F-Norm Theorems |
2020-10-05 |
|
|
| 4481 |
Treatment Using IFNs |
2020-10-03 |
|
|
| 4482 |
Antiviral Activity of Interferons |
2020-10-03 |
|
|
| 4483 |
Randomized Controlled Clinical Studies |
2020-10-03 |
|
|
| 4484 |
Retrospective and Observational Studies Using HCQ for Prophylaxis |
2020-10-03 |
|
|
| 4485 |
The Identification of HCQ And Type I Interferon as Potential Therapy for COVID-19 |
2020-10-03 |
|
|
| 4486 |
Mechanism of Viral Entry and Hallmarks of Severe COVID-19 |
2020-10-03 |
|
|
| 4487 |
Responding to Attacks |
2020-10-01 |
|
|
| 4488 |
Impact on the Response |
2020-10-01 |
|
|
| 4489 |
Theorems and Proofs |
2020-10-01 |
|
|
| 4490 |
Application Example |
2020-10-01 |
|
|
| 4491 |
Distributed Algorithm |
2020-10-01 |
|
|
| 4492 |
Social Media Addiction |
2020-09-30 |
|
|
| 4493 |
Malnutrition |
2020-09-29 |
|
|
| 4494 |
Age Related Diseases |
2020-09-29 |
|
|
| 4495 |
Declaration of Competing Interests |
2020-09-28 |
|
|
| 4496 |
Different ethnic group of tribals in Western Ghats |
2020-09-28 |
|
|
| 4497 |
Estimation Of Prediction Output |
2020-09-28 |
|
|
| 4498 |
Building a Prediction Model |
2020-09-28 |
|
|
| 4499 |
Feature and Data Analysis |
2020-09-28 |
|
|
| 4500 |
Data Resources |
2020-09-28 |
|
|
| 4501 |
Declaration on Conflict of Interest |
2020-09-28 |
|
|
| 4502 |
Proposed Interventions |
2020-09-26 |
|
|
| 4503 |
Malnourishment and Undernourishment |
2020-09-26 |
|
|
| 4504 |
Traditional Medicine versus Precision Medicine |
2020-09-26 |
|
|
| 4505 |
Research Contribution and Achievement |
2020-09-25 |
|
|
| 4506 |
Guarantor |
2020-09-25 |
|
|
| 4507 |
Ethical Approval and Registration of Research Studies |
2020-09-25 |
|
|
| 4508 |
Results and Calculations |
2020-09-25 |
|
|
| 4509 |
Investigating Tools |
2020-09-25 |
|
|
| 4510 |
A Peer to Peer Network for Healthcare Payment Method |
2020-09-25 |
|
|
| 4511 |
An Algorithm for Identification of Pairing Members |
2020-09-25 |
|
|
| 4512 |
An Algorithm for Identification of Pairing Members |
2020-09-25 |
|
|
| 4513 |
Research tools |
2020-09-23 |
|
|
| 4514 |
Limitation of Study |
2020-09-22 |
|
|
| 4515 |
Rational Study |
2020-09-22 |
|
|
| 4516 |
Treatment of Diabetes at Some Stage in Covid 19 Contamination |
2020-09-22 |
|
|
| 4517 |
Metabolic Active Abdominal Obesity Is Associated With an Accelerated Risk |
2020-09-22 |
|
|
| 4518 |
What Increases the Risk of Diabetes? |
2020-09-22 |
|
|
| 4519 |
Type 2 Diabetes as a Risk Element |
2020-09-22 |
|
|
| 4520 |
Generalized Anxiety |
2020-09-20 |
|
|
| 4521 |
Panic Attacks |
2020-09-20 |
|
|
| 4522 |
Psychosis |
2020-09-20 |
|
|
| 4523 |
Bipolar and Depression |
2020-09-20 |
|
|
| 4524 |
Objects of Research |
2020-09-19 |
|
|
| 4525 |
Competing Interests (optional as appropriate) |
2020-09-18 |
|
|
| 4526 |
Authors' Contributions (optional as needed) |
2020-09-18 |
|
|
| 4527 |
Factors associated with outcomes of ICCM of Childhood Illnesses |
2020-09-18 |
|
|
| 4528 |
Very High Global Risk of Transmission |
2020-09-18 |
|
|
| 4529 |
Circular Economics is the Next Economics |
2020-09-18 |
|
|
| 4530 |
Discussion and Concluding Remarks |
2020-09-17 |
|
|
| 4531 |
Research/Design Methodology |
2020-09-17 |
|
|
| 4532 |
Aim Of This Work |
2020-09-17 |
|
|
| 4533 |
Dependence of the Force on the Earth Motion in Space |
2020-09-17 |
|
|
| 4534 |
Electrostatic Pendulum Experiment |
2020-09-17 |
|
|
| 4535 |
Previous Experimental Work |
2020-09-17 |
|
|
| 4536 |
Pattern of Articular Affection |
2020-09-17 |
|
|
| 4537 |
Characteristics of Pain |
2020-09-17 |
|
|
| 4538 |
Age and Gender |
2020-09-17 |
|
|
| 4539 |
Diagnostic Tests |
2020-09-17 |
|
|
| 4540 |
Lifestyles |
2020-09-17 |
|
|
| 4541 |
Risk Factor's |
2020-09-17 |
|
|
| 4542 |
Polyarthralgias |
2020-09-17 |
|
|
| 4543 |
Complementary Exams |
2020-09-17 |
|
|
| 4544 |
Toxic Myopathy |
2020-09-17 |
|
|
| 4545 |
Hereditary Myopathies |
2020-09-17 |
|
|
| 4546 |
Specific Clinical Characteristics |
2020-09-17 |
|
|
| 4547 |
Inflammatory Myopathies |
2020-09-17 |
|
|
| 4548 |
Types and Classification |
2020-09-17 |
|
|
| 4549 |
Generalities |
2020-09-17 |
|
|
| 4550 |
Other Causes Not Visible With Dinamic Rx |
2020-09-17 |
|
|
| 4551 |
Other Causes Not Visible With Dinamic Rx |
2020-09-17 |
|
|
| 4552 |
Lesions Observed In The Dynamics Rx |
2020-09-17 |
|
|
| 4553 |
Measurement Of Angles |
2020-09-17 |
|
|
| 4554 |
Dynamic Radiological Examination |
2020-09-17 |
|
|
| 4555 |
Secondary Symptoms |
2020-09-17 |
|
|
| 4556 |
Definition |
2020-09-17 |
|
|
| 4557 |
Anatomy |
2020-09-17 |
|
|
| 4558 |
Author Disclosures |
2020-09-17 |
|
|
| 4559 |
Co-Investigators |
2020-09-17 |
|
|
| 4560 |
Principles and Strategies for Handling Healthcare Wastes |
2020-09-16 |
|
|
| 4561 |
Dangers of Medical Waste from Health and Environmental Perspectives |
2020-09-16 |
|
|
| 4562 |
Justification for the Study |
2020-09-16 |
|
|
| 4563 |
Authors |
2020-09-16 |
|
|
| 4564 |
Interview |
2020-09-16 |
|
|
| 4565 |
Literary Review |
2020-09-16 |
|
|
| 4566 |
Optional Use of Filter |
2020-09-15 |
|
|
| 4567 |
With Thanks |
2020-09-15 |
|
|
| 4568 |
Emotional Distress |
2020-09-15 |
|
|
| 4569 |
Precedent Case Law Includes |
2020-09-15 |
|
|
| 4570 |
Fresh Evidence |
2020-09-15 |
|
|
| 4571 |
Evidence in the Authors Case Experience |
2020-09-15 |
|
|
| 4572 |
Summary Investigation |
2020-09-15 |
|
|
| 4573 |
Author’s Experience |
2020-09-15 |
|
|
| 4574 |
A Mysterious Something |
2020-09-15 |
|
|
| 4575 |
Forensic Aspects of Hypoglycaemia Investigation |
2020-09-15 |
|
|
| 4576 |
Infracontrol-Ventilation |
2020-09-15 |
|
|
| 4577 |
Safety Features |
2020-09-15 |
|
|
| 4578 |
Professional Biography |
2020-09-15 |
|
|
| 4579 |
Study Assessments |
2020-09-15 |
|
|
| 4580 |
Research Design and Methods |
2020-09-15 |
|
|
| 4581 |
Affirmations |
2020-09-15 |
|
|
| 4582 |
Study Constraints |
2020-09-15 |
|
|
| 4583 |
Techniques |
2020-09-15 |
|
|
| 4584 |
Phase I |
2020-09-15 |
|
|
| 4585 |
Phase I/II |
2020-09-15 |
|
|
| 4586 |
Phase II Trials |
2020-09-15 |
|
|
| 4587 |
Phase III Trials |
2020-09-15 |
|
|
| 4588 |
Market Growth and Analysis in Healthcare Industry |
2020-09-15 |
|
|
| 4589 |
Patients & Methods |
2020-09-14 |
|
|
| 4590 |
Impact Factor |
2020-09-13 |
|
|
| 4591 |
Surgical Technique |
2020-09-13 |
|
|
| 4592 |
Conclusions: Professionalsâ?? Training |
2020-09-12 |
|
|
| 4593 |
Conclusions: Professionals’ Training |
2020-09-12 |
|
|
| 4594 |
Integrated Therapy (Main Text) |
2020-09-12 |
|
|
| 4595 |
The Nursi Character Analysis (NURCA) Model |
2020-09-10 |
|
|
| 4596 |
Awards 2020 |
2020-09-08 |
|
|
| 4597 |
Situation Report and Ongoing Challenges on Zamfara Lead Poisoning |
2020-09-07 |
|
|
| 4598 |
Potential Hazards of Lead Contamination |
2020-09-07 |
|
|
| 4599 |
Mechanism of Lead Contamination |
2020-09-07 |
|
|
| 4600 |
Sources of Lead Contamination |
2020-09-07 |
|
|
| 4601 |
Lead Decontamination Activities |
2020-09-07 |
|
|
| 4602 |
Assessment of Lead Contamination in Zamfara Communities |
2020-09-07 |
|
|
| 4603 |
Heavy Metals Concentration and Environmental Concerns |
2020-09-07 |
|
|
| 4604 |
“A guidance at the Addiction and the recovery science” |
2020-09-05 |
|
|
| 4605 |
Journal Scope |
2020-09-04 |
|
|
| 4606 |
Antibiotic Use In Treatment Of Cholera |
2020-09-04 |
|
|
| 4607 |
Host Factor |
2020-09-04 |
|
|
| 4608 |
2021 Conference Announcement |
2020-09-03 |
|
|
| 4609 |
Outstanding Thesis |
2020-09-03 |
|
|
| 4610 |
Outstanding speaker |
2020-09-03 |
|
|
| 4611 |
Prospective |
2020-09-03 |
|
|
| 4612 |
Lactic Acid Bacteria |
2020-09-02 |
|
|
| 4613 |
Benefits of Probiotics and How They Work |
2020-09-02 |
|
|
| 4614 |
New Status Regarding The Strategy To Protect Healthy Gut Microbes From Antibiotics |
2020-09-02 |
|
|
| 4615 |
Role Of The Gut Microbiota In The Health And Diseases Of Pigs |
2020-09-02 |
|
|
| 4616 |
Brief Summary |
2020-09-02 |
|
|
| 4617 |
Biochemistry |
2020-09-01 |
|
|
| 4618 |
Prevention of HIV Transmission |
2020-09-01 |
|
|
| 4619 |
To the Horizon Twenty-Twenty (2020) |
2020-09-01 |
|
|
| 4620 |
Types of Cancer |
2020-09-01 |
|
|
| 4621 |
Personal Genetic Chart (Pass) |
2020-09-01 |
|
|
| 4622 |
Clinical Relevance |
2020-09-01 |
|
|
| 4623 |
Immunotherapy and COVID-19: Hope or Fear? |
2020-08-31 |
|
|
| 4624 |
COVID-19 |
2020-08-31 |
|
|
| 4625 |
Immunotherapy and COVID-19 Available Data |
2020-08-31 |
|
|
| 4626 |
Covid-19 Global Epidemiology and Evidence in Cancer Patients |
2020-08-31 |
|
|
| 4627 |
Conclusion of Interest |
2020-08-31 |
|
|
| 4628 |
Food for Covid-19 patient |
2020-08-31 |
|
|
| 4629 |
Multidisciplinary Approach |
2020-08-31 |
|
|
| 4630 |
FMR |
2020-08-31 |
|
|
| 4631 |
Thrower's Ten Protocol |
2020-08-31 |
|
|
| 4632 |
Editorial Comment |
2020-08-31 |
|
|
| 4633 |
The Limitations of this Study |
2020-08-30 |
|
|
| 4634 |
Paraganglioma |
2020-08-29 |
|
|
| 4635 |
Hematoma |
2020-08-29 |
|
|
| 4636 |
Advance Treatment in Thyroid |
2020-08-28 |
|
|
| 4637 |
SGLT2 Inhibitors and Its Role in Diabetes |
2020-08-28 |
|
|
| 4638 |
Method of Induction of Ulcer |
2020-08-27 |
|
|
| 4639 |
Botanical Aspects |
2020-08-27 |
|
|
| 4640 |
Dear Editor, |
2020-08-26 |
|
|
| 4641 |
Respected Sir, |
2020-08-26 |
|
|
| 4642 |
Data Analysis and Result |
2020-08-26 |
|
|
| 4643 |
Review of the Related Literature |
2020-08-26 |
|
|
| 4644 |
Side Effect |
2020-08-26 |
|
|
| 4645 |
Clinical Benefit of Favipiravir |
2020-08-26 |
|
|
| 4646 |
Mechanism of Action of Favipiravir |
2020-08-26 |
|
|
| 4647 |
Circular Economics: The Case |
2020-08-25 |
|
|
| 4648 |
Circular Economics in Detail |
2020-08-25 |
|
|
| 4649 |
Circular Economics is the Next Economics |
2020-08-25 |
|
|
| 4650 |
Circular Economics in Action |
2020-08-25 |
|
|
| 4651 |
Background and Focus |
2020-08-25 |
|
|
| 4652 |
Dear Editor |
2020-08-25 |
|
|
| 4653 |
Pathophysiology Of Aplastic Anemia |
2020-08-25 |
|
|
| 4654 |
Infertility |
2020-08-25 |
|
|
| 4655 |
Hormonal Therapy |
2020-08-25 |
|
|
| 4656 |
Interpretation of Results |
2020-08-25 |
|
|
| 4657 |
Classification |
2020-08-25 |
|
|
| 4658 |
Management of Covid-19 |
2020-08-25 |
|
|
| 4659 |
Origin and Spread of Infection |
2020-08-25 |
|
|
| 4660 |
Epidemiology and Prevalance |
2020-08-25 |
|
|
| 4661 |
Background and Objectives |
2020-08-25 |
|
|
| 4662 |
Presentation of the Study Area and Methodology |
2020-08-21 |
|
|
| 4663 |
Spatial Multiple Criteria Analysis (SMCA) |
2020-08-21 |
|
|
| 4664 |
Scope of Study |
2020-08-21 |
|
|
| 4665 |
Statement Of Financial Disclosure And Conflict Of Interest |
2020-08-21 |
|
|
| 4666 |
Institutional Review Board Of Ethics Committee |
2020-08-21 |
|
|
| 4667 |
Two of the following: |
2020-08-19 |
|
|
| 4668 |
Primary progressive MS (PPMS) |
2020-08-19 |
|
|
| 4669 |
Secondary progressive MS (SPMS) |
2020-08-19 |
|
|
| 4670 |
Relapsing-remitting MS (RRMS) |
2020-08-19 |
|
|
| 4671 |
Clinically Isolated Syndrome (CIS) |
2020-08-19 |
|
|
| 4672 |
Tools for making a diagnosis |
2020-08-19 |
|
|
| 4673 |
Criteria for a diagnosis of MS |
2020-08-19 |
|
|
| 4674 |
How does PPMS differ from the other disease courses? |
2020-08-19 |
|
|
| 4675 |
Why are modifiers used to characterize PPMS? |
2020-08-19 |
|
|
| 4676 |
How does SPMS differ from the other disease courses? |
2020-08-19 |
|
|
| 4677 |
Why are modifiers used to characterize SPMS? |
2020-08-19 |
|
|
| 4678 |
How does RRMS differ from progressive types of MS? |
2020-08-19 |
|
|
| 4679 |
Why are modifiers used to describe RRMS? |
2020-08-19 |
|
|
| 4680 |
How is CIS different from MS? |
2020-08-19 |
|
|
| 4681 |
CIS progression to MS |
2020-08-19 |
|
|
| 4682 |
Types of MS |
2020-08-19 |
|
|
| 4683 |
Previous Presentation |
2020-08-19 |
|
|
| 4684 |
Financial Disclosures |
2020-08-19 |
|
|
| 4685 |
Conclusions and Clinical Implications |
2020-08-19 |
|
|
| 4686 |
Limitations and Recommendations for Future Research |
2020-08-19 |
|
|
| 4687 |
Clinical Characteristic and Diagnosis |
2020-08-19 |
|
|
| 4688 |
Locality Of Study |
2020-08-18 |
|
|
| 4689 |
Advantages and Limitations of Using Polysaccharide-Based Materials For Adsorption oF Metal Ions |
2020-08-18 |
|
|
| 4690 |
Recent Developments On New Polysaccharidebased Materials |
2020-08-18 |
|
|
| 4691 |
Review of Metal Ion Biosorption Processes |
2020-08-18 |
|
|
| 4692 |
Modelling Approach |
2020-08-18 |
|
|
| 4693 |
Binding Mechanisms Of Metal Ions Onto Monoand Polysaccharides |
2020-08-18 |
|
|
| 4694 |
Influence Of Experimental Conditions |
2020-08-18 |
|
|
| 4695 |
General Considerations On Metal Ions Complexation Process |
2020-08-18 |
|
|
| 4696 |
Chikungunya Virus |
2020-08-18 |
|
|
| 4697 |
Bottlenecks And Transmission Of West Nile Virus |
2020-08-18 |
|
|
| 4698 |
Studied Cases |
2020-08-18 |
|
|
| 4699 |
Fitness Potentials And Evolutionary Pressures On Arboviruses |
2020-08-18 |
|
|
| 4700 |
Viral Diversity And Transmission Cycles |
2020-08-18 |
|
|
| 4701 |
Bottlenecks |
2020-08-18 |
|
|
| 4702 |
1. Bottlenecks |
2020-08-18 |
|
|
| 4703 |
Inflammation |
2020-08-18 |
|
|
| 4704 |
Proposed Treament Of Covid-19 |
2020-08-18 |
|
|
| 4705 |
Covid-19 In India |
2020-08-18 |
|
|
| 4706 |
Proposed Treatment Of Covid-19 |
2020-08-18 |
|
|
| 4707 |
Strengths and Limitations of the Study |
2020-08-18 |
|
|
| 4708 |
Aims And Objectives Of The Study |
2020-08-18 |
|
|
| 4709 |
Strannik Neuromodulation Therapy - Outcomes |
2020-08-18 |
|
|
| 4710 |
SVS Results |
2020-08-18 |
|
|
| 4711 |
Cardiology Diagnostic Devices |
2020-08-17 |
|
|
| 4712 |
Advantages |
2020-08-17 |
|
|
| 4713 |
Medical Procedure |
2020-08-17 |
|
|
| 4714 |
Editorial Note for Journal of Sleep Disorders & Therapy |
2020-08-14 |
|
|
| 4715 |
Predictors of Mad Withdrawal |
2020-08-14 |
|
|
| 4716 |
Evaluation of the Mad During Phone Contact |
2020-08-14 |
|
|
| 4717 |
Report of Case |
2020-08-14 |
|
|
| 4718 |
List of Abbrivations |
2020-08-14 |
|
|
| 4719 |
Risk |
2020-08-14 |
|
|
| 4720 |
Preventions |
2020-08-14 |
|
|
| 4721 |
Symptoms |
2020-08-14 |
|
|
| 4722 |
Lessons that can be Learned from Global Eradication Of Rinderpest (Grep) |
2020-08-14 |
|
|
| 4723 |
Global Paste Des Petits Ruminants Eradication Campaigns |
2020-08-14 |
|
|
| 4724 |
Control Paste Des Petits Ruminant |
2020-08-14 |
|
|
| 4725 |
Founding Facts about Paste Des Petits Ruminants |
2020-08-14 |
|
|
| 4726 |
Current State of the Art |
2020-08-13 |
|
|
| 4727 |
Example of an Ethical Situation |
2020-08-13 |
|
|
| 4728 |
The Medical Data Collection Issue by the Robot and the Manufacturer or a Secondhand Buyer |
2020-08-13 |
|
|
| 4729 |
Concept of Damage and Insurance |
2020-08-13 |
|
|
| 4730 |
The Responsibility of the Robot for Its Decision Making |
2020-08-13 |
|
|
| 4731 |
Editor’s Note |
2020-08-13 |
|
|
| 4732 |
Major Food Poisoning Bacteria |
2020-08-13 |
|
|
| 4733 |
Food Safety in Lebanon |
2020-08-13 |
|
|
| 4734 |
Food Safety in Arab Countries |
2020-08-13 |
|
|
| 4735 |
The Impact of Foodborne Illnesses on Human Health |
2020-08-13 |
|
|
| 4736 |
Fortified Products of Quince Cydonia Oblonga |
2020-08-13 |
|
|
| 4737 |
Processed/ Value Added Productsfrom Quince Cydonia Oblonga |
2020-08-13 |
|
|
| 4738 |
Modern Medicinal Uses/ Pharmacological Uses of Quince |
2020-08-13 |
|
|
| 4739 |
Traditional Medicinal Uses of Quince |
2020-08-13 |
|
|
| 4740 |
Phytochemistry of Different Parts of Quince |
2020-08-13 |
|
|
| 4741 |
Quince Profile |
2020-08-13 |
|
|
| 4742 |
Origin and geographical Distribution |
2020-08-13 |
|
|
| 4743 |
Technique |
2020-08-12 |
|
|
| 4744 |
Presentation of Findings and Discussions |
2020-08-12 |
|
|
| 4745 |
Study Area and Methodology |
2020-08-12 |
|
|
| 4746 |
How Supportive is the Prediction that Chinese Flows Can Alleviate or Support this European Challenge? |
2020-08-12 |
|
|
| 4747 |
Demand for European Tourism (Changes and Elasticity) and Investment Orientation Policies |
2020-08-12 |
|
|
| 4748 |
Strategic Orientation and Measurement Policies |
2020-08-12 |
|
|
| 4749 |
European Tourism and the New Trends |
2020-08-12 |
|
|
| 4750 |
Tourists Statistics of Kerala |
2020-08-12 |
|
|
| 4751 |
Collection of Data |
2020-08-12 |
|
|
| 4752 |
Objectives of Research |
2020-08-12 |
|
|
| 4753 |
Glycosphingolipid |
2020-08-12 |
|
|
| 4754 |
Glycosylation |
2020-08-12 |
|
|
| 4755 |
Monosaccharides |
2020-08-12 |
|
|
| 4756 |
Causes |
2020-08-11 |
|
|
| 4757 |
Signs and Symptoms |
2020-08-11 |
|
|
| 4758 |
Executive Summary |
2020-08-11 |
|
|
| 4759 |
Conflicts of Interest/Competing Interests |
2020-08-11 |
|
|
| 4760 |
Declerations |
2020-08-11 |
|
|
| 4761 |
Autoimmune Disease |
2020-08-11 |
|
|
| 4762 |
Registries |
2020-08-11 |
|
|
| 4763 |
Causes of Syndrome |
2020-08-11 |
|
|
| 4764 |
Implementation Examples |
2020-08-07 |
|
|
| 4765 |
Incorporation of Ergonomics into Architecture |
2020-08-07 |
|
|
| 4766 |
Spectroscopic Analytical Methods |
2020-08-07 |
|
|
| 4767 |
Aim of the Work |
2020-08-05 |
|
|
| 4768 |
Quantitative analytical validation |
2020-08-05 |
|
|
| 4769 |
How Can We Control Plant Pathogens? |
2020-08-05 |
|
|
| 4770 |
Genetically Modified Food |
2020-08-05 |
|
|
| 4771 |
Genetically Modified Organisms |
2020-08-05 |
|
|
| 4772 |
Current Trends In Genetically Modified Crops |
2020-08-05 |
|
|
| 4773 |
How Can We Control Plant Pathogens |
2020-08-05 |
|
|
| 4774 |
RNA Interface Technology |
2020-08-05 |
|
|
| 4775 |
How do Farmers Incresase the Yield of their Crops? |
2020-08-05 |
|
|
| 4776 |
How Can We Protect Crops From Pathogens? |
2020-08-05 |
|
|
| 4777 |
How Can We Protect Crops From Pathogens |
2020-08-05 |
|
|
| 4778 |
Market Value on Nursing |
2020-08-05 |
|
|
| 4779 |
Research Methodology/Protocol |
2020-08-05 |
|
|
| 4780 |
Cases |
2020-08-04 |
|
|
| 4781 |
Psychosomatic Medicine 2017: Depression and impulsivity mediating the relationship between social anxiety and Internet addiction-Catherine So-Kum Tang-National University of Singap |
2020-08-03 |
|
|
| 4782 |
Psychiatrists and Forensic Psychology 2016: The resilience of personality disorders: The possible change through an integrated approach-Barbara Sartini-Università Cattolica del Sa |
2020-08-03 |
|
|
| 4783 |
Psychiatrists and Forensic Psychology 2016: The effects of the location of a bed in a ward on the length of stay-Jai Sung NOH-Ajou University School of Medicine |
2020-08-03 |
|
|
| 4784 |
Psychiatrists and Forensic Psychology 2016: Early attachment trauma and the impact on childâ??s development-Doris D'Hooghe-EMDR Practitioner |
2020-08-03 |
|
|
| 4785 |
Forensic Research 2016: Are We Contaminating Victims in Sexual Assault Referral Centres?-Lucy Love-Mountain Healthcare |
2020-08-03 |
|
|
| 4786 |
Forensic 2020: Comparative study of the mental health of hate crime and crime victims-Ishangi Mishra-Jain (Deemed-to-be-university) |
2020-08-03 |
|
|
| 4787 |
Forensic 2020: Meeting the Pedophile: Attitudes toward Pedophilia among Psychology Students-Rebecca Heron-University of Houston-Victoria |
2020-08-03 |
|
|
| 4788 |
Forensic 2020: Assessing Symptom Exaggeration of Psychopathology in Forensic Contexts: Correctional Inmates and Mentally Ill Offenders- Natthawut Arin- Chiang Mai University |
2020-08-03 |
|
|
| 4789 |
Induction of Diabetes |
2020-08-03 |
|
|
| 4790 |
What's New in our Paper |
2020-08-03 |
|
|
| 4791 |
What is known about this Subject? |
2020-08-03 |
|
|
| 4792 |
Current State of Knowledge |
2020-08-03 |
|
|
| 4793 |
The Limitation of this Study |
2020-08-03 |
|
|
| 4794 |
Author Contributorship |
2020-08-02 |
|
|
| 4795 |
Strength and Weakness |
2020-08-01 |
|
|
| 4796 |
Case and Method |
2020-08-01 |
|
|
| 4797 |
Letter to Editor |
2020-08-01 |
|
|
| 4798 |
Data Analysis and Findings |
2020-08-01 |
|
|
| 4799 |
Authors’ affiliations and contacts |
2020-07-31 |
|
|
| 4800 |
Authors affiliations and contacts |
2020-07-31 |
|
|
| 4801 |
Description of the Clinical Image |
2020-07-31 |
|
|
| 4802 |
Conclusion/Final Reflection |
2020-07-31 |
|
|
| 4803 |
Trial Registration (Name Of The Registry And Url) |
2020-07-31 |
|
|
| 4804 |
Detectors of Gases |
2020-07-30 |
|
|
| 4805 |
Detection of Volatile Organic Compounds for Lung Cancer Diagnosis |
2020-07-30 |
|
|
| 4806 |
Detection of H2s for Diagnosing Halitosis |
2020-07-30 |
|
|
| 4807 |
Detection of Acetone for Diagnosing Diabetes |
2020-07-30 |
|
|
| 4808 |
Detection of No2 and Nh3 for the Diagnosis of Asthma and Renal Disease |
2020-07-30 |
|
|
| 4809 |
Nano-Based Antiviral Therapy |
2020-07-30 |
|
|
| 4810 |
General Discussion and Conclusion |
2020-07-30 |
|
|
| 4811 |
Homosexuality and Voiding Troubles |
2020-07-30 |
|
|
| 4812 |
Classes of Relations |
2020-07-30 |
|
|
| 4813 |
Recommendations for Further Studies |
2020-07-30 |
|
|
| 4814 |
Prophylactic and Therapeutic use of Probiotics in Covid-19 |
2020-07-30 |
|
|
| 4815 |
Covid-19-Specific Alterations in Intestinal Microbiome |
2020-07-30 |
|
|
| 4816 |
Intestinal Microbiota and Host’s Inflammatory Tone |
2020-07-30 |
|
|
| 4817 |
Intestinal Microbiota and Host’s Inflammatory Tone |
2020-07-30 |
|
|
| 4818 |
Intestinal Dysbiosis Associated with Covid-19 |
2020-07-30 |
|
|
| 4819 |
Recommendations For Future Studies |
2020-07-29 |
|
|
| 4820 |
Sub-Questions |
2020-07-29 |
|
|
| 4821 |
Population and Sample |
2020-07-29 |
|
|
| 4822 |
Research Method and Design |
2020-07-29 |
|
|
| 4823 |
Research Question |
2020-07-29 |
|
|
| 4824 |
Treatment and Prevention of ASD |
2020-07-29 |
|
|
| 4825 |
Results in Level of Activity |
2020-07-29 |
|
|
| 4826 |
Results for Stereotypic Behaviour |
2020-07-29 |
|
|
| 4827 |
Results in Sleep |
2020-07-29 |
|
|
| 4828 |
Results for Social Interaction |
2020-07-29 |
|
|
| 4829 |
Results for Eye Contact |
2020-07-29 |
|
|
| 4830 |
Results for Verbal Communication |
2020-07-29 |
|
|
| 4831 |
First Published Evidence to Support Our Treatment |
2020-07-29 |
|
|
| 4832 |
How We Treat Our Patients |
2020-07-29 |
|
|
| 4833 |
Prevalence of Clinical Manifestations of Food Allergy in Patients with Autistic Spectrum Disorder |
2020-07-29 |
|
|
| 4834 |
Food Allergy is a Pre-Existing Condition for ASD |
2020-07-29 |
|
|
| 4835 |
Malt's Affecteds in ASD and FA |
2020-07-29 |
|
|
| 4836 |
Immune Medications |
2020-07-29 |
|
|
| 4837 |
Immune Medication and "Homing" in ASD and FA |
2020-07-29 |
|
|
| 4838 |
Epidemiology Aspects |
2020-07-29 |
|
|
| 4839 |
Brain-Gut Connection |
2020-07-29 |
|
|
| 4840 |
Etiology and Pathology |
2020-07-29 |
|
|
| 4841 |
Data Availablity |
2020-07-29 |
|
|
| 4842 |
Author Contributors |
2020-07-29 |
|
|
| 4843 |
Pancreatic Cancer Treatment |
2020-07-29 |
|
|
| 4844 |
Pancreatic Cancer and Its Complications |
2020-07-29 |
|
|
| 4845 |
Editorial Letter |
2020-07-29 |
|
|
| 4846 |
Objectives for 2020 |
2020-07-28 |
|
|
| 4847 |
Journal of Clinical Research & Bioethics - 2019 Highlights |
2020-07-28 |
|
|
| 4848 |
HOME-MADE Kits |
2020-07-27 |
|
|
| 4849 |
ONE-POT Methods |
2020-07-27 |
|
|
| 4850 |
PCR Product Quantification |
2020-07-27 |
|
|
| 4851 |
PCR Overcycling |
2020-07-27 |
|
|
| 4852 |
Cloning Modified Small RNAs |
2020-07-27 |
|
|
| 4853 |
Cloning Strategies |
2020-07-27 |
|
|
| 4854 |
RNA Quality And Quantity |
2020-07-27 |
|
|
| 4855 |
Vascular Aging And Sex Hormones |
2020-07-27 |
|
|
| 4856 |
Sirt1 And Vascular Aging |
2020-07-27 |
|
|
| 4857 |
Sex Hormones And Aging |
2020-07-27 |
|
|
| 4858 |
Author’s Contribution |
2020-07-27 |
|
|
| 4859 |
End of Life Care |
2020-07-27 |
|
|
| 4860 |
General Comparisons |
2020-07-27 |
|
|
| 4861 |
Small Hecs |
2020-07-27 |
|
|
| 4862 |
Large Regional Medical Center Hecs |
2020-07-27 |
|
|
| 4863 |
2nd Position From The Lens Of Organization |
2020-07-27 |
|
|
| 4864 |
1st Position (From The Lens Of Health Care Leader) |
2020-07-27 |
|
|
| 4865 |
Justification of My Position |
2020-07-27 |
|
|
| 4866 |
2nd Position (From the Lens of Parents) |
2020-07-27 |
|
|
| 4867 |
1st Position (From the Lens of Health Care Provider) |
2020-07-27 |
|
|
| 4868 |
Data Sources and Methods |
2020-07-25 |
|
|
| 4869 |
Climate and Environment of Kenya |
2020-07-25 |
|
|
| 4870 |
Recent Efforts at Resource Recovery by Lagos State |
2020-07-24 |
|
|
| 4871 |
Disclousures and Ethics |
2020-07-24 |
|
|
| 4872 |
Compting Interests |
2020-07-24 |
|
|
| 4873 |
Case-2 |
2020-07-24 |
|
|
| 4874 |
Case-1 |
2020-07-24 |
|
|
| 4875 |
Consent to Publication |
2020-07-24 |
|
|
| 4876 |
Scope of The Journal |
2020-07-24 |
|
|
| 4877 |
Disease |
2020-07-24 |
|
|
| 4878 |
Investigations |
2020-07-23 |
|
|
| 4879 |
Types and Pathophysiology |
2020-07-23 |
|
|
| 4880 |
Role of Extracellular Histones in Infectious Sepsis |
2020-07-22 |
|
|
| 4881 |
Role of C5a in Sepsis (Infectious, Non-Infectious) |
2020-07-22 |
|
|
| 4882 |
An Overview |
2020-07-22 |
|
|
| 4883 |
Human and Animal Participants |
2020-07-21 |
|
|
| 4884 |
Further Researches |
2020-07-21 |
|
|
| 4885 |
Genetically Engineered Biomaterials |
2020-07-21 |
|
|
| 4886 |
Ecopolitical and psychological Motivation |
2020-07-21 |
|
|
| 4887 |
Environmentalism |
2020-07-21 |
|
|
| 4888 |
Presentation |
2020-07-21 |
|
|
| 4889 |
Ethics Approval & Consent to Participate |
2020-07-21 |
|
|
| 4890 |
Authors Contribution Statement |
2020-07-20 |
|
|
| 4891 |
Author’s Contribution Statement |
2020-07-20 |
|
|
| 4892 |
Miracles of Alkalizing Diet In Combating Disease |
2020-07-20 |
|
|
| 4893 |
Integrative Approach to Disease |
2020-07-20 |
|
|
| 4894 |
Planets and Disease |
2020-07-20 |
|
|
| 4895 |
Text |
2020-07-20 |
|
|
| 4896 |
Data and Methodology |
2020-07-19 |
|
|
| 4897 |
Methods of Study |
2020-07-19 |
|
|
| 4898 |
Decleration of Interests |
2020-07-19 |
|
|
| 4899 |
Study Area and Methods |
2020-07-19 |
|
|
| 4900 |
Future Suggestions |
2020-07-17 |
|
|
| 4901 |
Level Of Functional Abilities |
2020-07-17 |
|
|
| 4902 |
Sit To Stand Task |
2020-07-17 |
|
|
| 4903 |
Forward Reaching Task |
2020-07-17 |
|
|
| 4904 |
Test Procedure |
2020-07-17 |
|
|
| 4905 |
Conflicts of Attentiveness |
2020-07-17 |
|
|
| 4906 |
Editorial Highlights |
2020-07-17 |
|
|
| 4907 |
Letter |
2020-07-16 |
|
|
| 4908 |
Editor Note |
2020-07-16 |
|
|
| 4909 |
Ethical Issues |
2020-07-16 |
|
|
| 4910 |
Do the following; Fighting with me is no Rocket Science. |
2020-07-16 |
|
|
| 4911 |
Our Existence in Nature |
2020-07-16 |
|
|
| 4912 |
Political Factors |
2020-07-16 |
|
|
| 4913 |
Socioeconomic |
2020-07-16 |
|
|
| 4914 |
Environment |
2020-07-16 |
|
|
| 4915 |
Study Analysis |
2020-07-16 |
|
|
| 4916 |
The Real Me |
2020-07-16 |
|
|
| 4917 |
My Origin |
2020-07-16 |
|
|
| 4918 |
Diagnosis Capacities |
2020-07-16 |
|
|
| 4919 |
Can Covid-19 Transmit Vertically? |
2020-07-16 |
|
|
| 4920 |
Lasers and Forensic Dentistry |
2020-07-15 |
|
|
| 4921 |
Funding Details |
2020-07-15 |
|
|
| 4922 |
Therapeutic Improvements |
2020-07-15 |
|
|
| 4923 |
Optimisation of the Reaction Condition and Reagents for the Colour Development |
2020-07-14 |
|
|
| 4924 |
Optimisation of the Reaction Condition and Reagents for the Colour Development |
2020-07-14 |
|
|
| 4925 |
Instrumentation |
2020-07-14 |
|
|
| 4926 |
Chemicals and Reagent Preparations |
2020-07-14 |
|
|
| 4927 |
Validation of Developed Method |
2020-07-14 |
|
|
| 4928 |
Robustness |
2020-07-14 |
|
|
| 4929 |
Mobilephase Stability |
2020-07-14 |
|
|
| 4930 |
Filter Validation |
2020-07-14 |
|
|
| 4931 |
Linearity |
2020-07-14 |
|
|
| 4932 |
Precision |
2020-07-14 |
|
|
| 4933 |
Accuracy |
2020-07-14 |
|
|
| 4934 |
Validation Parameters |
2020-07-14 |
|
|
| 4935 |
Preparation Methods |
2020-07-14 |
|
|
| 4936 |
Access to Material |
2020-07-14 |
|
|
| 4937 |
Material Selection |
2020-07-14 |
|
|
| 4938 |
Intervention Options for Veterans |
2020-07-14 |
|
|
| 4939 |
New Research on Veterans and Hearing Loss |
2020-07-14 |
|
|
| 4940 |
Risk Factors |
2020-07-14 |
|
|
| 4941 |
Caspian Tern |
2020-07-14 |
|
|
| 4942 |
Discussion And Future Directions |
2020-07-14 |
|
|
| 4943 |
The Study |
2020-07-14 |
|
|
| 4944 |
Provenance and Peer Review |
2020-07-14 |
|
|
| 4945 |
Patients Consent For Publication |
2020-07-14 |
|
|
| 4946 |
Consultation With A Yoga Instructor |
2020-07-14 |
|
|
| 4947 |
Chronic Illness |
2020-07-14 |
|
|
| 4948 |
Demographic Characteristics |
2020-07-14 |
|
|
| 4949 |
Mirror Therapy Combined With Different Techniques |
2020-07-14 |
|
|
| 4950 |
Mirror Therapy On Acute Stroke Patients |
2020-07-14 |
|
|
| 4951 |
Mirror Therapy On Subacute Stroke Patients |
2020-07-14 |
|
|
| 4952 |
Mirror Therapy On Chronic Stroke Patients |
2020-07-14 |
|
|
| 4953 |
Usefulness Of Ventilatory Gas Analysis |
2020-07-14 |
|
|
| 4954 |
Distinguishing Between CTEPH and PAH Using Posture-Based Ventilatory Gas Analysis |
2020-07-14 |
|
|
| 4955 |
Evaluation Of Severity Using Posture-Based Ventilatory Gas Analysis |
2020-07-14 |
|
|
| 4956 |
Ventilatory Gas Parameters In The Sitting And Supine Positions |
2020-07-14 |
|
|
| 4957 |
Cardiopulmonary Exercise Testing For Pulmonary Hypertension |
2020-07-14 |
|
|
| 4958 |
Association Between The Risk of LS and Blood Parameters |
2020-07-14 |
|
|
| 4959 |
Vascular Dementia |
2020-07-14 |
|
|
| 4960 |
Stroke |
2020-07-14 |
|
|
| 4961 |
Authors Declaration |
2020-07-13 |
|
|
| 4962 |
Discussion on the Frame of Practices |
2020-07-13 |
|
|
| 4963 |
Frame of Research: A Selective Review |
2020-07-13 |
|
|
| 4964 |
Proposed Biosecurity Measures |
2020-07-11 |
|
|
| 4965 |
Abbrevation |
2020-07-11 |
|
|
| 4966 |
Examples Of Cancer Biomineralization |
2020-07-09 |
|
|
| 4967 |
Dual Inhibition Of Mir-92a-3p And Mir-489-3p In Atherosclerosis-Related CKD |
2020-07-09 |
|
|
| 4968 |
Mir-92a In Atherosclerosis-Related CKD |
2020-07-09 |
|
|
| 4969 |
Mir-92a In Atherosclerosis - Related Cad (Inverse Relationship Between Mir-92a Expression And Fmd Study) |
2020-07-09 |
|
|
| 4970 |
Mir-92a As Therapeutic Target In Atherosclerosisrelated Disease |
2020-07-09 |
|
|
| 4971 |
Associations Of Cvd And Ckd With Early Stage Mediated By Endothelial Dysfunction |
2020-07-09 |
|
|
| 4972 |
Frailty |
2020-07-09 |
|
|
| 4973 |
Covid-19 And Probiotics |
2020-07-09 |
|
|
| 4974 |
Ethics Statement File |
2020-07-09 |
|
|
| 4975 |
Ethics and Consent to Participate |
2020-07-08 |
|
|
| 4976 |
Importance of Technologies in RBM |
2020-07-08 |
|
|
| 4977 |
Ethics Approval and Informed Consent |
2020-07-08 |
|
|
| 4978 |
Contribution of the Study to Science |
2020-07-08 |
|
|
| 4979 |
History Taking and Past History |
2020-07-08 |
|
|
| 4980 |
Target Volumes and Organs at Risk Planning |
2020-07-08 |
|
|
| 4981 |
Informed Consent for participation |
2020-07-08 |
|
|
| 4982 |
Consent to Publish |
2020-07-08 |
|
|
| 4983 |
Heat Tolerance Mechanism in Wheat |
2020-07-07 |
|
|
| 4984 |
Effect of Heat Stress on Wheat |
2020-07-07 |
|
|
| 4985 |
Measure |
2020-07-07 |
|
|
| 4986 |
Supplementary Materials |
2020-07-07 |
|
|
| 4987 |
Symptoms Appear Within 2 To 14 Days of Exposure to the Virus People with These Symptoms or Combination of Symptoms May Have Covid-19 |
2020-07-07 |
|
|
| 4988 |
Updates on Covid-19 Pandemic |
2020-07-07 |
|
|
| 4989 |
Copingtips for Nurses with the Covid-19 Pandemic “by Dr. Bernadette Melnyk” |
2020-07-07 |
|
|
| 4990 |
Other Considerations |
2020-07-07 |
|
|
| 4991 |
Boosting your Immune System against Coronavirus: How to minimize the Risk of Infection? |
2020-07-07 |
|
|
| 4992 |
The System Has Two Types of Response: Innate and Adaptive |
2020-07-07 |
|
|
| 4993 |
Innate Immune Responses to SARS-CoV-2 Infection: Gaining Insight from Strategies Used By SARS-CoV and MERS-CoV |
2020-07-07 |
|
|
| 4994 |
Hyaluronan: A Potential Cause of Fatalities |
2020-07-07 |
|
|
| 4995 |
HLA Haplotypes and SARS-CoV-2 Infection |
2020-07-07 |
|
|
| 4996 |
Cytokine Storm and Lung Damage |
2020-07-07 |
|
|
| 4997 |
Two-Phase Immune Responses Induced By Covid-19 Infection |
2020-07-07 |
|
|
| 4998 |
Articles Published In 2019 |
2020-07-06 |
|
|
| 4999 |
2020 Objectives |
2020-07-06 |
|
|
| 5000 |
Main Results |
2020-07-06 |
|
|
| 5001 |
Preliminaries |
2020-07-06 |
|
|
| 5002 |
Ethical Committee Approval |
2020-07-04 |
|
|
| 5003 |
Fundings |
2020-07-04 |
|
|
| 5004 |
Summary and Implications of Hypothesis |
2020-07-04 |
|
|
| 5005 |
Rationale for Hyperoxic Therapy for ASD |
2020-07-04 |
|
|
| 5006 |
ATEC |
2020-07-04 |
|
|
| 5007 |
Ablls-R |
2020-07-04 |
|
|
| 5008 |
Strength |
2020-07-04 |
|
|
| 5009 |
Future Significance |
2020-07-04 |
|
|
| 5010 |
Publication Time Scale |
2020-07-04 |
|
|
| 5011 |
Need to Evaluate the Role of Probiotics as a Therapeutic Tool to Manage the Gastrointestinal Dysfunction Among Children With ASD |
2020-07-04 |
|
|
| 5012 |
Ethics and Approval |
2020-07-04 |
|
|
| 5013 |
Transparency Decleration |
2020-07-04 |
|
|
| 5014 |
Material & Methods |
2020-07-04 |
|
|
| 5015 |
Using Social Media/Digital Marketing to Showcase Articles Published In Your Journal |
2020-07-04 |
|
|
| 5016 |
Conclusion: The Future Roadmap |
2020-07-04 |
|
|
| 5017 |
All is Not Lost: Resurgence in Market is Anticipated in Long-Run |
2020-07-04 |
|
|
| 5018 |
Global Electric Vehicles Market Prospects Set to Dim Across 2020 Amid Covid-19 Pandemic |
2020-07-04 |
|
|
| 5019 |
Context |
2020-07-03 |
|
|
| 5020 |
Funding Resources |
2020-07-03 |
|
|
| 5021 |
Discussion and Comments |
2020-07-03 |
|
|
| 5022 |
Declarations of Competing Interest |
2020-07-03 |
|
|
| 5023 |
Contributers Statement |
2020-07-03 |
|
|
| 5024 |
Ethics Approval and Consent |
2020-07-03 |
|
|
| 5025 |
The Ethics Committee's Approval |
2020-07-03 |
|
|
| 5026 |
Ethical Perspective |
2020-07-03 |
|
|
| 5027 |
Economical Analysis and Political Perspective |
2020-07-03 |
|
|
| 5028 |
Clinical and Epidemiologic Perspective |
2020-07-03 |
|
|
| 5029 |
Results, Discussion and Conclusion |
2020-07-03 |
|
|
| 5030 |
Description of Study Area |
2020-07-03 |
|
|
| 5031 |
Subjective |
2020-07-02 |
|
|
| 5032 |
Sources of Support |
2020-07-02 |
|
|
| 5033 |
Role of Cxcr2 in the Epithelial-Mesenchymal Transition via Expression of Snail |
2020-07-02 |
|
|
| 5034 |
Family of Cxc Chemokines and Cxcr2 Receptor in the Tumor Microenvironment |
2020-07-02 |
|
|
| 5035 |
Epithelial-Mesenchymal Transition |
2020-07-02 |
|
|
| 5036 |
Laparoscopic Liver Resection in Cancer Patients |
2020-07-02 |
|
|
| 5037 |
Data And Methods |
2020-07-02 |
|
|
| 5038 |
Nutritional Aspects of Seed Oil of C. Moschata |
2020-07-02 |
|
|
| 5039 |
Feeding Use and Nutritional Aspects of Fruit Pulp of C. Moschata |
2020-07-02 |
|
|
| 5040 |
C. Moschata is a Vegetable of High Socioeconomic Importance |
2020-07-02 |
|
|
| 5041 |
Domestication and Genetic Diversity of C. Moschata |
2020-07-02 |
|
|
| 5042 |
Botanical aspects of C. Moschata |
2020-07-02 |
|
|
| 5043 |
Literature Review and Discussion |
2020-07-01 |
|
|
| 5044 |
Results and Presentation |
2020-07-01 |
|
|
| 5045 |
Description of Procedures |
2020-07-01 |
|
|
| 5046 |
HIV Associated Eye Diseases |
2020-07-01 |
|
|
| 5047 |
Materials and Method |
2020-07-01 |
|
|
| 5048 |
Ending for a Happy World |
2020-07-01 |
|
|
| 5049 |
Education for a New World |
2020-07-01 |
|
|
| 5050 |
Ethics for a Better World |
2020-07-01 |
|
|
| 5051 |
Proposed Model Validation |
2020-06-28 |
|
|
| 5052 |
PV System Modelling |
2020-06-28 |
|
|
| 5053 |
A Case Study |
2020-06-28 |
|
|
| 5054 |
A Case Study< |
2020-06-28 |
|
|
| 5055 |
Function to failure structures |
2020-06-28 |
|
|
| 5056 |
Concept and functions |
2020-06-28 |
|
|
| 5057 |
Agile methodology |
2020-06-28 |
|
|
| 5058 |
What are social impacts? |
2020-06-28 |
|
|
| 5059 |
Experimentation |
2020-06-28 |
|
|
| 5060 |
CAD Technology and Model |
2020-06-28 |
|
|
| 5061 |
The Different Uses of Analyses |
2020-06-28 |
|
|
| 5062 |
Mechanical Analysis in Embodiment Design |
2020-06-28 |
|
|
| 5063 |
Fault Diagnosis |
2020-06-28 |
|
|
| 5064 |
Multiple Models Adaptive Estimation (MMAE) Technique |
2020-06-28 |
|
|
| 5065 |
Electrochemical Battery Model |
2020-06-28 |
|
|
| 5066 |
Battery chargers |
2020-06-28 |
|
|
| 5067 |
Motor |
2020-06-28 |
|
|
| 5068 |
DC to AC converter |
2020-06-28 |
|
|
| 5069 |
Battery |
2020-06-28 |
|
|
| 5070 |
Structure of Electric Vehicle |
2020-06-28 |
|
|
| 5071 |
Design Specifications |
2020-06-28 |
|
|
| 5072 |
Component Design |
2020-06-28 |
|
|
| 5073 |
Expermental Procedure |
2020-06-28 |
|
|
| 5074 |
Design Validation |
2020-06-28 |
|
|
| 5075 |
Experimental layout |
2020-06-28 |
|
|
| 5076 |
Transformation |
2020-06-28 |
|
|
| 5077 |
Integration |
2020-06-28 |
|
|
| 5078 |
Simulation |
2020-06-28 |
|
|
| 5079 |
Rediscovering |
2020-06-28 |
|
|
| 5080 |
Experimental Method |
2020-06-28 |
|
|
| 5081 |
Analyses |
2020-06-28 |
|
|
| 5082 |
Logic Programming Technique (LPT) |
2020-06-28 |
|
|
| 5083 |
Epidemiologic Theory |
2020-06-28 |
|
|
| 5084 |
Domino Theory |
2020-06-28 |
|
|
| 5085 |
Risk Analysis |
2020-06-28 |
|
|
| 5086 |
Statistical Analysis and Trends |
2020-06-28 |
|
|
| 5087 |
Culture And End Of Life Events |
2020-06-25 |
|
|
| 5088 |
End Of Life: The Terri And Michael Schiavo Case 1998 |
2020-06-25 |
|
|
| 5089 |
Conclusions and Research Implications |
2020-06-24 |
|
|
| 5090 |
Ergonomic Synthesis and Recommendations |
2020-06-24 |
|
|
| 5091 |
Scope for Future Research |
2020-06-24 |
|
|
| 5092 |
Accreditation |
2020-06-23 |
|
|
| 5093 |
Hemovigilance Program |
2020-06-23 |
|
|
| 5094 |
Product Issuance, and Transport |
2020-06-23 |
|
|
| 5095 |
Product Qualification, Processing and Release |
2020-06-23 |
|
|
| 5096 |
Product Collection and Transport |
2020-06-23 |
|
|
| 5097 |
Donor Evaluation |
2020-06-23 |
|
|
| 5098 |
Challenges of Management of Infectious Medical Waste in Taraba State |
2020-06-23 |
|
|
| 5099 |
Result of the Findings |
2020-06-23 |
|
|
| 5100 |
Conceptual Clarification |
2020-06-23 |
|
|
| 5101 |
What Was Done? |
2020-06-23 |
|
|
| 5102 |
Methods and Design |
2020-06-23 |
|
|
| 5103 |
Abstract |
2020-06-13 |
|
|
| 5104 |
Best E-Poster Award |
2020-06-11 |
|
|
| 5105 |
Best Poster Award |
2020-06-11 |
|
|
| 5106 |
Best Young Researcher Award |
2020-06-11 |
|
|
| 5107 |
Best Research Award |
2020-06-11 |
|
|
| 5108 |
Best Speaker Award |
2020-06-11 |
|
|
| 5109 |
Young Research Forum |
2020-06-11 |
|
|
| 5110 |
Awards |
2020-06-11 |
|
|
| 5111 |
Results and Analytics |
2020-06-11 |
|
|
| 5112 |
Case History |
2020-06-11 |
|
|
| 5113 |
Short Commentary |
2020-06-11 |
|
|
| 5114 |
Special Acknowledgment |
2020-06-11 |
|
|
| 5115 |
Therapeutic Options |
2020-06-09 |
|
|
| 5116 |
Differential Diagnosis |
2020-06-09 |
|
|
| 5117 |
Immune Histochemical Elucidation |
2020-06-09 |
|
|
| 5118 |
Histological Elucidation |
2020-06-09 |
|
|
| 5119 |
Genetic Elucidation |
2020-06-09 |
|
|
| 5120 |
Telehealth Programs |
2020-06-09 |
|
|
| 5121 |
Medical Devices |
2020-06-09 |
|
|
| 5122 |
Case Representation |
2020-06-06 |
|
|
| 5123 |
Experimental Methods |
2020-06-06 |
|
|
| 5124 |
Reviewers |
2020-06-01 |
|
|
| 5125 |
Editors |
2020-06-01 |
|
|
| 5126 |
Editor-In-Chief |
2020-06-01 |
|
|
| 5127 |
Journal Highlights |
2020-06-01 |
|
|
| 5128 |
Bioremediation by Trichoderma SP. |
2020-06-01 |
|
|
| 5129 |
Bioremediation by Trichoderma SP. |
2020-06-01 |
|
|
| 5130 |
Trichoderma as A Biofertilizer |
2020-06-01 |
|
|
| 5131 |
Trichoderma and Its Interaction With Microorganism |
2020-06-01 |
|
|
| 5132 |
Discussion of Numerical |
2020-06-01 |
|
|
| 5133 |
Declaration of Curiosity |
2020-06-01 |
|
|
| 5134 |
Clinical Trial 3: Chinese Noodles |
2020-06-01 |
|
|
| 5135 |
Clinical Trial 2: Soba Noodles |
2020-06-01 |
|
|
| 5136 |
Clinical Trial 1: Udon (Japanese Traditional Noodles) |
2020-06-01 |
|
|
| 5137 |
Examination of the Influence of Ca-Alg Content and Particle Size |
2020-06-01 |
|
|
| 5138 |
Mechanism of Suppression of Sugar Absorption |
2020-06-01 |
|
|
| 5139 |
Immunopathogenesis and Advantages of Convalescent Sera |
2020-06-01 |
|
|
| 5140 |
Convalescent Sera |
2020-06-01 |
|
|
| 5141 |
Level of evidence - Level I |
2020-06-01 |
|
|
| 5142 |
Consideration |
2020-06-01 |
|
|
| 5143 |
Study Description |
2020-06-01 |
|
|
| 5144 |
Surgical Repair |
2020-05-28 |
|
|
| 5145 |
Transcatheter Therapy |
2020-05-28 |
|
|
| 5146 |
Indications for Reintervention after Coa Repair |
2020-05-28 |
|
|
| 5147 |
Theoretical Perspectives |
2020-05-26 |
|
|
| 5148 |
Conclusion and Policy Implications |
2020-05-25 |
|
|
| 5149 |
Study Sites and Data Collection Method |
2020-05-25 |
|
|
| 5150 |
Analysis Theories and Models |
2020-05-25 |
|
|
| 5151 |
Editorial Note |
2020-05-23 |
|
|
| 5152 |
Disclosure of Conflict of Interest |
2020-05-22 |
|
|
| 5153 |
Concluding Remarks and Future Prospects |
2020-05-22 |
|
|
| 5154 |
Receptor of Irisin |
2020-05-22 |
|
|
| 5155 |
Other Effects of Irisin |
2020-05-22 |
|
|
| 5156 |
Irisin Combats Obesity in Human |
2020-05-22 |
|
|
| 5157 |
Irisin Combats Obesity in Mice |
2020-05-22 |
|
|
| 5158 |
Irisin, A Promising Myokine and Adipokine |
2020-05-22 |
|
|
| 5159 |
Three Types of Adipocytes |
2020-05-22 |
|
|
| 5160 |
Branched Chain Amino Acids |
2020-05-20 |
|
|
| 5161 |
Management of Frailty in Liver Cirrhosis Patients |
2020-05-20 |
|
|
| 5162 |
Frailty Scoring |
2020-05-20 |
|
|
| 5163 |
Frailty and Liver Transplantation |
2020-05-20 |
|
|
| 5164 |
Frailty and Meld Score |
2020-05-20 |
|
|
| 5165 |
Pathophysiology of Frailty in Liver Cirrhosis |
2020-05-20 |
|
|
| 5166 |
Frailty in Patients with Cirrhosis |
2020-05-20 |
|
|
| 5167 |
Major Findings |
2020-05-20 |
|
|
| 5168 |
Method of Data Collection |
2020-05-20 |
|
|
| 5169 |
Synthesis of Various Nanoparticles |
2020-05-14 |
|
|
| 5170 |
Experimental Setup |
2020-05-14 |
|
|
| 5171 |
Methods and Testing |
2020-05-14 |
|
|
| 5172 |
Statistical Analysis and Data Collection |
2020-05-13 |
|
|
| 5173 |
Social Media |
2020-05-13 |
|
|
| 5174 |
From All Authors |
2020-05-13 |
|
|
| 5175 |
Some Existing Models of Eco Tourism in India |
2020-05-13 |
|
|
| 5176 |
Discussions on Strategies |
2020-05-13 |
|
|
| 5177 |
Guiding Principles for Eco-Tourism Policy |
2020-05-13 |
|
|
| 5178 |
Central Theme of the Proposed Policy |
2020-05-13 |
|
|
| 5179 |
Sponsorship |
2020-05-12 |
|
|
| 5180 |
Characterization Of Partial Purified P.Javanicum Glucoamylase |
2020-05-12 |
|
|
| 5181 |
Our Findings |
2020-05-12 |
|
|
| 5182 |
Environmental Qualification Test Strategy |
2020-05-09 |
|
|
| 5183 |
Results and Conclusion |
2020-05-09 |
|
|
| 5184 |
Design and Information Gathering Approach |
2020-05-09 |
|
|
| 5185 |
Ethics Approval and Consent to Partcipate |
2020-05-06 |
|
|
| 5186 |
Aloe Vera Heals Gastric Ulcer in 7 Days than Omeprazole and Cimetidine: Prostaglandin? |
2020-05-05 |
|
|
| 5187 |
Availability of Data and Materials |
2020-05-05 |
|
|
| 5188 |
Recent Land and Forest Rights Movements in Jharkhand |
2020-03-18 |
|
|
| 5189 |
Alternative Development Paradigm in Social Movements |
2020-03-18 |
|
|
| 5190 |
Alternative Development |
2020-03-18 |
|
|
| 5191 |
Development Debate |
2020-03-18 |
|
|
| 5192 |
Jharkhand State and Development Discourse |
2020-03-18 |
|
|
| 5193 |
Post-Independence Policy Framework |
2020-03-18 |
|
|
| 5194 |
Ecological Impact |
2020-03-17 |
|
|
| 5195 |
Temperature Effect on Product Specificity |
2020-03-17 |
|
|
| 5196 |
Effect of Ph on The Product Profile of Mttps5 |
2020-03-17 |
|
|
| 5197 |
Metal Cofactors as Regulators of Terpene Biosynthesis |
2020-03-17 |
|
|
| 5198 |
Terpenoid Synthases Using Isomeric Prenyl Diphosphates |
2020-03-17 |
|
|
| 5199 |
Diterpene Promiscuity |
2020-03-17 |
|
|
| 5200 |
Terpene Synthases Utilizing Prenyl-Disphosphates of Different Chain Length |
2020-03-17 |
|
|
| 5201 |
Multiproduct Terpene Synthases |
2020-03-17 |
|
|
| 5202 |
Client Perspective |
2020-03-16 |
|
|
| 5203 |
3rd Position (Justification from My Side) |
2020-03-16 |
|
|
| 5204 |
2nd Position (From the Lens of Health Care Providers) |
2020-03-16 |
|
|
| 5205 |
1st Position (From the Lens of Organization) |
2020-03-16 |
|
|
| 5206 |
Unicondylar Knee Arthroplasty In Patellectomized Patients |
2020-03-16 |
|
|
| 5207 |
Case Scenario |
2020-03-16 |
|
|
| 5208 |
Osteoarthritis In Patellectomized Patients |
2020-03-16 |
|
|
| 5209 |
Patellectomy And Knee Function |
2020-03-16 |
|
|
| 5210 |
Practical Applications Of Gut Microbiota Manipulation |
2020-03-13 |
|
|
| 5211 |
Fa Therapies Targeting The Microbiota |
2020-03-13 |
|
|
| 5212 |
The Relevance Of Murine Studies In Elucidating Immunologic Pathways Involved In Human Pathology |
2020-03-13 |
|
|
| 5213 |
GI Microbiota And Immune Tolerance |
2020-03-13 |
|
|
| 5214 |
Factors That Influence The Composition Of The Gi Microbiota And Their Association With Predisposition To Fa Development |
2020-03-13 |
|
|
| 5215 |
GI Microbiota Composition Associated With Fa Immune Phenotype |
2020-03-13 |
|
|
| 5216 |
Composition And Development Of Microbiota In Healthy Gut |
2020-03-13 |
|
|
| 5217 |
Industrial Production Of Recombinant Monoclonal Antibody |
2020-03-13 |
|
|
| 5218 |
Batch Cultivation Of Hybridoma For Large Scale Production |
2020-03-13 |
|
|
| 5219 |
Small And Industrial Scale Production Of Therapeutics Monoclonal Antibodies |
2020-03-13 |
|
|
| 5220 |
Immunoglobulin G Subclasses |
2020-03-13 |
|
|
| 5221 |
Immunoglobulin G |
2020-03-13 |
|
|
| 5222 |
Discussion And Limitation |
2020-03-12 |
|
|
| 5223 |
Credit Author Statement |
2020-03-12 |
|
|
| 5224 |
Studies on Synthetic Derivatives of Solanum Alkaloids and Their Biological Activity Published in the Last 15 Years |
2020-03-12 |
|
|
| 5225 |
Biological Activity of Natural Glycoalkaloids |
2020-03-12 |
|
|
| 5226 |
Steroidal Alkaloids/Glycoalkaloids |
2020-03-12 |
|
|
| 5227 |
Techniques for Increasing TCR |
2020-03-12 |
|
|
| 5228 |
Theoretical Principles of TCR |
2020-03-12 |
|
|
| 5229 |
Discussion and Key Learnings |
2020-03-11 |
|
|
| 5230 |
Findings of the Study |
2020-03-11 |
|
|
| 5231 |
Interaction of Rpn2 And Egfr in Colorectal Cancer |
2020-03-11 |
|
|
| 5232 |
Rpn Ii Expression in Chemotherapeutic Resistant Cancer Cells |
2020-03-11 |
|
|
| 5233 |
Rpn Ii Silencing Contributes to the Inhibition of Crc Growth and Enhance Apoptosis of Drug Resistance Tumour |
2020-03-11 |
|
|
| 5234 |
Rpn Ii Promotes Crc Cell Cycle Progression and Proliferation |
2020-03-11 |
|
|
| 5235 |
Limitations of Our Study |
2020-03-11 |
|
|
| 5236 |
Study Methodology |
2020-03-06 |
|
|
| 5237 |
Area of Study |
2020-03-06 |
|
|
| 5238 |
Awards & Rewards: |
2020-03-06 |
|
|
| 5239 |
Neonatal 2020 Young Scientist Awards: |
2020-03-06 |
|
|
| 5240 |
Conference Highlights: |
2020-03-06 |
|
|
| 5241 |
Criteria for Selection: |
2020-03-06 |
|
|
| 5242 |
Neonatal Market Analysis |
2020-03-06 |
|
|
| 5243 |
Result and Findings |
2020-03-05 |
|
|
| 5244 |
Best Outstanding Speaker |
2020-03-05 |
|
|
| 5245 |
Women Scientist |
2020-03-05 |
|
|
| 5246 |
Scholar Level |
2020-03-05 |
|
|
| 5247 |
Professional Level |
2020-03-05 |
|
|
| 5248 |
Best Video Presentation Award |
2020-03-05 |
|
|
| 5249 |
Best Exhibitor Award |
2020-03-05 |
|
|
| 5250 |
Best Student Presentation Award |
2020-03-05 |
|
|
| 5251 |
Best Presentation Award |
2020-03-05 |
|
|
| 5252 |
Session`s Best Presentation Award |
2020-03-05 |
|
|
| 5253 |
The Gynecology 2020 Conference will have a keen focus on: |
2020-03-05 |
|
|
| 5254 |
Limitations In The Literature |
2020-03-05 |
|
|
| 5255 |
Field Case Studies |
2020-03-04 |
|
|
| 5256 |
Experemental Work |
2020-03-04 |
|
|
| 5257 |
Limitations and Future Directions |
2020-03-03 |
|
|
| 5258 |
Data Sources |
2020-03-03 |
|
|
| 5259 |
The Prevalence of Molecular Breast Cancer Subtypes in Ethiopia |
2020-03-02 |
|
|
| 5260 |
The Prevalence of Hormone Receptor Breast Cancer in Ethiopia |
2020-03-02 |
|
|
| 5261 |
Prognostic and Predictive Factors in Breast Cancer |
2020-03-02 |
|
|
| 5262 |
Contribution of Authors |
2020-03-02 |
|
|
| 5263 |
Pregnancy Counselling |
2020-03-02 |
|
|
| 5264 |
Pregnancy Outcomes In Kidney Transplantation |
2020-03-02 |
|
|
| 5265 |
Mini Review |
2020-03-02 |
|
|
| 5266 |
Disclosure of Interest |
2020-03-02 |
|
|
| 5267 |
Patient Consent |
2020-03-02 |
|
|
| 5268 |
Ethical Aspects |
2020-02-28 |
|
|
| 5269 |
Sample Size |
2020-02-28 |
|
|
| 5270 |
Applications |
2020-02-28 |
|
|
| 5271 |
Results in Testing of Particle Board Composite |
2020-02-28 |
|
|
| 5272 |
Materials Used in Preparation of Particle Board |
2020-02-28 |
|
|
| 5273 |
Clinical Cases and Methods |
2020-02-28 |
|
|
| 5274 |
Research Excellence Awards |
2020-02-28 |
|
|
| 5275 |
Preparation of Solutions |
2020-02-28 |
|
|
| 5276 |
Instrumentation and Chromatographic Conditions |
2020-02-28 |
|
|
| 5277 |
Materials and Reagents |
2020-02-28 |
|
|
| 5278 |
Optimization Experiments |
2020-02-28 |
|
|
| 5279 |
Young Researchers Forum |
2020-02-28 |
|
|
| 5280 |
Importance & Scope |
2020-02-28 |
|
|
| 5281 |
Management Options |
2020-02-27 |
|
|
| 5282 |
General Procedure |
2020-02-27 |
|
|
| 5283 |
Target Audience: |
2020-02-27 |
|
|
| 5284 |
Ophthalmic Therapeutic Drugs: |
2020-02-27 |
|
|
| 5285 |
Excipients in Pharmaceuticals: |
2020-02-27 |
|
|
| 5286 |
Antibiotics: |
2020-02-27 |
|
|
| 5287 |
Advanced Drug Delivery Systems: |
2020-02-27 |
|
|
| 5288 |
Metabolic Syndrome |
2020-02-26 |
|
|
| 5289 |
Oral Glucose Tolerance Test |
2020-02-26 |
|
|
| 5290 |
Metabolic Screening Test |
2020-02-26 |
|
|
| 5291 |
Hirsutism |
2020-02-26 |
|
|
| 5292 |
Psychosocial Element |
2020-02-26 |
|
|
| 5293 |
Fertility and Ovulation |
2020-02-26 |
|
|
| 5294 |
Obstructive Sleep Apnea (OSA) |
2020-02-26 |
|
|
| 5295 |
Research Gap Where the Work is Aimed |
2020-02-25 |
|
|
| 5296 |
Applications of Fly Ash/Epoxy/Nanocomposites |
2020-02-25 |
|
|
| 5297 |
Effect of Nanofillers on Mechanical, Morphological, and Thermal Properties of Polymer Nanocomposites |
2020-02-25 |
|
|
| 5298 |
Characterization of Polymer Nanocomposites |
2020-02-25 |
|
|
| 5299 |
Limitations and Process of Improvements |
2020-02-25 |
|
|
| 5300 |
Methods for Dispersion of Various Nanofillers in Matrix |
2020-02-25 |
|
|
| 5301 |
General Methods of Fabrication of Filler/Polymer-Based Nanocomposites |
2020-02-25 |
|
|
| 5302 |
Characteristics of Nanofillers |
2020-02-25 |
|
|
| 5303 |
Fabrication of Epoxy/Fly Ash Composites |
2020-02-25 |
|
|
| 5304 |
Characteristics of Epoxy Resin |
2020-02-25 |
|
|
| 5305 |
Trends of Fly Ash Production, Utilization, and Problems Encountered in Disposal of Fly ash |
2020-02-25 |
|
|
| 5306 |
Classification of Fly Ash |
2020-02-25 |
|
|
| 5307 |
Chemical and Physical Characteristics of Fly Ash |
2020-02-25 |
|
|
| 5308 |
Raw Materials for the Fabrication of Fly Ash/Epoxy Nanocomposite |
2020-02-25 |
|
|
| 5309 |
Adsorption Experiments |
2020-02-25 |
|
|
| 5310 |
Statement of Novelty |
2020-02-25 |
|
|
| 5311 |
Primary Surgical Repair |
2020-02-24 |
|
|
| 5312 |
Treatment Plan |
2020-02-24 |
|
|
| 5313 |
Data Analysis Procedure |
2020-02-20 |
|
|
| 5314 |
Data Collection Procedure |
2020-02-20 |
|
|
| 5315 |
Problem Statement |
2020-02-20 |
|
|
| 5316 |
Data Analysis and Interpretation |
2020-02-20 |
|
|
| 5317 |
Headaches |
2020-02-20 |
|
|
| 5318 |
Obesity |
2020-02-20 |
|
|
| 5319 |
Cardiovascular Diseases |
2020-02-20 |
|
|
| 5320 |
Diabetes |
2020-02-20 |
|
|
| 5321 |
Validity and Trustworthiness of the Data |
2020-02-20 |
|
|
| 5322 |
Analytic Approach |
2020-02-20 |
|
|
| 5323 |
Purpose and Aims of the Study |
2020-02-20 |
|
|
| 5324 |
Terminology and Concepts |
2020-02-18 |
|
|
| 5325 |
Application |
2020-02-18 |
|
|
| 5326 |
Therom 2 |
2020-02-18 |
|
|
| 5327 |
Theorem 1 |
2020-02-18 |
|
|
| 5328 |
Theoretical Results and Discussion |
2020-02-18 |
|
|
| 5329 |
Theory and Experimentation |
2020-02-18 |
|
|
| 5330 |
Contribution to Knowledge |
2020-02-18 |
|
|
| 5331 |
Data and Method |
2020-02-17 |
|
|
| 5332 |
Why to attend??? |
2020-02-11 |
|
|
| 5333 |
Importance and Scope: |
2020-02-11 |
|
|
| 5334 |
Limitations and Future Study |
2020-02-11 |
|
|
| 5335 |
Analysis and Discussion |
2020-02-11 |
|
|
| 5336 |
Disclosure Statement |
2020-02-11 |
|
|
| 5337 |
Sources of MSW |
2020-02-10 |
|
|
| 5338 |
Methods of the Data Collection |
2020-02-10 |
|
|
| 5339 |
Top Toxicology Companies: |
2020-02-10 |
|
|
| 5340 |
Top Universities in Europe: |
2020-02-10 |
|
|
| 5341 |
Top 10 Global Toxicology Laboratories |
2020-02-10 |
|
|
| 5342 |
Major Associations and Organizations around the Globe: |
2020-02-10 |
|
|
| 5343 |
Toxicology 2020 |
2020-02-10 |
|
|
| 5344 |
Applicants must: |
2020-02-10 |
|
|
| 5345 |
Benefits: |
2020-02-10 |
|
|
| 5346 |
Best Poster Presentation Award |
2020-02-10 |
|
|
| 5347 |
Why Toxicology 2020?? |
2020-02-10 |
|
|
| 5348 |
Discussion, Conclusion & Policy Implications |
2020-02-05 |
|
|
| 5349 |
Best Keynote speaker Awards |
2020-02-04 |
|
|
| 5350 |
MNP Based Cholesterol Biosensors |
2020-02-04 |
|
|
| 5351 |
Implications |
2020-02-04 |
|
|
| 5352 |
The Anti-Apoptotic Properties of H2 |
2020-02-04 |
|
|
| 5353 |
Anti-Inflammatory Effects of H2 in Different Disease Models |
2020-02-04 |
|
|
| 5354 |
H2 Acts As an Anti-Oxidant Agent |
2020-02-04 |
|
|
| 5355 |
Molecular Mechanisms of H2 Effects |
2020-02-04 |
|
|
| 5356 |
Methods of Administration of H2 |
2020-02-04 |
|
|
| 5357 |
Dental Patients Receiving Oral Anticoagulant Therapy |
2020-02-03 |
|
|
| 5358 |
Review of the Literature |
2020-02-03 |
|
|
| 5359 |
Health Care Manager/Professional with Spirituality |
2020-02-03 |
|
|
| 5360 |
Spirituality and Management Students |
2020-02-03 |
|
|
| 5361 |
Spirituality and Stress |
2020-02-03 |
|
|
| 5362 |
Design |
2020-02-03 |
|
|
| 5363 |
Subject and Methods |
2020-02-03 |
|
|
| 5364 |
RESULT AND DISCUSION |
2020-02-01 |
|
|
| 5365 |
Statistics |
2020-01-31 |
|
|
| 5366 |
Analysis and Measurements |
2020-01-31 |
|
|
| 5367 |
Discussion and Analysis |
2020-01-30 |
|
|
| 5368 |
Summary and Recommendations |
2020-01-30 |
|
|
| 5369 |
Challenges and Opportunities |
2020-01-30 |
|
|
| 5370 |
Factors for the Collapse of the Harla Culture and Civilization of Derbé Belanbel |
2020-01-30 |
|
|
| 5371 |
Geographical Location and Description of the Study Area |
2020-01-30 |
|
|
| 5372 |
Methodology of the Study |
2020-01-30 |
|
|
| 5373 |
Research Questions |
2020-01-30 |
|
|
| 5374 |
Finding and Result |
2020-01-29 |
|
|
| 5375 |
ISO Quality Standards |
2020-01-29 |
|
|
| 5376 |
Total Quality Management |
2020-01-29 |
|
|
| 5377 |
Future Prospects |
2020-01-29 |
|
|
| 5378 |
Algeriaâ??s Tourist Potentials |
2020-01-29 |
|
|
| 5379 |
Reasons for Adopting ICTS in the Tourismindustry in Algeria |
2020-01-29 |
|
|
| 5380 |
ICT and its Role in Tourism Sustainable Development |
2020-01-29 |
|
|
| 5381 |
Definition of Tourism Sustainable Development |
2020-01-29 |
|
|
| 5382 |
The Literature Review |
2020-01-29 |
|
|
| 5383 |
Topical Therapy, Evolving Scenario’s Application in Day-to-Day Practice |
2020-01-29 |
|
|
| 5384 |
Filaggrin |
2020-01-29 |
|
|
| 5385 |
Microanatomy and Physiology of Stratum Corneum |
2020-01-29 |
|
|
| 5386 |
Further Directions |
2020-01-28 |
|
|
| 5387 |
Effects of Autism Spectrum Disorder on the Endocannabinoid System |
2020-01-28 |
|
|
| 5388 |
Marijuana and the Endocannabinoid System |
2020-01-28 |
|
|
| 5389 |
Overview of the Endocannabinoid System |
2020-01-28 |
|
|
| 5390 |
Social Impact |
2020-01-28 |
|
|
| 5391 |
Financial Impact |
2020-01-28 |
|
|
| 5392 |
Sibling Impact |
2020-01-28 |
|
|
| 5393 |
The Stress of Father |
2020-01-28 |
|
|
| 5394 |
Maternal Stress |
2020-01-28 |
|
|
| 5395 |
Autism Impact on Parent |
2020-01-28 |
|
|
| 5396 |
Salmon Farming Production and Economic Impact in an International Perspective |
2020-01-28 |
|
|
| 5397 |
Salmon Farming Production and Economic Impact in an International Perspective |
2020-01-28 |
|
|
| 5398 |
Salmon Farming Production and Economic Impact in an International Perspective |
2020-01-28 |
|
|
| 5399 |
The Salmon Farming Licences Process |
2020-01-28 |
|
|
| 5400 |
Law and Regulations Governing Salmon Farming |
2020-01-28 |
|
|
| 5401 |
Guidelines: |
2020-01-27 |
|
|
| 5402 |
Criteria: |
2020-01-27 |
|
|
| 5403 |
Experimental Procedure |
2020-01-25 |
|
|
| 5404 |
Main Body |
2020-01-25 |
|
|
| 5405 |
Funding Organizations |
2020-01-25 |
|
|
| 5406 |
Subjects and Methodology |
2020-01-25 |
|
|
| 5407 |
Study inclusion |
2020-01-24 |
|
|
| 5408 |
Higher-esteem types supported in substance amalgamation |
2020-01-24 |
|
|
| 5409 |
Polymerization impetuses to ascend at solid pace |
2020-01-24 |
|
|
| 5410 |
World interest to rise 4.8% yearly through 2019 |
2020-01-24 |
|
|
| 5411 |
Review Of The Two Landmark Studies on SLE |
2020-01-24 |
|
|
| 5412 |
Kozhikode Criteria [1-3] |
2020-01-24 |
|
|
| 5413 |
Haematological Manifestations of SLE |
2020-01-24 |
|
|
| 5414 |
Case History 17 |
2020-01-24 |
|
|
| 5415 |
Case History 16 |
2020-01-24 |
|
|
| 5416 |
Case History 15 |
2020-01-24 |
|
|
| 5417 |
Case History 14 |
2020-01-24 |
|
|
| 5418 |
Case History 13 |
2020-01-24 |
|
|
| 5419 |
Case History 12 |
2020-01-24 |
|
|
| 5420 |
Case History 11 |
2020-01-24 |
|
|
| 5421 |
Case History 10 |
2020-01-24 |
|
|
| 5422 |
Case History 9 |
2020-01-24 |
|
|
| 5423 |
Case History 8 |
2020-01-24 |
|
|
| 5424 |
Case History 7 |
2020-01-24 |
|
|
| 5425 |
Case History 6 |
2020-01-24 |
|
|
| 5426 |
Case History 5 |
2020-01-24 |
|
|
| 5427 |
Case History 4 |
2020-01-24 |
|
|
| 5428 |
Case History 3 |
2020-01-24 |
|
|
| 5429 |
Case History 2 |
2020-01-24 |
|
|
| 5430 |
Case History 1 |
2020-01-24 |
|
|
| 5431 |
Systemic Lupus Erythematosus (SLE) |
2020-01-24 |
|
|
| 5432 |
Award Announcements: |
2020-01-23 |
|
|
| 5433 |
Conditions of Acceptance: |
2020-01-23 |
|
|
| 5434 |
Strength and Limitation |
2020-01-23 |
|
|
| 5435 |
Outcome Measures |
2020-01-23 |
|
|
| 5436 |
Source and Study Population |
2020-01-22 |
|
|
| 5437 |
Ethical Clearance |
2020-01-22 |
|
|
| 5438 |
Data Processing And Analysis |
2020-01-22 |
|
|
| 5439 |
Study Variables |
2020-01-22 |
|
|
| 5440 |
Importance & Scope |
2020-01-22 |
|
|
| 5441 |
A Glance at Market of Nutrition and Food |
2020-01-22 |
|
|
| 5442 |
Best Poster Award Euro Nutrition 2020 |
2020-01-22 |
|
|
| 5443 |
Outstanding Masters/Ph.D./PostDoc Thesis work presentation Euro Nutrition 2020 |
2020-01-22 |
|
|
| 5444 |
Best Organising Committee Member Euro Nutrition 2020 |
2020-01-22 |
|
|
| 5445 |
Best Key Note Speaker Euro Nutrition 2020 |
2020-01-22 |
|
|
| 5446 |
Outstanding Speaker Euro Nutrition 2020 |
2020-01-22 |
|
|
| 5447 |
Awards at Nutrition & Fitness 2020 |
2020-01-22 |
|
|
| 5448 |
Award recognizes Masters/Ph. D./Post Ph.D |
2020-01-22 |
|
|
| 5449 |
Best Poster Presentation |
2020-01-22 |
|
|
| 5450 |
Best Keynote Speaker |
2020-01-22 |
|
|
| 5451 |
Excellence Award |
2020-01-22 |
|
|
| 5452 |
Out Standing Award |
2020-01-22 |
|
|
| 5453 |
List of Related Journals |
2020-01-21 |
|
|
| 5454 |
Privileges |
2020-01-21 |
|
|
| 5455 |
Best Questioner award: |
2020-01-21 |
|
|
| 5456 |
Young Scientist Award: |
2020-01-21 |
|
|
| 5457 |
Poster Presentation Award: |
2020-01-21 |
|
|
| 5458 |
Best Speaker: |
2020-01-21 |
|
|
| 5459 |
Best Keynote Speaker: |
2020-01-21 |
|
|
| 5460 |
Glycolysis And Age-Related Macromolecular Modification |
2020-01-21 |
|
|
| 5461 |
Expert Level (Scientific service Achievement Award psychology congress 2020) |
2020-01-20 |
|
|
| 5462 |
Best E- poster Award in psychology congress 2020 |
2020-01-20 |
|
|
| 5463 |
Best Poster Presentation in psychology congress 2020 |
2020-01-20 |
|
|
| 5464 |
Best speaker in psychology congress 2020 |
2020-01-20 |
|
|
| 5465 |
Best Keynote Speaker in psychology congress 2020 |
2020-01-20 |
|
|
| 5466 |
Best Organizing Committee Member in Psychology congress 2020 |
2020-01-20 |
|
|
| 5467 |
Award Announcements |
2020-01-20 |
|
|
| 5468 |
Conditions of Acceptance |
2020-01-20 |
|
|
| 5469 |
Guidelines |
2020-01-20 |
|
|
| 5470 |
Criteria |
2020-01-20 |
|
|
| 5471 |
Dissemination Plan |
2020-01-14 |
|
|
| 5472 |
What is the Evidence? Is Risk Pooling Equitable and Lead to Financial Protection? |
2020-01-13 |
|
|
| 5473 |
Brief Overview of Issues related to various Risk Pooling Schemes [9] |
2020-01-13 |
|
|
| 5474 |
Where is Health Expenditure being done? |
2020-01-13 |
|
|
| 5475 |
Has Health Expenditure increased in India since 2004? What is the evidence available from National Health Accounts 2014 of India [11]? |
2020-01-13 |
|
|
| 5476 |
Where is the Gap? – Less % Total Health Expenditure (THE) of GDP or Less allocation of Government Spending on Health? |
2020-01-13 |
|
|
| 5477 |
Can Funding from Donor Agencies Solve the Problem? |
2020-01-13 |
|
|
| 5478 |
Press Release of Optics and Photonics 2020: |
2020-01-13 |
|
|
| 5479 |
Author Info |
2020-01-10 |
|
|
| 5480 |
Exploring the limitless potential of Aerospace for creation of better world Technology |
2020-01-10 |
|
|
| 5481 |
First Case Report |
2020-01-09 |
|
|
| 5482 |
Ethical Approval |
2020-01-09 |
|
|
| 5483 |
The Future of Device Treatments |
2020-01-08 |
|
|
| 5484 |
Congestive Heart Faliure (Novel Therapy) |
2020-01-08 |
|
|
| 5485 |
Problems Associated with the Treatment |
2020-01-08 |
|
|
| 5486 |
Surgery |
2020-01-08 |
|
|
| 5487 |
Devices |
2020-01-08 |
|
|
| 5488 |
Treatment & Conventional Therapies for Congestive Heart Failure |
2020-01-08 |
|
|
| 5489 |
Limitations of Study |
2020-01-07 |
|
|
| 5490 |
Author Contribution |
2020-01-06 |
|
|
| 5491 |
Fundamental Experiments that Ensures this Review Proposal |
2020-01-06 |
|
|
| 5492 |
Advantages of Embryonic Cell Molecules over Stem Cells |
2020-01-06 |
|
|
| 5493 |
Authors' Contribution |
2020-01-06 |
|
|
| 5494 |
Declarations of Interest |
2020-01-06 |
|
|
| 5495 |
Clinical Observations |
2020-01-06 |
|
|
| 5496 |
Methodology and Experimental |
2020-01-06 |
|
|
| 5497 |
Study Area Description |
2020-01-06 |
|
|
| 5498 |
Ethics Statement and Consent |
2020-01-06 |
|
|
| 5499 |
Strengths and Limitations |
2020-01-06 |
|
|
| 5500 |
Adapting To Bereavement |
2020-01-04 |
|
|
| 5501 |
Emotional Crises |
2020-01-04 |
|
|
| 5502 |
Particular problems in adapting to dying |
2020-01-04 |
|
|
| 5503 |
Adapting To Dying |
2020-01-04 |
|
|
| 5504 |
Personal Spirituality |
2020-01-04 |
|
|
| 5505 |
Secrets Of Death System |
2020-01-04 |
|
|
| 5506 |
Fear Of Death In Society |
2020-01-04 |
|
|
| 5507 |
Clinical Evolution |
2020-01-04 |
|
|
| 5508 |
Data and Statistical Analysis |
2020-01-03 |
|
|
| 5509 |
Trial Objectives, Materials and Methods |
2020-01-03 |
|
|
| 5510 |
Declaration of Conflicts of Interest |
2020-01-03 |
|
|
| 5511 |
Various Clinical Observations |
2020-01-03 |
|
|
| 5512 |
Technical Measurements |
2020-01-03 |
|
|
| 5513 |
Potential Conflicts of Interest |
2020-01-03 |
|
|
| 5514 |
Case Synopsis |
2020-01-03 |
|
|
| 5515 |
Antibody Mechanism of Action Against Leukemia and Lymphoma Treatment |
2020-01-02 |
|
|
| 5516 |
Monoclonal Antibody for Lymphoma Treatment |
2020-01-02 |
|
|
| 5517 |
Monoclonal Antibody Treatment of Leukemia and Lymphoma in Recent Perspectives |
2020-01-02 |
|
|
| 5518 |
Development of Therapeutic Antibody Technologies |
2020-01-02 |
|
|
| 5519 |
Voriconazole Prophylaxis |
2020-01-02 |
|
|
| 5520 |
Patient and Methods |
2020-01-02 |
|
|
| 5521 |
Methodological Approach |
2020-01-02 |
|
|
| 5522 |
Suggestions and Recommendations |
2020-01-02 |
|
|
| 5523 |
Future Work |
2019-12-31 |
|
|
| 5524 |
Open doors for Conference Attendees: |
2019-12-31 |
|
|
| 5525 |
Target Audience |
2019-12-31 |
|
|
| 5526 |
Key Major Trends |
2019-12-31 |
|
|
| 5527 |
Major players |
2019-12-31 |
|
|
| 5528 |
Results of Our Pilot Study |
2019-12-31 |
|
|
| 5529 |
noheading |
2019-12-28 |
|
|
| 5530 |
Confidentiality |
2019-12-27 |
|
|
| 5531 |
Clinical Trial Registry And Registration Number |
2019-12-27 |
|
|
| 5532 |
Study Analysis Considerations |
2019-12-27 |
|
|
| 5533 |
Study Setup and Conduct |
2019-12-27 |
|
|
| 5534 |
Patient Recruitment and Retention |
2019-12-27 |
|
|
| 5535 |
Strength and Limitation of the Study |
2019-12-26 |
|
|
| 5536 |
Business Awards (In conference) |
2019-12-26 |
|
|
| 5537 |
Author´s Contributions |
2019-12-26 |
|
|
| 5538 |
Thermotherapy Application Results |
2019-12-26 |
|
|
| 5539 |
Previous Confeernce Conference Gallery Proof |
2019-12-24 |
|
|
| 5540 |
Quality in Primary Care |
2019-12-24 |
|
|
| 5541 |
Contributorship |
2019-12-24 |
|
|
| 5542 |
Scope and Importance |
2019-12-23 |
|
|
| 5543 |
Call for Nominations |
2019-12-23 |
|
|
| 5544 |
Developing trends and modern diagnosis in Neurological Disorders and Stroke Treatment |
2019-12-23 |
|
|
| 5545 |
Annual Congress on Diabetes and Endocrinology-Endocrinology 2020 |
2019-12-23 |
|
|
| 5546 |
Conference Announcement |
2019-12-23 |
|
|
| 5547 |
Expert Level (Scientific Service Achievement Award) |
2019-12-23 |
|
|
| 5548 |
Expert Level |
2019-12-21 |
|
|
| 5549 |
International Conference on Gastroenterology and Digestive Disorders- Gastroenterology and Digestive Disorders 2020 |
2019-12-21 |
|
|
| 5550 |
Business Awards (In conference): |
2019-12-20 |
|
|
| 5551 |
Academic Awards (In conference): |
2019-12-20 |
|
|
| 5552 |
Aim of the Study |
2019-12-19 |
|
|
| 5553 |
Need of the Study |
2019-12-19 |
|
|
| 5554 |
Discussion and Avenues for Further Research |
2019-12-16 |
|
|
| 5555 |
The Age Profile of Successful Aging |
2019-12-16 |
|
|
| 5556 |
Implementation with Share |
2019-12-16 |
|
|
| 5557 |
Measures of Successful Aging |
2019-12-16 |
|
|
| 5558 |
Ethical and Legal Considerations |
2019-12-16 |
|
|
| 5559 |
Market Analysis |
2019-12-12 |
|
|
| 5560 |
Best Poster Awards |
2019-12-11 |
|
|
| 5561 |
Best Abstract Awards |
2019-12-11 |
|
|
| 5562 |
Outstanding Speaker Awards |
2019-12-11 |
|
|
| 5563 |
Survey Tools |
2019-12-11 |
|
|
| 5564 |
Materials and Methods of Work |
2019-12-11 |
|
|
| 5565 |
Conclusions And Future Directions |
2019-12-11 |
|
|
| 5566 |
Survival Outcomes |
2019-12-10 |
|
|
| 5567 |
Cancer-Related Outcomes |
2019-12-10 |
|
|
| 5568 |
Obstetric Outcomes |
2019-12-10 |
|
|
| 5569 |
Gastrointestinal Consequences |
2019-12-10 |
|
|
| 5570 |
Endocrine and Metabolic Consequences |
2019-12-10 |
|
|
| 5571 |
Respiratory Consequences |
2019-12-10 |
|
|
| 5572 |
Geophysical Survey |
2019-12-09 |
|
|
| 5573 |
Geological Setting and Seismicity of the Study Area |
2019-12-09 |
|
|
| 5574 |
Result and Interpretation |
2019-12-09 |
|
|
| 5575 |
Advanced Materials Market Research Scope: |
2019-12-07 |
|
|
| 5576 |
Advanced Materials Market Trends: |
2019-12-07 |
|
|
| 5577 |
Advanced Materials Market Key Players Perspective: |
2019-12-07 |
|
|
| 5578 |
Advanced Materials Market Report: Industry Coverage |
2019-12-07 |
|
|
| 5579 |
Advanced Materials Market Outlook: |
2019-12-07 |
|
|
| 5580 |
Advanced Materials Market Overview: |
2019-12-07 |
|
|
| 5581 |
The Proof of Theorem |
2019-12-06 |
|
|
| 5582 |
Acknowledgements and conflict of Interest |
2019-12-06 |
|
|
| 5583 |
Us Assessment |
2019-12-06 |
|
|
| 5584 |
Recommendations and Conclusion |
2019-12-06 |
|
|
| 5585 |
Future Developments |
2019-12-06 |
|
|
| 5586 |
Osteoarthritis |
2019-12-06 |
|
|
| 5587 |
Psoriatic Arthritis |
2019-12-06 |
|
|
| 5588 |
Systemic Lupus Erythematosus |
2019-12-06 |
|
|
| 5589 |
Rheumatoid Arthritis |
2019-12-06 |
|
|
| 5590 |
Exosome Functions |
2019-12-06 |
|
|
| 5591 |
Exosomes as Biomarkers |
2019-12-06 |
|
|
| 5592 |
Once exosomes are isolated from physiological fluids, it is essential to determine their purity. Exosomes contain certain universal lipids and proteins, including membrane t |
2019-12-06 |
|
|
| 5593 |
Markers Of Exosomes |
2019-12-06 |
|
|
| 5594 |
Immunological Separation |
2019-12-06 |
|
|
| 5595 |
Precipitation |
2019-12-06 |
|
|
| 5596 |
Chromatography |
2019-12-06 |
|
|
| 5597 |
Centrifugation |
2019-12-06 |
|
|
| 5598 |
Methods Of Isolation |
2019-12-06 |
|
|
| 5599 |
Biogenesis |
2019-12-06 |
|
|
| 5600 |
Review Of The History |
2019-12-06 |
|
|
| 5601 |
The Current Malariotherapy For Autoimmune Diseases |
2019-12-04 |
|
|
| 5602 |
The Other Face: Malariotherapy Of Psychiatric Diseases |
2019-12-04 |
|
|
| 5603 |
Malaria As A Lethal Disease |
2019-12-04 |
|
|
| 5604 |
Plant Growth Promoting Bacteria and their Applications |
2019-12-04 |
|
|
| 5605 |
Genomics of Endophytic Bacteria |
2019-12-04 |
|
|
| 5606 |
Current Culture-Independent Techniques for Studying Bacterial Endophytes |
2019-12-04 |
|
|
| 5607 |
Isolation and Identification of Endophytes Using Culture Dependent Methods |
2019-12-04 |
|
|
| 5608 |
Colonization of Endophytes |
2019-12-04 |
|
|
| 5609 |
Biodiversity of Endophytes |
2019-12-04 |
|
|
| 5610 |
Irb Approval |
2019-12-03 |
|
|
| 5611 |
Future Prospectus |
2019-12-03 |
|
|
| 5612 |
Significance of this Case |
2019-12-03 |
|
|
| 5613 |
History and MCG Impressions in January 2019 |
2019-12-03 |
|
|
| 5614 |
Parents Provided QST Therapy Beginning in the Fall of 2015 |
2019-12-03 |
|
|
| 5615 |
E.P. Response to the 12 Step QST Massage |
2019-12-03 |
|
|
| 5616 |
MCG Impressions in Aug 2015 |
2019-12-03 |
|
|
| 5617 |
Subject |
2019-12-03 |
|
|
| 5618 |
Generalizability |
2019-11-29 |
|
|
| 5619 |
Translational Statement |
2019-11-29 |
|
|
| 5620 |
Data Sources/Measurement |
2019-11-29 |
|
|
| 5621 |
Discussion and Literature Review |
2019-11-29 |
|
|
| 5622 |
Foundation |
2019-11-28 |
|
|
| 5623 |
Experiment Consents |
2019-11-28 |
|
|
| 5624 |
Conclusion And Future Prospective |
2019-11-28 |
|
|
| 5625 |
Planktonic Foraminiferal Biozones |
2019-11-27 |
|
|
| 5626 |
Lithostratigraphy |
2019-11-27 |
|
|
| 5627 |
Geological Setting |
2019-11-27 |
|
|
| 5628 |
Biological Pretreatment |
2019-11-27 |
|
|
| 5629 |
Physical-Chemical Pretreatment |
2019-11-27 |
|
|
| 5630 |
Physical Pretreatment |
2019-11-27 |
|
|
| 5631 |
Chemical Pretreatment |
2019-11-27 |
|
|
| 5632 |
Footnote |
2019-11-26 |
|
|
| 5633 |
Comorbidities and Risk Factors |
2019-11-26 |
|
|
| 5634 |
Conclusion and Future Studies |
2019-11-26 |
|
|
| 5635 |
The Limitations of the Study |
2019-11-25 |
|
|
| 5636 |
Notes |
2019-11-25 |
|
|
| 5637 |
Conclusion and Policy Implication |
2019-11-25 |
|
|
| 5638 |
Empirical Analysis and Discussion |
2019-11-25 |
|
|
| 5639 |
The Presented Algorithm |
2019-11-22 |
|
|
| 5640 |
The Acknowledgment of Bloom Filter and Cryptography Algorithm |
2019-11-22 |
|
|
| 5641 |
Conclusion and Future Scope |
2019-11-22 |
|
|
| 5642 |
Study Method and Population |
2019-11-18 |
|
|
| 5643 |
Case Study: Adama Agricultural Solutions |
2019-11-15 |
|
|
| 5644 |
Case Study: Microsoft India and Icrisat |
2019-11-15 |
|
|
| 5645 |
Methodology and Data Collection |
2019-11-15 |
|
|
| 5646 |
Test Methodologies |
2019-11-15 |
|
|
| 5647 |
Artificial Neural Network |
2019-11-15 |
|
|
| 5648 |
Ethical Approval and Informed Consent |
2019-11-15 |
|
|
| 5649 |
Seismogenic Losses |
2019-11-13 |
|
|
| 5650 |
Secondary Seismic Hazard |
2019-11-13 |
|
|
| 5651 |
Seismic Vulnerability of Built Environment |
2019-11-13 |
|
|
| 5652 |
About the Study |
2019-11-13 |
|
|
| 5653 |
Evaluation |
2019-11-13 |
|
|
| 5654 |
Key Message |
2019-11-12 |
|
|
| 5655 |
Investigations on Admission |
2019-11-12 |
|
|
| 5656 |
Conclusions and Outlooks |
2019-11-12 |
|
|
| 5657 |
Time to Act |
2019-11-12 |
|
|
| 5658 |
Child Abuse Cases Reported in Pakistan |
2019-11-12 |
|
|
| 5659 |
Psychological Therapies for Pedophiles |
2019-11-12 |
|
|
| 5660 |
Pharmacological Therapy for Pedophiles |
2019-11-12 |
|
|
| 5661 |
Level of Testosterone in Pedophiles |
2019-11-12 |
|
|
| 5662 |
Behavioural Changes and Eye Movements of Pedophiles |
2019-11-12 |
|
|
| 5663 |
Mental Illness of Pedophiles |
2019-11-12 |
|
|
| 5664 |
Pedophilia-A Psychiatric Disorder |
2019-11-12 |
|
|
| 5665 |
Groups, Modeling & Drug Administration |
2019-11-11 |
|
|
| 5666 |
Common Drug Carriers used in Breast Cancer |
2019-11-11 |
|
|
| 5667 |
Therapeutics Strategies Based on Telomeres and Telomerase |
2019-11-11 |
|
|
| 5668 |
Role of Telomeres and Telomerase in Colorectal Cancer |
2019-11-11 |
|
|
| 5669 |
Telomere Length in Multistep Carcinogenesis |
2019-11-11 |
|
|
| 5670 |
Telomere Homeostasis and Cancer |
2019-11-11 |
|
|
| 5671 |
Mechanisms of Cellular Senescence Induction and Their Connection with Cancer Biology |
2019-11-11 |
|
|
| 5672 |
Structure and Function |
2019-11-11 |
|
|
| 5673 |
Anti-inflammatory Effects of 4-HR |
2019-11-11 |
|
|
| 5674 |
4-Hexylresorcinol as a Non-Enzymatic Glycosylation Inhibitor |
2019-11-11 |
|
|
| 5675 |
4-Hexylresorcinol as Antioxidant |
2019-11-11 |
|
|
| 5676 |
4-Hexylresorcinol as Melanogenic Inhibitor |
2019-11-11 |
|
|
| 5677 |
What is 4-hexylresorcinol? |
2019-11-11 |
|
|
| 5678 |
Recombinant Antibodies |
2019-11-11 |
|
|
| 5679 |
High Mobility Group |
2019-11-11 |
|
|
| 5680 |
Hair Pin Formation |
2019-11-11 |
|
|
| 5681 |
Non-Homologous End Joining |
2019-11-11 |
|
|
| 5682 |
Limitation |
2019-11-09 |
|
|
| 5683 |
VR and Pregnancy |
2019-11-09 |
|
|
| 5684 |
Interactions between climate and Land-use |
2019-11-08 |
|
|
| 5685 |
Climate and Growth |
2019-11-08 |
|
|
| 5686 |
Assay Procedures of ELISA |
2019-11-06 |
|
|
| 5687 |
Description |
2019-11-06 |
|
|
| 5688 |
Complications and Adverse Events |
2019-11-06 |
|
|
| 5689 |
Post-Operative Medication Reduction and IOP Reduction |
2019-11-06 |
|
|
| 5690 |
Success Rates |
2019-11-06 |
|
|
| 5691 |
Lessons Learned |
2019-11-06 |
|
|
| 5692 |
Reasons for Case Selection |
2019-11-06 |
|
|
| 5693 |
Theoretical Background and Literature Review |
2019-11-06 |
|
|
| 5694 |
Surgical Procedure |
2019-11-04 |
|
|
| 5695 |
Statistical Analysis |
2019-11-04 |
|
|
| 5696 |
Review |
2019-11-04 |
|
|
| 5697 |
Limitations and directions for Future research |
2019-11-04 |
|
|
| 5698 |
Results of Factor Analysis and Regression |
2019-11-04 |
|
|
| 5699 |
Recommendations and Contribution to Knowledge |
2019-11-04 |
|
|
| 5700 |
Data Analysis, Results and Discussions |
2019-11-04 |
|
|
| 5701 |
Literature and Hypothesis Development |
2019-11-04 |
|
|
| 5702 |
Limitations of the Study and Direction for Future Research |
2019-11-04 |
|
|
| 5703 |
Conclusions and Policy Implications |
2019-11-04 |
|
|
| 5704 |
Empirical Studies and Hypothesis of the Study |
2019-11-04 |
|
|
| 5705 |
Analysis of Empirical Results |
2019-11-04 |
|
|
| 5706 |
Research Context |
2019-11-04 |
|
|
| 5707 |
Empirical Analysis |
2019-11-04 |
|
|
| 5708 |
Background/Significance |
2019-11-04 |
|
|
| 5709 |
Author’s Contributions |
2019-11-02 |
|
|
| 5710 |
Author’s Contributions |
2019-11-02 |
|
|
| 5711 |
Strengths and limitation of the Study |
2019-11-02 |
|
|
| 5712 |
Factors associated with birth Outcomes among postnatal mothers With diabetes delivered at mkh Hospital |
2019-11-02 |
|
|
| 5713 |
Fetal Outcome |
2019-11-02 |
|
|
| 5714 |
Purpose |
2019-11-01 |
|
|
| 5715 |
Fracture Mode Assessment |
2019-11-01 |
|
|
| 5716 |
Management of Oroantral Fistula |
2019-11-01 |
|
|
| 5717 |
Future Perspective |
2019-10-31 |
|
|
| 5718 |
Applications of the I-Screen |
2019-10-31 |
|
|
| 5719 |
Characteristics of the I-Screen |
2019-10-31 |
|
|
| 5720 |
Study Methods |
2019-10-30 |
|
|
| 5721 |
Treatment Options |
2019-10-30 |
|
|
| 5722 |
Sampling |
2019-10-30 |
|
|
| 5723 |
The Process of Regulation |
2019-10-30 |
|
|
| 5724 |
The Historical Context |
2019-10-30 |
|
|
| 5725 |
Ethical And Professional Considerations |
2019-10-30 |
|
|
| 5726 |
Data Collection and Statistics |
2019-10-30 |
|
|
| 5727 |
Nurses' Professional Needs |
2019-10-30 |
|
|
| 5728 |
The Perceived Ambiguity of Nurses’ Roles |
2019-10-30 |
|
|
| 5729 |
The Perceived Ambiguity of Nurses’ Roles |
2019-10-30 |
|
|
| 5730 |
The Role of Nurses: Nurses' Perceptions |
2019-10-30 |
|
|
| 5731 |
Quality of Nursing Care for Diabetes Patients In Kuwait |
2019-10-30 |
|
|
| 5732 |
Nurses' knowledge and Skills in Diabetes Care in Kuwait |
2019-10-30 |
|
|
| 5733 |
Conclusion and Suggestion |
2019-10-29 |
|
|
| 5734 |
Analysis and Results |
2019-10-29 |
|
|
| 5735 |
On-the-Spot Customer Complaints Feedback |
2019-10-29 |
|
|
| 5736 |
Enhanced Future Service |
2019-10-29 |
|
|
| 5737 |
Tipping |
2019-10-29 |
|
|
| 5738 |
Quality Control |
2019-10-29 |
|
|
| 5739 |
Computational Model |
2019-10-29 |
|
|
| 5740 |
Drift Flux Theory |
2019-10-29 |
|
|
| 5741 |
Flow Patterns |
2019-10-29 |
|
|
| 5742 |
Theoretical Framework |
2019-10-29 |
|
|
| 5743 |
Limitations and Suggestions |
2019-10-29 |
|
|
| 5744 |
Research Method |
2019-10-28 |
|
|
| 5745 |
Major Hypothesis of Fear of Crime |
2019-10-28 |
|
|
| 5746 |
Factors Affecting Fear of Crime |
2019-10-28 |
|
|
| 5747 |
Relevant Literature Linking Fear of Crime |
2019-10-28 |
|
|
| 5748 |
Empirical Background |
2019-10-28 |
|
|
| 5749 |
Scope |
2019-10-28 |
|
|
| 5750 |
Theoretical Justification |
2019-10-28 |
|
|
| 5751 |
Pottery-Making Craftmanship and Economic Empowerment |
2019-10-28 |
|
|
| 5752 |
Public Communication and Investigation |
2019-10-28 |
|
|
| 5753 |
What is Criminological Communication? |
2019-10-28 |
|
|
| 5754 |
“Pathologies” in the Human and digital Communication |
2019-10-28 |
|
|
| 5755 |
Media and Global Information |
2019-10-28 |
|
|
| 5756 |
Intervention Design |
2019-10-28 |
|
|
| 5757 |
Expository Profiles of Educated and Employed Youth Who Joined Anti-India Militant Organization |
2019-10-28 |
|
|
| 5758 |
Bioactive Components in Peanuts |
2019-10-26 |
|
|
| 5759 |
Health Benefits of Peanuts |
2019-10-26 |
|
|
| 5760 |
Peanut as a Functional Food |
2019-10-26 |
|
|
| 5761 |
Histopathological Results |
2019-10-26 |
|
|
| 5762 |
Histological Examination |
2019-10-26 |
|
|
| 5763 |
Material and Methodology |
2019-10-26 |
|
|
| 5764 |
Aim and Objectives of the Study |
2019-10-24 |
|
|
| 5765 |
Suggestions and Countermeasures |
2019-10-23 |
|
|
| 5766 |
Acknowledgment/Funding Sources |
2019-10-23 |
|
|
| 5767 |
Funding/Acknowledgments |
2019-10-23 |
|
|
| 5768 |
Conceptual Framework |
2019-10-22 |
|
|
| 5769 |
Objective of the Study |
2019-10-22 |
|
|
| 5770 |
Observation And Results |
2019-10-22 |
|
|
| 5771 |
Aim and Objective |
2019-10-22 |
|
|
| 5772 |
Assessment |
2019-10-22 |
|
|
| 5773 |
Advantages and Limitations with Using NHPS in Research |
2019-10-22 |
|
|
| 5774 |
Streptozocin-Induced Diabetes In Nhps |
2019-10-22 |
|
|
| 5775 |
Spontaneously Developed Diabetes In Nhps |
2019-10-22 |
|
|
| 5776 |
Different Scaffolds for Targeting Denv Proteins |
2019-10-21 |
|
|
| 5777 |
Composition of Denv |
2019-10-21 |
|
|
| 5778 |
Conclusion and Future Perspectives |
2019-10-21 |
|
|
| 5779 |
Limitations and Future Research |
2019-10-18 |
|
|
| 5780 |
Pilot Study |
2019-10-15 |
|
|
| 5781 |
Pragmatic Judgment Subtests |
2019-10-15 |
|
|
| 5782 |
The Clinical Assessment Of Pragmatics(Caps) |
2019-10-15 |
|
|
| 5783 |
Six Distinct Pragmatic Language Constructs |
2019-10-15 |
|
|
| 5784 |
Determinants of RTCs |
2019-10-14 |
|
|
| 5785 |
Strengths |
2019-10-14 |
|
|
| 5786 |
Procedures |
2019-10-14 |
|
|
| 5787 |
Materials |
2019-10-14 |
|
|
| 5788 |
Nonverbal Language Interventions |
2019-10-14 |
|
|
| 5789 |
Non-Verbal Language |
2019-10-14 |
|
|
| 5790 |
Commonly Occuring Viral Diseases |
2019-10-11 |
|
|
| 5791 |
ED Treatments |
2019-10-07 |
|
|
| 5792 |
OSA Treatment |
2019-10-07 |
|
|
| 5793 |
Association of OSA and ED |
2019-10-07 |
|
|
| 5794 |
Data Collection |
2019-10-07 |
|
|
| 5795 |
Polysomnography |
2019-10-07 |
|
|
| 5796 |
Method and Description of Sample Population |
2019-10-07 |
|
|
| 5797 |
Consent to Participate |
2019-10-07 |
|
|
| 5798 |
Objectives and Methodology |
2019-10-07 |
|
|
| 5799 |
Dosage form Performance |
2019-10-07 |
|
|
| 5800 |
Pharmacokinetics Proprieties |
2019-10-07 |
|
|
| 5801 |
Chemical Properties |
2019-10-07 |
|
|
| 5802 |
Therapeutic Indication |
2019-10-07 |
|
|
| 5803 |
General Characteristics |
2019-10-07 |
|
|
| 5804 |
Glossary of Terms |
2019-10-07 |
|
|
| 5805 |
General Approaches to Establish Bioequivalence |
2019-10-07 |
|
|
| 5806 |
Molecular Data Analysis |
2019-10-07 |
|
|
| 5807 |
Research Aim and Objectives |
2019-10-04 |
|
|
| 5808 |
Data Analysis Results |
2019-10-04 |
|
|
| 5809 |
Disclosures |
2019-10-04 |
|
|
| 5810 |
Statement of Ethics |
2019-10-04 |
|
|
| 5811 |
Histogram Equalization |
2019-10-04 |
|
|
| 5812 |
Percentiles of Pregnancy Outcomes with Maternal Age |
2019-10-04 |
|
|
| 5813 |
Adaptive Immune Response |
2019-10-01 |
|
|
| 5814 |
Innate Immune Response |
2019-10-01 |
|
|
| 5815 |
Immune Response |
2019-10-01 |
|
|
| 5816 |
Suggestions and counter measures |
2019-10-01 |
|
|
| 5817 |
Acknowledgements |
2019-09-28 |
|
|
| 5818 |
Competing Financial Interest |
2019-09-28 |
|
|
| 5819 |
Roles and Responsibilities of the Advanced Practice Nurse |
2019-09-27 |
|
|
| 5820 |
Bioethical Principles |
2019-09-27 |
|
|
| 5821 |
Analysis |
2019-09-27 |
|
|
| 5822 |
Current Issues & Future trends |
2019-09-27 |
|
|
| 5823 |
Health System Transformation |
2019-09-27 |
|
|
| 5824 |
National Health Stack |
2019-09-27 |
|
|
| 5825 |
The National Health Resource Repositor |
2019-09-27 |
|
|
| 5826 |
Financing NHPS |
2019-09-27 |
|
|
| 5827 |
Factors Necessitating Health Reform |
2019-09-27 |
|
|
| 5828 |
Others |
2019-09-27 |
|
|
| 5829 |
Enhancing the Capacity of Metabolite Transport Processes and Carbon Utilization |
2019-09-27 |
|
|
| 5830 |
Enhancing Enzyme Activity of Calvin Cycle |
2019-09-27 |
|
|
| 5831 |
Enhancing Rate of Chloroplast Electron Transport |
2019-09-27 |
|
|
| 5832 |
Enhancing CO2 Levels Around Rubisco to Maximize Catalytic Rate and Minimize Photorespiration |
2019-09-27 |
|
|
| 5833 |
Enhancing CO2 Levels Around Rubisco to Maximize Catalytic Rate and Minimize Photorespiration |
2019-09-27 |
|
|
| 5834 |
Increasing the Thermotolerance of Rubisco Activase to Sustain Rubisco Activity under High Temperatures |
2019-09-27 |
|
|
| 5835 |
Improving the Rubisco Performance via Quality Control and/or Quantity Control |
2019-09-27 |
|
|
| 5836 |
Conclusions and Future Perspectives |
2019-09-27 |
|
|
| 5837 |
Hormone Interactions During Nodule Development |
2019-09-27 |
|
|
| 5838 |
Hormones and Autoregulation of Nodulation |
2019-09-27 |
|
|
| 5839 |
Regulation of Cortex Responses and Primordium Formation |
2019-09-27 |
|
|
| 5840 |
Regulation of Cortex Responses and Primordium Formation |
2019-09-27 |
|
|
| 5841 |
Hormone Regulation of Root Hair and Epidermal Responses |
2019-09-27 |
|
|
| 5842 |
Concluding Remarks |
2019-09-26 |
|
|
| 5843 |
Physiological Roles of Oxylipins Produced via the HPL Branch |
2019-09-26 |
|
|
| 5844 |
Endocellular Localisation of HPLs |
2019-09-26 |
|
|
| 5845 |
Plant HPLs are Involved in Stress Induced Biosynthesis of Volatile Aldehydes |
2019-09-26 |
|
|
| 5846 |
The CYP74 Cytochrome P450 Family |
2019-09-26 |
|
|
| 5847 |
Supporting Information |
2019-09-26 |
|
|
| 5848 |
Conclusion and Further Research |
2019-09-25 |
|
|
| 5849 |
Methods of Treating Chronic Pain |
2019-09-25 |
|
|
| 5850 |
Economic Impact of Pain |
2019-09-25 |
|
|
| 5851 |
Way Forward |
2019-09-23 |
|
|
| 5852 |
Design Optimization |
2019-09-23 |
|
|
| 5853 |
Silicon Mechanical Properties |
2019-09-23 |
|
|
| 5854 |
Structural Design |
2019-09-23 |
|
|
| 5855 |
Model Validation and Numerical Results |
2019-09-23 |
|
|
| 5856 |
Mathematical Modelling |
2019-09-23 |
|
|
| 5857 |
FEM Simulation |
2019-09-23 |
|
|
| 5858 |
Methodology and Experiment |
2019-09-23 |
|
|
| 5859 |
Recomendations |
2019-09-20 |
|
|
| 5860 |
Consequence |
2019-09-20 |
|
|
| 5861 |
Opposing Point |
2019-09-20 |
|
|
| 5862 |
Thermodynamic Analysis of Test Cases |
2019-09-20 |
|
|
| 5863 |
Silver Oxygen Desorption Experiments |
2019-09-20 |
|
|
| 5864 |
Silver Aerosolization Experiments |
2019-09-20 |
|
|
| 5865 |
LMMHD Cycle |
2019-09-20 |
|
|
| 5866 |
Ethics approval and consent to Participate |
2019-09-19 |
|
|
| 5867 |
Acknowledgment |
2019-09-19 |
|
|
| 5868 |
Patents |
2019-09-19 |
|
|
| 5869 |
EBC pH as a Biomarker of Clinical Conditions |
2019-09-19 |
|
|
| 5870 |
Physiological Ph of EBC |
2019-09-19 |
|
|
| 5871 |
Sample Issues |
2019-09-19 |
|
|
| 5872 |
Meta-Analysis |
2019-09-19 |
|
|
| 5873 |
Discussion and Conclusions |
2019-09-19 |
|
|
| 5874 |
Effect of NPs on the carbon particle clearance of mice |
2019-09-19 |
|
|
| 5875 |
GAP ON LAW |
2019-09-19 |
|
|
| 5876 |
Lack of Awareness |
2019-09-19 |
|
|
| 5877 |
Causes for the Destruction |
2019-09-19 |
|
|
| 5878 |
The Current Situation of Archives |
2019-09-19 |
|
|
| 5879 |
Discussion of Findings |
2019-09-18 |
|
|
| 5880 |
Research Methods and Materials |
2019-09-18 |
|
|
| 5881 |
Summary and Concluding Remarks |
2019-09-18 |
|
|
| 5882 |
The Results and Findings |
2019-09-18 |
|
|
| 5883 |
Experimental Section |
2019-09-16 |
|
|
| 5884 |
Pathophysiology |
2019-09-16 |
|
|
| 5885 |
The Aim of the Work |
2019-09-14 |
|
|
| 5886 |
Overview of Pocket Parks |
2019-09-14 |
|
|
| 5887 |
Measures |
2019-09-12 |
|
|
| 5888 |
Availability of Data and Materials Section |
2019-09-12 |
|
|
| 5889 |
Clinical Observation |
2019-09-11 |
|
|
| 5890 |
Study Design |
2019-09-10 |
|
|
| 5891 |
Introduction And Objectives |
2019-09-10 |
|
|
| 5892 |
Clinical Studies |
2019-09-10 |
|
|
| 5893 |
Transparency |
2019-09-10 |
|
|
| 5894 |
Emulsion Characterization And Stability Tests |
2019-09-10 |
|
|
| 5895 |
Study Aim |
2019-09-10 |
|
|
| 5896 |
Complications |
2019-09-09 |
|
|
| 5897 |
Conservative Management and its limitation- Page Kidney |
2019-09-09 |
|
|
| 5898 |
Management According to Grade of Renal Injury |
2019-09-09 |
|
|
| 5899 |
Case 2 |
2019-09-09 |
|
|
| 5900 |
Case 1 |
2019-09-09 |
|
|
| 5901 |
Grant |
2019-09-09 |
|
|
| 5902 |
Method for Literature Review |
2019-09-07 |
|
|
| 5903 |
Discussion about Diagnostic Methods |
2019-09-07 |
|
|
| 5904 |
Calculation of the Mooring Force |
2019-09-06 |
|
|
| 5905 |
Calculation of the Wave Load and Motion Response |
2019-09-06 |
|
|
| 5906 |
Basic Theory |
2019-09-06 |
|
|
| 5907 |
Experimental Methodology |
2019-09-06 |
|
|
| 5908 |
Materials and Methodology |
2019-09-06 |
|
|
| 5909 |
Methods of Preparation |
2019-09-06 |
|
|
| 5910 |
Process Management and Change Management in the Organization |
2019-09-05 |
|
|
| 5911 |
Process Management and Change Management in the Organization |
2019-09-05 |
|
|
| 5912 |
Organization's Ability to Change |
2019-09-05 |
|
|
| 5913 |
The Role of Manager in Counteracting Crisis Phenomena |
2019-09-05 |
|
|
| 5914 |
The Reasons for the Crisis in the Enterprise |
2019-09-05 |
|
|
| 5915 |
Crisis Management and Risk Management Process in the Enterprise |
2019-09-05 |
|
|
| 5916 |
Literature Review |
2019-09-05 |
|
|
| 5917 |
Future Perspectives |
2019-09-05 |
|
|
| 5918 |
Geographic Distribution |
2019-09-05 |
|
|
| 5919 |
When Analysis Can Be Useful |
2019-09-05 |
|
|
| 5920 |
What Cell To Examine |
2019-09-05 |
|
|
| 5921 |
Why Membrane Phospholipids |
2019-09-05 |
|
|
| 5922 |
Eligibility |
2019-09-03 |
|
|
| 5923 |
Data Management |
2019-09-03 |
|
|
| 5924 |
Data Collection Methods |
2019-09-03 |
|
|
| 5925 |
Measurement of Variables |
2019-09-03 |
|
|
| 5926 |
Opinion |
2019-09-03 |
|
|
| 5927 |
Methods and Material |
2019-09-03 |
|
|
| 5928 |
Acronyms and Abbreviations |
2019-09-03 |
|
|
| 5929 |
Conclusions: Implications for Policy and Law Reform |
2019-09-03 |
|
|
| 5930 |
Sexual and Stress Immunisation Protocols |
2019-09-03 |
|
|
| 5931 |
Relapse-Prevention Innovation and Guided Stimulant Use |
2019-09-03 |
|
|
| 5932 |
The Fortified-Cognition Hypothesis and Psychopharmacological Treatment Potential Of Methamphetamine |
2019-09-03 |
|
|
| 5933 |
Evaluation of Immunohistochemically Stained Tissue Sections (Α-Smooth Muscle Actin) |
2019-09-03 |
|
|
| 5934 |
Evaluation of Immunohistochemically Stained Tissue Sections (Α-Smooth Muscle Actin) |
2019-09-03 |
|
|
| 5935 |
Procedure for Immunohistochemical Staining using Α- Smooth Muscle Actin |
2019-09-03 |
|
|
| 5936 |
Disclamier |
2019-09-03 |
|
|
| 5937 |
Research Methods |
2019-08-29 |
|
|
| 5938 |
Discussion of Result |
2019-08-28 |
|
|
| 5939 |
Data Presentation and Analysis |
2019-08-28 |
|
|
| 5940 |
Background of the Study |
2019-08-28 |
|
|
| 5941 |
Outcomes/Recommendations |
2019-08-28 |
|
|
| 5942 |
Authorship |
2019-08-28 |
|
|
| 5943 |
Future Directions/Follow-Up |
2019-08-28 |
|
|
| 5944 |
Due To This Discrepancy A Bioavailability Problem Is To Be Considered |
2019-08-28 |
|
|
| 5945 |
Physiochemical Data and Calculations |
2019-08-28 |
|
|
| 5946 |
Clinical Pharmaceutics Issues |
2019-08-28 |
|
|
| 5947 |
Additional Details |
2019-08-28 |
|
|
| 5948 |
Description Of The Problem |
2019-08-28 |
|
|
| 5949 |
FT–IR analysis of Alternanthera sessilis (Linn) |
2019-08-26 |
|
|
| 5950 |
GC-MS Analysis of Alternanthera sessilis (Linn) |
2019-08-26 |
|
|
| 5951 |
Cytotoxic Study of Alternanthera sessilis (Linn) Leaf and Stem Extracts on Corneal Cell Line (SIRC) Proliferation |
2019-08-26 |
|
|
| 5952 |
Antibacterial Activities of Alternanthera sessilis (Linn) Leaf and Stem Extract |
2019-08-26 |
|
|
| 5953 |
Ferric Reducing Ability (FRAP) Test |
2019-08-26 |
|
|
| 5954 |
Antioxidant activities |
2019-08-26 |
|
|
| 5955 |
Effect of Alternanthera sessilis (Linn) Aqueous Extracts on Corneal Cell (SIRC) Proliferation |
2019-08-26 |
|
|
| 5956 |
Antibacterial Activity |
2019-08-26 |
|
|
| 5957 |
Antioxidant Activity |
2019-08-26 |
|
|
| 5958 |
Mechanism of Pain Generation |
2019-08-24 |
|
|
| 5959 |
Diagnosis and Imaging |
2019-08-24 |
|
|
| 5960 |
Epidemiology |
2019-08-24 |
|
|
| 5961 |
Anatomical Changes and Pathology |
2019-08-24 |
|
|
| 5962 |
Prognosis of MD and Conclusion |
2019-08-24 |
|
|
| 5963 |
Treatment and Management of MD |
2019-08-24 |
|
|
| 5964 |
Pathophysiology of MD |
2019-08-24 |
|
|
| 5965 |
Clinical Signs and Symptoms of MD |
2019-08-24 |
|
|
| 5966 |
Risk Factors of MD |
2019-08-24 |
|
|
| 5967 |
Duchenne MD |
2019-08-24 |
|
|
| 5968 |
Facioscapulohumeral MD (FSHD) |
2019-08-24 |
|
|
| 5969 |
Genetic Predisposition and Variation in MD |
2019-08-24 |
|
|
| 5970 |
Complication of MD |
2019-08-24 |
|
|
| 5971 |
Emery-dreifuss MD |
2019-08-24 |
|
|
| 5972 |
Different Types of MD |
2019-08-24 |
|
|
| 5973 |
Incidence and Prevalence of MD Worldwide |
2019-08-24 |
|
|
| 5974 |
Bone Reconstruction |
2019-08-24 |
|
|
| 5975 |
Wound Coverage |
2019-08-24 |
|
|
| 5976 |
Internal Fixation |
2019-08-24 |
|
|
| 5977 |
Temporary Skeletal Stabilization |
2019-08-24 |
|
|
| 5978 |
Acute Compartment Syndrome |
2019-08-24 |
|
|
| 5979 |
Bone and Soft Tissue Debridement |
2019-08-24 |
|
|
| 5980 |
Evaluation of Vascular Injury |
2019-08-24 |
|
|
| 5981 |
Antibiotherapy |
2019-08-24 |
|
|
| 5982 |
Scores |
2019-08-24 |
|
|
| 5983 |
Open Fracture Classification |
2019-08-24 |
|
|
| 5984 |
Algorithm and Initial Evaluation |
2019-08-24 |
|
|
| 5985 |
Epidemiology and Etiology |
2019-08-24 |
|
|
| 5986 |
History |
2019-08-24 |
|
|
| 5987 |
Findings and Conclusion |
2019-08-23 |
|
|
| 5988 |
Palliative Therapy |
2019-08-23 |
|
|
| 5989 |
Forecast |
2019-08-23 |
|
|
| 5990 |
Data/Data Analysis |
2019-08-23 |
|
|
| 5991 |
Experiment Session |
2019-08-23 |
|
|
| 5992 |
Study Objectives |
2019-08-23 |
|
|
| 5993 |
Participants |
2019-08-23 |
|
|
| 5994 |
Preliminary Study |
2019-08-23 |
|
|
| 5995 |
Right-to-Live (RtL) Autism Centre |
2019-08-23 |
|
|
| 5996 |
Findings and Discussions |
2019-08-22 |
|
|
| 5997 |
Seasonal Outlook |
2019-08-22 |
|
|
| 5998 |
Rainfall Season Characteristics |
2019-08-22 |
|
|
| 5999 |
Mean Monthly Rainfall |
2019-08-22 |
|
|
| 6000 |
Boundary Conditions and Inputs |
2019-08-22 |
|
|
| 6001 |
CFD Modelling and Meshing |
2019-08-22 |
|
|
| 6002 |
Problem Definition |
2019-08-22 |
|
|
| 6003 |
Objective |
2019-08-22 |
|
|
| 6004 |
Location of the Municipalities of Rio Branco do Ivaí and Rosario do Ivai |
2019-08-22 |
|
|
| 6005 |
Tornadoes |
2019-08-22 |
|
|
| 6006 |
Data Base and Methodology |
2019-08-22 |
|
|
| 6007 |
Study Area |
2019-08-22 |
|
|
| 6008 |
Quality Assurance, Certification and Standardisation |
2019-08-22 |
|
|
| 6009 |
Rapid Tooling and Repairing |
2019-08-22 |
|
|
| 6010 |
Critical Attributes and Significant Applications of AM in the Aircraft Industry |
2019-08-22 |
|
|
| 6011 |
Melanin and Synthesis of Vitamin D3 |
2019-08-21 |
|
|
| 6012 |
Determination of curcumin content in turmeric extracts |
2019-08-20 |
|
|
| 6013 |
Biomarkers for Tailored Probiotics |
2019-08-20 |
|
|
| 6014 |
Dietary Globalization |
2019-08-20 |
|
|
| 6015 |
Factors Determine Probiotic Effects |
2019-08-20 |
|
|
| 6016 |
Microorganisms Activity in Food and its Impact on Human Beings |
2019-08-20 |
|
|
| 6017 |
Nutrifortified Diets and Preparations |
2019-08-20 |
|
|
| 6018 |
Future Research Work Recommendation |
2019-08-20 |
|
|
| 6019 |
Experimental |
2019-08-20 |
|
|
| 6020 |
The Potential of Membrane Application |
2019-08-20 |
|
|
| 6021 |
Membrane Separation |
2019-08-20 |
|
|
| 6022 |
Metals Impurities |
2019-08-20 |
|
|
| 6023 |
The Problem of Thickening and Hydration |
2019-08-20 |
|
|
| 6024 |
Coalescence |
2019-08-20 |
|
|
| 6025 |
Oswald Ripening |
2019-08-20 |
|
|
| 6026 |
Flocculation |
2019-08-20 |
|
|
| 6027 |
Creaming and Sedimentation |
2019-08-20 |
|
|
| 6028 |
Emulsions Stability |
2019-08-20 |
|
|
| 6029 |
Conflict of Interest Disclosures |
2019-08-16 |
|
|
| 6030 |
Summary of Results |
2019-08-16 |
|
|
| 6031 |
Patient Consent for Publication |
2019-08-16 |
|
|
| 6032 |
Need Assessment and the Socio-Cultural and Technical Feasibility Assessment |
2019-08-16 |
|
|
| 6033 |
Study Location |
2019-08-16 |
|
|
| 6034 |
Sustainable and User-Friendly Aspects of Developing a Mobile Application |
2019-08-16 |
|
|
| 6035 |
Theoretical Background |
2019-08-16 |
|
|
| 6036 |
Information Technological Interventions for Prevention of Dengue in Sri Lanka |
2019-08-16 |
|
|
| 6037 |
Open Source Technology as a Tool in the Field of Public Health Sector |
2019-08-16 |
|
|
| 6038 |
Authors' Information |
2019-08-16 |
|
|
| 6039 |
Patient Presentation |
2019-08-16 |
|
|
| 6040 |
Skin and Synthesis of Vitamin D3 |
2019-08-16 |
|
|
| 6041 |
Melanocytes |
2019-08-16 |
|
|
| 6042 |
Epidermal Cells |
2019-08-16 |
|
|
| 6043 |
Anatomy of Human Skin |
2019-08-16 |
|
|
| 6044 |
Authors’ Competing Interests |
2019-08-14 |
|
|
| 6045 |
Health System Leadership & Governance Situation |
2019-08-14 |
|
|
| 6046 |
Declaration |
2019-08-14 |
|
|
| 6047 |
Ethical Consideration |
2019-08-14 |
|
|
| 6048 |
Quality Assurance |
2019-08-14 |
|
|
| 6049 |
Time Plan for the Study |
2019-08-14 |
|
|
| 6050 |
Data Collection, Management, and Analysis |
2019-08-14 |
|
|
| 6051 |
Study Design and Sampling |
2019-08-14 |
|
|
| 6052 |
The Rationale for the Study |
2019-08-14 |
|
|
| 6053 |
Background of the Country and Sample District |
2019-08-14 |
|
|
| 6054 |
Prevention and Control Strategies |
2019-08-14 |
|
|
| 6055 |
Treatment and Antimicrobial Resistance |
2019-08-14 |
|
|
| 6056 |
Clinical Features |
2019-08-14 |
|
|
| 6057 |
The Status of Foodborne Campylobacter Spp. in Ethiopia |
2019-08-14 |
|
|
| 6058 |
Economic Significance |
2019-08-14 |
|
|
| 6059 |
Public Health Significance |
2019-08-14 |
|
|
| 6060 |
Zoonotic Potential and Sources Of Infection |
2019-08-14 |
|
|
| 6061 |
Host Distribution |
2019-08-14 |
|
|
| 6062 |
Survival and Growth Characteristics |
2019-08-14 |
|
|
| 6063 |
Morphology and Biochemical Properties |
2019-08-14 |
|
|
| 6064 |
Taxonomy |
2019-08-14 |
|
|
| 6065 |
Etiology |
2019-08-14 |
|
|
| 6066 |
Sources of Funding |
2019-08-14 |
|
|
| 6067 |
Possible Risks |
2019-08-14 |
|
|
| 6068 |
Potassium Intake Studies |
2019-08-14 |
|
|
| 6069 |
Adequate Potassium Intake and Its Benefits |
2019-08-14 |
|
|
| 6070 |
Potassium Homeostasis |
2019-08-14 |
|
|
| 6071 |
Review of HBM Constructs |
2019-08-14 |
|
|
| 6072 |
Neurogenic Tumors |
2019-08-14 |
|
|
| 6073 |
Germ Cell Tumors |
2019-08-14 |
|
|
| 6074 |
Clinical And Imaging Findings |
2019-08-14 |
|
|
| 6075 |
Results of the Study |
2019-08-14 |
|
|
| 6076 |
Introduction: Overview of Back Pain |
2019-08-13 |
|
|
| 6077 |
Explaining the Dependent Variable |
2019-08-13 |
|
|
| 6078 |
Discussing the Independent Variables |
2019-08-13 |
|
|
| 6079 |
Aims and Objectives |
2019-08-12 |
|
|
| 6080 |
Summary And Perspective |
2019-08-10 |
|
|
| 6081 |
Technologies For Mapm Fabrication |
2019-08-10 |
|
|
| 6082 |
Mechanism Of The Perm-Selective Separation Of Masms |
2019-08-10 |
|
|
| 6083 |
Results of Digital Human Modelling |
2019-08-02 |
|
|
| 6084 |
Mannequin posture during lifting Weight |
2019-08-02 |
|
|
| 6085 |
Second Line Therapy |
2019-08-02 |
|
|
| 6086 |
First Line Therapy |
2019-08-02 |
|
|
| 6087 |
Experimental and Practical Investigation of the Methodology Accepted |
2019-08-02 |
|
|
| 6088 |
Treatment Options |
2019-08-02 |
|
|
| 6089 |
Current Status of the Problem of Multiple Sclerosis |
2019-08-02 |
|
|
| 6090 |
Interest Conflict |
2019-08-02 |
|
|
| 6091 |
Integrated Pest Management (Ipm) |
2019-08-01 |
|
|
| 6092 |
Sterile Insect Release (Sir) |
2019-08-01 |
|
|
| 6093 |
Sterile Insect Technique (Sit) |
2019-08-01 |
|
|
| 6094 |
Sterile Insect Technique (Sit) |
2019-08-01 |
|
|
| 6095 |
Control and management strategies of sweet potato weevils |
2019-08-01 |
|
|
| 6096 |
Causes of Infestation of Sweet Potato Weevils |
2019-08-01 |
|
|
| 6097 |
Major sweet potato weevils; mode of Infestation |
2019-08-01 |
|
|
| 6098 |
Hemolytic Uremic Syndromes |
2019-08-01 |
|
|
| 6099 |
Case Series |
2019-08-01 |
|
|
| 6100 |
Headform kinematics |
2019-07-29 |
|
|
| 6101 |
Helmets |
2019-07-29 |
|
|
| 6102 |
Storage and Statistical Processing |
2019-07-27 |
|
|
| 6103 |
Ethical Repairs |
2019-07-27 |
|
|
| 6104 |
Source of Support |
2019-07-27 |
|
|
| 6105 |
Cost Comparision |
2019-07-27 |
|
|
| 6106 |
Future Directions |
2019-07-26 |
|
|
| 6107 |
Short Communication |
2019-07-26 |
|
|
| 6108 |
Data Collection Tools |
2019-07-26 |
|
|
| 6109 |
Suggestions For Further Research |
2019-07-26 |
|
|
| 6110 |
Suggestions Based On The Study |
2019-07-26 |
|
|
| 6111 |
Tenability Of Hypotheses |
2019-07-26 |
|
|
| 6112 |
Objective Wise Analysis |
2019-07-26 |
|
|
| 6113 |
Conclusion Based On The Findings Of The Study |
2019-07-26 |
|
|
| 6114 |
Sample |
2019-07-26 |
|
|
| 6115 |
Variables |
2019-07-26 |
|
|
| 6116 |
Discrimination Of The Tool |
2019-07-26 |
|
|
| 6117 |
Tools |
2019-07-26 |
|
|
| 6118 |
Research Design |
2019-07-26 |
|
|
| 6119 |
Hypothesis |
2019-07-26 |
|
|
| 6120 |
Operational Definitions |
2019-07-26 |
|
|
| 6121 |
Justification |
2019-07-26 |
|
|
| 6122 |
Purpose of the Study |
2019-07-26 |
|
|
| 6123 |
Loan And Credits |
2019-07-26 |
|
|
| 6124 |
Barriers To Pulmonary Rehabilitation: Poor Referral And Pr Completion Rates |
2019-07-25 |
|
|
| 6125 |
Literature Search |
2019-07-25 |
|
|
| 6126 |
Low Toxicity Of Functionalized Gd@C82 |
2019-07-24 |
|
|
| 6127 |
Antineoplastic activities of Functionalized Gd@C82 via disrupting Vasculature under radiofrequency |
2019-07-24 |
|
|
| 6128 |
Antineoplastic activities of Functionalized Gd@C82 via inhibiting Angiogenesis |
2019-07-24 |
|
|
| 6129 |
Fullerenes And Metallofullerenes |
2019-07-24 |
|
|
| 6130 |
Research Tasks |
2019-07-24 |
|
|
| 6131 |
Goal of Research |
2019-07-24 |
|
|
| 6132 |
Author's Contributions |
2019-07-24 |
|
|
| 6133 |
Rock Magnetic Results |
2019-07-23 |
|
|
| 6134 |
Sampling and Methods |
2019-07-23 |
|
|
| 6135 |
Literature Review: Characteristics of Dairy Value Chain in Ethiopia |
2019-07-23 |
|
|
| 6136 |
General Conclusions |
2019-07-23 |
|
|
| 6137 |
Afterword |
2019-07-23 |
|
|
| 6138 |
Modified Henderson |
2019-07-23 |
|
|
| 6139 |
DARKNESS INTO LIGHT |
2019-07-23 |
|
|
| 6140 |
Episode 3 of 3 |
2019-07-23 |
|
|
| 6141 |
Episode 2 of 3 |
2019-07-23 |
|
|
| 6142 |
Episode 1 of 3 |
2019-07-23 |
|
|
| 6143 |
Responding Methods |
2019-07-22 |
|
|
| 6144 |
Hardware |
2019-07-22 |
|
|
| 6145 |
Data Recording |
2019-07-22 |
|
|
| 6146 |
Declaration of Patient Consent |
2019-07-20 |
|
|
| 6147 |
Prevention and Control |
2019-07-15 |
|
|
| 6148 |
Antibiotic Resistance |
2019-07-15 |
|
|
| 6149 |
Laboratory Diagnosis |
2019-07-15 |
|
|
| 6150 |
Diseases |
2019-07-15 |
|
|
| 6151 |
Pathogenesis |
2019-07-15 |
|
|
| 6152 |
Transmission |
2019-07-15 |
|
|
| 6153 |
Growth and Biochemical Properties |
2019-07-15 |
|
|
| 6154 |
Epidemiological View of Campylobacter in Pakistan |
2019-07-15 |
|
|
| 6155 |
Review of Literature |
2019-07-15 |
|
|
| 6156 |
Perspective |
2019-07-15 |
|
|
| 6157 |
Authors Contribution |
2019-07-15 |
|
|
| 6158 |
Molecular Characterization of Bacterial Isolates |
2019-07-15 |
|
|
| 6159 |
Animal Based Fats |
2019-07-15 |
|
|
| 6160 |
Pathogens of Concern |
2019-07-15 |
|
|
| 6161 |
Undersea Acoustic Sensing |
2019-07-15 |
|
|
| 6162 |
Sound Speed Profiles |
2019-07-15 |
|
|
| 6163 |
Experiment |
2019-07-15 |
|
|
| 6164 |
Description Of Aquaqaud |
2019-07-15 |
|
|
| 6165 |
Future Research |
2019-07-08 |
|
|
| 6166 |
Mathematical Modeling |
2019-07-08 |
|
|
| 6167 |
Study Tasks and Justification |
2019-07-08 |
|
|
| 6168 |
Theoretical Research |
2019-07-08 |
|
|
| 6169 |
Management |
2019-07-06 |
|
|
| 6170 |
Statistical Analysis And Results |
2019-07-03 |
|
|
| 6171 |
Clinical Implications |
2019-07-03 |
|
|
| 6172 |
Ethics Statement |
2019-07-01 |
|
|
| 6173 |
Ethical Approval and Consent to Participate |
2019-07-01 |
|
|
| 6174 |
Limitation of the Study |
2019-07-01 |
|
|
| 6175 |
Strength of the Study |
2019-07-01 |
|
|
| 6176 |
Contributors Statement Page |
2019-06-29 |
|
|
| 6177 |
Clinical trial registration |
2019-06-29 |
|
|
| 6178 |
Funding Source |
2019-06-29 |
|
|
| 6179 |
Implementation |
2019-06-29 |
|
|
| 6180 |
Neutralizing Buffered Peptone Water |
2019-06-29 |
|
|
| 6181 |
Sanitizer Carry-Over |
2019-06-29 |
|
|
| 6182 |
Result and Discussion |
2019-06-28 |
|
|
| 6183 |
Definitions |
2019-06-28 |
|
|
| 6184 |
Submitral Aneurysm |
2019-06-28 |
|
|
| 6185 |
Treatment |
2019-06-28 |
|
|
| 6186 |
Diagnosis |
2019-06-28 |
|
|
| 6187 |
Microbiological Profile and Modified Duke’s Criteria |
2019-06-28 |
|
|
| 6188 |
Infective Endocarditis |
2019-06-28 |
|
|
| 6189 |
Procedure |
2019-06-28 |
|
|
| 6190 |
Case Description |
2019-06-28 |
|
|
| 6191 |
Experimental Design |
2019-06-27 |
|
|
| 6192 |
The Complex and Amazing Interpretation of Nature |
2019-06-27 |
|
|
| 6193 |
Symphonic Poem of 100 Metronomes and the Experimental Model |
2019-06-27 |
|
|
| 6194 |
Results of Experimental Assays |
2019-06-27 |
|
|
| 6195 |
Competing Interest |
2019-06-27 |
|
|
| 6196 |
Authors’ Contribution |
2019-06-27 |
|
|
| 6197 |
Component of Snake Venom (Bj46a) and Mmps |
2019-06-27 |
|
|
| 6198 |
OMEGA-3 FATTY ACIDS AND MMPs |
2019-06-27 |
|
|
| 6199 |
The Dependence between the Stress and MMPs |
2019-06-27 |
|
|
| 6200 |
The Relation between Caffeine and MMPs |
2019-06-27 |
|
|
| 6201 |
The Relation between Melatonin and MMPs Enzyme |
2019-06-27 |
|
|
| 6202 |
The Role of Vitamin C and E in MMPs Inactivity |
2019-06-27 |
|
|
| 6203 |
Correlations |
2019-06-18 |
|
|
| 6204 |
Possible Consequences |
2019-06-18 |
|
|
| 6205 |
Counter Arguments |
2019-06-18 |
|
|
| 6206 |
My Position |
2019-06-18 |
|
|
| 6207 |
Analysis of the Issue in Pakistani Context |
2019-06-18 |
|
|
| 6208 |
Scenario |
2019-06-18 |
|
|
| 6209 |
Method of the Study |
2019-06-18 |
|
|
| 6210 |
Conservative Management |
2019-06-17 |
|
|
| 6211 |
Operative Considerations |
2019-06-17 |
|
|
| 6212 |
Timing of Delivery |
2019-06-17 |
|
|
| 6213 |
Preoperative Planning |
2019-06-17 |
|
|
| 6214 |
Significance |
2019-06-17 |
|
|
| 6215 |
Ethical Statement |
2019-06-17 |
|
|
| 6216 |
Humanization as A Possible Solution to Overcoming the Psychological Vulnerability of A Mother Who Has Given Birth to A Preterm Baby |
2019-06-15 |
|
|
| 6217 |
The Psychological Vulnerability ofA Mother Giving Birth to A Premature Baby |
2019-06-15 |
|
|
| 6218 |
The Psychology of the Child and of the Mother in Preterm Birth |
2019-06-15 |
|
|
| 6219 |
Abbrevations and Acronyms |
2019-06-13 |
|
|
| 6220 |
Problems Facing The American Health Care System |
2019-06-12 |
|
|
| 6221 |
Factors Leading To The Native American Health Disparity |
2019-06-12 |
|
|
| 6222 |
Factors For The African Americans Health Disparity |
2019-06-12 |
|
|
| 6223 |
E-Hiv Disease |
2019-06-12 |
|
|
| 6224 |
Access Inequality To Health Care In The United States |
2019-06-12 |
|
|
| 6225 |
Comparative Analysis of the Australian Health Care System vs. The American Health Care System |
2019-06-12 |
|
|
| 6226 |
The United States of America |
2019-06-12 |
|
|
| 6227 |
Health Services Delivery In Australia |
2019-06-12 |
|
|
| 6228 |
Funding The Australian Health Care System |
2019-06-12 |
|
|
| 6229 |
Results and Analysis |
2019-06-11 |
|
|
| 6230 |
Method Validation |
2019-06-10 |
|
|
| 6231 |
Validation of Proposed Method |
2019-06-10 |
|
|
| 6232 |
SOURCE(S) OF SUPPORT |
2019-06-10 |
|
|
| 6233 |
Reforms In Health Sector Include |
2019-06-10 |
|
|
| 6234 |
Possible Solutions And Its Benefit |
2019-06-10 |
|
|
| 6235 |
Challenges For Health Ministry On Provincial Level Post 18th Amendment |
2019-06-10 |
|
|
| 6236 |
Health System Information, Communication & Technology Situation |
2019-06-10 |
|
|
| 6237 |
Health System Medical Products & Technologies Situation |
2019-06-10 |
|
|
| 6238 |
Health System Human Resource Situation |
2019-06-10 |
|
|
| 6239 |
Health System Finance And Expenditure Situation |
2019-06-10 |
|
|
| 6240 |
Health Care Service Delivery Situation |
2019-06-10 |
|
|
| 6241 |
Health System Leadership & Governance Situation |
2019-06-10 |
|
|
| 6242 |
Health Situation Post 18 Amendment |
2019-06-10 |
|
|
| 6243 |
The Road Ahead |
2019-06-10 |
|
|
| 6244 |
The Current Scenario |
2019-06-10 |
|
|
| 6245 |
Treatment Of Neurodegenerative Disease Through Diet |
2019-06-08 |
|
|
| 6246 |
Epigenetic Biomarker In Neurodegenerative Disease |
2019-06-08 |
|
|
| 6247 |
Epigenetics Biomarker In Huntington's Disease |
2019-06-08 |
|
|
| 6248 |
Epigenetic Biomarker In Parkinson’s Disease |
2019-06-08 |
|
|
| 6249 |
Epigenetic Biomarker In Alzheimer Disease |
2019-06-08 |
|
|
| 6250 |
Epigenetic Mechanism |
2019-06-08 |
|
|
| 6251 |
Declaration of Interest |
2019-06-07 |
|
|
| 6252 |
Limitations and Strengths of the Study |
2019-06-07 |
|
|
| 6253 |
Abbreviations and Acronyms |
2019-06-07 |
|
|
| 6254 |
Recommendations and Suggestions |
2019-06-07 |
|
|
| 6255 |
Summary of Findings |
2019-06-07 |
|
|
| 6256 |
E-Tailers in Indian Market |
2019-06-07 |
|
|
| 6257 |
Author’s Contributions |
2019-06-07 |
|
|
| 6258 |
Author’s Contributions |
2019-06-07 |
|
|
| 6259 |
Author’s Contributions |
2019-06-07 |
|
|
| 6260 |
Availability Of Data And Material |
2019-06-07 |
|
|
| 6261 |
Declarations |
2019-06-07 |
|
|
| 6262 |
Factors Associated With Fertility Intention |
2019-06-07 |
|
|
| 6263 |
List of Abbreviations |
2019-06-06 |
|
|
| 6264 |
Post Aruna Ramchandra Shanbaug Judgment |
2019-06-06 |
|
|
| 6265 |
Indian Scenario Pre Aruna Ramchandra Shanbaug Judgment |
2019-06-06 |
|
|
| 6266 |
Dutch Law On Euthanasia |
2019-06-06 |
|
|
| 6267 |
Ethics Approval and Consent-to-Participate |
2019-06-06 |
|
|
| 6268 |
Growth Conditions and Media Standardizations |
2019-06-06 |
|
|
| 6269 |
Rational Perturbations of Metabolic Pathways for Yield Enhancement |
2019-06-06 |
|
|
| 6270 |
Enhancing Flux Towards Isoprene |
2019-06-06 |
|
|
| 6271 |
Strategies Based on Plasmids and Chromosomal Integrations |
2019-06-06 |
|
|
| 6272 |
Metabolic Engineering of MVA Pathway |
2019-06-06 |
|
|
| 6273 |
Metabolic Engineering of MEP Pathway |
2019-06-06 |
|
|
| 6274 |
Mechanism of Isoprene Production |
2019-06-06 |
|
|
| 6275 |
Marine-Sourced Steroidal Compounds Having Cytotoxic Activity |
2019-06-06 |
|
|
| 6276 |
Further Work |
2019-06-05 |
|
|
| 6277 |
Implications For Clinical Work |
2019-06-05 |
|
|
| 6278 |
Application Of Conceptual Model On Composite Case Examples |
2019-06-05 |
|
|
| 6279 |
Insecure Attachment Styles’ Resilience Patterns Conceptual Model |
2019-06-05 |
|
|
| 6280 |
Process Capacities |
2019-06-05 |
|
|
| 6281 |
Resilience |
2019-06-05 |
|
|
| 6282 |
Recovery |
2019-06-05 |
|
|
| 6283 |
Attachment Styles |
2019-06-05 |
|
|
| 6284 |
Teachers’ Training Program: Facts and Figures |
2019-06-05 |
|
|
| 6285 |
Analysis of Data |
2019-06-05 |
|
|
| 6286 |
Current Recommendations |
2019-06-03 |
|
|
| 6287 |
Strengths and Weaknesses of the Study |
2019-06-03 |
|
|
| 6288 |
Summary and Future Directions |
2019-06-03 |
|
|
| 6289 |
Pitfalls and Alternative Strategies |
2019-06-03 |
|
|
| 6290 |
Potential Results |
2019-06-03 |
|
|
| 6291 |
Research Design and Methodology |
2019-06-03 |
|
|
| 6292 |
Research Plan |
2019-06-03 |
|
|
| 6293 |
Implications for Clinical Practice |
2019-06-01 |
|
|
| 6294 |
Observation |
2019-06-01 |
|
|
| 6295 |
Highlights |
2019-05-29 |
|
|
| 6296 |
Theory of Transmission of Traditional Cuisine |
2019-05-28 |
|
|
| 6297 |
Festival Tourism |
2019-05-28 |
|
|
| 6298 |
Traditional Cuisine Tourism |
2019-05-28 |
|
|
| 6299 |
Objectives |
2019-05-28 |
|
|
| 6300 |
Core Tip |
2019-05-28 |
|
|
| 6301 |
Conceptual Modeling: Definition, Purpose and Benefits |
2019-05-28 |
|
|
| 6302 |
Operative Report and Post-Operative Course |
2019-05-28 |
|
|
| 6303 |
Pre-Operative Studies |
2019-05-28 |
|
|
| 6304 |
Historical/Cultural Tourism Resources |
2019-05-28 |
|
|
| 6305 |
Potential Nature based Tourism Resources of Elkere District |
2019-05-28 |
|
|
| 6306 |
Tourism Industry in Ethiopia |
2019-05-28 |
|
|
| 6307 |
Literature |
2019-05-28 |
|
|
| 6308 |
No heading |
2019-05-28 |
|
|
| 6309 |
Opinion Article |
2019-05-28 |
|
|
| 6310 |
Human and Animal Rights |
2019-05-24 |
|
|
| 6311 |
Preoperative Imaging and Tumor Staging |
2019-05-24 |
|
|
| 6312 |
Evaluation at Diagnosis |
2019-05-24 |
|
|
| 6313 |
Overview |
2019-05-24 |
|
|
| 6314 |
Safety Requirements |
2019-05-23 |
|
|
| 6315 |
The General Principles |
2019-05-23 |
|
|
| 6316 |
The Technical Safety Standards Of Industrial Robotics |
2019-05-23 |
|
|
| 6317 |
The Eu Regulatory Framework For Robotics Safety |
2019-05-23 |
|
|
| 6318 |
Robotic Technology As A Source Of Risk And Improvement Of Working Conditions |
2019-05-23 |
|
|
| 6319 |
Declaration of Conflicting Interests |
2019-05-20 |
|
|
| 6320 |
Delta Plan 2100 has the following Specific Objectives |
2019-05-20 |
|
|
| 6321 |
Delta Plan 2100 |
2019-05-20 |
|
|
| 6322 |
Ocean Governance Framework |
2019-05-20 |
|
|
| 6323 |
Initiatives of Bangladesh for Coast and Marine Management |
2019-05-20 |
|
|
| 6324 |
Present Status and Future Trend of Coastal Zone Management |
2019-05-20 |
|
|
| 6325 |
Integrated Coastal Zone Management ICZM) Approach |
2019-05-20 |
|
|
| 6326 |
Coastal Hazards in Bangladesh Coast |
2019-05-20 |
|
|
| 6327 |
Coastal Habitat and Biodiversity of Bangladesh |
2019-05-20 |
|
|
| 6328 |
Conclusion and Recommendation |
2019-05-20 |
|
|
| 6329 |
Conclusion and Limitations |
2019-05-17 |
|
|
| 6330 |
A Letter to the Editor |
2019-05-17 |
|
|
| 6331 |
Data Availability |
2019-05-16 |
|
|
| 6332 |
Financial Disclosure |
2019-05-16 |
|
|
| 6333 |
Ethics Committee Approval |
2019-05-16 |
|
|
| 6334 |
Administration of HBO and NBO oxygen therapy |
2019-05-16 |
|
|
| 6335 |
Funding Statement |
2019-05-16 |
|
|
| 6336 |
Data Availability Statement |
2019-05-16 |
|
|
| 6337 |
Referees Comments |
2019-05-16 |
|
|
| 6338 |
Ancel keys and the U.S. government |
2019-05-16 |
|
|
| 6339 |
Insulin Resistance: Down Regulation of Insulin Receptor Sensitivity |
2019-05-16 |
|
|
| 6340 |
Author Contributions |
2019-05-16 |
|
|
| 6341 |
Quantitative Results Findings |
2019-05-16 |
|
|
| 6342 |
Contributors |
2019-05-13 |
|
|
| 6343 |
Author Disclosure Statement |
2019-05-13 |
|
|
| 6344 |
Disclaimer |
2019-05-13 |
|
|
| 6345 |
Source of Funding |
2019-05-04 |
|
|
| 6346 |
Lipid Profile |
2019-05-04 |
|
|
| 6347 |
Future Direction |
2019-05-03 |
|
|
| 6348 |
Hypothetical Integration and Updating |
2019-05-03 |
|
|
| 6349 |
Where does life come from? Insider or Outside |
2019-05-03 |
|
|
| 6350 |
Single Model (RNA World) vs Multitude Model |
2019-05-03 |
|
|
| 6351 |
Physical or Chemical Factor Comparisons |
2019-05-03 |
|
|
| 6352 |
Clinical Case |
2019-05-03 |
|
|
| 6353 |
Research Gaps Identified |
2019-05-03 |
|
|
| 6354 |
The Way Forward |
2019-05-03 |
|
|
| 6355 |
Closeness to the nature |
2019-05-02 |
|
|
| 6356 |
Current State Of The Art Technologies |
2019-05-02 |
|
|
| 6357 |
Therapy |
2019-05-02 |
|
|
| 6358 |
Surgical Planning And Navigation |
2019-05-02 |
|
|
| 6359 |
Training |
2019-05-02 |
|
|
| 6360 |
Medical Applications |
2019-05-02 |
|
|
| 6361 |
Definitions And Brief History |
2019-05-02 |
|
|
| 6362 |
Coming up Short: Linking the Quantitative and Qualitative |
2019-04-30 |
|
|
| 6363 |
A Case in Point: Budding in Hydras |
2019-04-30 |
|
|
| 6364 |
The Problem and Solution |
2019-04-30 |
|
|
| 6365 |
Contributions |
2019-04-26 |
|
|
| 6366 |
Hospital Course |
2019-04-22 |
|
|
| 6367 |
Case |
2019-04-22 |
|
|
| 6368 |
Conflict of Interest and Funding |
2019-04-22 |
|
|
| 6369 |
Retraction Note |
2019-04-20 |
|
|
| 6370 |
Clinical Implication |
2019-04-17 |
|
|
| 6371 |
Experience Post Treatment Completion |
2019-04-17 |
|
|
| 6372 |
First Reaction After Diagnosis |
2019-04-17 |
|
|
| 6373 |
Pre-Diagnosis Stage |
2019-04-17 |
|
|
| 6374 |
Ethics Approval |
2019-04-17 |
|
|
| 6375 |
Authors' Contributions |
2019-04-17 |
|
|
| 6376 |
Transparency Declaration |
2019-04-17 |
|
|
| 6377 |
Availability of Data and Material |
2019-04-17 |
|
|
| 6378 |
Background and Aim |
2019-04-17 |
|
|
| 6379 |
The Exemplary Pilot Study |
2019-04-17 |
|
|
| 6380 |
Experimental Results |
2019-04-16 |
|
|
| 6381 |
Vanadium in Marine Algae |
2019-04-16 |
|
|
| 6382 |
Vanadium in Ascidians |
2019-04-16 |
|
|
| 6383 |
Statistical Analysis |
2019-04-16 |
|
|
| 6384 |
Data Analysis And Interpretation |
2019-04-13 |
|
|
| 6385 |
Services To Be Provided By Udc |
2019-04-13 |
|
|
| 6386 |
Significance Of The Study |
2019-04-13 |
|
|
| 6387 |
Rationale Of The Study |
2019-04-13 |
|
|
| 6388 |
Statement of the Problem |
2019-04-13 |
|
|
| 6389 |
Comparative Evaluation Of The Social Implication Of The Defined Contributory Pension Scheme In Nigeria And Chile |
2019-04-13 |
|
|
| 6390 |
Comparative Evaluation Of The Economic Implication Of The Defined Contributory Scheme In Nigeria And Chile |
2019-04-13 |
|
|
| 6391 |
Implementation Of Defined Contributory Pension Scheme In Nigeria And Chile |
2019-04-13 |
|
|
| 6392 |
jgh |
2019-04-13 |
|
|
| 6393 |
Pros And Cons Of Defined Contributory Pension Scheme |
2019-04-13 |
|
|
| 6394 |
Research Limitations |
2019-04-13 |
|
|
| 6395 |
Discussion and Explanation |
2019-04-13 |
|
|
| 6396 |
Results and Findings |
2019-04-13 |
|
|
| 6397 |
Research Methodology |
2019-04-13 |
|
|
| 6398 |
Hypotheses |
2019-04-13 |
|
|
| 6399 |
Study Procedures |
2019-04-13 |
|
|
| 6400 |
Summary and Conclusion |
2019-04-12 |
|
|
| 6401 |
Conclusion and Recommendations |
2019-04-12 |
|
|
| 6402 |
Glycan Reactions |
2019-04-09 |
|
|
| 6403 |
Author’s Contribution |
2019-04-08 |
|
|
| 6404 |
Funding/Support |
2019-04-08 |
|
|
| 6405 |
Aim |
2019-04-08 |
|
|
| 6406 |
Financial Disclosure Statement |
2019-04-08 |
|
|
| 6407 |
Funding Source |
2019-04-08 |
|
|
| 6408 |
Conflicts of Interest |
2019-04-08 |
|
|
| 6409 |
Acknowledgment |
2019-04-08 |
|
|
| 6410 |
Result |
2019-04-08 |
|
|
| 6411 |
Patients and Methods |
2019-04-08 |
|
|
| 6412 |
Abbreviations |
2019-04-08 |
|
|
| 6413 |
Conflict Interests |
2019-04-08 |
|
|
| 6414 |
Case Reports |
2019-04-05 |
|
|
| 6415 |
Limitations of this Study |
2019-04-05 |
|
|
| 6416 |
Subjects and Methods |
2019-04-05 |
|
|
| 6417 |
Clinical Image |
2019-04-05 |
|
|
| 6418 |
HPV Infections, Immunity and Cancer |
2019-04-05 |
|
|
| 6419 |
The Impact of Human Papilloma Virus in the Upper Aerodigestive Tract |
2019-04-05 |
|
|
| 6420 |
The Role of HPV Seminal Infection |
2019-04-05 |
|
|
| 6421 |
HPV Virion or Virus: Infection or Cancer |
2019-04-05 |
|
|
| 6422 |
Funding Sources |
2019-04-05 |
|
|
| 6423 |
Conflict of Interest Statement |
2019-04-05 |
|
|
| 6424 |
Human Subjects Approval Statement |
2019-04-05 |
|
|
| 6425 |
Disclosure |
2019-03-27 |
|
|
| 6426 |
Nanocellulose |
2019-03-27 |
|
|
| 6427 |
Cellulose |
2019-03-27 |
|
|
| 6428 |
Conclusions and Recommendations |
2019-03-26 |
|
|
| 6429 |
Discussions |
2019-03-26 |
|
|
| 6430 |
Level of Vitamin D in our Body, Effects of Vitamin D and Requirement of Vitamin D in our Body |
2019-03-25 |
|
|
| 6431 |
Sources of Vitamin D |
2019-03-25 |
|
|
| 6432 |
Introduction about Vitamin D |
2019-03-25 |
|
|
| 6433 |
Constraint |
2019-03-25 |
|
|
| 6434 |
Key Points |
2019-03-25 |
|
|
| 6435 |
Review of Literature |
2019-03-25 |
|
|
| 6436 |
Discussions and Implications |
2019-03-25 |
|
|
| 6437 |
Literature Review |
2019-03-25 |
|
|
| 6438 |
Boosting Tourism Development in Meghalaya-Challenges and Prospects |
2019-03-25 |
|
|
| 6439 |
Trend of Tourist Inflow in Meghalaya |
2019-03-25 |
|
|
| 6440 |
Scope of Tourism in Meghalaya |
2019-03-25 |
|
|
| 6441 |
Discussion of Results and Policy Implications |
2019-03-25 |
|
|
| 6442 |
Data Analysis and Results |
2019-03-25 |
|
|
| 6443 |
Review of Related Literature |
2019-03-25 |
|
|
| 6444 |
Prediction Results |
2019-03-23 |
|
|
| 6445 |
Experimental Results and Analysis |
2019-03-23 |
|
|
| 6446 |
System Validation |
2019-03-23 |
|
|
| 6447 |
Related Work |
2019-03-23 |
|
|
| 6448 |
3R-Protocol |
2019-03-22 |
|
|
| 6449 |
Energy Efficient Clustering Algorithms |
2019-03-22 |
|
|
| 6450 |
GSO Algorithm |
2019-03-22 |
|
|
| 6451 |
Genetic Algorithm Based Energy Efficient Clustering Hierarchy |
2019-03-22 |
|
|
| 6452 |
Optimal-Distance Based Transmission Strategy (ODTS) |
2019-03-22 |
|
|
| 6453 |
Bat Optimization Algorithm |
2019-03-22 |
|
|
| 6454 |
Enhanced Optimized Energy Efficient Routing Protocol (E-OEERP) |
2019-03-22 |
|
|
| 6455 |
Hybrid Meta-Heuristic Based Routing Protocol in WSN |
2019-03-22 |
|
|
| 6456 |
Energy Aware Routing protocol (PDORP) |
2019-03-22 |
|
|
| 6457 |
Position Responsive Routing Protocol (PRRP) |
2019-03-22 |
|
|
| 6458 |
Co-operative Multiple Input and Multiple Output Spatial Modulation (CMIMO-SM) |
2019-03-22 |
|
|
| 6459 |
Energy Consumption Routing Protocol |
2019-03-22 |
|
|
| 6460 |
Energy Productive Routing |
2019-03-22 |
|
|
| 6461 |
Balanced Energy Consuming and Hole Alleviating and Energy Aware BECHA (EA-BECHA) |
2019-03-22 |
|
|
| 6462 |
Literature Survey |
2019-03-22 |
|
|
| 6463 |
Energy Efficient Routing Protocol |
2019-03-22 |
|
|
| 6464 |
Study Limitations |
2019-03-22 |
|
|
| 6465 |
Aim of Study |
2019-03-21 |
|
|
| 6466 |
Research Findings |
2019-03-21 |
|
|
| 6467 |
Implications for Practice |
2019-03-21 |
|
|
| 6468 |
Aim and Objectives of Study |
2019-03-21 |
|
|
| 6469 |
Objectives of Study |
2019-03-20 |
|
|
| 6470 |
Calculations |
2019-03-19 |
|
|
| 6471 |
Theory and Calculations |
2019-03-19 |
|
|
| 6472 |
Authors Contributions |
2019-03-18 |
|
|
| 6473 |
Competing Interests |
2019-03-18 |
|
|
| 6474 |
Availability of Data and Materials |
2019-03-18 |
|
|
| 6475 |
Consent for Publication |
2019-03-18 |
|
|
| 6476 |
Ethics Approval and Consent to Participate |
2019-03-18 |
|
|
| 6477 |
Background |
2019-03-18 |
|
|
| 6478 |
Conflict of Interests |
2019-03-18 |
|
|
| 6479 |
Compliance with Ethical Standards |
2019-03-18 |
|
|
| 6480 |
Data Analysis |
2019-03-18 |
|
|
| 6481 |
Data Collection and Methods |
2019-03-18 |
|
|
| 6482 |
Results and Discussions |
2019-03-14 |
|
|
| 6483 |
Recommendations |
2019-03-14 |
|
|
| 6484 |
Experimental Work |
2019-03-14 |
|
|
| 6485 |
Objectives of the Study |
2019-03-14 |
|
|
| 6486 |
Superscript |
2019-03-14 |
|
|
| 6487 |
Summary |
2019-03-14 |
|
|
| 6488 |
Model |
2019-03-14 |
|
|
| 6489 |
Subscripts |
2019-03-14 |
|
|
| 6490 |
Greek letters |
2019-03-14 |
|
|
| 6491 |
List of Symbols |
2019-03-14 |
|
|
| 6492 |
Measurements |
2019-03-14 |
|
|
| 6493 |
Authorship Contributions |
2019-03-14 |
|
|
| 6494 |
Case Report |
2019-03-14 |
|
|
| 6495 |
Effect of therapy |
2019-03-14 |
|
|
| 6496 |
Life Style Modifications |
2019-03-13 |
|
|
| 6497 |
Characteristic Feature |
2019-03-13 |
|
|
| 6498 |
Case Report 2 |
2019-03-13 |
|
|
| 6499 |
Case Report 1 |
2019-03-13 |
|
|
| 6500 |
Methods and Materials |
2019-03-13 |
|
|
| 6501 |
Commentary |
2019-03-13 |
|
|
| 6502 |
Recommendation |
2019-03-12 |
|
|
| 6503 |
Results and Discussion |
2019-03-12 |
|
|
| 6504 |
Financial Support |
2019-03-06 |
|
|
| 6505 |
Ethical Approval |
2019-03-02 |
|
|
| 6506 |
Method |
2019-03-02 |
|
|
| 6507 |
Authors’ Contributions |
2019-03-01 |
|
|
| 6508 |
Limitations of the Study |
2019-03-01 |
|
|
| 6509 |
Material and Methods |
2019-03-01 |
|
|
| 6510 |
Suggestions |
2019-03-01 |
|
|
| 6511 |
Ethical Considerations |
2019-03-01 |
|
|
| 6512 |
Discussion and Conclusion |
2019-03-01 |
|
|
| 6513 |
Ethics Concentration |
2019-03-01 |
|
|
| 6514 |
Some Recent Studies |
2019-03-01 |
|
|
| 6515 |
Special Items |
2019-03-01 |
|
|
| 6516 |
Case Study |
2019-03-01 |
|
|
| 6517 |
Informed Consent |
2019-03-01 |
|
|
| 6518 |
Limitations |
2019-03-01 |
|
|
| 6519 |
Findings |
2019-03-01 |
|
|
| 6520 |
Funding |
2019-03-01 |
|
|
| 6521 |
Conflict of Interest |
2019-03-01 |
|
|
| 6522 |
Conclusion |
2019-03-01 |
|
|
| 6523 |
Acknowledgements |
2019-02-19 |
|
|
| 6524 |
Letter to the Editor |
2019-02-19 |
|
|
| 6525 |
Consent |
2019-02-18 |
|
|
| 6526 |
Case Presentation |
2019-02-18 |
|
|
| 6527 |
Dear Editor in Chief |
2019-02-16 |
|
|
| 6528 |
Conflict of Interest |
2019-02-15 |
|
|
| 6529 |
Acknowledgments |
2019-02-15 |
|
|
| 6530 |
Questionnaire |
2019-01-18 |
|
|
| 6531 |
Clinical Examination |
2018-12-21 |
|
|
| 6532 |
Methodology |
2018-12-21 |
|
|
| 6533 |
Acknowledgement |
2018-11-14 |
|
|
| 6534 |
Materials and Methods |
2018-11-14 |
|
|
| 6535 |
Discussion |
2018-11-05 |
|
|
| 6536 |
Results |
2018-11-05 |
|
|
| 6537 |
Methods |
2018-11-05 |
|
|
| 6538 |
Abbrevations |
2018-11-05 |
|
|
| 6539 |
Keywords |
2018-11-05 |
|
|
| 6540 |
Editorial |
2018-11-05 |
|
|
| 6541 |
REFERENCES |
2018-11-05 |
|
|
| 6542 |
Conclusions |
2018-11-05 |
|
|
| 6543 |
Pediatric Resuscitation at School: Legally Ambiguous and Morally Troubling Policies |
2018-11-05 |
|
|
| 6544 |
End-of-Life in Pediatrics and the Child’s Right to an Open Future |
2018-11-05 |
|
|
| 6545 |
Introduction |
2018-11-05 |
|
|